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ABSTRACT 
 
Childhood obesity is a major global public health challenge with associated health, social, and 
emotional consequences, leading to long term direct and indirect costs. However, there are few 
published economic evaluations of interventions and only one from a Chinese setting. This 
thesis aims to explore and develop methods for the economic evaluation of school-based 
interventions to prevent obesity in children in low and middle income countries, thus making a 
methodological contribution to the literature.  
The methods for the economic evaluation were derived from a combination of published 
literature and guidelines for conducting economic evaluation. The systematic review 
undertaken within this thesis discovered heterogeneity regarding methods applied. The 
evaluation, conducted alongside the CHIRPY DRAGON trial, reported the intervention to be 
highly cost-effective. A number of methodological issues were explored: measuring household 
cost and outcome data and the construct validity of the CHU-9D in a Chinese sample. Including 
societal costs and effects increased the incremental cost-effectiveness ratio, however the 
intervention remained cost-effective using conventional decision making rules and throughout 
a series of sensitivity analyses. Furthermore, the thesis findings provide support for the 
construct validity of the CHU-9D within this population. 
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CHAPTER 1. INTRODUCTION 
 
This thesis aims to contribute towards reducing the burden of childhood obesity and helping 
public health decision making in low and middle income countries (LMICs). This has been 
done by exploring and developing methods for the economic evaluation of obesity interventions 
and was facilitated by estimating the cost-effectiveness of a childhood obesity programme in a 
school setting, using evidence from the CHIRPY DRAGON trial. This introductory chapter 
summarises the background behind the research question. It also describes the aims and 
objectives, and provides a summary of each of the remaining six chapters within the thesis.  
 
1.1 Childhood Obesity 
Childhood obesity, defined as “abnormal or excessive fat accumulation”, is one of the biggest 
public health challenges of this time with associated health, social, and emotional 
consequences, as well as long term direct and indirect costs [1-4]. Rapid socioeconomic and 
nutritional transitions in urban Chinese populations over a relatively short period have 
contributed to the rising prevalence of overweight/obesity among children [5-8]. In some 
populations, this prevalence is approaching the level of high-income countries [9, 10] and 
unlike Western countries, which are at a more advanced stage of the obesity epidemic, obesity 
prevalence, in China, is positively associated with socio-economic status (SES), particularly in 
boys [10, 11]. Most recent national data report that in China, 42% of adults and around one-
fifth of children are overweight or obese [12]. A Chinese case study found that the indirect 
effects of obesity and obesity‐related dietary and physical activity patterns reached 3.58% of 
gross national product (GNP) in 2000 and was projected to reach 8.73% in 2025 [13]. Therefore, 
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childhood obesity is a cause of concern for several stakeholders (including school teachers and 
local authorities) within China.  
Because of the health consequences of overweight and obesity and the lack of sustainable 
treatment options, prevention is likely to be the most (cost-) effective approach to address the 
childhood obesity problem in society. In 2016, the Chinese Government launched the “Healthy 
China 2030” policy, which seeks to improve health standards in China to be on a par with that 
in developed countries, through a range of initiatives including health promotion and 
improvement of public health services [14]. To achieve this grand vision there is an urgent need 
for effective preventive interventions to address the rapid increase of obesity prevalence. It is 
vital to develop effective, culturally appropriate, prevention interventions in China to control 
the obesity epidemic in children. 
A few Chinese studies have demonstrated that comprehensive school-based interventions, 
which targeted diet and physical activity, were effective [15-17]. However, there has been little 
research applying rigorous methods and established theoretical tools/framework to develop and 
evaluate prevention interventions for such a population [18-20], and only one study reported on 
the cost-effectiveness of a childhood obesity intervention (this study was not conducted from a 
societal perspective and only included clinical outcome measures) [17]. 
In China, obesity prevalence has been increasing year on year, and childhood obesity is a 
growing concern for health professionals and policy makers alike. The Centre for Disease 
Control and Prevention (CDC) has called for research on the costs and benefits of strategies to 
prevent childhood obesity. The CHIRPY DRAGON obesity prevention intervention study 
commenced in 2015. This intervention began development in 2009, using guidelines from the 
UK Medical Research Council (MRC) framework for complex interventions [21, 22], in 
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consultation with parents, grandparents, teachers and school staff. It targets children and their 
families, encouraging healthy eating and physical activity behaviours and is delivered in a 
school setting.  
 
1.2 Economic Evaluation and Outcome Measures 
Public health priorities vary from country to country, and also from region to region. Like many 
other countries, China suffers from a scarcity of public health resources and decision makers 
need to prioritise spending towards policies that offer the greatest value for money [23, 24]. 
Economic evaluation is a means to aid decisions about public resource allocation [24-26] and 
as obesity prevention and treatment often involves lifestyle interventions which have costs and 
consequences that fall outside the health care sector, a societal perspective for evaluation is 
usually recommended [26]. This means that all relevant resource use/costs and consequences 
are measured, outlining how these fit within a given sector, such as health, education or the 
wider community [27]. However, when incorporating costs and outcomes that span multiple 
sectors, it is not always clear how much society is willing to pay for a ‘health’ effect caused by 
an intervention funded from a ‘non-health care budget’ [28]. Also, the valuation of resources 
for which no market exists, such as informal care, or patient time costs (e.g travel to 
appointments), requires specific methods [23]. 
Within economic evaluations of clinical interventions, outcomes are often measured in natural 
units or quality-adjusted life years (QALYs). For the economic evaluation of public health 
interventions, other outcomes might be relevant including effects on individuals not directly 
targeted by the intervention and other non-health related effects such as educational or wider 
wellbeing outcomes. Some of these effects can be incorporated into QALYs, some not [29]. 
Costs and benefits may fall on parts of the public sector not confined to health alone, such as 
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the judicial system, education and housing. There is a consensus within the economic guidance 
that wider social and environmental costs and benefits should be looked at due to the complex 
nature of public health [29]. 
Implementation of a particular intervention is not recommended without evidence of both the 
effectiveness and cost effectiveness relative to usual practice [30]. To conduct an economic 
evaluation, information on the costs and benefits of competing interventions are considered. 
The findings of cost-effectiveness analyses will help to inform decisions on whether to 
implement multi-component interventions such as CHIRPY DRAGON within primary schools 
as so far, little is known about the costs of school-based childhood obesity prevention 
interventions in China. 
Health Technology Assessment (HTA) is a field of scientific policy research that adopts 
multidisciplinary approaches to undertake systematic evaluation of health technologies and 
inform policy and clinical decision-making [31]. There has been rapid development of HTA in 
China over the past two decades, and with the introduction of universal health care coverage 
and intensive collaborations of the China National Health Development Research Centre 
(CNHDRC) with NICE in the UK, the remit of HTA in China is continually expanding to 
support and guide decision-making for policy makers [32, 33]. HTA now includes a multitude 
of topics, such as drug resource allocation, medical devices, procedures, and vaccines [32]. 
However, despite these developments, since HTA in China remains fragmented and is not yet 
formally integrated into health policy as a mandatory component, health policy and decision-
making in China still largely relies on experience rather than research evidence [31]. 
In health economics there are two main alternative frameworks to conducting economic 
evaluations. These are welfarism and extra-welfarism. The theoretical and methodological basis 
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for carrying out economic evaluations is different within these frameworks, as each uses 
different value judgements to determine various states of resource allocation. Briefly, the aim 
of welfarism is to maximise social welfare whilst the aim of extra-welfarism is to maximize the 
total health of a population and allows the consideration of outcomes beyond utility. Extra-
welfarism goes beyond welfarism in four ways: ‘it permits the use of outcomes other than 
utility, it permits source of valuation other than the affected individuals, it permits the weighting 
of outcomes other than preference-based, and it permits interpersonal comparisons of well-
being’ [34].  
Currently, decision-makers, such as the National Institute for Health and Care Excellence 
(NICE), recommend the use of extra-welfarism as a framework for conducting economic 
evaluations, particularly cost-utility analysis (CUA) [35]. In a CUA, the costs are valued in 
monetary units and the effects are valued as a multi-dimensional unit (e.g. QALYs) [36]. The 
QALY incorporates length and quality of life (QoL) in a single metric. QALYs are used as the 
unit of assessment to make judgements about the relative cost-effectiveness of competing 
interventions [36] and require an understanding of the relationship between weight and health 
related QoL when measured in utility terms. QALYs are also used to inform resource allocation 
decisions in other country-settings [37]. 
Ideally, utility-based health-related quality of life (HRQoL) in children should be measured 
using an instrument specifically designed for them. Although there is no gold standard for 
measuring utility-based HRQoL in primary school-aged children, previous research has shown 
the Child Health Utility Nine Dimension (CHU-9D), a recently developed instrument, is the 
most appropriate choice [38]. It is not specific to any one condition or disease. Originally tested 
for children aged 7–11 years [39, 40], it has more recently demonstrated good construct validity 
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in 11–17 year olds [41]. The tool has successfully been applied to wider populations, from six 
years old up to 17 years old [42, 43]. Although there is emerging evidence regarding the 
psychometric properties of the CHU-9D instrument [41, 42, 44], more evidence is required with 
respect to its validity for use in different age groups and country settings considering different 
tariffs. This is important because the measure may have different construct validity in different 
populations. 
The acknowledgement that behaviour change interventions have spillover effects on family 
members has led to an increased interest on how to adapt methods for capturing these broader 
effects to maximise population health, rather than just the target participant’s health [45]. The 
choice of evaluative space of health (e.g. EuroQol Five Dimension (EQ-5D)), which is designed 
to measure a generic related HRQoL and is not specific to any one condition or disease, for 
economic evaluation is an important value judgment which can have a large impact on resource 
allocation decisions [30]. Currently EQ-5D is recommended by decision-makers to generate 
QALYs for adults [30]. However, when EQ-5D is not considered to be suitable for a condition, 
decision-makers will accept the QALY outcome derived from another HRQoL measure [30].  
For economic evaluation, the value that individuals place on healthcare is usually assessed using 
measures that assess preferences for possible outcomes (preference-based measures). This basis 
for measuring outcomes has been used in the case of the extra-welfarist (CUA measures: e.g. 
CHU-9D and EQ-5D) [36].  
When costs are valued in monetary units and benefits are measured in natural units (which are 
specific to the condition under analysis, e.g. Body Mass Index (BMI) z-score change), the 
economic evaluation is termed a cost-effectiveness analysis (CEA) [36]. CEA is useful to 
compare interventions, which target the same health condition, and is particularly useful in a 
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clinical setting. Although a CEA is an extra-welfarist evaluation, a major limitation of it for 
decision makers is its inability to directly compare cost-effectiveness of interventions across 
various areas of health conditions, or sectors of the economy, due to the disease-specific nature 
of the outcome measure used [46].  
 
1.3 Aim and Objectives 
To address the evidence gap, in China, of what interventions to implement to prevent childhood 
obesity and to address the methodological challenges of conducting an economic evaluation 
within this setting, the CHIRPY DRAGON study was developed. Using data from this study, 
the aim of this thesis is to (1) explore and develop methods for the economic evaluation of 
school-based interventions to prevent obesity in children in LMICs, and (2) consider the 
suitability of economic outcome measures for interventions in this age group and country 
setting. This will be useful, more broadly, to inform the design of future economic evaluations 
with the aim of generating economic evidence to assist decision makers in LMICs.  
The thesis has the following objectives: 
 Systematically review the literature to identify the current evidence regarding methods, 
study quality, and results of economic evaluation for childhood and adolescent obesity 
interventions. There is a lack of synthesised evidence available on appropriate 
methodology for the economic evaluation of obesity interventions. Undertaking this 
review will add to the evidence available.   
 Discuss the methodology of the CHIRPY DRAGON cluster-randomised controlled trial 
regarding its economic evaluation.  
 Explore the methodological challenges of conducting an economic evaluation within a 
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Chinese setting and including spillover effects. The findings of this objective will 
develop methods for the economic evaluation of school-based interventions to prevent 
obesity in children in low and middle income countries as, so far, little is known about 
this topic [47]. 
 Estimate the costs and health impacts associated with the implementation of the 
CHIRPY DRAGON prevention intervention programme by conducting trial-based cost-
effectiveness and cost-utility analyses from both public sector and societal perspectives. 
The findings of these analyses will help to inform decisions on whether to implement 
multi-component interventions such as CHIRPY DRAGON through primary schools 
as, so far, little is known about the costs of childhood obesity prevention interventions 
in China. 
 Estimate how weight status relates to HRQoL in children from a Chinese setting, and 
assess the construct validity of the CHU-9D in school-aged Chinese children. This will 
help to assess the suitability of economic outcome measures such as the CHU-9D for 
assessing qualify of life within an economic framework in this age group and country 
setting as, so far, the information regarding this topic is scarce [47]. These findings will 
be useful to inform the design of future economic evaluations both within a childhood 
population and within a LMIC setting. 
 
1.4 Thesis Outline 
This thesis is divided into three parts: background research; empirical work; and discussion.  
The first part, background research, comprises: Chapter 2, background regarding the 
epidemiology and public health context; and Chapter 3, the methodological foundations for the 
work developed within this thesis.  
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Chapter Two explores the epidemiology and public health context of obesity in China by 
describing the measurement and definitions, the prevalence and trends, the risk factors, and 
costs and consequences of obesity in this setting. It also summarises the evidence on prevention 
interventions. Finally, it provides a description of the CHIRPY DRAGON trial, within which 
this PhD is nested. Chapter Three explores the theoretical foundations of economic evaluation 
in healthcare, and describes the different types of economic evaluation in light of 
methodological considerations, presenting the possible applications and limitations of each 
method. It goes on to describe the other vehicles for economic evaluation and the HRQoL 
measurements for economic evaluation. It concludes by discussing decision-making beyond 
economic evaluation.  
The second part of the thesis describes the empirical work which comprises: Chapter 4, the 
background and methodological guidance from the previously published systematic review of 
economic evaluations; Chapter 5, reporting the economic evaluation alongside the CHIRPY 
DRAGON trial; and Chapter 6, consideration of the suitability of economic outcome measure 
for interventions in school-aged children. 
Chapter Four presents a systematic review of the literature with the aim of exploring the 
available evidence regarding the methods of economic evaluations used to estimate the costs 
and benefits of intervention strategies, including both trial-based and model-based evaluations, 
to prevent/treat obesity in children and adolescents. The review also provides a narrative 
synthesis of cost-effectiveness evidence and assesses the quality of the included studies. 
Chapter Five describes the intervention and its delivery. It presents the methods to estimate 
the costs and benefits of the CHIRPY DRAGON trial. It describes the sources for the resource 
use data, as well as the costs and effectiveness associated with implementation of the CHIRPY 
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DRAGON prevention intervention programme by conducting a trial-based cost-effectiveness 
and cost-utility analysis from both public sector and societal perspectives using both clinical 
and economic outcome measures. This is to provide robust evidence on the cost-effectiveness 
of this intervention programme compared to usual practice. It explains the economic evaluation 
structure and its main characteristics. It also discusses the methods and results for the base-case 
analysis, the uncertainty analyses and the sensitivity analyses. Furthermore, it explores the 
methodological challenges of conducting an economic evaluation within a Chinese setting 
when including spillover effects. Where possible, it reports the results using Consolidated 
Health Economic Evaluation Reporting Standards (CHEERS) guidelines [48]. Chapter Six 
considers the suitability of economic outcome measures for interventions in school-aged 
children in China. For this purpose, it firstly explores how weight status relates to HRQoL; then 
it assesses the construct validity of the CHU-9D. To facilitate this assessment, the CHU-9D is 
compared to the Paediatric Quality of Life Inventory (PedsQL) instrument which is a widely 
used, validated generic HRQoL measure in children. This chapter uses the baseline data from 
the CHIRPY DRAGON trial.  
Finally, Chapter Seven starts by revisiting the aims of this thesis; and provides a summary of 
the key findings from the entire thesis perspective and discusses them within the context of the 
wider literature. This is followed by discussing the applied findings to inform policy 
development and reflections on the methods used for conducting the economic evaluation, 
highlighting the main strengths and limitations of the approach. The final sections discuss the 
implications for current policy making, and suggest future research recommendations. 
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CHAPTER 2. CHILDHOOD OBESITY 
 
2.1 Introduction 
The overall aim of this thesis is to explore and develop methods for the economic evaluation of 
school-based interventions to prevent obesity in children in LMICs. This chapter begins with a 
discussion on the epidemiology of childhood obesity with a specific focus on China, followed 
by a summary of the evidence-based decision-making, the evidence on prevention interventions 
and, finally, an introduction into the design of the CHIRPY DRAGON trial.  
 
2.2 Epidemiology of Childhood Obesity 
2.2.1 Measurement and Definitions   
The World Health Organization (WHO) defines overweight and obesity as “abnormal or 
excessive fat accumulation that may impair health” [49]. Although not as sensitive as some 
other measurements, the most simple and frequently used measure to classify overweight and 
obesity is the BMI [50]. This is defined as an individual’s weight in kilograms divided by their 
height in meters squared (kg/m2) [49]. Based on observational studies that report major 
morbidity and mortality risks associated with different BMI levels, the WHO have defined 
thresholds for overweight (BMI >=25<30) and obesity (BMI>=30) [49]. 
These BMI-cut offs are, however, not used for children and adolescents age 2 to 18 years and 
assessing the BMI of children and adolescents is more complicated than for adults. This is 
because children’s BMI normally changes considerably as they mature over time, with a fast 
increase in the first year, followed by a decrease between 2-4 years of age and then a gradual 
increase from ages 5-6 until age 18 [51]. Also, these patterns of growth differ between boys and 
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girls. In addition, the association between different thresholds and health outcomes is not 
straightforward. Therefore, a statistical approach is used for assigning thresholds for high or 
low BMI in children, based on the child’s gender and age [52].  
The most widely used reference standard to classify weight status has been established by the 
International Obesity Task Force (IOTF). Thresholds are derived to line up with the adult BMI 
thresholds for obesity and overweight at age 18 years. However, many countries have their own 
population‐specific reference standards for assessing BMI in children. For example, in England 
the British 1990 growth reference (UK90) is recommended for population monitoring and 
clinical assessment in children aged 4 years and over. Other BMI standards are sometimes used, 
particularly for international comparison of obesity prevalence [53]. An alternative to IOTF is 
the WHO standard, which is used for children up to 5 years of age and based on a sample of 
healthy breastfed children from six countries (Brazil, Ghana, India, Norway, Oman, and the 
USA). The WHO standard denotes overweight as > 2 standard deviations above the WHO 
growth standard median [54]. Using different approaches might lead to different classification.  
 
2.2.2 Prevalence and Trends 
Childhood obesity is a growing problem worldwide. Recent reports state that it has increased 
ten-fold from 1975 to 2016, affecting 41 million children under the age of 5 years [55]. 
Estimated age-standardised prevalence of obesity in children and adolescents in 2016 ranged 
from higher than 30% in, for example, Nauru, the Cook Islands, and Palau to lower than 2% in 
other countries, including Ethiopia [55]. Obesity is as much an issue in developing as in 
developed countries. Although the prevalence of childhood obesity may be higher in developed 
countries, the rate of increase over the last decade is steeper in many developing countries [55]. 
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In the past three decades, there have been rapid socioeconomic and nutritional transitions in 
many urban Chinese populations (e.g. Guangzhou), which are important centres of China’s 
trade and economic power [5-7]. Along with these life-style changes, the prevalence of 
overweight and obesity among Chinese school-aged children has increased more rapidly and 
over a shorter period of time in comparison with other countries [8, 56]. In some populations, 
this prevalence is approaching the level of high-income countries [9, 10] and unlike Western 
countries, which are at a more advanced stage of the obesity epidemic, obesity prevalence, in 
China, is positively associated with socio-economic status (e.g. maternal education level), 
particularly in boys [10, 11]. Studies across China have also highlighted increasing childhood 
obesity rates in rural areas [57]. 
In the 1980s, childhood obesity was not a public health problem in China (the prevalence of 
being overweight or obese in school children was approximately 1% (in both genders) in 1985) 
[58]. It increased to 8.8% in 2000 and then to 17.1% in 2011 [59]. After three decades (in 2015), 
this prevalence has increased to 28.2% in boys and 16.4% in girls [58]. Most recent national 
data reports that in China, 42% of adults and around one-fifth of children are overweight or 
obese [12]. In major cities, around one-third of boys are overweight or obese [60]. Without 
comprehensive effective interventions, it is predicted that more than one in four Chinese school 
children (around 50 million) will be overweight/obese by 2030 [58].  
In response to this, two nation-wide Public Health interventions introduced by the Chinese state 
are:  
1) Annual measurement of height, weight and fitness of 7-18 year old registered students. This 
is for everybody in all year groups and is conducted by either local education (Education Bureau 
at city and district levels) or health (Health Commission at city and district levels) authorities. 
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The data is analysed locally (at city and province levels) and sent to central government. The 
analysed data is published every 5 years, which forms the basis for national monitoring of 
trends. 
2) A requirement for children to have one hour of physical activity on campus every school 
day. However, local implementation has been poor due to contextual issues and the exam-
oriented education system [61]. This was the reason why one of the CHIRPY DRAGON 
components targeted this problem. The local authorities have responsibility of monitoring the 
implementation of this national policy, however, this is complicated by the fact schools often 
manipulate behaviour which makes it difficult for local authorities to accurately track adherence 
[61]. 
In 2016, the Chinese Government launched the “Healthy China 2030” policy, which seeks to 
improve health standards in China to be on a par with that in developed countries, through a 
range of initiatives including health promotion and improvement of public health services [62]. 
This recent Heathy China 2030 national action plan includes elements relating to nutrition and 
physical activity interventions in schools but these actions predominantly focus on educating 
individuals (e.g. providing information and encouragement to help them to eat and live more 
healthily) [63]. 
 
2.2.3 Risk Factors  
Individual health behaviours (e.g. physical activity, sedentary behaviour, dietary intake and 
eating behaviours), environmental factors (e.g. green space availability, healthy food access), 
policies (e.g. food marketing, nutritional labelling, transport policies), culture, other factors 
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(e.g. maternal pre-pregnancy weight) and interactions between these play an important role in 
the aetiology of obesity [64]. 
 
Individual health behaviours 
A lack of physical activity (PA) and an increase in time spent sedentary are known to be 
associated with various chronic diseases (e.g. obesity). It is recommended by WHO that 
children and youths aged 5-17 years spend at least one hour per day in moderate to vigorous 
physical activity (MVPA) [65]. Most of these daily physical activities should be aerobic. 
Physical activity for all healthy children at this age, to increase their energy output, includes 
active play, sports, games, chores, recreation, planned exercise, physical education, in the 
context of family, school, and community activities [65].  
Any waking behaviour characterised by low energy expenditure (e.g. resting metabolic rate, 
typically ≤ 1.5 metabolic equivalents (METs)) while in a sitting, reclining or lying posture is 
defined as sedentary behaviour [66]. This includes sitting at school, or sitting at home while 
watching TV or playing with electronic devices [67]. Based on expert opinion, WHO 
recommend, for example, children aged 1-4 years should not be sedentary for more than 1 hour 
at a time [68]. Over the past few years, there has been a large increase in sedentary behaviour 
in various societies. This is largely associated with the workplace demands and increase in 
screen time [69]. Similar trends have been seen among children. A recent systematic review 
indicated that there is limited available evidence for an association between sedentary behaviour 
and health outcomes in children and adolescents when accounting for MVPA [70]. However, 
other studies have shown contrasting results [71, 72]. According to the NICE guidelines, five 
reviews in children and youths found a positive association between amount of screen time in 
childhood and weight related outcomes, although the association was not statistically 
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significant in one of the reviews [73]. As physical inactivity and sedentary behaviour can 
coexist, they may need to be targeted separately [74]. 
Obesity is due to energy intake being greater than energy expenditure and the importance of 
dietary intake for obesity development is undebatable [64]. Nevertheless, the evidence base 
regarding energy intake, diet composition and intake of particular food items; and children 
being overweight or obese is not fully clarified. This can be partly because an accurate 
assessment of dietary intake and eating behaviours is notoriously challenging to obtain as 
individuals vary greatly in their interpretation of how much they eat [64]. The only sound 
evidence regarding a risk of overweight or obesity has been noted with consumption of sugar-
sweetened beverages [75]. Higher consumption of fruits and vegetables has been significantly 
associated with a lower risk of some diseases (e.g. cancer) [76]. However, an inverse 
relationship between fruit and vegetable intake and obesity among children is unclear [77].  
Parents can negatively impact their children’s food preferences and eating patterns [78]. This 
may include, for example, intake of certain unhealthy food items as part of regular family meals, 
pressuring them to eat (e.g. finishing the plate) or giving food as a reward [79], all of which 
might possibly lead them to develop obesity [80]. On the other hand, good parental practices, 
feeding styles, nutritional knowledge and health behaviours are of major importance for 
children’s development of healthy eating and physical-activity habits [81]. 
 
Culture 
Cultural factors may have specific influence on habits and development of obesogenic 
behaviours. For example, most Chinese parents and, moreover, grandparents, aspire for 
children to be overweight, as (in common with many cultures where there has been a recent 
history of poverty and famine) this is taken to be a sign of health, growth and prosperity [82]. 
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A major reason for higher rates of obesity among Chinese boys may be because of a cultural 
preference for boys to be overweight [83], leading to overfeeding.  
In China, there is a high prevalence of grandparents taking an active role in child care. 
Additionally, the one-child policy means that often 4 grandparents as well as the parents are 
involved in the care of a single child. A mixed methods study based on the families of primary 
school children in Guangzhou, suggested that Chinese grandparents contribute to childhood 
obesity through their misperceptions (e.g. children with obesity are healthy), lower levels of 
knowledge about healthy eating and harms of obesity (e.g. beliefs that obesity related diseases 
do not affect children; or that foods with higher dietary energy/fat content are more nutritious) 
and promotion of unhealthy behaviours out of their desire to please and protect their 
grandchildren (e.g. overfeeding and indulging through excusing children from household 
chores) [84]. 
The popularity of cross-generation living, conflicting child care beliefs and practices between 
parents and grandparents, and between grandparents and school teachers are also important 
factors contributing to childhood obesity in China, and can undermine efforts to promote 
healthy behaviours in children [84]. 
In a recent qualitative study to explore how children and parents make eating and physical 
activity decisions in China, three main themes were identified [12]. Firstly, children chose food 
based on flavour: commonly consuming high-calorie snacks rather than fruits and vegetables. 
Secondly, there were inconsistent standards and practices regarding lunch services across 
schools: children and parents’ perceptions of school lunch services differed among schools. 
Thirdly, children spent limited time on physical activity because of study burdens (e.g. 
excessive homework and weekend studies for academic attainment). 
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Other Factors 
A large number of other genetic, lifestyle, environmental and social factors have also been 
implicated. Prenatal and the early postnatal periods are considered to be “critical” for the 
development of obesity [85]. Some of the more commonly studied and consistent risk factors 
include maternal pre-pregnancy weight [86], smoking during pregnancy [87], high gestational 
weight gain, maternal socio-economic status [88], gestational diabetes [87], high birth weight 
[89], no or short duration of breastfeeding [90], rapid growth during the first year of life [91], 
short sleep duration [92], and early introduction of solid foods [93]. 
 
2.2.4 Costs and Consequences  
Childhood overweight/obesity is a major global public health problem for three main reasons.  
Firstly, obesogenic behaviours can persist from childhood to adulthood, and children who are 
overweight or obese run an increased risk of becoming obese in adulthood [94, 95].  
Secondly, overweight and obesity is linked to serious physiological, psychological and social 
consequences in both children and adults [3, 4, 96]. Once people develop overweight or obesity, 
it is more likely that they will develop chronic disease conditions, such as diabetes [97] 
cardiovascular diseases [98], musculoskeletal disorders [99], and some types of cancer [100]. 
Even during childhood, they are more likely to develop early symptoms and signs of co-
morbidities, hypertension and insulin resistance [101]. There is growing evidence that obesity 
in childhood has a detrimental effect on HRQoL, as children living with severe obesity have 
reported HRQoL that is comparable with cancer [102]. In addition, childhood obesity is 
associated with low self-esteem and, because of stigmatisation and weight-related teasing, it 
can lead to symptoms of depression and (perceived) social rejection [103, 104].  
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Thirdly, the obesity epidemic leads to significant economic and societal consequences via both 
direct and indirect costs [1, 2]. Direct costs relate to the healthcare needs arising from associated 
health problems (both childhood related diseases and those in adulthood), whilst indirect costs, 
which are estimated to exceed the direct costs, result from productivity losses associated with 
overweight and obesity (e.g. sick leave, disability pension, death before retirement) and other 
types of exclusion from the labour market (e.g. stigmatisation) [2, 105-107]. Furthermore, lower 
academic achievement among children with overweight and obesity could hinder future 
employment prospects [101].  
The Chinese government established the Basic Health Insurance Scheme (BHIS) for urban 
residents in 1997. The BHIS is operated by the local municipal governments and has 
implemented extensive cost-containment measures. Only drugs and services approved by the 
BHIS can be reimbursed. The BHIS provides limited coverage. Its worst limitation is that it 
does not cover dependents. Commercial health insurance plans are only available in some cities, 
and premiums are high. As a consequence, according to a survey in 2003, about 45% of China’s 
urban residents did not have any access to health insurance coverage [108]. China launched the 
New Cooperative Medical System (NCMS) for the rural population in 2003. As of 2006, the 
system had reached about 50% of the rural population [108]. Overall, China is still in the early 
stages of building a health safety net for China’s citizens. The Chinese low insurance coverage 
makes patient out-of-pocket expenses the major financing source for health care (58% in 2002) 
[108]. 
According to a recent systematic review, which included studies from high income country 
settings, the mean total lifetime costs due to obesity in childhood and adolescence were 
estimated to be €149,206 (range: €129,410 to €178,933) for a boy and €148,196 (range: 
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€136,576 to €173,842) for a girl, with the vast majority of the cost being due to productivity 
losses and, more specifically, income penalties [109]. A Chinese case study found that the 
indirect effects of obesity and obesity‐related dietary and physical activity patterns reached 
3.58% of GNP in 2000 and was projected to reach 8.73% in 2025 [13]. However, there is a lack 
of evidence regarding the economics of childhood obesity and the long-term economic 
consequences of childhood obesity in China. 
 
2.3 Evidence-Based Decision Making 
Randomised Controlled Trials 
Randomised controlled trials (RCTs) are considered the gold standard for evaluating the 
efficacy of interventions [110]. Randomly assigning participants to either an intervention or 
control group minimises the risk of bias, allowing causal interpretation of the findings [111]. 
RCTs are known to provide the most rigorous method regarding whether a relationship exists 
between the treatment and outcome. This means that the results of economic evaluations (to 
identify the cost-effectiveness of a new intervention), alongside these trials, are one of the most 
robust forms of evidence [112]. Evidence on effectiveness and cost-effectiveness is required by 
decision-makers when making decisions regarding resource allocation.  
However, the use of RCT in a public health setting, particularly in the case of behavioural 
interventions, faces some difficulties mainly for two reasons [113]. Firstly, the complex causal 
processes in public health interventions makes RCT results subject to effect modification in 
various populations. Secondly, there are issues concerning ethics and feasibility. 
Lack of perfect blinding, losses to follow-up, and cross-over between groups are some of the 
reasons that internal validity sometimes cannot be assured. Both the internal and external 
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validity of RCT findings can be largely enhanced by observational studies using adequacy or 
plausibility designs [113]. 
 
Cluster Randomised Controlled Trials  
As explained above, RCT is the most efficient design for allowing causal interpretation of the 
findings. However, in some cases randomisation at the individual level is inadequate or 
impractical. In these cases a cluster RCT, which is a sub-type of RCT, is chosen in which groups 
or clusters of individuals, rather than individuals themselves, are randomized [114]. Indeed, for 
the evaluation of certain types of intervention (e.g. those used in health promotion and 
educational interventions) a cluster RCT is the only valid approach [114]. Cluster RCTs are 
preferred in two study situations:  
 The intervention is delivered at an organisational level or unit (e.g. a surgery unit). 
 The intervention cannot be directly targeted at individuals (e.g. school, class room). 
However, the cluster RCT design has the disadvantage that there is a need for more study 
participants to reach the same statistical power. 
 
2.4 Evidence on Prevention Interventions 
It is vital to develop effective, culturally appropriate, prevention interventions in order to 
control the obesity epidemic in children in society. 
Schools are considered an ideal place to implement prevention interventions [115]. 
International research including the updated published Cochrane review, which included trials, 
approximately 90% of which were conducted in high income countries, has shown that well-
designed and well-implemented school obesity prevention interventions were effective in the 
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reduction of BMI in children [116, 117]. However, for instance, findings of three large, well 
conducted childhood obesity prevention trials in the UK found no evidence for the effectiveness 
of school based prevention interventions [118-120]. This highlights the importance of ‘context’ 
in determining intervention effectiveness. Also, some systematic reviews demonstrate that 
some short-term interventions (less than 12 months), which focused on combining dietary and 
physical activity initiatives, did not significantly decrease BMI [121, 122]. 
It is unknown whether rigorous development frameworks and research methods established in 
the West can be applied in a low/middle income country setting to develop effective childhood 
obesity prevention interventions. 
Relatively few intervention studies have been conducted in low and middle income countries 
(LMICs) [123] but these suggest that combining dietary and physical activity initiatives were 
effective in the reduction of BMI in children [124].  
A few Chinese studies have demonstrated that comprehensive school-based interventions, 
which combined diet and physical activity, were effective [15-17]. However, according to 
previous [18, 19] and the most recent systematic reviews of childhood obesity intervention 
studies conducted in China [20], there has been little research applying rigorous methods and 
established theoretical tools/framework to develop and evaluate prevention interventions for 
such a population. Shortcomings (methodological flaws) included: poor reporting of process 
and implementation measures; lack of sub-group analyses (e.g. gender and socio-economic 
status); short-term follow-up; lack of a control group, randomisation, blinding; failure to report 
dropouts; insufficient adjustment of confounders; no intention to treat (ITT) analysis and little 
information on potentially harmful effects in Chinese studies. In addition, the success of the 
interventions when scaled up remains unclear. Also, most prevention interventions in China 
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have focused on physical activity promotion and most previous intervention studies were 
treatment focused [20]. 
As previously mentioned, in light of the limited public resources available, interventions must 
not only be effective but also cost-effective. With regard to the number of intervention studies 
in the field of childhood obesity, the number of economic evaluations is relatively small [26]. 
Only one Chinese study has reported on the cost-effectiveness of a childhood obesity prevention 
intervention in China [17, 47]. Economic evaluation is important as a means to aid decisions 
about public resource allocation and it provides information on the relative costs and effects of 
competing interventions (see chapter 3) [36].  
China is in the early stage of the childhood obesity epidemic. The epidemic only became a 
public health concern from the early 20th century. The range and quality of public health 
interventions are generally behind those tried in high income countries where the epidemic has 
been a longer-lasting issue. In fact CHIRPY DRAGON is believed to be the first example of 
rigorous development and evaluation of a childhood obesity prevention intervention 
programme not only in China but in LMICs, in general. To date, government/environmental 
interventions (i.e. interventions beyond school and home settings - e.g. banning unhealthy food 
adverts during children's peak TV viewing time, sugar taxation) have not been implemented in 
China. Two nation-wide public health interventions introduced by the Chinese state are: (1) 
annual measurement of height, weight and fitness of 7-18 year old registered students; and (2) 
a requirement for children to have one hour of physical activity on campus every school day. 
The recent Heathy China 2030 national action plan includes elements relating to nutrition and 
physical activity interventions in schools but these actions predominantly focus on educating 
individuals [63]. Government provision of effective policy measures such as control of 
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advertising, use of taxation of certain food and drinks, introducing healthy food policies in 
workplaces/schools; cross-sector collaboration; increasing corporate social responsibility; and 
reforming health insurance policies could be introduced to curb the trend toward overweight 
and obesity in China but as yet there is no evidence to show that is happening [63]. 
 
2.5 The CHIRPY DRAGON Trial 
In summary, China is a useful case study because: 
It is a large middle income country which shares several features with other LMIC settings and 
other South East Asian countries. These include a rapidly increasing prevalence of childhood 
obesity within the context of limited evidence on how to prevent this. Though there have been 
previous trials, economic analysis has been limited and not comprehensively undertaken. 
China is in a similar stage of the nutrition transition as many other LMICs, with similar social 
and cultural influences, as well as its economic situation, to these settings [7, 56]. Thus learning 
from China is potentially more transferrable to these settings than those from the West. 
To address the evidence gap of what interventions to implement to prevent childhood obesity 
in China, and to address the methodological challenges of conducting an economic evaluation 
within this setting, the CHIRPY DRAGON study was developed using guidelines from the UK 
MRC Framework for complex interventions [21, 22]. Intervention development was led by 
researchers from the University of Birmingham in partnership with China Guangzhou CDC, in 
consultation with parents, grandparents, teachers and school staff [21, 22].  
A range of behaviour change techniques and social marketing principles were incorporated in 
designing the CHIRPY DRAGON (CHInese pRimary school children PhYsical activity and 
DietaRy behAviour chanGes InterventiON) intervention and a feasibility study was conducted 
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to test and refine the intervention prior to the main cluster randomised controlled trial (cRCT) 
reported in this thesis. This study provides one of the first examples of a rigorous development 
and evaluation of a childhood obesity prevention programme outside of high income countries. 
This study also provides one of the first examples of rigorous economic evaluation of a 
childhood obesity prevention programme in a low/middle income country (non-western 
population). The study was funded through a philanthropic donation from Zhejiang Yong Ning 
Pharmaceutical Ltd Co from 2014 to 2018 and was evaluated from 2015 to 2017 (It was 
developed from 2009 to 2015 [84, 125]). 
My role in the trial was the development of the analysis plan for the economic evaluation; 
undertaking the statistical and economic analysis including ‘bottom-up’ costing of the 
intervention; analysis of outcomes; expanding the evaluation to include spillover effects; 
undertaking sensitivity analysis, and helping interpret the clinical and cost-effectiveness results. 
 
2.5.1 Trial Design 
Study Design and Setting 
The CHIRPY DRAGON trial protocol has been published previously [126]. The protocol was 
implemented without changes. The parallel, two-arm cRCT evaluated the CHIRPY DRAGON 
obesity prevention intervention, designed for boys and girls aged 6-7 years at baseline. This 
was implemented within 40 non-boarding, state-funded primary schools located in the largest 
Southern Chinese city of Guangzhou, a socio-economically advanced city with an urban 
population of 12.9 million [5].  
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Ethics Statement 
Ethical approval was received from the Life and Health Sciences Ethical Review Committee at 
the University of Birmingham on 2nd March, 2015 (ERN_14-1440). In addition, local ethical 
approval was obtained by the Ethical Committee of Guangzhou CDC on 1st December, 2014. 
The trial registration number is ISRCTN11867516. 
 
School/Participant Identification/Recruitment  
All year-one schools (n=353) from non-boarding, state-funded (residents) public primary 
schools (clusters) located in the largest Southern Chinese city of Guangzhou were eligible for 
inclusion. The majority of Chinese children attend this type of school [11, 127]. There are also 
a few private schools, mainly for foreign children from a lower socio-economic background 
[11, 127], which were not eligible. Basic education in China includes pre-school (usually three 
years), primary-school (six years, usually starting at the age of six), middle-school (three years) 
and high-school (three years) periods with the primary- and middle-school education being 
compulsory [128]. The academic year is divided into two terms for all educational institutions: 
February to mid-July (six weeks summer vacation) and September to mid/late-January (three 
weeks winter vacation). There are no half-terms. On average, a primary school student spends 
about six to seven hours per day at school including a lunch break and mid-day nap (at home 
or school), while for a middle- or high-school student this rises to about ten hours (excluding a 
lunch break and mid-day nap but including evening self-study time in classroom) [128]. 
A research team member randomly selected 40 schools, using a random number generator. 
From the first week of September 2015, the selected schools were invited to take part in the 
trial. Each school was sent an official support letter from the relevant local education and health 
authority/bureau. They additionally received personal visits (with written information 
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sheet/consent form) or telephone communication from the research team members. All 40 
schools agreed to take part in the trial within 1-2 weeks.  
In China, primary schools have an average of four (range two to eight) year-one classes in each 
school. Each class consists of approximately 45 children. There is a senior teacher (known as a 
class-level head teacher) for each class. In the participating schools, all children from year-one 
classes (age 6-7), along with their family members, were eligible for inclusion and were offered 
the opportunity to take part in the prevention programme. One year-one class was randomly 
selected (by a research member during a personal visit to the school) from each of the 
participating schools to have outcome measurements taken. The research team members 
distributed invitation letters, information sheets and consent forms to the head teacher of each 
selected class. These were then given to each child to take home and pass to their parents/other 
family members. Those who returned a completed/signed consent form were allowed to take 
part in outcome measures. Parents (or family members) of children were advised to inform the 
research team if they believed that there were any medical reasons why a child should not take 
part in any outcome measures and/or intervention activities; and/or if they would like to 
withdraw from the study at any time for other reasons.  
 
Participant/Cluster Baseline/Primary Follow-Up Assessment 
Baseline assessments were completed in the first/autumn term (September to December 2015) 
when participating children were in year one (aged 6-7 years), followed by the delivery of the 
12-month intervention programme which started in the second/spring term after the school 
winter holiday. The primary (first) follow- up measurements were taken upon completion of 
the 12 months intervention (April to July 2017) when all participating children had reached 
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year two (aged 7-8 years). A second follow up measurement was taken after a further 12 
months, but is not reported here. 
 
Sample Size 
1,641 children from 40 schools were needed to have 80% power at a 5% significance level to 
detect a difference of 0.17 units in the mean BMI z-score between the treatment groups, 
assuming an average of 45 children per cluster (school). Loss to follow up was anticipated to 
be 10%. 
 
Randomisation and Blinding/Masking 
Randomisation took place after consent was obtained from the 40 schools/clusters and all 
participating children, and after baseline measurements (January 2016). A UK-based trial 
statistician used a computer generated sequence (ralloc function in STATA version 14) to 
allocate schools to the intervention and control groups, and performed stratified randomisation 
based on whether the school provided mid-morning snacks or had an indoor activity space. 
These two factors were selected based on the advice received from the trial’s lead statistician 
and local education authority who hold good knowledge of local primary schools. These factors 
were most likely to impact on the delivery of the intervention programme (potentially influence 
dietary and physical-activity behaviours of children in local primary schools). Schools were 
randomly allocated to either the usual practice (n=20) or the intervention arm (n=20). 
Participating schools were then informed of their allocation. 
Because of the nature of the intervention, school staff, children, parents and other live-in adult 
family members of the participating children and trained project staff who delivered the 
intervention could not be masked to group allocation during the intervention period. Therefore, 
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independent and trained external assessors (research staff), who were blinded to study 
allocation and who were not involved in any part of the intervention delivery, were employed 
to undertake all outcome measures. 
 
2.5.2 Intervention and Comparator 
The intervention and its delivery are described in full in chapter 5. Briefly, the CHIRPY 
DRAGON programme was a 12-month multi-component intervention which was implemented 
from March 2016 to March 2017. It consisted of four components targeting diet and physical 
activity behaviours, inside and outside of school, through nine interactive workshops, daily 
family home activities, and supporting school physical-activity and food provision. It aimed to 
facilitate the development and/or maintenance of a healthy weight through improving diet and 
promoting physical activity in children. The intervention was delivered by five full-time 
Chinese trained project staff (known as CHIRPY DRAGON teachers/researchers). For equity 
and practical reasons, in the intervention schools, the workshops and activities were delivered 
to every child in the target year, and the school meal component was a whole school 
intervention. However, for research practical reasons and to stay within resources, study 
measurements were limited to children in one class per school. 
Schools allocated to the comparator/control arm continued with their ongoing standard 
provision (usual practice) during the full trial period with no access to any of the CHIRPY 
DRAGON intervention activities and resources.  
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2.5.3 Outcome Measures 
The outcome measures are described in detail in chapters 3 and 5. Briefly, the clinical measure 
of effectiveness was BMI z-score. The economic outcome measure was QALYs. Utility-data 
was collected using the CHU-9D for children and EQ-5D-3L for parents/carers. 
 
2.5.4 Participant Flow during the Trial 
1,799 children from the 40 consented schools were eligible in September 2015. 158 of them did 
not reply to the recruitment letters. The remaining 1,641 (91.2%) consented and participated in 
study measurements. 20 schools (832 consented children) were randomly allocated to the 
intervention programme and 20 schools (809 consented children) to the control group. No 
schools dropped out of the trial. Loss to follow up was lower (3·4% overall, 3·3% in the 
intervention, and 3·5% in the control arms) than the estimated level used (10%) in the sample 
size determination. 794 children (95.4%) from the intervention group and 768 (95.0%) from 
the control group were included in the primary outcome analysis. A CONSORT flow diagram 
of the CHIRPY DRAGON trial participants is presented in Figure 1.1. The results of the 
CHIRPY DRAGON trial and its economic evaluation based on cost per QALY and BMI z-
score change are reported in chapter 5.  
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Figure 2.1 - CONSORT flow diagram of the CHIRPY DRAGON trial participants 
Li et al. (2019) [129] 
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2.6 Conclusion 
Approximately 42% of adults and around one-fifth of children in China are overweight or living 
with obesity. Overweight and obesity is linked to serious consequences and costs. Despite an 
increasing number of behavioural obesity prevention intervention studies, there are relatively 
few published economic evaluations. That is why the CHIRPY DRAGON study was 
developed. 
In the following chapter, a background to the methods for economic evaluation is provided to 
help build the context for the subsequent chapters reporting the economic evaluation alongside 
the CHIRPY DRAGON trial.  
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CHAPTER 3. THEORETICAL FOUNDATIONS AND 
APPLICATION OF ECONOMIC EVALUATION 
 
3.1 Introduction 
Providing better health and well-being for all individuals in society is the ultimate goal of health 
care and public health. A key aspect of this is organizing health services around individuals’ 
needs and expectations [130]. However, as discussed in chapter 1, the resources used to provide 
healthcare services – facilities, equipment, people, time and knowledge – are scarce in relation 
to the demand for them [36, 131]. Public health goes beyond the health care sector, acting across 
several fronts such as environment, housing and education. Public health programmes typically 
aim to reduce the risk of illness or premature death.  
Because provision of healthcare and public health is seen as fundamental to individuals’ lives, 
and due to the scarcity of resources, decisions regarding how to allocate these resources are 
difficult. Therefore, assessing an intervention’s relative costs and benefits using economic 
evaluation is important to enable public health decision-makers to maximise the efficient use 
of resources. Implementation of a particular intervention is not recommended without evidence 
of both the effectiveness and cost effectiveness relative to a comparator which is, commonly, 
usual practice [30].  
Some policy decision-making bodies have published methodological guidelines for 
submissions of economic evaluations to adhere to. These include NICE, the American CDC, 
the WHO, along with many others [132].  
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According to Drummond et al (2015) economic evaluation is important for three main reasons 
[36]. Firstly, it minimizes the chances of an important alternative being excluded from 
consideration. Secondly, it considers different viewpoints, for example: the patient, the 
particular institution, the target group for particular services, the budget of the decision-makers, 
the overall budget of the government, and the societal or community viewpoint. Thirdly, it seeks 
to estimate the opportunity cost and to compare it with the programme benefits.  
Economic evaluation has two characterizing features. Firstly, the linkage between inputs and 
outputs (sometimes called costs and consequences) of activities is established. Secondly, it is 
concerned with choices. Many criteria, both implicit and explicit, have to be taken into 
consideration in making these choices [36]. Economic evaluation attempts to identify and make 
explicit a set of criteria which might help in deciding between various possible uses of scarce 
healthcare or public health resources [36]. 
These characteristics lead to economic evaluation being defined as the comparative analysis of 
alternative courses of action considering both their cost and consequences [133]. Hence, 
identification, measurement, valuation, and comparison of the costs and consequences of the 
alternatives being considered are the fundamental tasks of any economic evaluation [36]. 
Shiell et al (2002) suggest that efficiency is a criterion which can be used to help decision-
makers choose between alternative courses of action [134]. Economics considers two key types 
of efficiency: allocative and technical. Allocative efficiency concerns whether or not particular 
resources should be allocated to an intervention. Technical efficiency relates to how best to 
allocate resources, either minimising costs to achieve a desired level of output, or maximising 
a particular output relative to its input [134]. These efficiency concerns are addressed to varying 
degrees by the different methods within economic evaluation. 
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It is important to always specify within an economic evaluation the perspective for measuring 
and valuing the costs and benefits included [36]. This matters because an intervention may be 
cost-effective from one point of view (e.g. healthcare), but not from another (e.g. societal). As 
discussed in chapter 1, a more comprehensive economic evaluation should consider both the 
healthcare and societal perspectives. However, the likelihood of studies using a societal 
perspective is usually based on the decision-makers recommendations or policies (e.g. in the 
UK, the NICE reference case specifies a (Personal Social Services/National Health Service 
(PSS/NHS) perspective). Clearly stating the perspective adopted is accordingly a required task 
for the researcher(s) and is consistently recommended in guidelines for economic evaluations. 
This chapter describes the two main theoretical foundations of economic evaluation in the 
context of health care and public health: welfarism and extra-welfarism. Then, it discusses the 
five types of economic evaluation. These are: cost-benefit analysis (CBA), cost-effectiveness 
analysis (CEA), cost-utility analysis (CUA), cost-minimisation analysis (CMA) and cost-
consequence analysis (CCA). It continues by describing the other vehicles for economic 
evaluation and the HRQoL measurements for economic evaluation; and conclude by discussing 
decision-making beyond economic evaluation.  
 
3.2 Theoretical Foundations 
Economics is divided into two main streams: positive and normative economics. Positive 
economics answers objective and verifiable questions [131]. For instance, it would determine 
the relationship between user charges and the demand for care. Normative economics is a 
subjective approach that involves addressing decisions regarding how economic systems should 
work. For example, how the demand for healthcare should be addressed [135]. Normative 
economics assess the most desirable resource allocation in accordance with value judgements. 
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Black, Hashimzade and Myles (2012) state that normative economics is required for making 
decisions regarding the production and distribution of scarce healthcare resources [135]. Its 
value judgements being informed by efficiency and equity considerations. Economic 
evaluations are normative in their nature [131]. This is because there is a fundamental normative 
stage of deciding what costs and benefits should be considered within the analysis [36], along 
with how benefits are valued and what is regarded as the optimal option [131].  
There are two frameworks, within health economics, which can be used to conduct economic 
evaluations: welfarism and extra-welfarism. According to NICE, extra-welfarism is widely 
implemented in health economics and is recommended by decision-makers [35]. The 
methodological basis for conducting economic evaluations is different within the welfarist and 
extra-welfarist framework, as each uses different value judgements to determine various states 
of resource allocation. In the following sections these two different approaches to economic 
evaluation are discussed. 
 
3.2.1 Welfarism 
Welfarism or the neo-classical framework is the traditional theoretical basis for economic 
evaluation [136]. Welfarism tries to maximize individuals’ utilities subject to a budget 
constraint [131]. A utility is described as the representation of the preference of an individual 
for a particular good, regarding the satisfaction and/or happiness which they gain from it [34]. 
In a welfare economic approach, the best judges of their own welfare are the individuals 
themselves [137].  
According to consumer theory, a welfare economic approach considers only the outcomes and 
resulting utilities for people with regard to their consumption of particular goods or services 
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[131]. In theory the aim of a welfare economic approach is to generate improvements in social 
welfare. Other people’s judgements, such as those of health care professionals or decision 
makers, are irrelevant [137].  
In order to identify efficient resource allocations, economists use the Pareto principle. This 
determines that a policy change is socially desirable if either everyone is made better off (weak 
Pareto improvement: formed by a weak value judgement, i.e., one that gathers consensus) or at 
least some are made better off while no one is made worse off (strong Pareto improvement: 
based on a strong value judgement, i.e., a less consensual and therefore a more debatable 
judgement) [131, 138]. A resource allocation is judged to be Pareto optimal if and only if there 
is no alternative state that would increase one individual’s utility without decreasing another’s 
[133].  
Although considered relatively uncontroversial, this approach is not particularly useful for 
decision-makers because, for any health care or public health decision that involves providing 
resources to one group at the expense of another, this value judgement offers little indication as 
to the appropriate course of action [137]. Also, measuring social welfare only with regard to 
the utility that individuals gain from consumption is too restrictive [139, 140] as firstly, social 
welfare is a function of only utility and judgements regarding the superiority of one state of the 
world over another are made irrespective of the non-utility aspects of each state and secondly, 
the utilities are a function only of goods and services consumed by the individual himself [34, 
141]. 
Policy decisions which are able to satisfy every individual and/or guarantee no losers are very 
few [142]. The practical drawbacks related to the Pareto optimality criterion resulted in the 
adoption of the Potential Pareto Improvement concept. This concept expects the losers to be 
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compensated and, if after compensation, the gainers are still better-off, the change is desirable 
[143]. This is more easily understood if gains and losses are expressed in monetary terms. 
However, the Potential Pareto Improvement concept might be viewed as representing a serious 
compromising of Pareto optimality. It makes explicit interpersonal comparisons of 
uncompensated gains or losses (by allocating an equal unitary shadow weight to each one) and, 
at the same time, it ignores all other types of uncompensated change and any initial differences 
between individuals [34].  
From a practical perspective and on the basis of the use of the Potential Pareto improvement 
criterion, welfare economics is criticised because decisions can result in an inequitable 
distribution of healthcare resources [136, 144]. The extra-welfarist approach was developed in 
response to these criticisms. 
 
3.2.2 Extra-Welfarism 
Extra-welfarism tries to maximise the total health of a population and allows the consideration 
of outcomes beyond utility. Healthcare or public health resources ought to be allocated on the 
basis of need. As the need for healthcare implies a deprivation in health, this deprivation can be 
reduced by healthcare provision [141]. The extra-welfarist approach takes people’s 
characteristics into account in making its decisions. These characteristics, such as whether or 
not a person is happy, free of pain, physically mobile, describe and provide a comparison of an 
individual’s health [34, 141].  
The extra-welfarist approach adds something ‘extra’ to welfare economics. Extra-welfarism 
goes beyond welfarism in four ways. That is: ‘it permits the use of outcomes other than utility, 
it permits source of valuation other than the affected individuals, it permits the weighting of 
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outcomes other than preference-based, and it permits interpersonal comparisons of well-being’ 
[34].  
Health measures such as the quality adjusted life year (QALY) allow individuals to be 
compared within a health domain [141]. QALYs might be interpreted as a principal outcome 
of effective health care that reflects the principal dimensions of QoL deemed to be of 
significance by the decision-maker involved [34]. 
Indeed, health economists’ major criticism of the commonly applied extra-welfarist approach, 
in practice, has been that it relies purely on health as the single outcome which is too narrow 
and restrictive [137]. Within the extra-welfarist framework, an intervention’s benefits can only 
be valued regarding the intervention’s ability to produce health. There is a possibility that other, 
non-health related, benefits such as education and housing, could be generated as a result of a 
special healthcare programme [34]; but, these cannot be captured using health measures, such 
as the QALY. However, other measures such as capabilities measures under the extra-welfarist 
paradigm have been proposed.  
Capability wellbeing or wider wellbeing is an evaluative space and assesses well-being based 
on an individual’s ability to do and be the things they value in life. It goes beyond consideration 
of peoples’ health as a simple function. Instead it focuses on their ability to do or be in life e.g. 
the difference between starving due to lack of food versus starving due to voluntary fasting. 
Sufficient capability is an egalitarian approach to decision making that aims to ensure everyone 
in society achieves a normatively sufficient level of capability wellbeing [145]. There are cases 
where researchers have applied this approach [145, 146]. For example, a study showed that 
capability wellbeing can be incorporated into economic evaluation when considering the impact 
of addiction treatments, in direct comparison to QALYs [146]. 
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Extra-welfarism using QALYs is typically the basis on which economic evaluation in health 
care is undertaken within the UK and internationally [137, 144]. It offers a pragmatic approach 
that is seen to fit well with decision makers’ goals. A summary of the five main differences 
between the welfarist and extra-welfarist approaches are presented in Table 3.1.  
 
Table 3.1 - Summary of welfarist and extra-welfarist approaches 
Welfarism Extra-Welfarism 
 
Maximise social welfare (utility) Maximise health, outcomes beyond utility 
Allocative efficiency Technical efficiency 
Combine health and non-health benefits Consider only health benefits 
Consider affected individuals’ values Consider societal values 
Distribution and equity are considered separate Distribution and equity are not separable 
 
Adapted from Brouwer et al. (2008) [34] 
 
3.3 Types of Economic Evaluation 
The different types of economic evaluation will be described in light of these methodological 
considerations. It is common to differentiate between five types of economic evaluation: 
 
3.3.1 Cost-Benefit Analysis (CBA) 
CBA provides a systematic assessment of the costs and benefits of an intervention [147]. CBA 
is theoretically grounded in the welfare economic approach and is a method of economic 
evaluation where both the costs and benefits of a healthcare intervention are quantified in 
monetary units [147]. This enables the analyst to compare the discounted future streams of 
incremental benefits of a programme along with its incremental costs [36]. Thus, it can be used 
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in a comparative analysis of alternatives that have various objectives [133]. The difference 
between the two streams being the net benefit of the programme. 
The aim of CBA is to establish if the benefits of a programme exceed its costs. A positive net 
benefit (NB>0) demonstrates that an intervention is cost-beneficial and that a programme is 
worthwhile and should be implemented [147]. Using monetary units as a measure of (positive 
and negative) benefit allows not only a comparison of the cost-benefits of interventions and 
services within the health sector, but also between various areas of expenditure within different 
sectors of the economy [148]. 
The value of a commodity, in a normal market, is determined directly by observing how an 
individual responds to changes in quantity and price [149]. Thus, whether the individual 
consumes the commodity is associated with their willingness to pay (WTP) and ability to pay 
(ATP) [131]. The healthcare market does not resemble a normal market. Thus, it is impossible 
to measure individual's preferences for healthcare by assessing their response to changes in 
price because health care is free at the point of use. Therefore, it is necessary to use other 
measures to assess the benefits of an intervention, which can be measured either directly or 
indirectly. 
Human capital, revealed preferences and stated preferences of WTP (known as contingent 
valuation) are three general approaches to the monetary valuation of health outcomes [36]. 
Stated preference is a direct method that can measure the observed change in welfare from the 
provision of an intervention [149]. The outcome measure used is known as WTP, which is a 
measure of the maximum amount of money individuals are willing to sacrifice for their 
treatment [36, 150]. A less commonly used outcome measure is called willingness-to accept 
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(WTA), which is a measure of the minimum amount of money the individuals are willing to 
accept to abandon a good [36, 150].  
In practice, healthcare decisions are associated with the addition of a new intervention and tend 
to measure welfare gain (WTP). Revealed preference is an indirect method and is rarely used 
in health economics because most health care markets are either financed by tax revenue or 
social insurance and therefore free at the point of use.  It was proved by Olsen (1997) that some 
analysts have attempted to use WTP for comparing health and non-health programmes [151].  
CBA is broad in scope and enables both technical and allocative efficiency concerns to be 
addressed. Relative values are allocated to health and non-health related goals to assess which  
are worth achieving [36]. CBA is considered to be a tool that can be used by decision makers 
to assess various alternatives [131]. However, in economic evaluation and policy decision-
making, the cost-benefit approach has had limited use due to the difficulty in measuring the 
value of all health benefits in monetary units. In addition, there might be moral objections 
regarding the influence of ATP in the process of valuing the effects [152]. Although CBA is 
still used, other types of analysis, namely CEA and CUA are more frequently used in health 
care. Nonetheless, CBAs are still the preferred type of evaluation in other sectors such as 
transport [153] and environment [153, 154]. Although the use of CBA in public health is a 
relatively recent phenomenon, it has been used in recent years to evaluate a number of accident 
prevention strategies (such as introduction of roundabouts, speed cameras and 20 mph zones), 
capturing a wide range of health and non-health impacts such as congestion, time saving and 
CO2 emissions [35]. CBAs have not to date been used in obesity prevention interventions [35].  
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3.3.2 Cost-Effectiveness Analysis (CEA) 
CEA is theoretically grounded in the extra-welfarist approach. Here, the incremental cost of a 
programme is compared to its incremental health benefits, measuring the health effects in 
natural units related to the objective of the programme such as life years saved or improvements 
in functional status (units of BMI z-score, cholesterol or blood pressure) [36]. Therefore, CEA 
is useful to compare interventions, which target the same health condition, and is particularly 
useful in a clinical setting. 
Since costs and benefits of a CEA are measured in non-comparable units, their ratio can be used 
to assess productive or technical efficiency [46]. The results of a CEA can address questions of 
technical efficiency, by demonstrating if an intervention compares favourably to an alternative. 
In particular, it can show whether an intervention can minimise costs to achieve a specified 
level of health benefit [155]. However, a major limitation of CEA for decision makers is its 
inability to directly compare cost-effectiveness of interventions across various areas of health 
conditions, or sectors of the economy. Therefore, it cannot directly address allocative efficiency 
[36, 46]. This limits the CEAs usefulness in informing budget allocation decisions. This is 
because, at a national and local level, these decisions need to consider a variety of interventions 
in various areas of public health, health and social care.  
For two alternative interventions, an incremental cost-effectiveness ratio (ICER) is calculated 
by dividing the differences in total costs (incremental cost) by the difference in the chosen 
measure of health outcome or effect (incremental effect) [152]. This can be interpreted as the 
extra cost of obtaining an additional unit of health outcome from a particular health 
intervention, when compared to an alternative, or the welfare loss from removal of an 
intervention [156]. 
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The cost-effectiveness plane is used to visually represent the differences in costs and health 
effects between treatment alternatives in two dimensions, by plotting the costs against effects 
on a graph [157]. Health effects are usually plotted on the x axis and costs on the y axis. 
Frequently ‘current practice’ is plotted at the origin, and so the x and y values represent the 
incremental health effects and incremental costs versus current practice. More than two points 
can be represented on the plane, with the line connecting cost-effective alternatives being called 
the cost-effectiveness frontier. Cost-effectiveness planes are also useful to show the uncertainty 
around cost-effectiveness outcomes, often represented as a cloud of points on the plane 
corresponding to different iterations of an economic model in a Probabilistic Sensitivity 
Analysis (PSA). The cost-effectiveness plane is divided into four quadrants [157]: 
North West (NW): When a new intervention generates poorer health effects and is also more 
costly, which indicates that current practice is dominant. 
South East (SE): A new intervention is considered to be dominant, when both less expensive 
and more effective than its alternative. Therefore, it is the most cost-effective option [36].  
North East (NE): In many economic evaluations, an intervention might be relatively more 
effective than usual care, yet also be more costly.  
South West (SW): In some cases the intervention generates lower costs but it is less effective. 
In these two last cases, in order to judge if the intervention is a cost-effective use of public 
resources, the ICER should be compared to a cost-effectiveness threshold that is based on the 
amount society is willing to pay for an extra unit of health benefit [131, 152, 158]. 
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3.3.3 Cost-Utility Analysis (CUA) 
CUA is theoretically grounded in the extra-welfarist approach and focuses on the comparison 
of healthcare preventions or treatments regarding both the quantitative and qualitative aspects 
of health outcomes (morbidity and mortality) produced [46]. CUA is an adaptation of the CEA 
approach. The incremental cost of a programme is compared to its incremental health 
improvement. Health improvement is measured in utility terms which can be framed as either 
a QALYs (the product of the preference based measure of QoL ’utility’ and length of life) [152] 
or a disability-adjusted life year (DALY). Both are used as a unit of assessment to make 
judgements about the relative cost-effectiveness of competing interventions [131]. In fact, in a 
LMIC setting, the DALY is the more popular outcome unit. 
In theory, the QALY measure is universal; therefore, various programmes across different 
health conditions which are evaluated using QALYs can be compared. However, there are 
limitations to using CUA for the reasons that QALY measures vary by method; QALY results 
vary by respondent (for example, the patient, family, clinician, or general public) and society 
might value a QALY for various population groups differently [159, 160]. The use of QALYs 
in economic evaluation of public health interventions has been criticised. This is partly for 
considering health as the only relevant outcome, and ignoring the production of wider benefits 
which are not captured in the QALY.  
However, the use of a single measure of health benefit enables comparison of diverse healthcare 
interventions, so CUA allows both technical and allocative efficiency questions to be addressed 
[46]. Like CEA, the most cost-effective intervention, from those compared, is considered to be 
the one which generates the most QALYs for the lowest incremental cost, considering a budget 
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constraint [144]. CUA is more useful to decision-makers with a broad ruling than CEA, because 
of its broad applicability [36].  
There is uncertainty around how the cost-effectiveness threshold should be defined and current 
cost-effectiveness thresholds are valued in cost-per-QALY terms. For instance, in the UK, using 
NICE public health guidelines, ICER values under £20,000-30,000 per QALY are deemed a 
cost-effective use of resources [161]. By contrast in the USA the recommendation is US$50,000 
per QALY [162] and in many countries (e.g. China) there are no clearly defined thresholds at 
all. The uncertainty around the ICER is typically assessed through the use of the net-benefit 
regression (NBR) framework [163, 164] using non-parametric bootstrapping. Decision 
uncertainty is presented using cost-effectiveness acceptability curves (CEACs) [164]. CEACs 
are developed to estimate the probability of the intervention being cost-effective across a range 
of values of WTP for an extra QALY.  
Different healthcare systems have different HTA contexts, systems and priorities.  Some 
countries do not apply specific thresholds. Where they do not, the WHO make 
recommendations for cost-effectiveness thresholds of 1 to 3 times the Gross Domestic Product 
(GDP) per capita of that country [165, 166]. 
The GDP per capita, which calculates all the goods and services produced in a country in one 
year divided by the total population, is a useful metric for categorizing countries as either 
developing or developed. According to WHO, countries are considered to have developed 
economies when they have a GDP per capita of >= US$12,000 [166, 167]. However, some 
economists believe that US$25,000 is a more realistic threshold [167]. 
With a GDP/capita of US$19,000 [166, 168], China’s status is complex. Despite having the 
world's second-largest economy and third-largest military, it is generally not classified as a 
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developed country (e.g. it is on the Development Assistance Committee (DAC) list of LMICs, 
developed by OECD [169]). This is because many economists argue that the country's per capita 
GDP remains below the accepted minimum thresholds for developed-country status. In 
addition, it has a low level of technological innovation [167]. However, the status is 
controversial, as despite the GDP, it shares many social, cultural and economic features of other 
middle income countries. 
It is inevitable that an economic evaluation contains some degree of uncertainty in its 
assessment. The choice of sensitivity analysis may depend on the methodology applied or the 
setting in which the intervention was conducted. In order to assess the level of uncertainty, one 
can apply a deterministic and probabilistic sensitivity analyses. In a deterministic sensitivity 
analysis (DSA), model parameters are changed individually. To assess the level of uncertainty 
for analyses, it has become common practice and it is the gold standard to apply a Probabilistic 
Sensitivity Analysis (PSA), where model parameters are changed simultaneously according to 
a given distribution [30, 170]. 
 
3.3.4 Cost-Minimisation Analysis (CMA) 
CMA focuses solely on costs’ differences therefore questions such as “Is the extra effectiveness 
worth the extra cost?” cannot be answered [152]. CMA is the analysis of choice either when 
the common outcomes are equal or assumed to be equal (owing to outcomes being roughly 
identical). It identifies the lowest cost alternative [133]. One of the advantages of this analysis 
is that only cost data needs to be collected.  
CMA is inappropriate in cases where there might be a difference in effectiveness, because 
effectiveness is not measured and the option which is cheaper might be harmful for the patient 
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[152]. In these situations, researchers should use an economic evaluation that allows the 
competing interventions or treatments to have different effectiveness; CEA is the simplest of 
these types. Because the estimations of costs and outcomes are not certain, it is difficult to have 
equal outcomes unless the alternatives are approximately identical [133]. In a review of 
economic evaluation approaches [171], CMA was deemed inappropriate because it is very rare 
to have a set of circumstances whereby intervention effectiveness are known with certainty and 
are assessed as identical in advance of analysis. 
 
3.3.5 Cost-Consequence Analysis (CCA) 
CCA makes the influence of the new treatment as comprehensive as possible. It simply lists out 
all the cost-incurring events and the consequences in a disaggregated fashion. Therefore, it will 
enable decision makers to select which components are most relevant to their perspective. In 
addition, it will give them confidence that the data are valid to use as the basis for resource 
allocation decisions [172]. However, the decision made by an individual may not be in the best 
interest of either patients or society.  
The details of characteristics of health care evaluation and types of economic evaluation are 
provided in Tables 3.2 and 3.3.  
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Table 3.2 - Distinguishing characteristics of healthcare evaluation 
                               Are both costs and consequences of the alternatives examined? 
 
 
Is there a 
comparison of 
two or more 
alternatives?                      
 
 
 
 
Adapted from Drummond et al. (2015) [36] 
 
Table 3.3 - Economic evaluation types 
Method of 
analysis 
Valuation of costs Valuation of effects Paradigm 
CBA Monetary units Monetary units (WTP) Welfarism 
 
 
CEA Monetary units Natural units: One-
dimensional unit (e.g. 
BMI z-score) 
Extra-welfarism 
 
CUA Monetary units Multi-dimensional unit 
(e.g. QALYs) 
 
Extra-welfarism 
 
CMA Monetary units Equivalent: None 
(alternatives are assumed 
to have equal outcomes)  
Extra-welfarism 
 
CCA Monetary units Description - 
 
 
 
Adapted from Drummond et al. (2015) [36] 
  
 NO  YES 
 Only consequences Only costs 
 
 
NO Partial economic 
evaluation 
 
Outcome description 
Partial economic 
evaluation 
 
Cost description 
Partial economic 
evaluation 
 
Cost outcome 
description 
YES Partial economic 
evaluation 
 
Efficiency or 
effectiveness evaluation 
Partial economic 
evaluation 
 
Cost analysis 
 
Full economic 
evaluation 
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3.4 Other Vehicles for Economic Evaluation 
Decision-modelling can be used as a vehicle to conduct an economic evaluation. Modelling can 
be done following a trial and/or using a framework of evidence synthesis [173]. For example, 
following a trial, the model-based economic evaluation goes beyond the observed time of the 
trial and extrapolates the effectiveness and costs over a longer time horizon with using 
assumptions applied to the trial data and/or combining the trial data with evidence from multiple 
sources [174]. These methods provide a framework for developing and applying an appropriate 
structure for the natural progression of the underlying disease which enables an assessment of 
the long term costs and benefits of relevant options; all existing evidence can be brought to bear 
and, through PSA, the implication of parameter uncertainty on the recommendation can be 
quantified [173]. 
In addition, modelling links intermediate outcomes to final outcomes and it supports the 
analysis using secondary data (e.g. morbidity and mortality data) [174]. This role of modelling 
in economic evaluation is especially relevant in the field of obesity prevention or treatment 
interventions in children and adolescents, where the outcomes may only be realised long after 
the trial has finished. Model-based economic evaluation can capture the uncertainty linked to 
any assumptions made and could also improve the generalization of results obtained in one 
setting to other settings [174].  
The most common types of model structures are decision trees and Markov models. Decision 
trees are commonly used, and are one of the most simplistic model structures in decision 
analytic modelling [131]. Markov models are a more complex type of model, widely used in 
economic evaluation, which overcome the limitations of decision trees [36]. They reflect 
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various health states or consequences of treatment, where the probability of transitioning 
between health states occurs in accordance with the time cycle of the model [36].  
To assess the level of uncertainty for model-based analyses, it has become common practice to 
apply a Probabilistic Sensitivity Analysis (PSA), where model parameters are changed 
simultaneously according to a given distribution [30, 170]. It is also common to conduct a more 
comprehensive approach which is a combination of DSA and PSA to assess the uncertainty 
around the parameters included [170]. 
 
Discounting 
Discounting is the process that enables a comparison between the value of a good consumed in 
the future with the value of that same good consumed now. Lipscomb et al (1996) state that in 
economic evaluation, discounting is based on the principle that, all future costs and health 
benefits/consequences should be considered in relation to their present value to the decision 
maker [175]. Discounting enables a comparison between interventions that produce benefits 
and incur costs over a number of years [36]. Preventive interventions will usually require costs 
to be incurred in the present for effects to be enjoyed in the later stages of life. For instance, 
interventions to prevent obesity will result in a lower risk of some types of cancer that will be 
experienced later in life. Currently, NICE recommend a discount rate of 3.5% per year for both 
costs and outcomes for economic evaluation of public health interventions that extend beyond 
one year, with a sensitivity analysis of 1.5% [30]. For childhood obesity prevention 
interventions, the effect of discounting will cause future health gains to be devalued [26]. 
However, failure to discount future benefits would consider interventions to be more cost 
effective than they would otherwise appear [176]. 
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Methodological challenges of conducting economic evaluations 
There are four key methodological challenges that face the economic analyst when conducting 
evaluations of public health interventions [29]: 
These comprise firstly, the problems of attributing effects and time scales to a specific public 
health intervention: most published guidelines, including NICE, recommend the use of RCTs 
to compare alternatives. There are likely to be fewer controlled trials of public health 
interventions because of the very large sample size required to power pragmatic trials of public 
health interventions adequately. Whilst public health interventions could be expected to have 
an impact over the longer term, follow up in clinical trials is often limited to one or two years 
at most. 
Secondly, measuring and valuing outcomes: in economic evaluations of clinical interventions, 
outcomes are often measured in natural units or QALYs. In the economic evaluation of public 
health interventions, other outcomes might be important including effects on individuals not 
directly targeted by the intervention and other non-health related effects such as education. 
Some of these effects can be incorporated into QALYs, some not. So alternative measures need 
to be adopted and offset against costs using different frameworks for economic evaluation. 
Thirdly, incorporating equity considerations: in many cases the aim of the public health 
intervention is to reduce inequalities. The normal assumption in economic evaluation methods 
is that a QALY is of the same value to everyone who receives it and resources are allocated 
using a maximisation principle to achieve the greatest amount of QALYs for every unit of 
resource. It is possible to move to a position in society where inequalities in QALYs are reduced 
but this would require a trade-off from the most efficient allocation, and requires a change to 
the framework of economic evaluation. 
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Fourth, identifying inter-sectoral costs and consequences: the impact of the public health 
interventions can be wide-ranging. The costs and benefits may fall on parts of the public sector 
not confined to health alone, such as the judicial system, education and housing. There is a 
consensus within the economic guidance that wider social and environmental costs and benefits 
should be looked at due to the complex nature of public health but it is unclear how this is done 
in practice with the opportunity costs in other non-health settings unknown [29]. 
There are also some additional technical (methodological) and context specific challenges of 
conducting economic evaluations in LMICs as below [177]: 
Technical (methodological) difficulties include: 
 Scarcity of robust local clinical data. 
 Lack of data on costing (e.g. unit cost, source of cost). 
 Paucity of commonly accepted guidelines (e.g. perspective, discounting) for economic 
evaluations. 
 Lack of local data or appropriate value sets for estimating QALYs or DALYs (in CUA). 
 Difficulty in interpreting and using the findings of a CEA and CUA (e.g. lack of an 
equivalent threshold value for a QALY). 
Context specific difficulties include: 
 Economic evaluations are not formally linked to the healthcare decision-making 
process. 
 Limited local research capacity to undertake economic evaluation. 
 Lack of funding for the necessary research. 
 Communication barriers between researchers, academia and end users of the evidence. 
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 Limited number of published local journals with a standard review process. 
 
3.5 HRQoL Measurements for Economic Evaluation  
The concept of HRQoL takes into account several dimensions of health. It has been recognised 
as an increasingly important concept, because it acknowledges the subjective perception of 
disease and health [69]. It may be more accurate and appropriate in assessing someone’s health 
status as it allows assessment of health benefits before the consequences of disease are 
physically manifested. 
 
3.5.1 HRQoL in Children 
Weight prevention and management interventions have increasingly targeted primary school-
aged children to address the growing problem of childhood obesity [47]. This has implications 
for choosing the methods of outcome measurement within economic evaluation of these 
interventions as few instruments exist which are designed to generate utilities in this age group 
[47].  
HRQoL for adults has been widely accepted as an endpoint in a research and clinical setting. 
In contrast, the assessment of HRQoL among children has only gained interest and awareness 
in recent years. Assessment of health status in children differs from adults as it requires a 
different conceptual approach because of rapid rates of development, dependency on 
parents/caregivers and differences in disease epidemiology [178]. The assessment of each 
individual’s HRQoL relies on their subjective evaluation of functioning in different domains. 
It was believed that children’s subjective health reports were not reliable and were therefore of 
limited use [179]. But, research demonstrates that primary school-age children, aged 8-10 years 
[180], and maybe even younger [181] can adequately reflect and report their health state if 
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instruments are adapted to them. HRQoL measurements may either be self-administered or 
administered by parents, caregivers or researchers. Because the cognitive and language skills 
of young children are not completely developed, it is essential to rely on parents/caregivers or 
researchers for the assessment of HRQoL in this age group. Many aspects of QALY 
measurement in young children are not completely developed and as a result hinder their 
application in CUA [182]. 
 
Generic Measures 
Currently, there are a range of generic health related QoL instruments available which can be 
used in all conditions. These measures include: CHU-9D; EuroQol-5 Dimension Youth (EQ-
5D-Y); Health Utility Instrument (HUI-2); and Paediatric Quality of Life Inventory TM 
(PedsQL). 
 
CHU-9D 
As discussed in chapter 1, ideally, utility-based HRQoL in children should be measured using 
an instrument specifically designed for them. Although there is no gold standard for measuring 
utility-based HRQoL in primary school-aged children, previous research has shown the CHU-
9D, a recently developed instrument, is the most appropriate choice [38]. As a utility-based 
instrument, it is preference-based and thus generates utility values anchored between the values 
of 0 (death) and 1 (perfect health), with negative values denoting states worse than death. It is 
not specific to any one condition or disease. It is designed for application in cost-effectiveness 
analyses of prevention, treatment and service programmes targeted at young people where the 
QALY is the desired outcome measure [183]. Originally tested for children aged 7–11 years 
[39, 40], it has more recently demonstrated good construct validity in 11–17 year olds [41]. The 
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tool has successfully been applied to wider populations, from six years old up to 17 years old 
[42, 43]. 
The CHU-9D instrument combines nine dimensions of HRQoL: worried; sad; pain; tired; 
annoyed; schoolwork/homework; sleep; daily routine; and ability to join in activities [39, 184]. 
Each dimension comprises five severity levels, resulting in 1,953,125 unique health states 
associated with the measure. Each child under investigation completes the questionnaire and an 
analyst (researcher) can attach a utility value for the child’s health state by using the appropriate 
algorithm. QALYs are calculated for each individual, over the specific period, using the 
standard area under the curve approach [36]. 
 
EQ-5D-Y and HUI-2 
In 2010, the EQ-5D-Y was developed which is designed specifically for children [185]. The 
EQ-5D-Y has been tested for feasibility, validity and reliability in children, adolescents and 
young adults aged 8–19 [186]. This instrument is not applicable for infants and young children 
younger than 4 years. The EQ-5D-Y was adapted directly from the EQ-5D. The EQ-5D-Y 
describes five dimensions of HRQoL and wording of the questions in each dimension is 
modified to make it relevant to a younger age range. For instance, mobility is referred to as 
‘walking about’ [186]. Similar to the 3L-version adult instrument, there are three severity levels 
for each dimension (no problems, some problems, extreme problems). Until the EuroQol group 
produces tariff values for the EQ-5D-Y, the use of EQ-5D-Y is not recommended for utility 
elicitation in young children [38].  
The HUI-2 is a generic measure of health status which has been used extensively in both clinical 
and general populations, in both children and adolescents [187]. But, it has rarely been studied 
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with regard to child and adolescent obesity [188]. This instrument has been valued using a 
sample of parents from Hamilton, Canada and allows utility estimation. The HUI-2 
questionnaire has six dimensions: sensation, mobility, emotion, cognition, self-care and pain. 
Each of these has between three and five levels. The use of HUI2 has been recommended by its 
developers for use in children of five years and older.  
 
PedsQL 
The PedsQL is a non-preference based instrument and therefore does not apply any explicit 
weighting between item domains. It therefore cannot be used to generate utility values for the 
construction of QALYs. However, it would be expected to produce HRQoL values which move 
in the same direction as the utility measures. This instrument is a widely used HRQoL 
instrument validated for use with young children over 5 years old. It has good reliability and 
validity in both sick and healthy populations [189, 190]. It is a 23-item instrument comprising 
four domains: physical (8 items), emotional (5 items), social (5 items), and school (5 items) 
functioning [189]. Each item has five response options: never; hardly ever; sometimes; often; 
almost always. Emerging from the instrument is a score (transformed on to a 0–100 scale) for 
each domain and a score for total HRQoL. A low score indicates a poor HRQoL, and a high 
score indicates high HRQoL.  
 
3.5.2 HRQoL in Adult (Spillover Effects)  
The acknowledgement that behaviour change interventions have spillover effects on family 
members has led to an increased interest on how to adapt methods for capturing these broader 
effects to maximise population health, rather than just the target participant’s health [45]. The 
choice of evaluative space of health (e.g. EQ-5D), which is designed to measure a generic-
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related HRQoL and is not specific to any one condition or disease, for economic evaluation is 
an important value judgment which can have a large impact on resource allocation decisions 
[30].  
 
Generic Measures 
Currently, there are a range of generic health related utility-based QoL multi-attribute 
instruments available which can be used in all conditions. These measures are used in 
conducting a CUA. These include: EQ-5D (3L and 5L); Short Form 6 Dimension (SF-6D); and 
Health Utility Instrument (HUI3) [36]. 
 
EQ-5D 
EQ-5D is recommended by decision-makers (NICE) [30] and it is one of the most commonly 
used instruments to estimate HRQoL. The EQ-5D is a measure used to capture HRQoL through 
a combination of five dimensions: mobility; self-care; usual activities; pain and discomfort; and 
anxiety and depression [191]. Each dimension comprises three (no problems, some problems, 
extreme problems (unable)) or five (no problems, slight problems, moderate problems, severe 
problems, extreme problems (unable)) possible levels to describe the extent of the problem 
associated with each domain. The individual under investigation completes the questionnaire 
and an analyst (researcher) can attach a utility value for the individual’s health state by using 
the appropriate algorithm derived from a population sample. This accounts for public 
preferences, to obtain an overall EQ-5D utility index score for the individual [192]. QALYs are 
calculated for each individual, over the specific period, using the standard area under the curve 
approach [36]. 
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However, EQ-5D may not be appropriate in all cases as it may not be sufficiently sensitive or 
relevant for all conditions. It is recognised that some clinicians and researchers do not consider 
EQ-5D to be a suitable measure because they are usually interested in condition specific 
outcomes [193].  
 
SF-6D and HUI-3 
The SF-6D is a measure used to capture HRQoL through a combination of six dimensions: 
physical functioning; role limitations; social functioning; pain; mental health; and validity. SF-
6D was not originally designed as a preference based measure. It is developed from a non-
preference based measure (SF-36) [194] and generated by mapping either the non-utility based 
SF-12 or SF-36 to SF-6D. 
The HUI3 is recommended for primary analysis in adults. Dimensions include vision, hearing, 
speech, ambulation, dexterity, emotion, cognition and pain. The system exists in two 
complementary forms: HUI2 and HUI3 and the use of both can result in insightful results.  
 
3.6 Decision-Making beyond Economic Evaluation 
As described above and in chapter 2, in public health, decisions should be based on the best 
available evidence, and provide the best value for money. However, there are other additional 
factors which decision-makers need to consider when deciding on the implementation of public 
health interventions [195]. These factors may not be directly quantifiable. These, which were 
primarily developed for the assessment of childhood obesity interventions, include the 
following criteria: “strength of evidence”, “feasibility of implementation”, “equity”, 
“sustainability”, “side-effects”, and “acceptance by other stakeholders” [196]. These criteria 
are applicable to decision-making regarding other public health interventions as well. 
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3.7 Conclusion 
This chapter has described the theoretical foundations of economic evaluation in healthcare. 
The different types of economic evaluation have been discussed in light of methodological 
considerations, presenting the possible applications and limitations of each method (e.g 
discount rate, perspectives, sensitivity analysis). It has shown that the extra-welfarist approach 
is inclusive of welfarism; and is typically the basis on which economic evaluation is undertaken 
particularly in the West as well as internationally. There is no ‘gold standard’ method by which 
to evaluate public health interventions, although CUA has been recommended in many 
countries, for instance, in the UK by NICE. It has highlighted that model based analyses, as a 
widely used and powerful instrument, are particularly relevant to the evaluation of the cost-
effectiveness of public health interventions.  
The condition and trends in obesity rates have been described in chapter 2. This chapter has 
provided a background to economic evaluation to set the sense for later chapters. The next 
chapter will provide an up-to-date review of methods for generating economic evidence for the 
treatment and prevention of childhood and adolescent obesity.  
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CHAPTER 4. A SYSTEMATIC REVIEW OF 
METHODS, STUDY QUALITY, AND RESULTS OF 
ECONOMIC EVALUATION FOR CHILDHOOD AND 
ADOLESCENT OBESITY INTERVENTION 
 
4.1 Introduction 
As described in chapter 2, childhood obesity is a major global public health problem. Cost-
effective obesity prevention and treatment in children and adolescents is therefore a priority. 
However, despite an increasing number of intervention studies, there are relatively few 
published economic evaluations [197-199]. 
As discussed in chapter 3, economic evaluation is a means to aid decisions about public resource 
allocation [25, 26] and as obesity prevention and treatment often involves lifestyle interventions 
that have costs and consequences that fall outside the health care sector, a societal perspective 
for evaluation is usually recommended [26]. 
Seven recent reviews [101, 196, 200-204] have summarised the cost-effectiveness of obesity 
prevention and/or treatment interventions in young people however none were designed to offer 
a rigorous review of methods applied for economic evaluation. Five reviews had language 
restrictions [101, 196, 200, 201, 203] and four excluded studies that were conducted in 
developing countries [101, 196, 201, 203], limiting global interpretation. Only two reviews 
appraised methods for handling inter-sectoral costs [101, 203]. Just three of the reviews used 
established criteria e.g. Drummond checklist [36] to assess the quality of the primary studies 
62 
 
[101, 200, 203]. The search strategy was inadequate (e.g. search terms not fully reported) in 
three reviews [196, 201, 204], and in the remaining four there were omissions of relevant 
databases, which means that relevant studies could have been missed [101, 200, 202, 203]. 
Furthermore, the most recent review, which only focused on interventions in pre-school 
children, included studies reported up to November 2015 and, at least 3 new economic 
evaluation studies of childhood obesity interventions have been published since then [205-207].  
This chapter reports on a systematic review of published economic evaluations of obesity 
prevention and/or treatment interventions in children and adolescents (0-19 years) with the 
primary objective of appraising the methods used and assessing the quality of the economic 
evaluations using the Drummond checklist [36]. More specifically this review provides a 
systematic overview of the study context; the type of economic evaluation and measures of 
effectiveness; the evaluation perspective taken; the time horizon considered and type of 
modelling approach taken; the choice of discount rate; the methods for collecting and estimating 
resource use/costs; and the type of sensitivity analyses undertaken. A secondary objective was 
to undertake a narrative synthesis of the evidence of the cost-effectiveness.  
A systematic review is a widely used methodology. It is supported by many research groups 
and policy-makers. In general, it is placed at the top of hierarchy evidence regarding 
effectiveness studies, and it is robust, replicable and its results are reliable [208].  
 
4.2 Methods 
This systematic review follows the reporting guidelines of Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) [209]. The protocol is registered with the 
international prospective register of systematic reviews (PROSPERO) database ref 
(CRD42017062236) and has previously been published [210]. 
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4.2.1 Literature Search 
The following electronic health economics/biomedical databases were searched: MEDLINE 
(Ovid); EMBASE (Ovid); Web of Science; CINAHL Plus; EconLit; PsycINFO; Cochrane 
Database of Systematic Reviews (CDSR); Database of Abstracts of Reviews of Effects 
(DARE); the National Health Service Economic Evaluation Database (NHS EED); Health 
Technology Assessment (HTA) and Cost-Effectiveness Analysis (CEA) Registry. The 
following sources were also used to identify potential additional studies: Google Scholar; 
relevant NICE guidelines; the reference lists of eligible studies and review articles; and Grey 
literature such as OpenSIGLE, National Obesity Observatory, NHS Evidence, National 
Technical Information Service, Healthcare Management Information Consortium (HMIC) and 
RepEC (Economic Working papers) database. The search was conducted in May 2017 and 
studies were sought between January 2001 and April 2017. The year 2001 was chosen since the 
first study evaluating the cost-effectiveness of a childhood obesity treatment intervention was 
published then followed 2 years later by the first economic evaluation of a childhood obesity 
prevention intervention [202]. Search strategies included Medical Subject Headings (MeSH) 
terms and text words of key papers that were identified beforehand. The search terms and text 
words were adapted for use within other bibliographic databases. The full search strategy is 
provided in Appendix 1.1. 
 
4.2.2 Inclusion and Exclusion Criteria 
Economic evaluations were included or excluded based on the following criteria: 
Types of study: Primary full economic evaluations were included (studies in which both the 
costs and outcomes of the alternatives are examined and in which a comparison of two or more 
interventions or case alternatives are undertaken) including trial-based and model-based (using 
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trial data) evaluations. Partial economic evaluations; qualitative studies; conference abstracts; 
and study protocols were excluded. 
Participants/ population: Children and adolescents aged 0-19 years at the start of the 
intervention and/or their parents/guardians were included. Family based interventions were also 
included when the target participants were the children. Economic evaluations undertaken 
within any country context were included. Interventions to tackle obesity due to a secondary 
cause (e.g. Prader-Willi syndrome) were excluded. 
Intervention(s), exposure(s): All behavioural (focused on individual behaviour change 
techniques), environmental (focused on modifying the local environment) or policy (focused 
on population-wide legislative or fiscal action) interventions for the treatment or prevention of 
overweight/obesity in children and/or adolescents were included. Pharmacological or surgical 
interventions were excluded. 
Comparator(s)/control: Only studies with a clearly defined comparator were included with no 
restrictions on the types of comparator(s).  
Outcome(s): No restrictions on outcomes measures. Potentially relevant outcomes were: 
DALYs; QALYs; effectiveness outcomes such as kilogramme weight loss; % Body Fat; BMI 
z-score; waist circumference; overweight and obesity cases avoided; additional minute of 
MVPA; increase in overall physical activity level and METs hour gained.  
Other criteria: There were no restrictions based on language, evaluation perspective taken, 
duration of intervention, time horizon for evaluation or setting. 
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4.2.3 Study Selection Procedure 
The review followed a two-stage method. First, the main researcher (Mandana Zanganeh) and 
an independent researcher (James Hall) individually screened titles and abstracts of identified 
publications against the selection criteria. If in doubt, the full text version was requested. 
Second, full-text papers were reviewed by both researchers and a final decision made with 
respect to the inclusion/exclusion criteria. There was 85% agreement between the 2 reviewers. 
Any disagreements between the reviewers over the eligibility of specific studies were resolved 
by discussion between the main reviewer and all supervisors (Emma Frew, Peymane Adab, Bai 
Li). To aid study selection and analysis of non-English language articles, translation either in 
part or in whole was undertaken by academic colleagues with the appropriate language skills. 
The literature search results were managed using EndNote X7 (Thomson Reuters). 
 
4.2.4 Data Extraction 
The study characteristics and findings were recorded by the main researcher (Mandana 
Zanganeh) using a standardised, pre-piloted data extraction form. Extracted information 
included: authors; publication year; country; study design; setting; target population/age group; 
N (analytical sample); parent/guardians included; intervention overview/target; aim of the 
intervention/mode of delivery; comparator; measures of effectiveness; type of modelling 
approach; study perspective; duration of intervention/follow-up; time horizon; price year; 
currency unit; discount rate; methods for estimating/collecting resource use; costs categories; 
largest cost drivers; excluded costs; total/average costs per participant; funding source; 
ICER/average cost per benefit; uncertainty analysis; sensitivity analysis; and cost-effectiveness 
results.  
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This process was checked for completeness and accuracy by an independent researcher (James 
Hall). Any discrepancies between the reviewers over the data extraction process was identified 
and resolved by discussion or by consensus with all three supervisors. Missing data was 
requested from study authors. 
 
4.2.5 Quality Assessment of Included Studies 
To allow a comparison of the economic evaluation methods used in the studies, the Drummond 
checklist was used by the main researcher (Mandana Zanganeh) [36]. Given that none of the 
available checklists or scoring schemes had been validated to quantify the methodological 
quality, quality assessment of individual items or an overall summary score was not applied. 
Instead, the quality assessment provides a systematic and critical descriptive overview of key 
methodological elements. A full copy of the quality assessment sheet is presented within 
Appendix 1.2. Quality assessment of the included studies was independently checked for 
completeness and accuracy by an independent researcher (James Hall) and any discrepancies 
were resolved by discussion with all three supervisors. 
 
4.3 Results 
Figure 4.1 illustrates the flow of papers identified, screened and included in the review. Of the 
4,185 studies identified in the initial literature search, 2,607 were screened. From the screened 
papers, 2,559 were excluded based on titles and abstracts. 48 articles were considered 
potentially relevant and remained for subsequent detailed assessment. Of these, 39 were in line 
with the eligibility criteria. Therefore, these articles were included in the analysis and synthesis. 
The most common reasons for exclusion were the lack of (full) economic evaluations, being a 
protocol study, or including an ineligible target population. 
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Figure 4.1 - Adaptation of PRISMA 2009 flow diagram  
 
4.3.1 Details about Study Context 
Full details about study context are presented in Appendix 1.3 (i) - 1.3 (iv), and summarised in 
Table 4.1.   
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Table 4.1 - Summary of general characteristics of the studies 
Study characteristics Number of studies identified (%)  
Year of publication 
2001-2009 17 (44)  
2010-2017 22 (56)  
Study approach 
Trial-based            Prevention 9 (23)  
          Treatment 7 (18) 
 
 
Model-based           Prevention 19 (49)  
          Treatment 4 (10)  
Comparator selected 
Usual care 33 (85)  
Another intervention 6 (15)  
Country 
High-income            
Australia 
New Zealand 
The USA 
Canada 
The UK                          
 
15 (38.5) 
2 (5) 
12 (31.5) 
1 (2.5) 
4 (10) 
 
Germany 2 (5)  
Finland 1 (2.5)  
Spain 
Low and middle-income 
China 
1 (2.5) 
 
1 (2.5) 
 
Setting 
Prevention 
School                                  
US/Australian state         
 
21 (54) 
5 (13) 
 
Community                    1 (2.5)  
Home           
 
Treatment 
Clinical                          
1 (2.5) 
 
 
9 (23) 
 
School 
Community            
1 (2.5) 
1 (2.5) 
 
 
 
Intervention and Comparator 
Approximately half of the economic evaluations (23/39) were model-based [196, 207, 211-226] 
compared to trial-based evaluations. A range of interventions were identified, all containing 
individual behaviour change elements (Figure 4.2). A large proportion (25/39) (including all 
treatment interventions) were focused exclusively on behaviour change techniques, the rest 
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combined individual behaviour change elements with either an environmental component 
(modifying the local environment e.g. active school transport) [115, 206, 215-219, 227] or a 
policy component (population-wide legislative or fiscal interventions such as banning 
unhealthy food advertising or a physical education policy) [211, 213, 214, 221, 224, 228]. 
Approximately half of the interventions (21/39; 12 prevention and 9 treatment) targeted a 
combination of physical activity and dietary behaviours [17, 115, 196, 205, 212, 218, 222-227, 
229-234], the rest focused on either physical activity [206, 211, 215-217, 219, 228, 235-237] 
or dietary habits only [196, 207, 213, 214, 221, 238].  
 
 
Figure 4.2 - Summary of the interventions 
 
The intensity of the interventions differed considerably. For prevention interventions, this 
ranged from one session per 3 months [229] to approximately 2 sessions per month [235]; and 
for treatment interventions, ranged from one [205] to 12 sessions per week [230]. The duration 
of the interventions also differed, ranging from 8 months [237] to 4 years [236] for prevention 
studies; and from 3 months [205] to 1 year [230] for treatment studies. Overall therefore, the 
treatment interventions were generally more intensive but delivered over a shorter time period 
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compared to prevention interventions. The comparison or control group was not always clearly 
specified but was assumed to be “usual care” in most of the studies (33/39) and often the studies 
did not justify their rationale for choosing the comparator. 
 
Country and Setting 
The evaluations were spread across a wide range of countries and study settings. The vast 
majority (38/39) originated from high-income countries, mainly Australasia (Australia (n=15) 
[196, 206, 214-218, 226, 229, 234] and New Zealand (n=2) [220, 227]), with 13 from North 
America (USA (n=12) [115, 207, 211-213, 221-224, 228, 230, 233], Canada (n=1) [231]) and 
8 from Europe (UK (n=4) [205, 219, 225, 232], Germany (n=2) [235, 236], Finland (n=1) [238], 
Spain (n=1) [237]). Only one study was from a developing country context - China [17]. In 
terms of study setting, the majority of prevention interventions (21/28) were school-based [17, 
115, 206, 207, 212, 215-218, 220, 222, 223, 227, 233, 235-237] and for treatment interventions, 
most (9/11) took place in clinical settings [196, 205, 225, 226, 230-232, 234, 238]. 
 
4.3.2 Review of Economic Evaluation Methods  
A detailed account of the economic evaluation methods are presented in Appendix 1.4 (i) - 1.4 
(iv), Appendix 1.5 (i) - 1.5 (iv), and Appendix 1.6 (i) - 1.6 (iv). 
 
Type of Economic Evaluation and Measures of Effectiveness 
Focusing on the methods of economic evaluation, most studies performed a CEA using raw or 
standardised BMI as a measure of clinical outcome (26/39) (18 prevention and 8 treatment), 
whilst a few used other outcomes (e.g. cost per case of overweight/obesity prevented, cost per 
unit increase in MET minutes, reduction in body fat). Within these studies, more than half 
(16/26) conducted a CEA only [17, 115, 206, 211, 224, 225, 227-233, 235, 237, 238], whereas 
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the rest combined a CEA approach with a CUA [205, 213-219, 221, 226] using QALYs as the 
outcome measure. Eleven further studies conducted a CUA only [196, 207, 212, 220, 222], 
while only two used a CCA [234, 236]. The vast majority of trial-based economic evaluations 
(15/16) did not use QALYs/DALYs whereas the model-based evaluations (n=20) tended to 
report QALYs/DALYs as the main health outcome measure. When QALYs were used, the age 
of the participants was between 6 and 11 years in the trial-based economic evaluation [205], 
and between 2 and 19 years in the model-based economic evaluations. Educational attainment 
outcomes were not explored in any of the studies. Approximately half of the studies did not 
justify the choice of form of economic evaluation related to the question and the outcome 
measure selected. 
A pattern with preferred type of economic evaluation by country context was apparent. Within 
Australasia (13/17) a CUA or a combination of CUA and CEA [196, 214-218, 220, 226] was 
most popular, whereas the majority of studies from North America (7/13) [115, 211, 224, 228, 
230, 231, 233], and the only study from China [17] conducted a CEA only. Across Europe, only 
UK-based studies used CUA [205, 219]. In terms of study setting, a CEA was most common in 
clinical settings (7/9), whereas within school settings a mixed approach was applied with around 
half conducting a CEA (12/22). There was no clear pattern found in terms of approach taken to 
evaluate prevention or treatment interventions. Similarly, mixed approaches were applied to 
evaluate the different type of interventions. Slightly more studies used QALYs/DALYs to 
evaluate “behavioural interventions” (14/25), compared with “behavioural and environmental” 
(5/8) [215-219] and “behavioural and policy” (3/6) [213, 214, 221] interventions, but there was 
no clear pattern identified.  
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Evaluation Perspective Taken 
An economic evaluation is of most importance to policy makers as it points out to whom the 
costs and benefits occur. Most (35/39) studies clearly reported the study perspective. The 
majority (n=28) were from a societal perspective. Interestingly, none of the UK studies [205, 
219, 225, 232], compared to most of those conducted within Australia and the USA, applied a 
societal perspective. Two studies reported using a health care perspective, but from the data 
reported it was clear that wider societal costs were included within a secondary analysis [205, 
234].  
For all interventions that included either a policy or environmental component (12/14), the 
perspective was societal, whereas for interventions focused exclusively on individual behaviour 
change a combination of societal (17/25) and healthcare (6/25) perspectives was undertaken. A 
societal perspective was also adopted by the vast majority of interventions in school settings 
(19/22), compared to less than half of the interventions in clinical settings (4/9) [196, 226, 230, 
234].  
 
Time Horizon Considered and Type of Modelling Approach Taken 
The time horizon within economic evaluation refers to the duration over which outcomes and 
costs are measured and this should be explicit and justified. The evaluated duration of 
intervention delivery should ideally reflect how the intervention would be applied in real life.  
The time durations for the trial-based economic evaluations were predicted by the period of the 
trial. Of interest this ranged from 8 months [237] to 6 years [236] in the prevention studies; and 
from 10 months [233] to 15 months [234] for the treatment interventions. For the model-based 
evaluations, the time horizon was more at the analysts discretion and within this review ranged 
from at least 10 years (n=5) [211, 213, 221, 223, 224] to a lifetime (15/23) [196, 207, 214-218, 
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220, 225, 226]. The time horizon was also found to be much shorter within clinical settings 
(6/9) [205, 230-232, 234, 238] compared to the other study settings such as schools for example. 
The majority of the studies did not justify their choice of time horizon. The vast majority of 
model-based studies (20/23) were from Australia and the USA, with the rest from the UK and 
New Zealand [219, 220, 225]. The time horizon was also found to vary by intervention setting 
with clinical settings having the shortest time horizon (6/9) [205, 230-232, 234, 238]. 
With respect to modelling, the vast majority of model-based studies (18/23) applied Markov 
modelling [196, 211, 213-218, 220, 221, 224-226] compared to decision tree [207, 212, 219, 
222, 223]. The majority of the model-based studies did not justify their model choice and the 
description of model details was suboptimal in most of them. 
 
Choice of Discount Rate 
For the majority of the trial-based studies (10/16) (4 prevention and 6 treatment), discounting 
was not appropriate as the time horizons considered were relatively short (less than one year) 
[17, 115, 205, 230-233, 235, 237, 238]. For all the trial-based studies of more than one year, all 
reported using a discount rate in accordance with the relevant country guidelines apart from one 
prevention trial from New Zealand [227], which used a 5% discount rate per year for costs, 
rather than the 3.5% discount rate per year for both costs and outcomes recommended [239]. 
Most model-based studies (22/23) applied a discount rate for both costs and outcomes (3% per 
year for Australia (n=12) [196, 214-218, 226], the USA (n=8) [207, 211-213, 221-224] and the 
UK (n=1) [225], and 3.5% per year for New Zealand (n=1) [220]. Interestingly, the rates used 
for studies from Australia and the UK were not in accordance with their respective country 
guidelines (which is 5% per year for Australia according to Pharmaceutical Benefits Advisory 
Committee (PBAC) and 3.5% per year for the UK according to NICE) [161, 240]. However, 
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different state governments in Australia recommend different rates and the discount rate used 
in the included Australian and UK studies was consistent with the US panel recommendations 
[162]. Most of the studies did not justify their choice of discount rate. 
 
Methods for Collecting and Estimating Resource Use/Costs  
Half of the trial-based evaluations (8/16) (4 prevention and 4 treatment) reported their methods 
for collecting resource use [205, 206, 229, 230, 232, 234-236], while only 10 out of 23 model-
based evaluations (9 prevention and 1 treatment) did so [207, 211, 213, 215-218, 221, 224, 
226].  
As expected, the choice of inclusion of a particular type of cost varied considerably according 
to the study purpose, perspective, setting and the nature of the intervention being evaluated. 
Costs tended to be categorised into programme delivery, direct medical (e.g. healthcare visits), 
direct non-medical (e.g. travel time/cost for participants) and indirect (e.g. productivity losses 
because of parents’ absence from work). In line with recommendations for CEA [241], the 
development/set up costs were not considered in the vast majority of studies, apart from one 
trial-based prevention study from the USA [228]. 
Of the 9 studies (5 prevention and 4 treatment) that included indirect costs incurred by parents 
[115, 205, 215, 216, 218, 226, 230, 234, 236], these were mainly from Australia (n=5) and most 
of them were for preventive “behavioural” interventions within a school-based setting (5/9). 
Also, direct non-medical costs were reported by 4 prevention studies from Australia [215, 218, 
226, 234] and 1 treatment study from the USA [230]. Most of these types of costs (3/5) were 
for “behavioural” interventions implemented within a clinical setting. 
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Sensitivity Analysis Undertaken 
The majority of the trial-based studies (10/16) conducted a deterministic sensitivity analysis to 
assess the robustness of the results [115, 205, 206, 227, 229, 234-238], while the other 6 
prevention/treatment studies did not conduct any type of sensitivity analysis. Three of these 6 
studies were from the USA [228, 230, 233], while the others were from Canada, China and the 
UK [17, 231, 232].   
Most of the model-based studies (22/23) apart from the study by Pringle et al (2010) from the 
UK [219], conducted at least one type of sensitivity analysis. The majority of these studies 
(n=20) conducted both DSA and PSA, while one treatment study from the UK within a hospital-
community setting conducted only a DSA [225] and the other prevention study from the USA 
within a school setting conducted only a PSA [212]. Almost half of the studies did not justify 
the choice of the variables for sensitivity analysis. 
 
4.3.3 Narrative Synthesis of Cost-Effectiveness Evidence 
The most common method for presenting cost-effectiveness evidence was the ICER (30/39). 
The vast majority of the studies (33/37), excluding the CCA ones, reported results that were 
cost-effective. Some of these (13 of the model-based prevention/treatment studies including 5 
by Carter et al (2009)), [196, 213, 214, 219, 221-225] illustrated cost saving results. For 
instance, Long et al (2015) concluded that a sugar-sweetened beverage excise tax would 
increase benefits in terms of DALYs averted and result in healthcare cost savings in the USA 
[213]. Almost half of these 13 studies that illustrated cost-savings were from Australia, 
followed by 5 from the USA and 2 from the UK. None of the trial-based evaluations reported 
cost saving results, probably due to shorter time horizons. Whilst the findings are not directly 
comparable between studies due to the heterogeneous nature of the methods used, all of the 
76 
 
studies which evaluated interventions targeting only dietary habits (8/8) and the majority of the 
studies targeting both physical activity and dietary habits (19/21) indicated cost-effective or 
cost saving results. However, the studies which focused on only physical activity indicated a 
proportionally smaller number of cost-effective or cost saving results (7/10). Furthermore, the 
evidence suggests that the majority of behavioural interventions supported by a policy 
intervention (4/6) were cost-saving [213, 214, 221, 224].  
A small number of studies (n=4) [205, 215-217] reported interventions to not be cost-effective. 
The UK trial-based treatment study [205], which targeted a combination of physical activity 
and dietary habits with the aim to reduce weight gain in children with obesity remained cost-
ineffective using a CEA/CUA approach regardless of the choice of perspective. Also, the 3 
model-based studies that targeted only physical activity were not cost-effective, for example, 
the “Walking School Bus” programme which had a high cost of delivery coupled with low 
participation rates [215]. 
 
4.3.4 Quality Assessment of the Included Studies  
The quality of reporting the economic evaluations was assessed using the Drummond checklist 
- a 35-item instrument with a total of 3 domains. The expected possible responses to each 
question were: Y=Yes, N=No, NC=Not clear, N.A.=Not Applicable. Full details of the quality 
assessment are presented in Appendix 1.7 (i) – 1.7 (iv). None of the included studies fulfilled 
all of the quality criteria. The most positive aspect of the quality assessment is that none of the 
studies was ranked as “worthless”. Most studies fulfilled a large number of the quality criteria 
and only a small number of the studies were poor. One challenge regarding the quality 
assessment was that quality was judged based on the published data only and there might be a 
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difference in what has been reported and what has actually been done. So a bad scoring study 
might just be due to lack of transparency rather than lack of quality.  
Certain criteria were simply not applicable to each respective study (e.g. items 12–15, due to 
different perspectives chosen), while others were not reported. As there are 16 trial-based 
studies, all the questions dealing with the quality of models had to be answered with “N.A.” for 
them. The three criteria which were least well addressed were the rationale for the comparator, 
the justification for the choice of discount rate, and the model choice. The description of model 
details was suboptimal in most of the model-based studies. Whilst the time horizon for each 
study was generally well specified, most studies omitted to provide reasons for choice. 
Additionally, approximately half of the studies did not justify the choice of economic evaluation 
nor offered justification for what was explored within a sensitivity analysis. 
 
4.4 Discussion 
This is the first study to conduct a rigorous review of the methods for economic evaluation and 
to determine how these methods vary by setting, country and intervention type. Therefore this 
review provides an important contribution to the current knowledge gap in a relevant and fast 
growing field. 
In this systematic review, it was found that most of the studies (38/39) were from high income 
countries. Only one evaluation was identified from a developing country context [17], where 
the obesity epidemic is rapidly increasing. It was also found that economic evaluation of obesity 
interventions in children and adolescents is an expanding area of research, with a third of 
included studies being published within the last 5 years. Whilst growing attention is being given 
to effective and well-conducted intervention studies to prevent or treat obesity in children [198, 
199], few interventions to date have been subjected to economic evaluation and therefore the 
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number of published economic evaluations is relatively small. Also, the interventions which 
have been evaluated in terms of their economic credentials are narrow in terms of their content; 
most related to health promotion programs, with only a couple targeting tax legislation. 
The review identified some emerging patterns. The results suggest that among the published 
economic evaluations, there was no consistent measure of outcomes. Around half of the studies 
reported clinical (e.g. BMI), rather than health-related outcome measures commonly used 
within economic evaluation (QALYs/DALYs). The dearth of trial-based studies that included 
QALYs or DALYs (1/16) [205] suggests that the measurement of these types of outcomes 
within obesity trials is not firmly established or may relate to reported lack of sensitivity of 
utility-based HRQoL instruments to changes in overweight/obesity in younger children [42]. 
This heterogeneity of outcome measures will hinder comparability of cost-effectiveness.  
The overall pattern to emerge from the results of one systematic review suggests that there is a 
weak negative association between obesity and educational attainment in children and young 
people. I.e.  higher weight is weakly associated with lower educational attainment [242]. 
Obesity is also associated with other variables, such as socio-economic status, and when these 
are taken into consideration, they may better explain much of the negative association between 
obesity and attainment [242]. The results from longitudinal studies indicate that, in general, 
obesity in children was associated with lowered educational outcomes [243, 244], especially 
for girls. It was also found that having friends with overweight and obesity drives down the 
odds of educational success. Attendance at a higher SES school or a school with a lower 
percentage of minority students was positively associated with the odds of college attendance 
and obtaining an undergraduate degree [243]. 
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Educational attainment outcomes were not explored in any of the studies. This is because the 
measurement of these types of outcomes within obesity trials is not firmly established globally. 
Also, as educational outcome data are very rarely considered in economic evaluations, 
guidelines for including these data are limited. It is challenging to estimate what a given society 
may be willing to pay for a unit gain in an educational outcome. It might be more appropriate 
to use a CBA or a CCA to report improvement in educational outcomes alongside costs but not 
to try and offset the two against each other. A more disaggregated analysis (e.g. a CCA) 
alongside a CEA and CUA would give a ‘list’ rather than offset against the costs. 
No evaluation applied a CBA approach. Consideration of broader outcomes going beyond the 
health sector allows for inclusion of costs and effects from multiple sectors and is particularly 
relevant for obesity intervention. This is an emerging area of development within economic 
evaluation and efforts are being made to adapt methodologies to promote the use of CBA [245]. 
These approaches have been recommended by the UK Treasury guidance to evaluate (usually 
non-health) public sector projects [246]. 
Model-based evaluations offer the opportunity to improve the generalisability of results as they 
combine data from a variety of sources. However the findings from five of the model-based 
evaluations identified within this review were based on small samples [207, 212, 219, 222, 223] 
and only one of these offered data based on a lifetime horizon. Furthermore, all of the model-
based evaluations were for interventions that targeted individual health behaviours and were 
therefore highly dependent on cultural, infrastructural and other system-related aspects. So the 
generalisability of results to other contexts, particularly from developed to developing country 
settings, would be questionable [247]. The majority of the papers did not make explicit mention 
of procedures for checking their models. Despite associated assumptions with modelling 
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studies, the studies evaluated are important as model-based health economic evaluations are 
today widely accepted as policy-making tools that can inform resource allocation decisions. 
Almost half of the model-based studies chose a lifetime perspective. 
Most trial-based and model-based evaluations in this review applied recommended discount 
rates in accordance with the relevant country guidelines. Methods for collecting resource use 
and the type of cost included were found to vary across the studies. In particular, the indirect 
costs of overweight and obesity (e.g. productivity losses) were not generally collected alongside 
the trials. It is considered good practice to report results both with and without indirect costs. 
Including indirect costs (e.g. costs incurred by families) has the potential to alter the treatment 
recommendations. 
The narrative synthesis of the economic evidence and the quality assessment of the included 
studies are useful for informing health economists/modellers and the direction for future 
research in this area. In terms of judging cost-effectiveness of interventions, context-specific 
assessment is problematic as there are different thresholds for cost-effectiveness in different 
countries. For example, in the UK, NICE recommends a threshold willingness to pay of 
£20,000-£30,000 per QALY [30], by contrast in Australia the recommendation is AU$ 50,000 
per QALY [215] and in many countries there are no clearly defined thresholds at all. Whilst 
most interventions in this review appear cost-effective using standard rules of cost-
effectiveness, there is substantial variation by intervention design.  
 
4.4.1 Review of Recent Papers Published since the Original Search 
The same search strategy used in the initial search for this study was used in September 2019 
to update the systematic review. Studies published between May 2017 and September 2019 
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were sought. Four studies were found, which were in line with the eligibility criteria. Therefore, 
these articles were included in a brief analysis and synthesis for updating this systematic review 
as below. 
Consistent with the earlier results, these 4 studies (2 prevention, 2 treatment) were also from 
high income countries [248-251] and only one of these used QALYs as an outcome measure 
[249], with the rest reporting only clinical outcome measures (e.g. BMI). Two of the studies 
used a societal perspective [248, 250]. Three conducted a sensitivity analysis to assess the 
robustness of the results [248-250]. The only model-based study was likely to be cost-effective 
[248]. Among the trial-based evaluations two, one from the UK within a school setting [249] 
and one from Sweden with a child health centre setting [250], were neither effective nor cost-
effective using clinical outcomes. The UK study was cost-effective using QALYs (ICER: 
£26,815 per QALY gained from a public sector perspective), however there was a high level of 
uncertainty as demonstrated by the net-benefit equation and the corresponding CEAC [249]. 
The other trial-based study, which was from Denmark, is one of the first studies to have assessed 
the cost-effectiveness of a camp-based obesity management intervention programme [251]. 
This study compared a standard group with a weight management camp group and, after 12 
months, showed favourable effects in the intervention arm (decreased BMI). However, the 
camp group was more costly. 
 
4.4.2 Comparison with Previous Systematic Reviews  
The finding of this study that most interventions were cost-effective or even cost-saving, is 
similar to those reported by two other reviews [200, 204], with some overlap between included 
studies. Other reviews have focused on particular age groups (e.g. pre-schoolers [101]), specific 
interventions (e.g. only physical activity [203]), or particular outcomes (e.g. anthropometric 
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measurements [101]). Two additional reviews from Australia [196] and the US [201] used the 
Assessing Cost-Effectiveness (ACE) obesity approach to summarise and compare the cost-
effectiveness of a range of interventions. However, none of the previous studies reviewed the 
methods of the economic evaluations in the way it has been outlined in this review.  
 
4.4.3 Strengths and Limitations of this Review 
One of the important strengths of this review is the comprehensive search strategy applied 
encompassing a broad range of electronic bibliographic databases of published studies and the 
grey literature (six additional studies were identified). Furthermore, the results were not limited 
to only those published in English (two non-English publications identified) and there were no 
country restrictions (there was one publication from china as a developing country), resulting 
in a more complete review than those published previously. Also, the formal quality assessment 
of the economic evaluations undertaken adds strength to the conclusions. The vast majority of 
the studies were found to be of very good reporting quality. 
The review had some limitations. As the focus was on full economic evaluations, some 
important data contained within partial evaluations may have been missed. Further limitations 
relate to the shortcomings of the included studies and underlying evidence base. There was 
heterogeneity in both the methods used and with the type of intervention being evaluated, which 
made synthesising the evidence base challenging. Not all included studies used the same 
definition of obesity, which may impact on the results. Most of the included studies reported an 
economic evaluation for an intervention that had previously been reported as clinically 
effective. It is possible that any trial which had ineffective results did not conduct an economic 
evaluation or, if they did, failed to get it published, introducing potential publication bias.   
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4.5 Conclusions 
This systematic review in this chapter suggests that current economic evaluations are mainly 
set in developed countries and the majority focus on the prevention of obesity in children, 
compared to treatment. The findings of this study show that the majority of published economic 
evaluations are for interventions with an individual behaviour change component. The majority, 
particularly “behavioural and policy” preventive interventions, were cost-effective, even cost-
saving. However, this review found that relatively few policy interventions designed to prevent 
obesity have been subject to a rigorous economic evaluation. The review found heterogeneity 
with respect to methods applied. So, to improve the evidence base further and to enhance 
comparability across interventions, we recommend a consistent and expanded form of 
economic evaluation which captures both health and non-health costs and consequences beyond 
health-gain.  
In general, the systematic review results showed that the following main gaps exist in the 
current literature: 
 Number of reported economic evaluations of obesity prevention interventions in 
developing countries is very low. 
 Inclusion of societal costs and outcomes in economic evaluations that are relevant to 
family members are rarely included within economic evaluations. 
 Number of CUAs of trial-based studies comparing obesity prevention strategies, whose 
results can be compared with other public health programmes is low across the world. 
In the next chapter, the methodological challenges of conducting an economic evaluation within 
a Chinese setting and including spillover effects are explored. This is done by evaluating the 
CHIRPY DRAGON intervention and undertaking an economic evaluation from a public sector 
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and societal perspective using both clinical and economic outcome measures. The aim is to 
provide robust evidence on the cost-effectiveness of the school- and family-based prevention 
programme when compared to usual practice in China, and to highlight the methodological 
challenges. 
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CHAPTER 5. COST-EFFECTIVENESS OF THE 
CHIRPY DRAGON OBESITY PREVENTION 
INTERVENTION IN CHINESE PRIMARY SCHOOL-
AGED CHILDREN: A CLUSTER-RANDOMISED 
CONTROLLED TRIAL 
 
5.1 Introduction 
Chapter 4 reported that the majority of preventive interventions were cost-effective. However 
the review found heterogeneity with respect to methods applied. Current economic evaluations 
are mainly set in developed countries and the measurement of QALYs within obesity trials is 
not firmly established.  
As discussed in chapters 3 and 4, QALYs are commonly used as the unit of assessment to make 
judgements about the relative cost-effectiveness of competing interventions [36] and to inform 
resource allocation decisions worldwide [37]. As obesity prevention often involves lifestyle 
interventions which have costs and consequences that fall outside the health care sector, a 
societal perspective for evaluation is usually recommended [26]. This means that all relevant 
resource use/costs and consequences are measured, outlining how these fit within a given sector 
[27].  
As discussed in chapter 2, to address the evidence gap of what interventions to implement to 
prevent childhood obesity in China, and to address the methodological challenges of conducting 
economic evaluation within this setting, the CHIRPY DRAGON study was developed using 
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guidelines from the UK MRC Framework for complex interventions [21, 22], in consultation 
with parents, grandparents, teachers and school staff. 
This is a case study used to explore and develop methods for the economic evaluation of school-
based interventions to prevent obesity in children in LMICs. This chapter will conduct a 
comprehensive economic evaluation (from a public sector and societal perspective using both 
clinical and economic outcome measures) alongside the CHIRPY DRAGON trial to provide 
robust evidence on the cost-effectiveness of this intervention programme compared to usual 
practice in China. In doing so, it will highlight, the methodological challenges of conducting an 
economic evaluation within a Chinese setting and explore and investigate the impact of 
including spillover effects. Where possible, the results are reported using CHEERS guidelines 
[48] (Appendix 2.1).  
As the CHIRPY DRAGON trial has been described in full in chapter 2, only a brief overview 
of the trial is provided (Part 1). The remainder of the methods section describes the study 
intervention and its delivery; how the resource use and costs are measured; outcome measures; 
how missing data is dealt with; and the statistical analysis plan for each of the perspectives 
separately. The results then follow. The results are separated into two parts: Part 2 refers to the 
economic evaluation from a public sector perspective and Part 3 to the economic evaluation 
from a societal perspective. Finally, in Part 4, the discussion and methodological challenges are 
reported.  
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5.2 Part 1: Methods 
5.2.1 Details about Study Context 
Trial Design and Participants 
The evaluation of the CHIRPY DRAGON obesity prevention intervention, targeting children 
aged 6-7 years at baseline, was undertaken using a cluster randomised controlled trial (cRCT) 
in 40 state-funded primary schools in Guangzhou, China. Schools were randomly allocated to 
either the usual practice (n=20) or intervention arm (n=20). In China, primary schools have an 
average of four (range two to eight) year-one classes per school. Each class consists of 
approximately 45 children. In the participating schools, all children from year-one classes (age 
6-7), along with family members, were eligible for inclusion and were offered the opportunity 
to take part in the prevention programme. One year-one class was randomly selected from each 
of the participating schools to have outcome measurements taken. Written consent was sought 
for each study participant from parents/guardians. 
 
CHIRPY DRAGON Study Intervention and Its Delivery 
The CHIRPY DRAGON programme was a 12-month multi-component intervention which was 
implemented from March 2016 to March 2017. It consisted of four components targeting diet 
and physical activity behaviours, inside and outside of school, through nine interactive 
workshops, daily family home activities, and supporting school physical-activity and healthy 
food provision. It aimed to facilitate the development and/or maintenance of a healthy weight 
through improving diet and promoting physical activity in children. The intervention was 
delivered in 20 schools randomised to the intervention arm by five full-time trained Chinese 
project staff (known as CHIRPY DRAGON teachers/researchers). This means that each of the 
five CHIRPY DRAGON teachers employed and trained by the research team were responsible 
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for the facilitation, coordination and delivery of the programme activities in four intervention 
schools. There were tailored activities for various target groups, including children; main carers 
(parents/ guardians or grandparents); school staff (principals, class teachers, physical education 
(PE) teachers, school meal director) and school lunch providers (including catering staff 
(managers and workers)). School staff had direct roles in supporting the delivery of the 
CHIRPY DRAGON intervention programme. 
The four core components within the CHIRPY DRAGON intervention were: 
Component 1: improving childhood obesity related knowledge and behaviour among 
children and their main carers 
Component 2: improving the nutritional quality of school lunch provision (generally a set 
lunch box for each child) 
Component 3: increasing children’s physical activity levels outside school 
Component 4: increasing children’s physical activity levels inside school 
Component 1 consisted of four activities. These were: 
1) Two interactive educational workshops per year (in the term one and two), held in 
school, for main carers with a leaflet to take home. 
2) Four interactive educational workshops/classroom sessions per year, held in school, for 
children. 
3) Ongoing family-wide healthy behavioural challenges and child self-monitoring during 
the week, held at home, for children and their main carers. 
4) One cross-generation health quiz event, held in school during the second term, for 
children and their main carers. 
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Main carers’ workshops focused on correcting common misperceptions identified through the 
formative research in relation to child healthy weight and healthy behaviours, and introducing 
practical parenting tips for encouraging healthy behavioural change in children. Children’s 
workshops focussed on key messages related to healthy eating and an active lifestyle. To 
encourage adoption and maintenance of the promoted healthy behaviours for this component, 
the CHIRPY DRAGON teachers asked children to set individual goals, which were challenging 
but achievable, based on their current habits within their family and rotate them every two 
weeks. These included restricting themselves to less than two hours of sedentary screen-based 
activities per day; eating at least five portions of vegetables and fruit per day and reducing 
consumption of drinks and snacks containing high levels of fat and/or sugar. All three behaviour 
challenges required written feedback from their main carers, using specially designed cards 
(“fun cards”), to be returned to CHIRPY DRAGON teachers for evaluation alongside each 
child’s self-monitoring records. The cards were used to encourage main carers’ involvement 
and support in behaviour challenges. After reviewing the cards and judging them objectively, 
based on children’s behavioural outputs, the CHIRPY DRAGON teachers rewarded best 
performance and improvements. Children were given CHIRPY DRAGON stamps for meeting 
goals or making good behaviour progress. These stamps were collected by children and were 
shown on a reward board at the back of each classroom. Each term, the three children who 
collected the most stamps, in each class were presented with an incentive prize.   
Component 2 involved introducing five school lunch improvement targets to lunch providers 
(catering staff from companies who were responsible for producing meals for intervention 
schools). These were jointly developed by Chinese nutrition experts, obesity prevention 
specialists within the research team and Chinese school meal providers (including both 
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managers and catering workers e.g. chefs). They were tested for feasibility and acceptability in 
a feasibility trial. The aims were:  
1) To restrict provision of deep-fried meals to no more than once a week. 
2) To decrease portion size for rice or noodles in younger children. 
3) To provide children with vegetables every day. 
4) To reduce high fat and processed meats from the school menu. 
5) To ensure the amount of cooking oil, salt and added sugar in each school meal was not 
more than one-third of the recommended daily intake for the Chinese children (6-7 years 
old) [252].  
These aims allowed maximum flexibility for local adoption/adaptation in response to changes 
in costs, seasonal food availability and local resources. The implementation of these aims was 
achieved through inviting representatives of each catering team, two (one manager and one 
chef) from each company, to an introductory meeting held at the Guangzhou CDC. Here it was 
explained what the catering team were required to do and how the CDC would support them. 
Regular supportive school lunch evaluation and constructive feedback in relation to the 
improvement objectives was given weekly to the lunch providers by the CHIRPY DRAGON 
teachers. Each school was scored on a weekly basis using a range of 0 - 5 by CDC [5 - excellent; 
0 - bad] according to how well they performed against each of the improvement goals. 
Component 3 promoted easy, fun and safe family-friendly physical games, exercises or sports 
activities for both children and their parents. These, which could be undertaken with minimal 
equipment and space at home, were taught and tried out during one taster session in every class 
each school term. Each family was assigned a “healthy behavioural challenge” to play one of 
the games learnt or to engage in any other sports or activities they preferred, outside of school 
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for a minimum of 30 minutes each weekend. This behaviour challenge required written parental 
feedback, using the same fun cards and procedures as Component 1. Again, the CHIRPY 
DRAGON teachers rewarded best performance and improvements. 
Component 4 consisted of improving the implementation of the Chinese national requirement 
of ‘One-Hour of Physical Activity on Campus every School Day’ in intervention schools. 
CHIRPY DRAGON teachers facilitated a 30-minute meeting at each school involving school 
principals, class-level head teachers, PE teachers and student representatives. They discussed 
their current situation, identified barriers to implementing the national requirement, which 
could be modified, as well as improvement opportunities. Additionally, monthly action goals 
and plans which were measurable, achievable and maintained or exceeded the national standard 
were set by the school staff. Continuous evaluation and feedback was provided by the CHIRPY 
DRAGON teachers on a monthly basis.  
All intervention components are summarised in Table 5.1.  
 
Comparator  
Schools allocated to the comparator/control arm continued with their ongoing standard 
provision (usual practice) during the full trial period with no access to any of the CHIRPY 
DRAGON intervention activities and resources.  
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Table 5.1 - Overview of the CHIRPY DRAGON programme 
Target groups Activities Number of sessions/workshops and setting 
Component 1: To improve childhood obesity related knowledge, skills and behaviours among children and their main carers 
Main carers (parents/guardians or 
grandparents) 
(A) Interactive educational workshops for main carers Two, school-based 
Children (B) Interactive educational activities for children Four, school-based 
Children and their main carers (C) Family-wide healthy behavioural challenges and child 
self-monitoring (during the week) 
Three daily challenges rotated every two 
weeks throughout the intervention year, home-
based 
(D) Health knowledge quiz for main cares and children One, school-based 
Component 2: To improve the nutritional quality of school lunch provision (usually a set lunch box for each child) 
School lunch providers including 
catering staff 
(A) Introduce school lunch improvement objectives which 
were set jointly by researchers and school lunch providers 
and then tested by school lunch providers (including both 
commercial suppliers and school funded catering units) 
One introduction meeting held in the 
Guangzhou CDC 
(B) Supportive school lunch evaluation and feedback in 
relation to the improvement objectives 
Continuous throughout the intervention year, 
school-based 
Component 3: To increase children’s physical activity level outside school 
Children and their parents (A) Fun and active family games taught and tried in school Two, school-based 
(B) Assign home work (a family-wide healthy behavioural 
challenge) - practice the games learnt or any other non-
sedentary activities involving the parents (at the weekend) 
At least 30 minutes of the challenge every 
weekend, home-based 
Component 4: To increase children’s physical activity level in school 
Children and school staff (A) Situation analysis in relation to current implementation 
of the Chinese national standard of having one-hour 
physical activity on campus every school day 
One staff meeting held at each school 
(B) Setting monthly goals (measurable and achievable) and 
action plans to meet, maintain or exceed the national 
standard and continuous evaluation and feedback  
Monthly meetings held throughout the 
intervention year, school-based 
Li et al. (2019) [129]
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5.2.2 Resource Use and Costs 
Rationale for Costing 
Costs collected focused on those that were likely to vary between the intervention and control 
arm.  
The costs linked to the intervention were divided into three categories: 
 Development/set-up 
 Implementation 
 Delivery/running 
Table 5.2 summarises the cost items associated with each intervention category.  
Category one consisted of costs related to the development and set-up of the intervention. 
Category two comprised costs regarding the implementation of the intervention. Category three 
costs were associated with the delivery of the intervention. 
According to standard practice, the base case analysis assumed that the intervention was in a 
‘running state’ and therefore only costs associated with the delivery of the intervention were 
included. All of the other costs (set-up and implementation) were, however, reported separately 
and implementation costs were fully explored within the sensitivity analysis.  
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Table 5.2 - Cost items by intervention category 
Category 1: Intervention development/set-up  Category 2: Intervention implementation  Category 3: Intervention delivery/running  
 Research staff time for development of 
the school teacher handbook explaining 
intervention 
 Hiring of a designer to optimise the 
presentation of intervention materials 
(leaflets and illustration media) 
 Researcher preparation time for CHIRPY 
DRAGON teacher training 
 Time and travel costs related to staff 
meeting at each school to discuss their 
current situation about children’s physical 
activity  
 
 Time and travel costs connected with 
the CHIRPY DRAGON teachers 
training to deliver workshops/sessions 
 Initial printing of school teacher 
handbooks  
 Time and travel costs related to the 
intervention set-up meeting to explain 
about the intervention components to 
school staff  
 Time and travel costs related to the 
catering team meeting for introducing 
five school lunch improvement 
objectives  
 
 
 Labour: CHIRPY DRAGON teachers’ 
time and workshop assistants’ time  
 Intervention materials used during 
workshops/sessions 
 Delivery fee for reward boards and 
loudspeakers 
 Office stationery 
 Relevant printing 
 Incentives: incentive prizes for meeting 
family healthy behaviour challenges 
and performance recognition 
certificates for catering teams 
 CHIRPY DRAGON teachers’ transport  
 CHIRPY DRAGON teachers’ 
telephone  
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Resource Use and Costs 
Resource use was collected from both the public sector and societal perspectives. For the 
former, all public sector resource use was multiplied by the relevant unit cost (Yuan currency), 
obtained from different Chinese sources such as the Guangzhou CDC, or valued at market 
prices (e.g. purchase order receipts collected by the trial team), to calculate the total cluster 
(school)-level cost. The cluster-level costs were then averaged across the number of classes and 
average number of children per class (n=45), to derive average class level and individual child 
costs for the intervention arm.  
All unit costs were reported in Chinese Yuan at a 2016-2017 price base. Gross Domestic 
Product Purchasing Power Parities (GDP PPPs) [253] were used to convert Yuan into 
Pound/Dollar (the conversion of Yuan to Dollar rate is 3.55 and to Pound rate is 5.05 using the 
Organisation for Economic Co-operation and Development (OECD) Data in 2017) [254]. [For 
details on the use of GDP PPPs - see Appendix 2.2. 
 
Public-Sector Resource Use Collection and Unit Costs (Delivery of the Intervention) 
Given the school-based multi-faceted nature of the intervention, when using a public sector 
perspective, only costs falling on the schools were included. There were four main components 
to the intervention. Study-specific resource use forms were developed for each of these and 
CHIRPY DRAGON teachers were asked to complete these during the intervention period 
(March 2016 – March 2017). A single standardized form was used to record all working time 
spent by each CHIRPY DRAGON teacher on the various intervention activities including their 
administration time. Each activity was denoted by a different letter on the form. An explanation 
of what the expected time requirements were for each intervention activity is presented in 
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Appendix 2.3, while the CHIRPY DRAGON teachers’ record of minutes worked per week on 
each intervention activity are presented in Appendices 2.4 i – iii.  
Detailed information of all resource use collected and associated unit costs applied is presented 
in Table 5.3. 
 
Component 1: Improving childhood obesity related knowledge and behaviour among children 
and their main carers (predominantly parents and grandparents) 
CHIRPY DRAGON teachers recorded how much time was spent on the delivery of the 
workshops, classroom sessions/quizzes and on reviewing/providing feedback about children’s 
performances during the week-only family healthy behavioural challenges associated with this 
intervention component, using a standardized form. Only the CHIRPY DRAGON teacher was 
involved in delivering the workshops/sessions. The materials used within the 
workshops/classroom sessions (e.g. food used in child carers workshops) or through healthy 
behavioural challenges (e.g. the CHIRPY DRAGON Reward Boards, used to record children’s 
achievements as well as the involvement of their main carers) were purchased by each CHIRPY 
DRAGON teacher either to be delivered or taken to a school in person. Any costs associated 
with delivering materials to the schools to facilitate the workshops were either directly 
calculated from an actual delivery fee or an estimation of the teacher transportation cost. 
Receipts for the materials used within the workshops/sessions (e.g. printing educational 
leaflets) were logged and costed.  
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Component 2: Improving the nutritional quality of school lunch provision  
CHIRPY DRAGON teachers recorded how much time was spent providing regular school 
lunch evaluation and feedback on the five school-lunch improvement objectives. This 
evaluation was undertaken by direct observation (once a month); review of daily lunch record 
forms (completed by lead chef) and photographs of lunch boxes (submitted weekly by catering 
or school staff). These materials were reviewed and scored weekly by the CHIRPY DRAGON 
teachers against the five pre-specified school lunch improvement goals. Reward certificates 
were issued to catering teams for best performance. Receipts for printing these were logged and 
costed.  
 
Component 3: Increasing children’s physical activity outside of school 
CHIRPY DRAGON teachers recorded how much time was spent on the delivery of the school-
based family friendly games (taster sessions) and on reviewing/providing feedback about 
children’s performances in the weekend-only family healthy behavioural challenges associated 
with this intervention component. On most occasions it was only the CHIRPY DRAGON 
teacher who was involved in delivering these workshops/sessions. However, on a few occasions 
when there was extra help from workshop assistants, these costs were also included. The 
materials used within the workshops/classroom sessions (e.g. finger board used in physically 
active family friendly games) or through the healthy behavioural challenge (e.g. CHIRPY 
DRAGON Reward Board or fun cards) were purchased by each CHIRPY DRAGON teacher 
either to be delivered or taken to the school in person. As before, any costs associated with 
delivering materials to the schools were either directly calculated from an actual delivery fee or 
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an estimation of the teacher transportation cost. Receipts for the materials (e.g. strips of cloth), 
used within the workshops/sessions were logged and costed.  
 
Component 4: Increasing children’s physical activity level in school 
Monthly meetings were held in each intervention school at which CHIRPY DRAGON teachers 
provided constructive feedback and action goals. Plans were reviewed and redefined for each 
subsequent month. CHIRPY DRAGON teachers reviewed record forms and scored each 
school’s performance against the goals (scores ranged from 0 to 3). CHIRPY DRAGON 
teachers also recorded how much time was spent attending these meetings. The costs associated 
with the CHIRPY DRAGON teacher’s travel to each school to attend these monthly sessions 
was estimated.  
Details for all unit costs applied to each component/activity of the intervention is outlined in 
Table 5.3. 
 
Unit Costs Associated with the Teaching Staff 
The monthly salary paid to CHIRPY DRAGON teachers was based on an estimation of the 
standard monthly salary rate for primary school teachers in China, provided by Guangzhou 
CDC. This was 4,500 Yuan (salary) + 1,517 Yuan (employer contribution for social security, 
insurance and pension) = 6,017 Yuan. The annual salary was calculated by multiplying the 
monthly rate by 12 months (72,204 Yuan). The annual salary was based on a contract of 1,440 
hours per year. Thus, to estimate the cost per hour, the annual salary was divided by 1,440. 
Annual salary scales were not available for teaching assistants. A unit cost for approximately 2 
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hours, was derived from an estimation of average salary levels in China provided by Guangzhou 
CDC. 
 
Other Unit Costs 
For components 1 and 3, the unit costs for the workshop materials, printing costs, and incentive 
prizes were based on the purchase price of each item and where relevant, included the delivery 
fee. For component 2, the cost of the incentives for the catering team (recognition certificates) 
was based on the purchase price. Office stationary was costed using the purchase price of each 
item, and then spread equally across the 4 components. The cost of telephone calls made by the 
CHIRPY DRAGON teachers, in relation to intervention delivery, were estimated by averaging 
the monthly cost of calls, and then dividing that equally across the 4 components. Finally, the 
unit cost for the CHIRPY DRAGON teachers’ transport was based on the average price of a 
train ticket from the office to each school, obtained from the China National Railways per 
month and was charged to components 1, 3 and 4 by considering the annual number of 
workshops/sessions, within each component. 
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Table 5.3 - Resource use and unit costs (Yuan, 2016/17 Prices), public sector perspective 
Type Resource use item for intervention delivery Unit cost (Yuan) Quantity 
for 12 month 
Total Source 
Office 
stationery 
Ink pads (Components 1, 2, 3 and 4) 4.9/each 4 19.6 Online (taobao.com) 
Permanent markers (Components 1, 2, 3 and 4) 1.2/each 12 14.4 Online (taobao.com) 
 
 
 
 
 
 
 
 
Printing 
Colourful educational leaflets for parents and 
families (Component 1) 
0.58/each 1950 1131 Feida Tu Wen store 
Family healthy behaviour challenges fun cards 
(Components 1 and 3) 
0.15/each 27000 4050 Feida Tu Wen store 
Stickers (with CHIRPY DRAGON logo) 
(Components 1 and 3) 
0.14/each 3700 500 Caiyi Bangong Haocai 
store 
Record cards of individual performance 
(Components 1 and 3) 
6.5/each 111 721.5 Wanmei Chongyin store 
Illustrative photo cards for child workshops  
(first semester) (Component 1) 
0.4/each card 2030 819 Wanmei Chongyin store 
Illustrative photo cards for child workshops  
(second semester) (Component 1) 
0.4/each card 1190 476 Wanmei Chongyin store 
Illustrative photo cards for child carers workshops 
(Component 1) 
0.35/each card 7300 2580 Wanmei Chongyin store 
Teaching boards for child carers workshops  
(Shahe School) (Component 1) 
0.15/each note 40 6 Wanmei Chongyin store 
Family healthy behaviour challenges reward board 
(Components 1 and 3) 
0.29/each  3000 850 Feida Tu Wen store 
  
  
Labour  
 
 
 
Workshops assistant (each practice = 2 hours) 
(Component 3) 
30.5/each practice 77 2348 Standard monthly salary 
rate (Guangzhou CDC) 
Hour of CHIRPY DRAGON teachers time 
(Components 1, 2, 3 and 4) 
50/hr 708.5 35425 Standard rates provided by 
Guangzhou CDC  
Delivery fee 
 
Family healthy behaviour challenges reward board 
(Components 1 and 3) 
20/delivery 2 40 Guangjun Tourism  
Loudspeakers (Components 1 and 3) 12/delivery 2 24 Guangzhou transportation 
group taxi Co. Ltd 
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Table 5.3 - Resource use and unit costs (Yuan, 2016/17 Prices), public sector perspective (continued) 
Type Resource use item for intervention delivery Unit cost (Yuan) Quantity 
for 12 month  
 
 
for 12 month 
Total Source 
 
 
 
 
 
 
 
 
 
 
 
 
Workshops 
materials 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PowerPoint remote control (Component 1) 32/each 7 224 Online (taobao.com) 
Canister (Component 1) 1/each 30 30 Online (taobao.com) 
 Measuring spoon (Component 1) 6/each 3 18 Online (taobao.com) 
AA batteries (Component 1) 3.1/each 25 77 Jinli store 
 Stamp (Components 1 and 3) 30/each 3 90 Jinli store 
Transparent plastic bag (Component 1) 0.01/each 200 19.4 Online (taobao.com) 
Suitcase (Components 1 and 3) 99/each 2 198 Online (taobao.com) 
Cart (Component 1 and 3) 36.8/each 3 110.4 Online (taobao.com) 
Paper plates for child workshops (Component 1) 
 
 
0.19/each plate 1500 295 
 
 
Online (taobao.com) 
 
 
 
Electronic scale (Component 1) 23/each 3 69 Online (taobao.com) 
Food used in child carer workshops (Component 1) 19.8/each workshop 40 793 Local market, Wal-Mart 
Canister (larger) (Component 1) 2.42/each 6 14.5 Online (taobao.com) 
Loudspeakers (Components 1 and 3) 160/each 
 
5 800 Online (taobao.com) 
 Stamp (with CHIRPY DRAGON logo) 
(Components 1 and 3) 
 
22.5/each 10 225 Qingqing Wenxue store 
 
 Balloon (Component 3) 0.1/each 2000 200 Online (taobao.com) 
Finger board used in physically active family 
friendly games (Component 3) 
37.5/each 2 75 Online (taobao.com) 
Pencils (Components 1 and 3) 6/each 5 30 Online (taobao.com) 
Rubber band (Component 3) 0.008/each 2000 15 Online (taobao.com) 
Megaphone (Components 1 and 3) 40/each 6 240 Online (taobao.com) 
Strips of cloth (Component 3) 
 
 
 
 
1/each 100 100 Qingqing Wenxue store 
 
 
 
 
 
 
 
 
Incentives 
Incentive prizes for meeting family healthy 
behaviour challenges (Components 1 and 3) 
9.7/each 
 
 
 
 
 
991 9620 
 
 
Jinli store,  
Qingqing Wenxue store 
Recognition certificates for catering teams 
(Component 2) 
14.8/each 33 489 Online (taobao.com) 
Teachers 
telephone 
 
 
CHIRPY DRAGON teachers average cost of 
mobile phone (Components 1, 2, 3 and 4) 
269.8/month 
 
 
10 2698 China mobile 
Teachers 
transport 
 
CHIRPY DRAGON teachers average cost of 
transport (Components 1, 3 and 4) 
(Components 1, 3 and 4) 
744.25/month 12 8931 China National Railways 
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Societal Resource Use Collection and Unit Costs (Delivery of the Intervention) 
Components 1 and 3 of the intervention included workshop elements which parents and other 
live-in adult family members were invited to attend. Family-specific resource use 
questionnaires were developed and used to obtain information. To form part of an exploratory 
analysis, these questionnaires were also used to help to understand families’ expenditure 
patterns by collecting data on household expenditure on food and other items. The data collected 
on household expenditure is not included in the societal economic evaluation – reasons 
explained later. All these self-reported questionnaires were completed by parents/main carers 
at home.  
 
School Lunch Cost 
The cost of providing lunch each day was recorded by the catering team in 38 schools (20 
control and 18 intervention). The other two intervention schools did not have a lunch provision 
during the intervention year. 
Generally all children eat school lunch (rather than a packed lunch) when it is provided. To 
estimate the mean (standard deviation (SD)) daily cost of lunch for each diner, the school mean 
lunch cost was divided by the average number of diners on each school day. The average daily 
cost of lunch per diner was then calculated for the control and intervention schools separately. 
As the intervention period was one year, for analysis purposes, this average cost was then 
multiplied by the number of days (250) which schools were open during the 12 month trial 
period to obtain the annual average lunch cost per child for the intervention versus control 
schools. To calculate the incremental cost of lunch paid for by the children’s families, the 
annual average lunch cost was linked to the children’s data. The overall average lunch cost per 
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year for the intervention group was assumed for the two intervention schools which did not 
have lunch provision during the intervention year.  
 
Parents/Other Family Members’ Attendance Time/Cost 
For the intervention workshops, either parents or main carers were invited to attend. On 
average, two parents or main carers per child attended each workshop. The travel costs for these 
parents/main carers to attend the workshops, were not collected. This was because most families 
lived close so travel costs were likely to be negligible.  
A summary of parents/other family members’ attendance time for these workshops is shown in 
Table 5.4.  
 
Table 5.4 - Parents/main carers’ workshop attendance time 
 Workshop’s name Term1 
(hours) 
Term2 
(hours) 
 
 
  
Total time spent at each 
workshop type across the 
whole trial duration (hours) 
Component 1 
(main carers) 
Education  1 1 2 
Family quiz - 1 1 
Component 3 
(parents) 
Family game 0.5 0.5 1 
 
 
Using questionnaires, family members of children from all the 20 intervention schools were 
asked what they would have been doing if not attending the workshop, to measure the 
opportunity cost of their time. The alternative activities they could select from were defined as: 
‘at work’ or ‘not at work’. As it was not possible to reliably source salary details for all the 
occupations provided, the population average salary was used to estimate the value of lost time 
104 
 
[255]. For those who would not have been at work, the national minimum wage [256] was 
assumed as a valid cost of leisure time [257, 258]. The data revealed that overall, across all the 
workshops, 61% of the parents/grandparents would have otherwise been at paid work and 
therefore 39% of them were using unpaid time. To measure the average cost of time spent by 
each family member attending the workshop the following method was applied:  
 
Step 1: 
Average cost of workshop time for each family member in employment = average hourly wage 
rate * workshop hours over trial duration = A 
Average cost of workshop time for each family member not in employment = average hourly 
leisure rate * workshop hours over trial duration = B 
Step 2: 
Number of paid family members attending the workshop = 61% * total attendees based on the 
process evaluation data = C 
Number of unpaid family members attending the workshop = 39% * total attendees based on 
the process evaluation data = D 
Step 3:  
Average cost of each family member time = (A*C) + (B*D) / total attendees based on the 
process evaluation data = E 
Steps 1 through to 3 were applied to calculate the average cost for each family member who 
attended the workshops. This cost was also assumed for family members with missing data.  
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Household Expenditure  
The following information, on monthly household expenditure of families within the control 
and intervention groups at both baseline and at 12 months follow up was collected: 
1) Household electricity and gas bills 
2) Transport (e.g. car fuel, parking and bus/train tickets) 
3) Recreation and culture (e.g. visiting a park, cinema or theatre; karaoke; sports 
centre/GYM membership) 
4) Shopping for food and non-alcoholic drinks (soft drinks) 
5) Alcoholic drinks, tobacco and narcotics 
6) Eating in restaurants (not for business purposes) and small sit-in outlets 
7) Clothing, footwear and other accessories  
8) Communications (e.g. phone and internet bills) 
9) Household goods (both buying and repairing) and services (e.g. house servant wages) 
10) Other goods and services (e.g. hair dressing, body massage, facial treatments etc.) 
11) Education (e.g. child interest lessons, after school childcare and adult learning courses) 
12) Healthcare (e.g. medical treatments & medication and food supplements) 
An open-ended questionnaire was used to collect information about the amount of money which 
each family spent per month on each of these categories. This approach revealed families’ 
consumption behaviour and revealed WTP values per month across the categories in the 
intervention and control groups at both baseline and at 12 months follow up. Data was also 
collected on total family income in the intervention and control groups at both baseline and at 
12 months follow up, using an open-ended question design.  
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More detailed questions on the weekly food household expenditure was also collected to 
measure the weekly pattern of food expenditure when compared to the monthly food 
expenditure pattern. This information was collected separately (for month and per week) using 
two different sets of questions as follows.  
 
Monthly 
1) Shopping for food and non-alcoholic drinks (soft drinks) 
2) Eating in restaurants (not for business purposes) and small sit-in outlets 
 
Weekly 
1) Total food expenditure (groceries, eating out and takeaways) 
2) Fruit and vegetables (fresh, frozen or canned) 
3) Ready meals (microwave meals), frozen fast food and takeaways  
The figures for weekly category (1) includes but is not limited to those for categories (2) and 
(3). The purpose of including the weekly food household expenditure was for behavioural 
change evaluation at the weekly level. A questionnaire with a payment scale was used to collect 
the weekly household expenditure and families were asked to circle a response. Then, midpoints 
of the ranges for the three categories were used to assign a value for each family. In the interval 
midpoint WTP model, it is assumed that the family’s WTP is distributed within the given 
interval [259]. Since a family’s true point valuation lies somewhere in the interval between the 
chosen value and the next higher one, this assumption is reasonable [259]. However, the WTP 
values calculated by this method are always relatively higher compared with those obtained 
using other methods. It is plausible that this method is an optimistic estimation [259].   
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The mean (SD) of monthly and weekly expenditures on each of the different categories and 
mean (SD) of family income were calculated at each time point (baseline and 12 months follow 
up) for all participants, control and intervention groups. The percentage/proportion of income 
spent on the different monthly household expenditure categories, was then calculated for both 
the control and intervention arms.  
 
Development and Implementation Unit Costs 
The justification of and source for the unit costs applied to the development and implementation 
categories are outlined in Table 5.5 and detailed below. 
 
Unit Costs Associated with the Research Staff  
These costs were associated with the development (i.e. school teacher handbook and researcher 
preparation time for CHIRPY DRAGON teachers’ training) and implementation (i.e. training 
CHIRPY DRAGON teachers to deliver workshops/sessions) of the intervention. To calculate 
the unit costs for each research associate; research fellow; and senior research fellow role, the 
2016-2017 Guangzhou CDC academic research staff salary scales were used (between 7,500 
and 9,200 Yuan). These salaries were then converted to an hourly rate assuming that research 
staff works 7.5 hours per day excluding weekends, university ‘closed days’ and public holidays.  
 
Unit Costs Associated with Catering Teams (Managers/Chefs) and Designer 
The monthly salary rate of catering staff (36 managers/chefs from 18 catering companies) was 
based on an estimation of the standard monthly salary rate in China provided by Chinese 
colleagues. This was 10,000 Yuan. The annual salary rate was then calculated by multiplying 
the monthly rate by 12 months (120,000 Yuan). The annual salary rate was based on a contract 
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of 1,350 hours per year. Thus, to estimate the cost per hour, the annual salary was divided by 
1,350. For the costs associated with the development of the intervention, a designer was 
employed to optimise the presentation of intervention materials (leaflets and illustration media). 
The cost of this designer was also included at an agreed fixed price of 20,000 Yuan for 2 
months. 
 
Other Unit Costs 
School principals (n=20) and class-level head teachers (n=20) were provided with a detailed 
programme handbook which explained all intervention activities and the support needed from 
them. The unit cost for the printing of handbooks was based on the purchase price of each 
handbook. This was included in the implementation costs.  
The intervention set-up meeting, which was for 20 school principals, was part of the 
implementation costs and held in China Guangzhou CDC. With regard to the school principals 
meeting time, their attendance was part of their existing/routine duties rather than additional 
work or unpaid work therefore no meeting time or cover cost has been calculated for them. The 
meeting lasted two hours and was facilitated by one of the CHIRPY DRAGON teachers. The 
cost of this is included in the implementation costs based on the previously calculated hourly 
rate. All the school principals travelled to the meeting by underground. The unit cost for their 
return train tickets was based on the China National Railways price of each ticket. The printed 
school teacher handbooks were handed out at this meeting. 
The catering team introduction meeting, for managers/chefs from the catering companies, was 
part of the implementation costs and held in China Guangzhou CDC. The meeting lasted one 
hour. The catering staff were paid to attend based on their previously calculated hourly rate. A 
lead CHIRPY DRAGON teacher facilitated this meeting and this was, again, costed at the 
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appropriate rate. The catering staff all travelled by underground and the same unit cost as above 
was applied.  
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Table 5.5 - Development, implementation resource use and unit costs (Yuan, 2016/17 Price) 
Type Resource use item Unit cost (Yuan) Quantity 
for 12 
months 
Total Source 
 
 
 
Teachers 
time costs 
 
 
CHIRPY DRAGON teachers time 
(Development and implementation) 
 
 
50/hr 
 
 
150.7 
 
 
7535 
 
 
Standard monthly salary rate  
(Guangzhou CDC)  
 
Research 
team time 
costs 
Senior research fellow time 
(Development) 
72/hr 2  
 
4251.6 
 
 
Academic research staff salary 
scales (Guangzhou CDC) 
Research fellow time 
(Development and implementation) 
67/hr 26.45 
Research associate time 
(Development and implementation) 
62/hr 39.2 
Catering 
team time 
costs 
Catering team time 
(Implementation) 
74/hr 36 2664 Standard monthly salary rate 
(CHIRPY DRAGON Chinese 
staff) 
Hiring a 
designer 
 
Designing diagrams  
(Development) 
10000/month 2 20000 An agreed fixed price 
Printing Handbooks  
(Implementation) 
0.4/each 40 16 Feida Tu Wen store 
Teachers, 
research 
staff, 
catering 
team and 
school 
principals 
travel costs 
 
 
Underground return train ticket 
(Development and implementation) 
 
 
4/each 
 
 
90 
 
 
360 
 
 
China National Railways 
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5.2.3 Outcome Measures 
All outcomes were collected at the individual level. Assessments were undertaken in each 
school by independent and trained assessors (research staff) who were blind to allocation, using 
standardised procedures and instruments at baseline (start of intervention) and first follow-up 
(end of intervention). Data on participants’ date of birth and gender were obtained from school 
records. 
 
Public Sector Outcome Measures 
The primary clinical outcome for effectiveness was the difference in BMI standard deviation 
scores (z scores) between arms at completion of the 12-month intervention. There is no agreed 
consensus on the minimal clinically important difference for BMI z-score. Clinical studies in 
obese children have shown improvements in clinical measures such as blood pressure and lipid 
levels with differences as small as 0.1 units in BMI z-score [260]. Other studies have suggested 
that a clinically important difference is 0.125 units [260]. However, for prevention 
interventions, at a population level, even smaller values could be clinically important.  
The primary economic outcome measure was QALYs. No other clinical/non-clinical outcomes 
were considered for the economic evaluation as only the most commonly used outcomes 
(QALYs/BMI) were explored. Other outcomes including body fat%; waist circumference; 
eating behaviours; physical activity; and sedentary behaviours were explored for the 
intervention clinical effectiveness. Other important outcomes such as educational attainment 
would have been useful to consider, but these data were not collected within the trial. 
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Anthropometric Measurements 
Height and weight measurements were undertaken without shoes and in light clothing. Standing 
height was measured at least twice with a TGZ-type height tester (Dalian). Weight was 
measured with an electronic scale (JH-1993T, weighing Apparatus Co. Ltd., Dalian, China). 
BMI was calculated as weight in kilograms divided by the square of height in metres (kg/m2). 
The WHO 2007 Growth charts, which are most widely used and known in the region, were 
used to calculate BMI z-scores and categorise the children into underweight, healthy weight, 
overweight and obese groups [261].  
 
Measurement of HRQoL 
CHU-9D and PedsQL, which are both generic instruments, were chosen for the measurement 
of HRQoL. Children were invited to complete both researcher-administered questionnaires 
(CHU-9D and PedsQL) at the same time at each time point when they were attending 
workshops.  
Although there is no gold standard for measuring utility-based HRQoL in primary school-aged 
children, previous research has shown the CHU-9D, a recently developed instrument, is the 
most appropriate choice [38]. As a utility-based instrument, it is preference-based. It is designed 
for application in cost-effectiveness analyses of prevention, treatment and service programmes 
targeted at young people where the QALY is the desired outcome measure [183].  
The PedsQL is a non-preference based instrument and therefore does not apply any explicit 
weighting between item domains. It therefore cannot be used to generate utility values for the 
construction of QALYs. However, it would be expected to produce HRQoL values which move 
in the same direction as the utility measures. This instrument is a widely used HRQoL 
113 
 
instrument validated for use with young children over 5 years old. It has good reliability and 
validity in both sick and healthy populations [189, 190]. 
 
CHU-9D 
The Chinese version of the CHU-9D (CHU9D-CHN) instrument was used to collect HRQoL 
information for the children [262]. Individual responses from the questionnaires were 
transformed into utility weights derived from a UK general population sample using an 
algorithm developed by Stevens et al [39, 184]. This presents a possible utility value set of 
between 0.33 (worst health state) and 1 (best health state). QALYs were calculated for each 
individual child, over the 12 month period, using the area under the curve approach which uses 
the trapezium rule [263]. The Chinese-specific preference weights applied in a sensitivity 
analysis as the Chinese version tariff was still under development at the time of analysis [264, 
265].  
 
PedsQL 
For this study the validated Chinese version of PedsQL 4.0 instrument was used [266]. Provided 
data were available for at least half of the relevant items, the mean score for each of the four 
domains was then calculated by summing the values for the relevant items and dividing by the 
number of items answered. This was repeated including “mean of all items” for the total score, 
“mean of physical functioning items” for the physical health score and “mean of emotional, 
social and school functioning items” for the psychosocial health score.  
 
Assessing QALY and BMI z-score Differences 
To control for differences in baseline utility values between the intervention and control arms, 
pre-specified school- and child-level covariates were adjusted for, based on a statistical analysis 
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plan [263]. Using regression analysis, there was a control for differences in cluster level 
variables used in the randomisation (provision of mid-morning snacks and having access to an 
indoor activity room); characteristics of children ((socio-demographic: gender and mother 
education level) and (health behaviour factors: consumption of fruit and vegetables; unhealthy 
snacks and sugar added drinks; minutes/day MVPA and sedentary time)); and baseline CHU-
9D utility scores between the intervention and control arm [126]. 
Therefore, three models were applied: 
 A linear regression model (unadjusted model) 
 Mixed linear regression model (account for clustering and controlling for baseline 
utility) 
 Mixed linear regression model (account for clustering, controlling for baseline utility 
and pre-specified school- and child-level covariates) 
The first model, linear regression of QALYs, is an unadjusted model. The data however were 
clustered therefore the second model adopts a hierarchical approach to account for clustering 
whilst also controlling for baseline utility differences. The third and final model, and the one 
which was used for the main analysis, adds the pre-specified school- and child-level covariates 
to model two. This model therefore adjusts for clustering, baseline utility and the covariates 
specified within the analysis plan.  
Regarding BMI z-scores, treatment effects (mean difference in BMI z-scores between the two 
arms at 12 months follow up) were tested using a mixed linear model adjusting for the child 
baseline BMI z-score and clustering by school [267]. The analysis was adjusted for pre-
specified school- and child-level covariates as well. 
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Societal Outcome Measures 
For the societal perspective, the analysis included QALY gains/losses falling on adult 
household members. 
 
Measurement of HRQoL 
EQ-5D-3L 
The validated Chinese version of the EQ-5D-3L was chosen for the measurement of adult 
HRQoL [191]. Parents and other adult household members were asked to complete the EQ-5D-
3L at home at each time point (baseline and 12 months follow up). Individual response 
permutations to the EQ-5D-3L were used to calculate health index scores (utility scores) based 
on the UK value set. This presents a possible utility value set of between -0.59 (worst health 
state) and 1 (best health state). QALYs were calculated for each individual parent/grandparent, 
over the 12 month period, using the standard area under the curve approach [36]. 
Parental/grandparental utility scores and QALYs were only estimated from data where the same 
parent/grandparent completed both the baseline and the follow up measures.  
The Chinese tariff scores were applied for parents/grandparents in a sensitivity analysis. There 
were two potential published papers to facilitate this analysis [268, 269]. Liu et al (2014) [268] 
was used as it included respondents from urban China whereas the other paper [269] only 
included respondents from both urban and rural China, which was less representative of the 
CHIRPY DRAGON trial population. 
 
Assessing QALY Differences 
To control for differences in baseline utility scores between the intervention and control arm, 
pre-specified parent-level covariates were adjusted for, based on a pre-specified statistical 
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analysis plan [263]. Using regression analysis, there was a control for differences in 
characteristics of parents ((socio-demographic: gender and mother/father education level); and 
baseline EQ-5D-3L utility scores between the intervention and control arm [126]. 
Therefore, three models were applied: 
 A linear regression model (unadjusted model) 
 Mixed linear regression model (account for clustering and controlling for baseline 
utility) 
 Mixed linear regression model (account for clustering, controlling for baseline utility 
and pre-specified parents-level covariates) 
 
5.2.4 Missing Data and Multiple Imputation 
Resource use data, using a public sector perspective, was collected at the cluster level whereas 
the outcome data and the resource use data from a societal perspective, were collected at the 
individual level. As a result, the reasons for missing data differed for these two types.  
 
Public Sector Missing Data and Multiple Imputation 
Given a very high retention rate and a high level of data completeness (0% missing for the 
resource use data; less than 4% for the children’s outcome data) for the public sector perspective 
analysis, there was no need to use multiple imputation methods to account for missing data. 
Therefore, a modified intention to treat (ITT) approach was used. This means all analyses were 
conducted on participants with non-missing data in their original randomisation groups. 
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Societal Missing Data and Multiple Imputation 
For the societal perspective analysis, although almost 25% of the outcome data for 
parents/grandparents were missing, multiple imputation for the base-case analysis was not 
required. This was for two main reasons: 
 The covariates in the model were fairly complete. 
 The baseline characteristics of the study participants were well balanced between the 
groups with available and missing outcome data. 
These analyses were therefore also conducted using the modified ITT approach. Missing data 
for the resource use regarding school lunch costs and workshop attendance time costs for 
parents and other family members were assumed.  
The impact of not imputing the missing data for the societal perspective analysis was explored 
in a sensitivity analysis. This was to avoid any loss of efficiency or potential bias of the results 
with the exclusion of participants with missing data [270, 271]. Health index scores for children 
(CHU-9D) and parents/grandparents (EQ-5D-3L) were imputed at baseline and 12 months 
[272] using predictive mean matching multiple imputation. The baseline health and relevant 
co-variates (gender, mother/father education level, provision of mid-morning snacks, having 
access to an indoor activity room, daily consumptions of fruit and vegetables, weekly servings 
of unhealthy snacks and sugar added drinks, objectively measured time in MVPA and sedentary 
time (minutes/day)) for each imputed variable were selected separately and included within the 
imputation model [273]. Predictive mean matching was chosen as it is reported superior for 
imputing continuous variables which are not normally distributed [274]. This method has the 
advantage that it produces imputed values which are more like real values because the imputed 
values are real values which are “borrowed” from individuals with real data [274].  
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The level of missing data was less than 16% for the monthly and weekly household expenditure, 
and monthly income data. A modified ITT approach was used as this analysis was not included 
in the economic evaluation and was only exploratory. 
 
5.2.5 Statistical/Economic Evaluation Methods 
An initial data analysis was performed to clean and validate the data entered in the dataset. The 
analysis of cost-effectiveness was undertaken according to current best practice methods for 
conducting economic evaluation alongside cluster randomised controlled trials [275]. 
A mixed linear model to analyse the primary clinical outcome was used. Logistic or mixed 
linear model functions were used to analyse binary or continuous primary outcomes (QoL) 
respectively. For analysing utility scores, mixed models were used. The cost data was highly 
skewed therefore a gllamm model (gamma log link) was used which allowed the data 
distribution to be specified. 
For continuous outcomes, the distribution of residuals for normality to conduct linear regression 
analysis was checked. For all outcomes, the residuals were normally distributed therefore no 
transformations were used. Means (SD) and 95% confidence intervals (CIs) were calculated for 
continuous variables which were normally distributed. For the outcomes that were not normally 
distributed, median (Inter-Quartile Range (IQR)) and 95% CIs were calculated. 
The economic analyses took an incremental approach and it was assumed that there were no 
costs associated with the control arm. Since a time horizon of 1 year was used, costs and 
outcomes were not discounted [36]. Both a CUA and a CEA were conducted. The results were 
expressed through the ICER based on the fully adjusted costs and effects.  
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Within the Chinese setting, as there is no equivalent threshold value for how much decision 
makers are willing to pay for a unit gain in QALY, recommendations were made using the 
established UK and US threshold values as a reference point [161, 162]. For instance in the UK, 
ICER values under £20,000-£30,000 per QALY is deemed a cost-effective use of resources 
[161]. In addition, given the lack of a specified threshold for China, both 1xGDP and 3xGDP 
per capita thresholds, recommended by WHO, were used in the analyses [165, 166]. All 
analyses were conducted in Stata 13.  
 
Public Sector Perspective for Economic Evaluation 
The primary analyses from a public sector perspective included:  
 A CUA estimating the cost per QALY gained.  
 A CEA evaluating the cost per change in BMI (z-score).  
The uncertainty around the ICER was assessed through the use of the NBR framework [163, 
164] using non-parametric bootstrapping and decision uncertainty presented using CEACs 
whilst controlling for any baseline differences, clustering effects and co-variates [164]. CEACs 
were developed to estimate the probability of the intervention being cost-effective across a 
range of values of WTP for an extra QALY. 
 
Sensitivity Analyses 
Three sensitivity analyses were undertaken to assess the robustness of the results to assumptions 
made in the analysis: 
 Sensitivity analysis 1: including costs associated with implementing the intervention 
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The base case analysis assumed that the intervention was in a ‘running state’ and therefore only 
costs associated with the delivery of the intervention were included. In this sensitivity analysis 
the implementation costs were included to assess the impact on the ICER. 
 Sensitivity analysis 2: using the Chinese tariff to estimate QALYs 
Individual responses from the CHU-9D questionnaires were transformed into utility scores 
using the Chinese tariff.  
 Sensitivity analysis 3: varying the class size to only including consented children 
Within the trial, parents had to provide consent for their children to have measurements taken. 
On average, there were 41 children with parental consent within each class. Sensitivity analysis 
3 assumed an average class based on number of children who consented to measurement instead 
of average total class size (n = 45).  
 
Societal Perspective for Economic Evaluation 
The secondary analysis from a societal perspective included a CUA estimating the societal cost 
per QALY gained for children and household members combined. Children and family 
members’ QoL data were linked and matched using a ‘multiplier’ approach. This involved 
adjusting children’s QALYs for family spillover effects using the following steps [276-278]: 
 
Step 1:  
Mean incremental QALYs per child was calculated. (CQ) 
Step 2:  
Mean incremental QALYs for each family member was calculated. (FQ) 
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A judgement was made regarding the mean number of family members per child and was 
assumed to be two because, on average, two family members (parents/grandparents) attended 
the intervention workshops. (n) 
Step 3: 
The multiplier for each child was then calculated as:  
[1 + (n*FQ / CQ)] 
Additionally, an allowance (a figure of around 1.1) was made for the spillovers displaced by 
the intervention [276, 277]. For further discussion and technical explanation see Al Janabi et al 
(2016) [276, 277]. 
The multiplier approach avoids averaging all benefits out. It represents the fact that family 
benefits are additional from the same intervention not that children and family members are 
receiving the intervention separately. 
The multiplier approach was not applied to the resource use data as it was not possible to link 
each component of the family-related costs to the related child. Instead, the costs were simply 
summed and averaged assuming that each child had at least two family members attend the 
workshops.  
For the societal perspective therefore the base-case ICER was calculated by applying the 
following formula:  
mean incremental public sector costs *     1.1            *     mean incremental societal costs 
                        CQ                               [1+(n*FQ/CQ)] mean incremental public sector costs  
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Sensitivity Analyses 
Four sensitivity analyses were undertaken to assess the robustness of the results to assumptions 
made in the analysis: 
 Sensitivity analysis 1: including costs associated with implementing the intervention 
 Sensitivity analysis 2: using the Chinese tariff to estimate QALYs 
 Sensitivity analysis 3: varying the class size to only include consented children 
 Sensitivity analysis 4: using predictive mean matching multiple imputation 
 
Exploratory Household Expenditure and Income Analyses 
In addition to the economic evaluation, an exploratory analysis on household expenditure was 
undertaken. The change in proportion (%), CI and p-value of income spent on the different 
monthly household expenditure categories between the intervention and control groups were 
calculated. These were done with no adjustment, adjustment for baseline, and adjustment for 
baseline and different covariates to control for differences in families’ characteristics (mother 
and father education level) using regression analysis.  
The result of this analysis may be interesting as, in theory, the intervention could have had 
substitution effects on consumption behaviour as families spend proportionally more on food 
(e.g. purchasing fruit and vegetables), and perhaps less on alcohol or eating out. A common 
perception is that healthy eating is more expensive and this analysis investigated how the 
families adjusted their spending habits and adapted to the intervention.  
Sub-group analysis was not conducted as the family income data was less accurate (not detailed 
enough to facilitate such an analysis). 
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A suitable model could be used to assess the long-term effects and cost-effectiveness. However, 
modelling was not applied for the research as it was beyond the scope of this thesis.  
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5.3 Part 2: Results: Economic Evaluation (Public Sector Perspective) 
5.3.1 Participant Flow during the Trial 
No schools dropped out of the trial. In total, 1641 children were recruited and randomized to 
20 intervention (n= 832) and 20 control (n= 809) schools. 794 children (95.4%) from the 
intervention group and 768 (95.0%) from the control group were included in the primary 
outcome analysis. An overview of the trial participants is presented in Table 5.6.  
 
Table 5.6 - CHIRPY DRAGON programme participants 
 Intervention 
 
 
 
 
Usual 
Practice 
 
  
Eligible children from the consented schools (September 2015)  1799 
Children consented  1641  
Children measured at baseline (September-December 2015)          1630 
Number of children after randomisation 
Children consented 832 809 
Children measured at baseline 826 804 
Children measured (first follow-up) (April-July 2017)                                                                         805 781
Children included in analysis for primary outcome 794 768 
 
 
5.3.2 Baseline Characteristics of the Study Participants 
The baseline characteristics of the study participants were well balanced between the two 
groups (Table 5.7). The mean age of the children was 6.1 years (SD= 0.35) and 54.5% were 
male. More than a third of parents did not have a university education. Approximately 18% of 
the children were either overweight (10.8%) or living with obesity (7.1%); comparable to 
national data for overweight/obesity in the same age group (20.4%) [127]. 
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Table 5.7 - Baseline characteristics of children participating in CHIRPY DRAGON study 
 
Intervention group 
(20 schools) 
n=832 
Control group 
(20 schools) 
n=809 
Age (years) 6·15 (0·36) 6·14 (0·35) 
Gender   
  Male 463 (55·6%) 431 (53·3%) 
  Female 369 (44·4%) 378 (46·7%) 
Mother education level   
Lower education   
  None 1 (0·1%) 1 (0·1%) 
  School education (Primary and Middle schools) 167 (20·5%) 137 (17·8%) 
  Occupation college 160 (19·6%) 132 (17·2%) 
Higher education   
  University education (Undergraduate level) 434 (53·3%) 433 (56·3%) 
  Postgraduate education 53 (6·5%) 66 (8·6%) 
Father education level   
Lower education   
None 0 (0%) 1 (0.1%) 
School education (Primary and Middle schools) 131 (15.8%) 122 (16.1%) 
Occupation college 162 (19.9%) 132 (17.2%) 
Higher education   
University education (Undergraduate level) 440 (54.9%) 407 (52.3%) 
Postgraduate education 76 (9.4%) 107 (14.3%) 
Anthropometric measures   
Weight (kg) 22.30 (4.32) 22.19 (4.28) 
Height (cm) 119.77 (5.47) 119.49 (5.50) 
Weight status*   
  Thinness 37 (4·5%) 44 (5·5%) 
  Normal weight 637 (77·5%) 610 (76·6%) 
  Overweight 92 (11·2%) 83 (10·5%) 
  Obese 56 (6·8%) 59 (7·4%) 
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Table 5.7 - Baseline characteristics of children participating in CHIRPY DRAGON study (continued) 
 Intervention group 
(20 schools) 
n=832 
Control group 
(20 schools) 
n=809 
Daily average servings of fruit and vegetables, median [IQR] 3·00 [2·00-4·00] 3·00 [2·00-4·00] 
Weekly average servings of unhealthy snacks and sugar-added drinks~,  
median [IQR] 
2·50 [0·00-4·50] 2·00 [0·00-3·50] 
Objectively measured time in MVPA (minutes/24hours) 64·68 (30·79) 67·91 (29·12) 
Objectively measured sedentary time (minutes/24 hours) 440·26 (90·11) 442·77 (87·01) 
 
Data are mean SD or n (%), unless specified as median [IQR] 
*based on WHO 2007 Growth Chart 
Unhealthy snack consumption is estimated as the sum of average servings of salty high fat snacks (e.g. crisp, deep fried snacks), sweet high 
fat snacks (e.g. chocolates, cake, ice cream, and biscuits), candies and sugared beverages (e.g. carbonated drinks) in the previous week, 
MVPA: moderate to vigorous physical activity 
 
Li et al. (2019) [129]
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5.3.3 Delivery Fidelity/Adherence and Attendance Rate 
A high delivery fidelity/adherence was achieved and CHIRPY DRAGON teachers successfully 
delivered the intended number of workshops/quizzes/active game tasters, meetings and other 
activities [129]. Overall, 78% of the intervention events were delivered for the intended time 
length. Child attendance rates for the workshops ranged between 98% and 99%. Family 
members of 88% of the children attended school-based intervention activities aimed at child 
carers [129]. No reports were received on adverse events related to the intervention [129].  
 
5.3.4 Impact of Intervention on Children’s HRQoL (CHU-9D) 
Table 5.8 outlines the response rate for the CHU-9D instrument. Missing/invalid data for this 
outcome was very low at both measurement points. There were no differences between the two 
study groups in completeness of this outcome measure. 
 
Table 5.8 - Number of consented children with completed CHU9D 
Time Point CHU-9D completed 
all participants 
(n (%)) 
 
CHU-9D completed 
control group 
(n (%)) 
CHU-9D completed 
intervention group 
(n (%)) 
Baseline 1605 (97.8%) 793 (98%) 812 (97.6%) 
 
12 months follow up 1587 (96.8%) 781 (96.6%) 806 (97%) 
 
 
 
Table 5.9 presents the mean utility scores at each time point (using the UK tariff) for the base-
case analysis. There was no baseline imbalance for utility scores, but nevertheless all 
incremental analyses were adjusted for baseline. At 12 months follow up, the mean utility scores 
for the intervention group was slightly higher than the control group. The mean utility scores at 
each time point (using the Chinese tariff for sensitivity analysis) were consistently lower 
compared to using the UK tariff (Appendix 2.5).  
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Table 5.9 - CHU9D utility scores at each time point (UK tariff) 
 CHU-9D utility scores 
 All participants Control group Intervention group 
Time Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) 
Baseline 
(N= 1605) 
0.937 
(.069) 
0.934 0.940 0.936 
(.069) 
0.931 0.941 0.938 
(.068) 
0.933 0.942 
12 months 
follow up  
(N= 1587) 
0.933 
(.061) 
0.929 0.936 0.928 
(.064) 
0.923 0.933 0.937 
(.058) 
0.933 0.941 
 
 
Examining the Impact of the Intervention on QALYs 
Table 5.10 describes the unadjusted mean QALYs (using the UK tariff). At 12 months follow 
up, the intervention group accrued 0.937 QALYs compared to 0.932 QALYs for the control 
group. The unadjusted mean QALYs (using the Chinese tariff) were consistently lower 
compared to using the UK tariff (Appendix 2.6). 
 
Table 5.10 - Unadjusted QALYs accrued (CHU9D, UK tariff) 
 Unadjusted QALYs accrued 
 All participants Control group Intervention group 
Time Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) 
12 months 
follow up  
(N= 1554) 
0.935 
(.051) 
0.932 0.937 0.932 
(.052) 
0.928 0.936 0.937 
(.049) 
0.934 0.941 
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Incremental Analysis – Effectiveness 
Table 5.11 describes the incremental difference in mean QALYs (using the UK tariff) between 
the intervention and control group for the data with no adjustment; adjustment for clustering 
and baseline differences; and adjustments for clustering, baseline differences and the pre-
specified covariates using mixed effect linear regression models. In the unadjusted model, the 
mean QALY difference for 12 months follow up was in favour of the intervention but did not 
reach statistical significance (mean difference (MD) = 0.005, 95% CI: -0.003 to 0.014, p = 
0.252) whereas when controlling for baseline utility and clustering, there was a significant 
difference in favour of the intervention group between the groups at 12 months follow up (MD 
= 0.004, 95% CI: 0.000 to 0.007, p = 0.034). Furthermore, after controlling for baseline utility, 
clustering, and the co-variates, there was some evidence of difference in the QALY for 12 
months follow up (MD = 0.004, 95% CI: 0.000 to 0.008, p = 0.056) at borderline significance 
level. The QALYs attained using the Chinese tariff were higher compared to using the UK tariff 
and the results were statistically significant for both baseline and further adjusted models 
(Appendix 2.7). 
 
 
130 
 
Table 5.11 - Incremental difference in QALYs (CHU9D, UK tariff) 
 No adjustment Adjusted for clustering and baseline utility a Adjusted for clustering, baseline utility, 
co-variates b 
Time Mean 
difference 
(95% CI) P-value Mean 
difference 
(95% CI) P-value Mean 
difference 
(95% CI) P-value 
12 
months 
follow 
up  
0.005 
 
-0.003 
 
0.014 
 
0.252 
 
0.004 0.000 0.007 0.034 0.004 0.000 0.008 0.056 
 
a: Adjusted for baseline outcome. b: Adjusted for baseline outcome, pre-specified school- (i.e. whether the school provides mid-morning 
snack, whether the school has an indoor activity room) and child-level covariates (sex, mother education level, daily average servings of fruit 
and vegetables, weekly servings of unhealthy snacks and sugar added drink, objectively measured time in MVPA (minutes/24 hours) and 
objectively measured sedentary time (minutes/24 hours).  
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5.3.5 Impact of Intervention on BMI z-score 
Table 5.12 outlines the response rate for the BMI z-score. Missing/invalid data for this outcome 
was very low at both measurement points. There were no differences between the two study 
groups having measurements taken. 
 
Table 5.12 - Number of consented children with completed BMI z-score 
Time Point BMI z-score 
completed 
all participants 
(n (%)) 
 
BMI z-score 
completed 
control group 
(n (%)) 
BMI z-score 
completed 
intervention group 
(n (%)) 
Baseline 1618 (98.6%) 
 
796 (98.4%) 822 (98.8%) 
12 months follow up 1581 (96.3%) 
 
777 (96%) 804 (96.6%) 
 
 
Incremental Analysis - Effectiveness 
There was no baseline imbalance for BMI z-score, but nevertheless all incremental analyses 
were adjusted for baseline. Table 5.13 describes the mean difference in BMI z-score between 
the intervention and control group. Overall, at 12 months (end of intervention period), the mean 
BMI z-score was significantly lower in the intervention compared to the control group, MD = 
- 0.13, 95% CI: -0.26 to 0.00, p = 0.048 in the baseline adjusted model; and MD = - 0.13, 95% 
CI: -0.26 to -0.01, p = 0.041 in the further adjusted model. 
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Table 5.13 - Adjusted differences for BMI z-score between groups at first follow up 
 
SD: Standard deviation. CI: Confidence interval. BL: baseline. a: Adjusted for baseline outcome. b: Adjusted for baseline outcome, pre-
specified school- (i.e. whether the school provides mid-morning snack, whether the school has an indoor activity room) and child-level 
covariates (sex, mother education level, daily average servings of fruit and vegetables, weekly servings of unhealthy snacks and sugar added 
drink, objectively measured time in MVPA (minutes/24 hours) and objectively measured sedentary time (minutes/24 hours). 
Li et al. (2019) [129] 
 
 
Follow up outcome 
variable 
 
Intervention arm Control arm 
Intervention vs control 
(BL adjusted)a 
Intervention vs control 
(Further adjusted)b 
N = total participants  
 
BL FU1 BL FU1 FU1 FU1 
  
Mean (SD) 
 
Mean (SD)  
 
MD (95 % CI)             p value 
 
 
MD (95% CI)              p value 
 BMI z-score 
N = 1581 
 
 
-0.13 (1.30) -0.35 (1.22) -0.13 (1.30) -0.23 (1.34) -0.13                            0.048 
(-0.26 to 0.00) 
-0.13                            0.041    
(-0.26 to -0.01) 
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5.3.6 Resource Use and Costs 
A breakdown of the resources used for the development, implementation and delivery of the 
intervention is presented in Tables 5.14 to 5.16. Regarding the implementation and delivery 
costs, the total mean cost per child, class and school is displayed in Tables 5.15 and 5.16 
respectively. However, regarding the development costs, only the total costs are presented in 
Table 5.14.  
Relative to the delivery costs, both the development and (in particular) implementation costs 
were low. With regard to the development costs, the largest cost component was hiring a 
designer to optimise the presentation of the intervention materials (leaflets and illustration 
media). CHIRPY DRAGON staff time made up the largest component of the implementation 
costs. Of the four main intervention components, the cheapest was improving the nutritional 
quality of school lunches. The most expensive was on improving childhood obesity related 
knowledge and behaviour among children and their main carers, which accounted for more than 
two thirds of the intervention costs. 
For the delivery of the intervention, the most expensive costs were related to labour (CHIRPY 
DRAGON teachers’ and workshop assistants’ time) and printing. The rest of the costs were 
related to CHIRPY DRAGON teachers’ transport, incentives, intervention materials used 
during workshops, CHIRPY DRAGON teachers’ telephone costs, delivery fee and office 
stationary respectively. 
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Table 5.14 - Resource use and cost associated with development of intervention 
Component Resource type Total  
resource use  
Total  
cost, Yuan 
Development of school teacher 
handbook  
(Explanation of the intervention) 
Research staff time (hours) 
Research Fellow 
Senior Research Fellow 
 
 
 
6 
2 
 
 
 
 
402 
144 
Hiring of a designer 
(To optimise the presentation of 
developed intervention materials 
(leaflets and illustration media)) 
 
Designer time (month) 
 
 
2 
 
 
 
20000 
 
 
 
 
Researcher preparation time  
(For CHIRPY DRAGON teachers 
training) 
 
Research staff time (hours) 
Research Associate 
Research Fellow 
 
12 
6 
 
744 
402 
 
Staff meeting at each school  
(To discuss their current situation about 
children’s physical activity) 
CHIRPY DRAGON teachers time (hours) 
 
CHIRPY DRAGON travel costs (transport) 
             Return train ticket 
10 
 
 
20 
500 
 
 
80 
 
 
22272 Yuan 
(6273 $, 4410 £) 
 
Notes: Total number of intervention schools (n = 20), Total number of intervention classes (n = 85), Total number of intervention consented 
classes (20), Assumed average class size (45), Total number of intervention consented children (n = 832) 
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Table 5.15 - Mean resource use and cost associated with implementation of intervention 
Component Resource type Mean 
annual 
resource use 
per class 
Mean annual 
cost per class, 
Yuan 
Average cost 
per child 
(assuming 
average class 
size of 45), 
Yuan 
Workshops/sessions training  
(CHIRPY DRAGON teachers training 
to deliver workshops/sessions) 
 
 
Research staff time (hours) 
Research Associate 
Research Fellow 
Research associate and research fellow travel costs  
Return train ticket 
CHIRPY DRAGON teachers time (hours) 
 
 
0.32 
0.17 
 
0.16 
1.62 
 
18.69 
11.98 
 
0.65 
81.17 
 
 
0.42 
0.27 
 
0.01 
1.80 
 Initial printing of handbooks  
 
 
 
Number of handbooks 
 
 
0.47 0.18 
 
0.004 
Intervention set-up meeting  
(To explain about the intervention 
components to school staff) 
CHIRPY DRAGON teachers time (hours) 
School principal travel costs (transport) 
Return train ticket 
 
0.02 
 
0.24 
1.18 
 
0.94 
0.03 
 
0.02 
Catering team introduction meeting  
(Managers and chefs meeting for 
introducing five school lunch 
improvement objectives) 
 
CHIRPY DRAGON teachers time (hours) 
Catering team time (hours) 
             Managers and chefs time 
Managers and chefs travel costs (transport) 
             Return train ticket 
0.01 
 
0.42 
 
0.42 
 
0.59 
 
31.34 
 
1.69 
0.01 
 
0.69 
 
0.04 
 Total mean intervention implementation cost per school 
 
Total mean intervention implementation cost per class 
                                                     
Total mean intervention implementation cost per child assuming a class of 45 
 
Total mean intervention implementation cost per consented child (averagely 41 per class) 
 
 
630.74 Yuan (177.67 $, 124.89 £) 
 
148.41 Yuan (41.80 $, 29.39 £) 
 
3.29 Yuan (0.92 $, 0.65 £) 
 
3.62 Yuan (1.02 $, 0.71 £) 
Notes: Total number of intervention schools (n = 20), Total number of intervention classes (n = 85), Total number of intervention consented 
classes (20), Assumed average class size (45), Total number of intervention consented children (n = 832) 
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Table 5.16 - Mean resource use and costs associated with delivery of intervention 
Intervention 
component 
Resource type Mean 
annual 
resource 
use per 
class 
Mean annual 
cost per class, 
Yuan 
Average cost 
per child 
(assuming 
average class 
size of 45), 
Yuan 
 
 
 
 
 
 
 
 
 
 
 
 
Component 1:  
Improving childhood 
obesity related 
knowledge and 
behaviour among 
children and their main 
carers 
Labour: CHIRPY DRAGON teachers time (hours) 
Interactive educational activities for main carers * 
Interactive educational activities for children 
Quiz for main cares and children * 
Family-wide healthy behavioural challenges 
Office stationery 
Ink pads 
Permanent markers 
Printing 
Colourful educational leaflets for parents and families * 
Family healthy behaviour challenges fun cards 
Stickers (with CHIRPY DRAGON logo) 
Record cards of individual performance 
Illustrative photo cards for child workshops (first semester) 
Illustrative photo cards for child workshops (second semester) 
Illustrative photo cards for child carers workshops * 
Teaching boards for child carers workshops (Shahe School) * 
Family healthy behaviour challenges reward board 
Delivery fee 
Family healthy behaviour challenges reward board 
Loudspeakers * 
Workshops materials 
PowerPoint remote control 
Canister 
Measuring spoon 
AA batteries 
Stamp  
 
4.85 
2.32 
0.9 
2.56 
 
0.01 
0.04 
 
97.5 
238.12 
32.64 
0.98 
23.88 
14 
365 
2 
26.47 
 
0.017 
0.08 
 
0.08 
0.35 
0.04 
0.29 
0.03 
 
242.5 
115.88 
45 
128.38 
 
0.06 
0.04 
 
56.55 
35.73 
4.41 
6.37 
9.64 
5.6 
129 
0.3 
7.50 
 
0.21 
0.96 
 
2.64 
0.35 
0.21 
0.91 
0.79 
 
5.38 
2.58 
1 
2.85 
 
0.001 
0.0008 
 
1.25 
0.79 
0.10 
0.14 
0.21 
0.12 
2.87 
0.007 
0.17 
 
0.005 
0.021 
 
0.06 
0.008 
0.005 
0.02 
0.017 
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Transparent plastic bag 
Suitcase 
Cart 
Paper plates for child workshops 
Electronic scale 
Canister (larger) 
Loudspeakers * 
Stamp (with CHIRPY DRAGON logo)  
Pencils 
Megaphone  
Food presenting in child carers workshops  
Incentives: Family healthy behavioural challenges 
Incentive prize 
Telephone 
CHIRPY DRAGON teacher telephone 
Transport 
CHIRPY DRAGON teacher transport 
 
2.35 
0.02 
0.03 
17.64 
0.04 
0.07 
0.2 
0.09 
0.04 
0.06 
0.56 
 
8.24 
 
0.03 
 
0.06 
0.23 
1.86 
1.04 
3.47 
0.81 
0.17 
32 
1.99 
0.26 
2.26 
9.35 
 
95.32 
 
7.93 
 
46.70 
0.005 
0.04 
0.02 
0.08 
0.02 
0.004 
0.71 
0.04 
0.006 
0.05 
0.20 
 
2.12 
 
0.18 
 
1.04 
Component 1 total mean intervention running/delivery cost per school 
Component 1 total mean intervention running/delivery cost per class 
Component 1 total mean intervention running/delivery cost per child assuming a class of 45 
Component 1 total mean intervention running/delivery cost per consented child (on average 41 per class) 
 
 
2549.52 Yuan (718.17 $, 504.85 £) 
996.42 Yuan (280.68 $, 197.33 £) 
22.12 Yuan (6.23 $, 4.38 £) 
24.30 Yuan (6.84 $, 4.81 £) 
 
 
 
Component 2: 
Improving the nutritional 
quality of school lunch 
provision 
Labour: CHIRPY DRAGON teachers time (hours) 
Supportive regular evaluations and feedbacks to the catering 
teams 
Office stationery 
Ink pads 
Permanent markers 
Incentives: Catering teams 
Recognition certificate 
Telephone  
CHIRPY DRAGON teacher telephone  
 
0.01 
 
 
0.01 
0.04 
 
0.51 
 
0.03 
 
0.59 
 
 
0.06 
0.04 
 
5.75 
 
7.93 
 
 
 
 
0.01 
 
 
0.001 
0.0008 
 
0.13 
 
0.18 
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Component 2 total mean intervention running/delivery cost per school 
Component 2 total mean intervention running/delivery cost per class 
Component 2 total mean intervention running/delivery cost per child assuming a class of 45 
Component 2 total mean intervention running/delivery cost per consented child (on average 41 per class) 
 
 
 
61.1 Yuan (17.21 $, 12.09 £) 
14.37 Yuan (4.05 $, 2.85 £) 
0.32 Yuan (0.09 $, 0.06 £) 
0.35 Yuan (0.10 $, 0.07 £) 
  
 
 
 
 
 
 
 
 
 
 
 
 
Component 3: 
Increasing children’s 
physical activity level 
outside school 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Labour: CHIRPY DRAGON teachers time (hours) 
Physically active family friendly games learnt and practiced at 
school for children and their parents * 
Family-wide healthy behavioural challenges 
Workshops assistant time (hours) * 
Office stationery 
Ink pads 
Permanent markers 
Printing 
Family healthy behaviour challenges fun cards 
Stickers (with CHIRPY DRAGON logo) 
Record cards of individual performance 
Family healthy behaviour challenges reward board 
Delivery fee 
Family healthy behaviour challenges reward board 
Loudspeakers * 
Workshops materials 
Stamp * 
Suitcase * 
Cart * 
Loudspeakers * 
Stamp (with CHIRPY DRAGON logo) * 
Balloon * 
Finger board used in physically active family friendly games * 
Pencils * 
Rubber band * 
Megaphone * 
Strips of cloth * 
Incentives: Family healthy behavioural challenges 
Incentive prize 
 
 
4.52 
 
0.86 
3.85 
 
0.01 
0.04 
 
79.41 
10.88 
0.33 
8.82 
 
0.006 
0.02 
 
0.04 
0.02 
0.03 
0.05 
0.12 
100 
0.1 
0.06 
100 
0.06 
5 
 
3.41 
 
226.25 
 
42.8 
117.4 
 
0.06 
0.04 
 
11.91 
1.47 
2.12 
2.49 
 
0.07 
0.24 
 
1.12 
1.98 
1.1 
8 
2.81 
10 
3.75 
0.37 
0.75 
2.4 
5 
 
15.71 
 
 
5.03 
 
0.95 
2.61 
 
0.001 
0.0008 
 
0.26 
0.03 
0.05 
0.06 
 
0.002 
0.005 
 
0.02 
0.04 
0.02 
0.18 
0.06 
0.22 
0.08 
0.008 
0.02 
0.053 
0.11 
 
0.35 
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Telephone 
CHIRPY DRAGON teacher telephone 
Transport 
CHIRPY DRAGON teacher transport * 
 
 
0.03 
 
0.06 
 
7.93 
 
49.61 
 
0.18 
 
1.10 
 
Component 3 total mean intervention running/delivery cost per school 
Component 3 total mean intervention running/delivery cost per class 
Component 3 total mean intervention running/delivery cost per child assuming a class of 45 
Component 3 total mean intervention running/delivery cost per consented child (on average 41 per class) 
 
790.41 Yuan (222.65 $, 156.51 £) 
515.38 Yuan (145.18 $, 102.05 £) 
11.43 Yuan (3.22 $, 2.26 £) 
12.57 Yuan (3.54 $, 2.49 £) 
 
 
 
Component 4: 
Increasing children’s 
physical activity level in 
school 
 
 
 
Labour: CHIRPY DRAGON teachers time (hours) 
Monthly meeting with relevant school staff and student 
representatives 
Office stationery 
Ink pads 
Permanent markers 
Telephone  
CHIRPY DRAGON teacher telephone 
Transport 
CHIRPY DRAGON teacher transport 
 
0.16 
 
 
0.01 
0.04 
 
0.03 
 
0.08 
 
8.23 
 
 
0.06 
0.04 
 
7.93 
 
58.37 
 
0.18 
 
 
0.001 
0.0008 
 
0.18 
 
1.30 
Component 4 total mean intervention running/delivery cost per school 
Component 4 total mean intervention running/delivery cost per class 
Component 4 total mean intervention running/delivery cost per child assuming a class of 45 
Component 4 total mean intervention running/delivery cost per consented child (on average 41 per class) 
 
 
317.23 Yuan (89.36 $, 62.81 £) 
74.63 Yuan (21.02 $, 14.77 £) 
1.66 Yuan (0.47 $, 0.33 £) 
1.82 Yuan (0.51 $, 0.36 £) 
Total mean intervention running/delivery cost per school 
Total mean intervention running/delivery cost per class 
Total mean intervention running/delivery cost per child assuming a class of 45 
Total mean intervention running/delivery cost per consented child (averagely 41 per class) 
 
 
3718.26 Yuan (1047.39 $, 736.28 £) 
1600.8 Yuan (449.73 $, 317 £) 
35.53 Yuan (10.01 $, 7.04 £) 
39.04 Yuan (10.97 $, 7.73 £) 
 
Notes: Total number of intervention schools (n = 20), Total number of intervention classes (n = 85), Total number of intervention consented classes (20), 
Assumed average class size (45), Total number of intervention consented children (n = 832). Mean cost per class: the total cost for delivery across the 
whole intervention arm for the specific resource type divided by the number of classes (either 85 or 20). Some parts of the intervention, which involved 
family members, were only delivered to intervention consented classes (1 class per school). These costs were collected at class level and were related to 
interactive educational activities for main carers, quiz for main carers and children; and physically active family friendly games learnt and practiced at 
school for children and their parents. These resource type costs are indicated with * in the table. The rest of the intervention was delivered to all year one 
children (85 classes in 20 schools).  
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Incremental Analysis of Cost (Yuan, US Dollar, Pound) 
Given the assumed ‘no costs’ associated with the control, the intervention was statistically 
significantly more expensive than the control: 35.53 Yuan (£7.04/US$10.01) per child who 
received the intervention (assuming an average class size of 45). 
 
5.3.7 Cost-Utility Analysis 
The ICER associated with the base case was £1,760 (US$2,502) per QALY gained, which is 
far below the £20,000 and $50,000 per QALY thresholds for cost-effectiveness in the UK and 
US respectively [30, 279]. In addition, even using a 1xGDP per capita threshold (US$19,000), 
recommended by WHO, the ICER is far below the threshold for cost-effectiveness [165, 166]. 
Figure 5.1 shows the net-benefits associated with the intervention at different levels of WTP.  
 
 
Figure 5.1 - Net-benefit of intervention at different WTP levels (base case analysis) 
 
The decision uncertainty is presented using Cost Effectiveness Acceptability Curve for the 
further adjusted model. Figure 5.2 shows the probability of the intervention being cost-effective 
at different levels of WTP. At the UK NICE recommended threshold, there is a 96% probability 
141 
 
of the intervention being cost-effective. Even at a WTP of nearly £5,000 per QALY, the 
probability of cost-effectiveness remains high at 90%. 
 
Figure 5.2 - CEAC (base case analysis) 
 
5.3.8 Sensitivity Analyses Regarding Cost-Utility Analysis 
Sensitivity Analysis 1: Implementation Costs Included 
The inclusion of the implementation costs resulted in a slight increase in the ICER associated 
with the intervention and produced almost the same CEAC (Figure 5.3). The addition of the 
implementation costs increased average costs by 3.29 Yuan (£0.65/$0.92), increasing costs to 
38.82 Yuan (£7.69/$10.93) per child. This increase in cost had little impact on the overall 
recommendation from the economic evaluation, increasing the ICER to just £1,922/$2,732 per 
QALY. Even at a WTP of £10,000 per QALY, the probability of the intervention being deemed 
cost-effective is 94%. 
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Figure 5.3 - CEAC (sensitivity analysis 1: implementation costs included) 
Sensitivity Analysis 2: Chinese Tariff Applied for Utility Values 
The second sensitivity analysis tested the sensitivity of the results to using the Chinese tariff to 
estimate QALYs. The average QALY increased to 0.006 per child. This rise had a small impact 
on the results, decreasing the ICER to just £1,173/$1,668 per QALY. The CEAC (Figure 5.3) 
shows the impact of the slightly higher levels of QALY moving the CEAC slightly upwards, 
particularly at the lower levels of WTP, in comparison with the base-case analysis. However, 
even at a WTP of £10,000 per QALY, the probability of the intervention being deemed cost-
effective is 96%. 
 
 
Figure 5.4 - CEAC (sensitivity analysis 2: Chinese tariff applied for utility values) 
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Sensitivity Analysis 3: Class Size only Included Consented Children 
In this scenario, on average there were 41 children with parental consent to undertake 
measurements within each class. As a result, the cost increased to 39.04 Yuan (£7.73/$10.97) 
per child. This produced almost the same CEAC (Figure 5.5) with the ICER, rising to just 
£1,932/$2,742 per QALY. Again even at a WTP of £10,000 per QALY, the probability of the 
intervention being deemed cost-effective is 94%. 
 
 
Figure 5.5 - CEAC (sensitivity analysis 3: class size only included consented children) 
 
5.3.9 Cost-Effectiveness Analysis 
The significant difference between arms made it possible to assess the cost per BMI z-score 
change. The ICER was £54 (US$77) per BMI z-score change. 
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5.4 Part 3: Results: Economic Evaluation (Societal Perspective)  
5.4.1 Impact of Intervention on Parents/Household Members’ HRQoL (EQ-5D-3L) 
Table 5.17 outlines the response rate for the EQ-5D-3L instrument. Missing/invalid data for 
this outcome was almost 25% at both measurement points. As explained in part 2, section 
5.2.4.2, multiple imputation for the base-case analysis was not required. 
 
Table - 5.17 Number of consented parents/household members with completed EQ-5D-
3L 
Time point 
 
EQ-5D-3L completed 
all participants 
(n (%)) 
EQ-5D-3L completed 
control group 
(n (%)) 
EQ-5D-3L completed 
intervention group 
(n (%)) 
Baseline 
 
1235 (75.3%) 596 (73.7%) 639 (76.9%) 
12 months follow up 1226 (74.7%) 584 (72.2%) 642 (77.2%) 
  
 
Table 5.18 presents the mean utility scores at each time point (using the UK tariff) for the base-
case analysis. There was no baseline imbalance for utility scores, but nevertheless all 
incremental analyses were adjusted for baseline. At 12 months follow up, the mean utility scores 
for the intervention group was slightly higher than the control group. The mean utility scores at 
each time point (using the Chinese tariff for sensitivity analysis) were consistently higher 
compared to using the UK tariff (Appendix 2.8). 
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Table 5.18 - EQ-5D-3L utility scores at each time point (UK tariff) 
 EQ-5D-3L utility scores (parents/grandparents) 
 All participants Control group Intervention group 
Time Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) 
Baseline 
(N= 1235) 
0.961 
 
(.083) 
0.957 0.966 0.961 
 
(.085) 
0.954 0.968 0.962 
 
(.081) 
0.956 0.968 
12 months 
follow up 
 
(N = 1226) 
 
0.968 
 
(.078) 
0.963 0.972 0.965 
 
(.075) 
0.959 0.972 0.969 
 
(.081) 
0.963 0.976 
 
 
Examining the Impact of the Intervention on QALYs 
Table 5.19 describes the unadjusted mean QALYs (using the UK tariff). At 12 months follow 
up, the intervention group accrued 0.966 QALYs compared to 0.965 QALYs for the control 
group. The unadjusted mean QALYs (using the Chinese tariff) were consistently higher 
compared to using the UK tariff (Appendix 2.9).  
 
Table 5.19 - Unadjusted QALYs accrued (EQ-5D-3L, UK tariff) 
 Unadjusted QALYs accrued 
 All participants Control group Intervention group 
Time Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) 
12 months 
follow up  
(N= 1224) 
 
0.966 
 
(.064) 
 
 
0.962 0.969 0.965 
 
(.061) 
0.960 0.970 0.966 
 
(.066) 
0.961 0.971 
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Incremental Analysis – Effectiveness 
Table 5.20 describes the incremental difference in mean QALYs (using the UK tariff) between 
the intervention and control group for the data with no adjustment; adjustment for clustering 
and baseline differences; and adjustments for clustering, baseline differences and the pre-
specified covariates using mixed effect linear regression models. The mean QALY difference, 
using the three models, was in favour of the intervention for 12 months follow up but did not 
reach statistical significance. The QALYs attained were very similar compared to using the UK 
tariff (only marginally lower using the Chinese tariff with further adjusted model). These results 
were also not statistically significant using the three models (Appendix 2.10). After conducting 
multiple imputation, the results remain similar to those pre-imputation (Appendix 2.11). 
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Table 5.20 - Incremental difference in QALYs (EQ-5D-3L, UK tariff) 
 No adjustment  Adjusted for clustering and baseline utility Adjusted for clustering, baseline utility,  
co-variates 
Time Mean 
difference 
(95% CI) 
 
P-value Mean 
difference 
(95% CI) P-value Mean 
difference 
(95% CI) P-value 
12 
months 
follow up 
 
 
0.001 -0.006 0.008 0.784 0.002 -0.002 0.006 0.329 
 
 
0.002 -0.002 0.007 0.421 
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5.4.2 Resource Use and Costs  
A breakdown of the mean cost of lunch per diner per day and per year in each of the intervention 
and control schools is presented in Table 5.21. As the cost of lunch was paid for by the 
household, these costs assume a societal perspective. The total mean annual cost of lunch per 
diner was higher in the intervention schools 1765 Yuan (£349.50/$497.18) compared to the 
control schools 1637.5 Yuan (£324.25/$461.26). A comparison of the mean cost of lunch per 
diner per day in Yuan in the intervention versus the control schools is presented in Figure 5.6. 
As can be seen, interestingly, the variation in the mean cost is larger in the control schools 
compared to the intervention schools.
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Table 5.21 - Mean (SD) cost of lunch per diner per day and per year in each school 
 School Mean (SD) cost of 
lunch per school 
per day over the 
12 month trial 
period in Yuan 
Mean (SD) 
number of diners 
per school per day 
over the 12 month 
trial period 
Mean (SD) 
cost of lunch 
per diner per 
day in Yuan * 
 
 
Average cost of 
lunch per diner 
per year in Yuan 
** 
 
Average cost of 
lunch per diner 
per year in US£  
Average cost of 
lunch per diner 
per year in £  
 
 
 
 
 
 
 
 
 
 
 
 
Intervention 
group 
1 3740.49 (218.47) 596 (0) 6.28 (0.36) 1570  
 
442.25 310.89 
2 3419.88 (330.16) 465.95 (37.91) 7.33 (0.26) 1832.5 516.19 362.87 
 3 4149.05 (142.41) 643.76 (2.92) 6.44 (0.21) 1610 
 
453.52 318.81 
4 3667.24 (2641.25) 362.78 (202.49) 8.24 (3.38) 2060 580.28 407.92 
 5 4807.07 (144.92) 892.92 (10.58) 5.38 (0.16) 1345 378.87 266.34 
 6 1494.82 (97.28) 265.93 (5.58) 5.62 (0.33) 1405 395.77 278.21 
 7 4149.42 (178.72) 756.75 (13.45) 5.48 (0.21) 1370 385.91 271.28 
 8 7077.36 (143.39) 1040.79 (20.54) 6.8 (0.03) 1700 478.87 336.63 
 9 4620.75 (1387.71) 568.78 (163.84) 8.09 (0.39) 2022.5 569.72 400.49 
 10 8553.28 (44.18) 1006.26 (5.19) 8.5 (0) 2125 598.59 420.79 
 11 7834.54 (5640.71) 784.94 (55.14) 9.38 (0.44) 2345 660.56 464.35 
 12 4622.03 (847.66) 477.97 (23.38) 9.7 (1.8) 2425 683.09 480.19 
 13 1996.13 (1446.23) 275.73 (260.63) 8.22 (1.27) 2055 578.87 406.93 
 14 4296.01 (557.45) 641.96 (73.29) 6.69 (0.37) 1672.5 471.12 331.18 
 15 828.07 (28.16) 148.01 (3.93) 5.59 (0.07) 1397.5 393.66 276.73 
 16 4691.11 (546.03) 873.51 (71.59) 5.38 (0.5) 1345 378.87 266.34 
 17 4625.72 (613.50) 597.59 (7.22) 7.88 (0.23) 1970 554.92 390.09 
 18 4105.75 (277.65) 668.98 (42.80) 6.13 (0.18) 1532.5 431.69 303.46 
 Total 
Mean (SD) 
 4469.12 (2433.28) 631.24 (257.88) 
 
7.06 (1.66) 1765  497.18 349.50 
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 School Mean (SD) cost of 
lunch per school 
per day over the 
12 month trial 
period in Yuan 
Mean (SD) 
number of diners 
per school per day 
over the 12 month 
trial period 
Mean (SD) 
cost of lunch 
per diner per 
day in Yuan * 
 
 
Average cost of 
lunch per diner 
per year in Yuan 
** 
 
Average cost of 
lunch per diner 
per year in US£  
Average cost of 
lunch per diner 
per year in £  
 
 
 
  
 
 
 
 
 
 
 
 
 
Control  
group 
 
1 2763.93 (0.17) 500 (0) 5.53 (0) 1382.5 389.44 273.76 
 2 757.42 (179.26) 110.159 (18.18) 6.94 (1.56) 1735 488.73 343.56 
 3 331.66 (0.23) 60 (0) 5.52 (0) 1380 388.73 273.27 
 4 2159.56 (25.65) 398.2 (3.88) 5.42 (0.02) 1355 381.69 268.32 
 5 9355.67 (1147.67) 1325.12 (34.47) 7.05 (0.79) 1762.5 496.48 349.01 
 6 7579.64 (426.62) 1363.23 (48.39) 5.56 (0.38) 1390 391.54 275.25 
 7 3815.64 (680.06) 543.85 (25.84) 7.02 (1) 1755 494.36 347.52 
 8 7625.85 (649.41) 1013.52 (35.94) 7.51 (0.47) 1877.5 528.87 371.78 
 9 1957.52 (96.7) 351.46 (7.54) 5.57 (0.31) 1392.5 392.25 275.74 
 10 2006.05 (592.53) 550 (0) 3.64 (1.07) 910 256.34 180.19 
 11 3599.47 (376.53) 599.58 (19.83) 6.01 (1.38) 1502.5 423.24 297.52 
 12 3531 (17.39) 379.10 (10.51) 9.32 (0.25) 2330 656.34 461.38 
 13 5659.1 (234.21) 908.57 (10.48) 5.77 (0.29) 1442.5 406.34 285.64 
 14 5580.32 (1028.29) 606.37 (14.68) 9.18 (1.56) 2295 646.47 454.45 
 15 1107.29 (125.06) 138.52 (15.53) 7.99 (0.1) 1997.5 562.67 395.54 
 16 2525.53 (340.44) 331.98 (39.48) 7.63 (0.96) 1907.5 537.32 377.72 
 17 5765.19 (841.25) 1027.33 (5.77) 5.61 (0.82) 1402.5 395.07 277.72 
 18 3238.51 (749.09) 384.49 (89.85) 8.43 (0.45) 2107.5 593.66 417.32 
 19 1309.62 (222.08) 272.28 (9.71) 4.82 (0.87) 1205 339.43 238.61 
 20 2271.04 (0.09) 395 (0) 5.74 (0) 1435 404.22 284.16 
 Total 
Mean (SD) 
 3944.63 (2675.93) 607.43 (399.02) 6.55 (1.57) 1637.5 461.26 324.25 
 
Notes: * Mean cost per day was measured by taking the average of the total daily cost of lunch divided by the number of diners on each 
given day. **Average cost of lunch per diner per day was multiplied by the number of days (250) when schools were open during the 12 
month trial period to obtain estimated annual lunch cost per child. 
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Figure 5.6 - Mean cost of lunch per diner per day in intervention versus control schools 
 
A breakdown of the cost of the parents/main carers’ workshop attendance time is presented in 
Table 5.22. The data revealed that overall, across all the workshops, 61% of the 
parents/grandparents would have otherwise been at paid work, therefore 39% of them were 
using unpaid time. As on average, two parents or main carers attended the workshops, the total 
mean cost of family members’ time was therefore 373.92 Yuan (£74.4 /$105.32) per child. With 
regard to this cost, the largest proportion was on interactive educational workshops for main 
carers which accounted for half of the family members’ time costs. 
 
Incremental Analysis of Cost (Yuan, US Dollar, Pound) 
The intervention was statistically significantly more expensive than the control: 536.95 Yuan 
(£106.33/US$151.25) per child/family who received the intervention (assuming an average 
class size of 45). 
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Table 5.22 - Parents/main carers’ workshop attendance time cost 
 Workshop 
 
Average cost of 
workshop time for 
each family member 
in employment A 
Average cost of 
workshop time for 
each family member 
not in employment B 
Number of paid 
family members 
attending the 
workshop C 
Number of unpaid 
family members 
attending the 
workshop D 
Average cost of 
each family 
member time E 
Component 1 
(main carers) 
Education  65 * 2  18.3 * 2 61% * 683 39% * 683 93.48 Yuan (18.6 
£) 
Family quiz 65 * 1 18.3 * 1 61% * 491 39% * 491 46.74 Yuan (9.3 £) 
Component 3 
(parents) 
Family game 65 * 1 18.3 * 1 61% * 680 39% * 680 46.74 Yuan (9.3 £) 
Total  
  
186.96 Yuan  
(37.2 £/52.66 $) 
 
Notes:  
E = Average cost of each family member time = (A*C) + (B*D) / total attendees based on the process evaluation data 
A = Average cost of workshop time for each family member in employment = average hourly wage rate * workshop hours over trial duration 
B = Average cost of workshop time for each family member not in employment = average hourly leisure rate * workshop hours over trial 
duration 
C = Number of paid family members attending the workshop = 61% * total attendees based on the process evaluation data 
D = Number of unpaid family members attending the workshop = 39% * total attendees based on the process evaluation data 
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5.4.3 Cost-Utility Analysis 
To account for family member effects, the multiplier for each child was calculated as:  
[1 + (2 * (0.002) / 0.004)]  
The base-case ICER was therefore calculated using the following formula:  
£7.04   * 1.1   * £106.33 
0.004        2       £7.04 
In the base-case model, the impact from including household member QALYs and household 
costs increased the ICER from £1,760 (US$2,502) to £14,620 (US$20,796) per QALY gained, 
which is still well below the established UK and US thresholds for cost-effectiveness [30, 279]. 
Using a 1xGDP per capita threshold (US$19,000), recommended by WHO, the ICER is slightly 
above the threshold for cost-effectiveness. However, when a 3xGDP per capita threshold (US$ 
57,000) is used the ICER is well below the threshold for cost-effectiveness [165, 166]. 
 
5.4.4 Sensitivity Analyses 
The four sensitivity analyses had the following impact on the ICER: implementation costs 
included (ICER increased to £14,709/$20,923 per QALY), Chinese tariff applied for utility 
values (ICER remained the same as base-case £14,620/$20,796 per QALY), using consented 
children only (ICER increased to £16,047/$22,823 per QALY) and using predictive mean 
matching multiple imputation (ICER increased to £16,709/$23,767 per QALY). 
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5.4.5 Exploratory Analysis of Household Expenditure 
Appendices 2.12 i – iii outline the response rate for the household expenditure and income data. 
Missing/invalid data for these were less than 16% at both measurement points. There were no 
differences between the two study groups in completeness of the data. 
The mean household expenditure at each time point is presented in Appendices 2.13 i – ii and 
Table 5.23 presents the mean income data at each time point. There was no baseline imbalance 
for these data. At 12 months follow up, there were no noticeable differences in mean 
expenditure between the intervention and control groups over a range of different expenditure 
categories. 
 
Table 5.23 - Monthly mean (SD) of total income of families in Yuan  
 Baseline 
 
12 months follow up 
All 
Participants 
Control 
group 
Intervention 
group 
All 
participants 
Control 
Group 
Intervention 
group 
Total 
income of 
families 
 
19048.24 
(17180.51) 
18752.87 
(16428.8) 
19323.54 
(17858.8) 
19411.04 
(15725.78) 
19589.94 
(15758.07) 
 
19241.63 
(15703.99) 
 
 
Table 5.24 and Figure 5.7 present the proportion (%) of household monthly income spent on 
different items. There was no baseline imbalance for these data, nevertheless all incremental 
analyses were adjusted for baseline. As can be seen, in general, families spent the greatest 
proportion of their income on food and non-alcoholic drinks, and the least on alcoholic drinks, 
tobacco and narcotics.  
Table 5.25 describes the incremental difference in the proportion of monthly income spent on 
the different categories between the intervention and control groups, using three models: i) no 
adjustment; ii) adjustment for baseline differences; and iii) adjustments for baseline differences 
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and the pre-specified covariates using mixed linear regression models. The differences were 
small and none of them were statistically significant. 
 
Table 5.24 - Proportion of income spent monthly on the different household expenditure 
Categories of family expenditure Baseline 12 months follow up 
Control Intervention Control Intervention 
Electricity/gas 4.6% 4.5% 4.8% 4.5% 
Transport 7% 6.9% 6.4% 6.7% 
Recreation 3% 2.8% 2.8% 2.9% 
Food/non-alcoholic drinks 13.7% 15.2% 13.7% 14.5% 
Alcoholic drinks, tobacco/narcotics 1.9% 1.9% 1.9% 1.8% 
Eating out 5.6% 5.9% 5.5% 5.6% 
Clothing 5.8% 6.1% 6.1% 5.9% 
Communications 3% 3% 2.9% 2.8% 
Household goods/services 3.7% 4.3% 4.6% 4.7% 
Other goods/services 1.9% 2.3% 2.2% 2.1% 
Education 7.9% 7.3% 10.2% 9.8% 
Healthcare 3.1% 3% 3.1% 2.9% 
Total 61.2% 63.2% 64.2% 64.2% 
 
 
Figure 5.7 - Proportional household expenditure 
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Table 5.25 - Incremental difference in different categories of family monthly expenditure 
Categories of monthly family 
expenditure 
No adjustment  Adjusted for baseline  Adjusted for baseline and  
co-variates 
% 
differe
nce 
(95% CI) P- 
value 
% 
differe
nce 
(95% CI) P-value % 
differe
nce 
(95% CI) P-value 
Electricity/gas -0.3% -1.3% 0.7% 0.577 -0.1% -0.9% 0.8% 0.900 -0.3% -1.1% 0.5% 0.435 
Transport 0.3% -0.4% 1.0% 0.457 0.3% -0.5% 1.0% 0.507 0.3% -0.5% 1.0% 0.482 
Recreation 0.1% -0.4% 0.5% 0.806 0.2% -0.1% 0.6% 0.133 0.2% -0.1% 0.6% 0.179 
Food/non-alcoholic drinks 0.7% -0.7% 2.2% 0.318 0.6% -0.8% 2% 0.395 0.5% -0.9% 1.9% 0.478 
Alcoholic drinks, 
tobacco/narcotics 
-0.1% -0.5% 0.2% 0.523 -0.2% -0.6% 0.2% 0.429 -0.3% -0.7% 0.1% 0.396 
Eating out 0.1% -0.5% 0.6% 0.863 0.1% -0.5% 0.5% 0.970 0.1% -0.4% 0.5% 0.933 
Clothing -0.2% -0.1% 0.5% 0.526 -0.1% -0.5% 0.8% 0.683 -0.1% -0.6% 0.8% 0.809 
Communications -0.1% -0.3% 0.2% 0.712 -0.1% -0.2% 0.4% 0.560 -0.1% -0.3% 0.3% 0.944 
Household goods/services 0.1% -0.5% 0.4% 0.981 0.3% -0.7% 0.5% 0.373 0.3% -0.8% 0.6% 0.427 
Other goods/services -0.1% -0.3% 0.2% 0.441 -0.2% -0.4% 0.3% 0.176 -0.2% -0.5% 0.2% 0.182 
Education -0.3% -0.8% 0.7% 0.680 -0.2% -0.6% 0.3% 0.772 -0.3% -0.7% 0.5% 0.822 
Healthcare -0.2% -0.7% 0.2% 0.398 -0.2% -0.6% 0.2% 0.415 -0.2% -0.6% 0.2% 0.364 
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5.5 Part 4: Discussion 
5.5.1 Statement of Principal Findings 
The economic evaluation from a public sector perspective showed that the CHIRPY DRAGON 
intervention had a relatively low cost and significant intervention benefits over the course of 12 
months, suggesting it is highly cost-effective. The intervention is cost-effective using the 
conventional decision making rules within a CEA and CUA. Broadening the evaluative space 
to include household costs and QALYs had the effect of increasing the ICER however the 
intervention remained cost-effective. Both these results were robust in sensitivity analyses. 
The impact of the intervention on proportional spend on different household categories was 
minimal and none of the differences were statistically significant.  
 
5.5.2 Methodological Challenges of Conducting Economic Evaluation 
A number of methodological challenges were encountered from undertaking an economic 
evaluation within a Chinese setting. All costs had to be converted into either UK pounds or US 
dollars using GDP PPPs. All unit costs had to be sourced that were relevant to a Chinese context. 
Using the appropriate value-set for either the CHU-9D or EQ-5D-3L as, although there is a 
Chinese version, the recommendation was to use the UK set since the Chinese value set was 
still under development. Furthermore, as economic evaluation is uncommon in China and due 
to the lack of an equivalent threshold value for a Chinese setting, the established UK and US 
threshold values for a QALY were used to judge cost-effectiveness. It is unclear whether these 
values reflect society’s valuation of a QALY gain within a Chinese setting. 
This study also highlighted some methodological challenges related to the inclusion of spillover 
effects. First, the spillover data was not complete due to non-response. Second, as household 
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members’ resource use and outcome data are very rarely considered in economic evaluations, 
guidelines for including these data were limited therefore an exploratory analysis was only 
possible.  
 
5.5.3 Strengths and Limitations of this Study 
Strengths include the large sample size (1641 children), standardised data collection procedures 
as part of the RCT, training for the CHIRPY DRAGON teachers, very good follow up rates, 
the low level of attrition throughout the follow up period, and the use of a pre-specified analysis 
plan which took account of school clustering. The intervention programme was well delivered 
and received. A very low level of missing data regarding resource use and outcomes, using a 
public sector perspective, proved to be a significant strength. This was largely because 
purposely employed staff collected the data, which was collected alongside the trial as 
recommended by best practice [22, 36, 275]. Where possible, the results of this economic 
evaluation was reported using CHEERS guidelines [48]. Detailed analysis of the resource items 
was provided. Furthermore, this study is one of the very few economic evaluations of obesity 
prevention studies worldwide and the first in China, which collected utility-based HRQoL 
information in children as young as 6 years and family members to calculate QALYs, and 
included societal costs. It used both the UK and Chinese tariffs for calculating the utility scores. 
This study reported the ICER from two alternative perspectives and included both clinical and 
economic outcomes. This enabled comparison with other studies. Moreover, this is the first 
CUA study worldwide to consider health spillover effects generated from a behavioural obesity 
intervention using a multiplier approach. As a result it may provide policy makers with 
additional useful information when making policy decisions. The intuition behind the multiplier 
approach is that there is a bigger health dividend for the population than is represented just by 
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considering children’s QALYs and therefore this wider health dividend should be captured 
within an economic evaluation [276, 277].  
The study also had some limitations. One potential limitation relates to the way HRQoL 
information was collected from children. There may have been an influence on how children 
completed the questionnaire as items and possible responses within the CHU-9D were read to 
children, on a one-to-one basis, by the interviewers (research staff). This could have led to 
responder-bias [42]. However, given the young age of the participants, this collection strategy 
was chosen to optimise data quality and completion. Furthermore, interviewers were blind to 
allocation, minimising any differential bias. A further limitation was that the number of 
responses from household members was smaller than the number of children. This may result 
in a lack of statistically significant results regarding household members’ outcomes. 
Furthermore, both children’s and household members’ incremental QALYs were estimated 
separately before aggregating the mean estimates. In future studies, where the number of 
children and household members are more similar, we would recommend using a dyadic 
approach. The advantage of dyadic analysis, compared to the multiplier approach, for including 
health spillovers is that it enables a probabilistic sensitivity analysis to be conducted to explore 
cost-effectiveness uncertainty. Additionally, there was a lack of information on the salaries of 
parents/grandparents. Instead, the Chinese population average salary was applied to estimate 
the value of lost time due to participation in the trial. Furthermore, the analysis was constrained 
by the time horizon of the intervention. Whilst the intervention appears to be cost-effective and 
able to obtain benefits for both clinical and economic outcomes in children for a relatively low 
cost, the sustainability of these effects remains unknown. Moreover, there is an ongoing 
methodological debate concerning the use of the CHU-9D to capture HRQoL in young children 
and whether this instrument is responsive to change in weight status [280]. Finally, as this is a 
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behavioural intervention, therefore highly dependent on cultural, infrastructural and other 
system-related aspects, the generalisability of results to other contexts, particularly to developed 
country settings, could be questionable [247]. 
 
5.5.4 Comparison with Other Studies 
Based on the most recent systematic review of economic evaluations reported in this thesis [47], 
there is no consistent measure of outcomes across published evaluations. Most reports of trial-
based economic evaluations of school-based child obesity interventions used clinical outcome 
improvements (e.g. BMI or waist circumference) [17, 115, 206, 227, 235, 237] and studies 
based on QALYs gained were limited [249]. This heterogeneity of outcome measures hinders 
comparability of cost-effectiveness. Also, in terms of judging cost-effectiveness of 
interventions, context-specific assessment is problematic as there are different thresholds for 
cost effectiveness in different countries. Apart from one study [249], the rest of these school-
based obesity interventions appeared cost-effective using a ‘cost per weight-specific outcome’. 
However, without thresholds for obesity-related outcomes, it is difficult to judge value for 
money. Currently, for example, there is no national or international threshold on WTP for the 
prevention of a BMI gain in childhood. 
The cost-effectiveness analysis results showed that the ICER from a public sector perspective 
was £54 (US$77) per BMI z-score change. This was lower than two previous trial-based 
intervention studies which used BMI z-score as their measure of effectiveness: one Chinese 
study, targeting dietary habits and physical activity in children 6-13 years, (US$ 249.3 per BMI 
z-score change) [17]; the other Australian, targeting physical activity in adolescents 13-16 
years, (AU$ 563 per 10 % reduction in BMI z-score) [206]. Neither of these studies included 
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indirect costs. Contrary to this study, a similar study in the UK, targeting dietary habits and 
physical activity in children 6-7 years, was not cost-effective using BMI z-score [249].  
Contextual factors including differences in the stage of the childhood obesity epidemic and 
cultural factors, as well as intervention differences (e.g. target, components and how these were 
delivered) may have contributed to the observed differences in findings. It has been determined 
that obesity prevention interventions are more effective when delivered by dedicated staff rather 
than classroom teachers [281]. The staff employed to deliver the intervention in this trial were 
well accepted by schools and their costs were incorporated in the economic evaluation. 
In terms of understanding the impact of the intervention on multiple outcomes, a more 
disaggregated analysis (e.g. a CCA) alongside a CEA and CUA could have been undertaken. 
This would give a ‘list’ rather than offset against the costs. Thus decision makers would 
understand how the benefits are distributed across the different sectors (health and education) 
and this could then act as a tool to facilitate cross-sectoral decision making. Using a CCA could 
also give decision makers confidence that the data are valid to use as the basis for resource 
allocation decisions. 
 
5.5.5 Implications for Practice, Policy and Research 
The research in this thesis demonstrates the feasibility of collecting and including household 
members’ cost and outcome data in cost utility analysis. However, as household members’ 
resource use and outcome data are very rarely considered in economic evaluations, guidelines 
for how to include these data are limited. For preventive public health interventions (e.g. obesity 
prevention) the use of a societal perspective in economic evaluations is more complex 
compared to health perspective, and the vast majority of consequences and therefore costs 
prevented fall in the future. To capture all possible societal costs and effects, data from various 
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sources (e.g. clinical, epidemiological, and economic) are needed. The development of a 
toolbox including good-practice guidelines for intervention developers and evaluators would 
be useful in order to collect relevant data alongside trials. All methods for estimating societal 
costs should explicitly be documented and reported to provide information that will inform 
future evaluations and policy making. 
The economic evaluation results can inform future research and policy decisions in China. 
Future studies need to evaluate whether the effects and the cost-effectiveness results are 
sustainable in the long term, and a suitable model could be used to assess the long-term cost-
effectiveness. 
 
5.6 Conclusion 
The economic evaluation from a public sector perspective suggested that this intervention, 
delivered through schools and families with high implementation adherence, was highly cost-
effective. This study demonstrated the feasibility of collecting and including household 
members’ cost and outcome data in cost utility analysis. In this case the intervention did not 
impact significantly on household members’ health, but inclusion of household spillovers may 
make a difference in other contexts. Including societal costs and effects increased the ICER, 
however the intervention remained cost-effective using established cost-effectiveness 
thresholds. Although this chapter contributes robust applied evidence, a number of 
methodological issues remains unknown. The next chapter reports on the following 
methodological evidence gaps using data from the CHIRPY DRAGON trial: 
 The association between weight status and HRQoL 
 The construct validity of the CHU-9D when used in a Chinese population  
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CHAPTER 6. EXPLORING HOW WEIGHT STATUS 
RELATES TO HRQOL; AND AN ASSESSMENT OF 
THE CONSTRUCT VALIDITY OF THE CHU-9D IN 
SCHOOL-AGED CHILDREN: EVIDENCE FROM THE 
CHINESE TRIAL 
 
6.1 Introduction 
Chapter 5 reported that the CHIRPY DRAGON obesity prevention intervention, delivered 
through schools and families with high implementation adherence, was highly cost-effective. 
The intervention was deemed cost-effective using the conventional decision making rules 
within a CEA and CUA.  
There is evidence to suggest that HRQoL is affected by culture [282], may differ by gender 
[283] and is positively associated with socio economic status [42]. As discussed in chapter 2, 
in some communities obesity is not recognized as a problem and is associated with good health, 
so HRQoL may be less influenced by obesity in these communities [82, 284, 285]. Obesity 
trends follow a different pattern in China compared with high-income countries (which are at a 
more advanced stage of the obesity epidemic) with the risk of obesity being greater in children 
from higher socio-economic backgrounds and much greater in boys compared to girls [10, 11]. 
It is important to explore further how this relates to utility-based HRQoL in this population as 
this directly impacts on QALY measurement for cost-utility analysis. 
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HRQoL is influenced by culture, gender and socioeconomic status and is, obviously, impaired 
in ill-health. However, obesity may not be perceived as ill-health and has a different meaning 
to different cultures, gender and social groups. Therefore it is important to examine how weight 
status relates to HRQoL. QALYs are used as the unit of assessment to make judgements about 
the relative cost-effectiveness of competing interventions [36] and require an understanding of 
the relationship between weight and health related QoL when measured in utility terms. QALYs 
are also used to inform resource allocation decisions in other country-settings [37]. This is why 
it is important to analyse how weight status relates to HRQoL in this unique country context. 
To date, very few studies examining the relationship between weight status and utility-based 
HRQoL in children have been conducted and of the few that do exist, they are predominantly 
from western or high income countries [42, 286]. This chapter directly addresses this evidence 
gap to support the interpretation of QALY results and provides further information within 
economic analysis. 
The first aim (a) of this chapter was to examine how children’s weight status relates to their 
HRQoL in China. The objectives were to: 
 Examine the relationship between HRQoL and weight status, gender and socio-
economic status. 
 Examine the relationship between weight status and HRQoL, adjusting for age, 
gender and socio-economic status. 
 Examine whether any relationship between weight status and HRQoL differs by 
gender. 
As discussed in chapter 3, the CHU-9D is a recently developed paediatric utility measure for 
application in the economic evaluation of prevention and treatment interventions. Although 
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there is emerging evidence regarding the psychometric properties of the CHU-9D instrument 
[41, 42, 44], more evidence is required with respect to its validity for use in different age groups 
and country settings considering different tariffs. This is important because the measure may 
have different construct validity in different populations. 
The second aim (b) within this chapter was to assess the construct validity of the CHU-9D 
instrument in primary school-aged children in a Chinese setting, with the objectives being: 
 To determine the discriminant validity of the instrument (discriminant validity 
refers to the degree with which the instrument discriminates between groups 
with known differences [287] (e.g. socio-economic status) [41, 42]).  
 To determine the convergent validity of the instrument (convergent validity 
refers to the degree to which two theoretically related measures of construct are 
correlated [287]).  
To facilitate this assessment, the CHU-9D was compared to the PedsQL instrument which is a 
widely used, validated generic HRQoL measure in children. 
As the CHIRPY DRAGON trial and its measurements have been described in full in chapters 
2 and 5, only a brief overview of the trial and its measurements are provided below as part of 
the methods. The remainder of the methods section describes the statistical analyses plan for 
each of the two aims separately.  
 
6.2 Methods 
6.2.1 Trial Design and Participants 
The analysis presented uses data from the CHIRPY DRAGON cluster-randomised controlled 
trial assessing effectiveness and cost-effectiveness of a childhood obesity prevention 
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intervention in Guangzhou, China [126]. Children were aged 6-7 years old at baseline, and 
initially followed up 12 months later. At baseline, a range of measurements were undertaken, 
including the PedsQL; CHU-9D; height; weight; gender; age; and socio-economic factors 
(described in detail in chapter 5). This chapter only uses data collected at baseline. Utility-based 
HRQoL was measured using the Chinese-translated version of the CHU-9D instrument. 
General HRQoL was measured using the validated Chinese version of the PedsQL instrument. 
Mother/father’s education level was collected through a parent completed questionnaire and 
used as a proxy for socio-economic status. Within a sensitivity analysis, the mother/father’s 
employment status was used as an alternative proxy for socio-economic status. 
 
6.2.2 Statistical Analyses 
Descriptive Statistics of the Sample Characteristics 
Descriptive statistics for the variables of interest which were reported extensively in chapter 5 
are summarised in this chapter. All statistical analyses were undertaken in 2019, using Stata 
version 13. 
 
Factors Associated with HRQoL 
The relationship between HRQoL (measured using the CHU-9D combined with the UK and 
Chinese tariffs, and PedsQL) and weight status category (defined as overweight/obese vs. 
healthy/underweight or underweight vs. normal weight, overweight, obese); and with gender 
were examined using descriptive analyses. HRQoL was also assessed in relation to socio-
economic status using the mother/father’s education level coded as a binary variable ((did or 
did not attend university) and a categorical variable (school education, occupation college, 
university undergraduate education, university postgraduate education)). For the 
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mother/father’s employment status, used in a sensitivity analysis, this was coded as a binary 
variable ((did or did not work) and a categorical variable (working full time, working part time, 
unemployed or looking for work, looking after the family/house, other)).  
Differences in HRQoL scores between groups were estimated using either the Kruskal-Wallis 
test (across all levels of categorical variables), or the non-parametric test for trend (across 
ordered categories of a variable). Non-parametric tests were used because the HRQoL variables 
did not follow a normal distribution (based on Kolmogorov–Smirnov test). 
A linear mixed regression model (with random effect for school), adjusted for potential 
confounders (age, gender and mother/father’s education) was used to compare the CHU-9D 
utility values (using the UK and Chinese tariffs) between the two weight status groups 
(overweight/obese as compared with healthy/underweight).  
 
Relationship between Weight Status and HRQoL by Gender  
This analysis was used to assess if any relationship between HRQoL and weight status differed 
in boys versus girls.  
 
Construct Validity 
Discriminant Validity 
Three tests were used to explore the discriminant validity: firstly, statistical tests of difference 
were used to determine if the CHU-9D instrument was able to discriminate between groups 
with known differences. Studies from both a UK and Australian setting report a lower HRQoL 
for children from worse socio-economic backgrounds [41, 42, 280], therefore socio-economic 
status was used for this analysis.  
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Secondly, the sample was split according to the median PedsQL total score. The mean (SD) 
and median CHU-9D utility values (using the UK and Chinese tariffs) were compared for 
children who had a score either on/above, or below, this median PedsQL score, using the t-test.  
Thirdly, it was examined how well the mean PedsQL scores corresponded with the options for 
each of the CHU-9D dimensions, and for this, the mean PedsQL total score was estimated for 
each level of CHU-9D response on every dimension. This analysis was done with the 
expectation that the mean PedsQL total score would decrease linearly with increasing severity 
on each of the CHU-9D dimensions. 
 
Convergent Validity 
Convergent validity was explored, using statistical tests of association, to determine how the 
CHU-9D correlated with the PedsQL measure. 
Graphical means (scatter plots), along with fitted regression line and 95 % CIs, for the CHU-
9D utility values (using the UK and Chinese tariffs) and the PedsQL total scores were used to 
show the relationship between the instruments.  
Then, using the Spearman’s rho statistic, the correlation coefficient between the CHU-9D utility 
values (using the UK and Chinese tariffs) and the PedsQL total scores was calculated. 
Spearman’s Rank correlation coefficient Rs is a technique which can be used to summarise the 
strength and direction (negative or positive) of a relationship between two instruments. The 
result is always between 1 and -1. The meaning of the strength of the correlation using the guide 
for the value of Rs [288] is shown in Table 6.1. 
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Table 6.1 - Meaning of the strength of the correlation for the value of coefficient Rs 
Value of coefficient Rs (positive or negative) Meaning 
0.00 to 0.19 A very weak correlation 
0.20 to 0.39 A weak correlation 
0.40 to 0.69 A moderate correlation  
0.70 to 0.89 A strong correlation 
0.90 to 1.00  A very strong correlation 
 
The content and coverage of the two instruments were further estimated by examining the 
correlation between individual CHU-9D dimensions and the theoretically similar PedsQL 
domains (Table 6.2). 
 
Table 6.2-Mapping of CHU9D dimensions against theoretically similar PedsQL domains  
PedsQL instrument CHU9D instrument 
 
Physical functioning Pain, Tired, Sleep, Daily routine 
 
Emotional functioning Worried, Sad, Annoyed 
 
Social functioning Ability to join in activities 
 
School functioning School work/Home work 
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6.3 Results 
6.3.1 Participant Characteristics 
Full data (including PedsQL total score and its sub-scales; CHU-9D dimensions and utility 
value; height and weight (converted to BMI z-score and weight status); gender; age; and 
parents’ education level) were available for 1539 children (93.8% of those who consented and 
participated in study measurements) and are described in Table 6.3. Data on parental 
employment status was available for 1539 children and is presented in Appendix 3.1. 
The mean age of the children was 6.6 years (SD= 0.42) and 54% were male. Around a third of 
parents did not have a university education. The mean BMI z-score was -0.12 (SD=1.29), whilst 
more than 17% of the children were either overweight (10.7%) or living with obesity (7.2%); 
comparable to national data for overweight/obesity in the same age group (20.4%) [127]. The 
mean utility scores of the total sample was, on average, slightly higher for CHU-9D using the 
UK tariff (mean = 0.937 (SD= 0.068) compared to using the Chinese tariff (mean = 0.920 (SD= 
0.094). The mean total PedsQL score was 82.92 (SD= 11.21). 
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Table 6.3 - Characteristics of the study population 
Characteristics 
Gender: n (%)  
Male 
Female 
831 (54.0) 
708 (46.0) 
Age (years): mean (SD)  6.6 (0.42) 
Measures of socio-economic status  
Maternal university education: n (%)  
Yes 
No 
963 (62.6) 
576 (37.4) 
Maternal education level: n (%)  
1 School education 
2 Occupation college 
3 University undergraduate education 
4 University postgraduate education 
296 (19.2) 
280 (18.2) 
847 (55.1) 
116 (7.5) 
Paternal university education: n (%)  
Yes 
No 
1005 (65.3) 
534 (34.7) 
Paternal education level: n (%)  
1 School education 
2 Occupation college 
3 University undergraduate education 
4 University postgraduate education 
247 (16.2) 
287 (18.6) 
824 (53.5) 
181 (11.7) 
Weight status: n (%)  
Underweight 
Healthy weight 
Overweight 
Obese 
75 (4.9) 
1189 (77.2) 
165 (10.7) 
110 (7.2) 
Underweight/Healthy weight compared to Overweight/Obese: n (%)  
Underweight/Healthy weight 
Overweight/Obese 
1264 (82.1) 
275 (17.9) 
BMI: mean (SD)  15.45 (2.13) 
BMI z-score: mean (SD)  -0.12 (1.29) 
CHU-9D mean score (SD)  
CHU-9D: using UK tariff  
CHU-9D: using Chinese tariff 
0.937 (0.068) 
0.920 (0.094) 
PedsQL mean score (SD) 
PedsQL Total scale score  
PedsQL Physical functioning  
PedsQL Psychosocial functioning  
PedsQL Emotional functioning  
PedsQL Social functioning  
PedsQL School functioning 
82.92 (11.21) 
83.67 (13.15) 
82.52 (12.36) 
81.69 (17.54) 
84.09 (15.30) 
81.77 (15.36) 
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6.3.2 Relationship between HRQoL and Weight Status, Gender and SES 
Table 6.4 summarises the CHU-9D utility values and PedsQL total scores according to the 
weight status, socio-economic status and gender of the children. The direction of the 
relationships were similar between instruments. 
Of interest, the mean and median utility scores using both UK and Chinese tariffs and mean 
and median PedsQL total scores were all marginally higher for children who were 
overweight/obese compared to those who were not. 
The CHU-9D using both UK and Chinese tariffs discriminated by gender (p =0.003 and p 
=0.004 respectively), with girls having slightly higher mean and median utility scores. The 
mean and median PedsQL total score in girls was also slightly higher than that in boys, although 
these differences were not statistically significant. 
All HRQoL measures were also marginally higher in children whose parents did not have a 
university education (lower socio-economic status) compared to those who did. However, these 
differences were not statistically significant. The analyses were re-run using parental 
employment status as an alternative proxy for socio-economic status and the results were 
similar (Appendix 3.2). 
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Table 6.4 - Mean (SD), median (IQR) for CHU9D, PedsQL scores based on characteristics 
 
 
 
 
 
Number 
(%) 
CHU-9D Utility, UK tariff CHU-9D Utility, Chinese tariff PedsQL total score 
Mean (SD), Median (IQR) 
 
Mean (SD), Median (IQR)                  Mean (SD), Median (IQR) 
 
Gender 
Male 
 
Female 
831 
(54.0) 
708 
(46.0) 
0.932 (0.072), 0.952 (0.897-1.000) 
 
0.943 (0.063), 0.963 (0.909-1.000) 
0.914 (0.098), 0.939 (0.873-1.000) 
 
0.927 (0.089), 0.955 (0.881-1.000) 
82.29 (11.72), 83.69 (75.00-91.30) 
 
83.66 (10.54), 85.86 (77.17-91.30) 
p-value*  0.003* 0.004* 0.06 
Mother’s university education 
Yes 
 
No 
963 
(62.6) 
576 
(37.4) 
0.936 (0.068), 0.956 (0.903-1.000) 
 
0.938 (0.068), 0.963 (0.903-1.000) 
0.920 (0.091), 0.943 (0.876-1.000) 
 
0.921 (0.099), 0.952 (0.874-1.000) 
82.58 (11.29), 83.69 (76.08-91.30) 
 
83.49 (11.07), 85.86 (77.17-91.30) 
p-value*  0.27 0.42 0.08 
Mother education level 
1 School education 
 
2 Occupation college 
 
3 University undergraduate 
education 
4 University postgraduate 
education 
296 
(19.2) 
280 
(18.2) 
847 
(55.1) 
116 
(7.5) 
0.937 (0.070), 0.963 (0.895-1.000) 
 
0.940 (0.067), 0.963 (0.907-1.000) 
 
0.937 (0.068), 0.958 (0.903-1.000) 
 
0.932 (0.070), 0.952 (0.901-1.000) 
0.921 (0.096), 0.953 (0.870-1.000) 
 
0.919 (0.102), 0.945 (0.879-1.000) 
 
0.920 (0.091), 0.943 (0.876-1.000) 
 
0.919 (0.092), 0.942 (0.885-1.000) 
83.06 (11.18), 85.86 (76.08-91.30) 
 
83.95 (10.96), 85.86 (78.26-91.30) 
 
82.58 (11.37), 83.69 (76.08-91.30) 
 
82.59 (10.71), 84.23 (75.00-89.13) 
p-value**  0.27 0.36 0.19 
Father’s university education 
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Yes 
 
No 
1005 
(65.3) 
534 
(34.7) 
0.936 (0.068), 0.955 (0.902-1.000) 
 
0.939 (0.069), 0.963 (0.904-1.000) 
0.920 (0.091), 0.943 (0.876-1.000) 
 
0.921 (0.100), 0.955 (0.876-1.000) 
82.90 (11.06), 84.78 (76.08-91.30) 
 
82.97 (11.51), 85.86 (76.08-91.30) 
p-value*  0.17 0.38 0.61 
Father education level 
1 School education 
 
2 Occupation college 
 
3 University undergraduate 
education 
4 University postgraduate 
education 
247 
(16.2) 
287 
(18.6) 
824 
(53.5) 
181 
(11.7) 
0.931 (0.075), 0.963 (0.892-1.000) 
 
0.946 (0.062), 0.963 (0.915-1.000) 
 
0.937 (0.067), 0.960 (0.903-1.000) 
 
0.932 (0.072), 0.952 (0.897-1.000) 
0.911 (0.110), 0.943 (0.864-1.000) 
 
0.928 (0.090), 0.955 (0.882-1.000) 
 
0.921 (0.090), 0.943 (0.877-1.000) 
 
0.916 (0.096), 0.943 (0.870-1.000) 
82.27 (11.65), 83.69 (75.00-91.30) 
 
83.57 (11.36), 85.86 (76.08-92.39) 
 
83.11 (11.14), 84.78 (76.08-91.30) 
 
81.91 (10.65), 83.69 (76.08-89.13) 
p-value**  0.42 0.63 0.53 
Weight status groups 
Underweight 
 
Healthy weight 
 
Overweight 
 
Obese 
75 
(4.9) 
1189 
(77.2) 
165 
(10.7) 
110 
(7.2) 
0.942 (0.067), 0.963 (0.908-1.000) 
 
0.936 (0.069), 0.962 (0.900-1.000) 
 
0.941 (0.064), 0.963 (0.909-1.000) 
 
0.939 (0.071), 0.962 (0.914-1.000)  
0.923 (0.092), 0.938 (0.873-1.000) 
 
0.919 (0.095), 0.943 (0.876-1.000) 
 
0.925 (0.086), 0.955 (0.874-1.000) 
 
0.921 (0.096), 0.943 (0.890-1.000) 
82.47 (12.06), 85.86 (72.82-92.39) 
 
82.84 (11.13), 83.69 (76.08-91.30) 
 
83.18 (11.65), 85.86 (76.08-91.30) 
 
83.69 (10.94), 86.95 (77.17-91.30) 
p-value**  0.73 0.89 0.29 
Weight status groups 
Underweight/Healthy 
weight 
Overweight/Obese 
1264 
(82.1) 
275 
(17.9) 
0.936 (0.069), 0.963 (0.901-1.000) 
 
0.940 (0.067), 0.964 (0.909-1.000) 
0.919 (0.095), 0.943 (0.875-1.000) 
 
0.923 (0.090), 0.944 (0.876-1.000) 
82.82 (11.18), 83.69 (76.08-91.30) 
 
83.38 (11.35), 85.86 (76.08-91.30) 
p-value**  0.38 0.66 0.27 
*Kruskal-Wallis test; **non-parametric test for trend 
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Table 6.5 shows the results of the linear mixed regression model which compared the CHU-9D 
utility score between the two weight status groups, adjusted for potential confounders (age, 
gender and mother/father’s education). The results were similar to the unadjusted analyses as 
children who were overweight or obese had a marginally higher CHU-9D utility value, using 
UK and Chinese tariffs, compared to underweight/healthy weight but this association was not 
statistically significant. Girls had slightly higher mean CHU-9D utility values compared to boys 
(p = 0.001 and p = 0.003 for UK and Chinese tariffs respectively), whilst children whose parents 
had a university education reported a lower HRQoL (not statistically significant). 
 
Relationship between Weight Status and HRQoL by Gender  
Table 6.6 summarises the CHU-9D utilities and PedsQL total scores by gender further classified 
into weight status and socio-economic groups. As before, although the direction of the 
relationships between each instrument and; weight status and socio-economic status were very 
similar, the mean CHU-9D utilities using the UK tariff were, on average, slightly higher than 
those using the Chinese tariff. 
When children were categorised by gender, there was no evidence of differentiating HRQoL, 
using either instrument, in either of the gender groups according to their weight status and 
parent’s university education. 
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Table 6.5 - Results of linear mixed model to assess variation in CHU9D 
Variables 
 
 
CHU-9D utility score UK tariff CHU-9D utility score Chinese tariff 
Mean 
difference 
95 % CI p-value Mean 
difference 
95 % CI p-value 
Age (months) 0.001 (0.000, 0.001) 0.01** 0.001 (0.000, 0.002) 0.01** 
 
Weight  
 
Underweight/Healthy weight - 
 
Overweight/Obese 0.005 (-0.003, 0.014) 0.25 0.004 (-0.007, 0.016) 0.45 
 
Gender  
 
Male - 
 
Female 0.011 (0.005, 0.018) 0.001** 0.014 (0.004, 0.023) 0.003** 
 
Mother’s university  
Education 
No - 
 
Yes -0.003 (-0.012, 0.005) 0.46 -0.005 (-0.017, 0.007) 0.41 
 
Father’s university  
Education 
No - 
 
Yes -0.001 (-0.010, 0.007) 0.80 -0.002 (-0.009, 0.014) 0.66 
 
**Significant at p = 0.05 
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Table 6.6 - Mean (SD), median (IQR) for CHU9D, PedsQL scores by sex characteristics 
                                n                                                                                                                                            Boys n Girls 
Mean (SD), 
Median (IQR) 
CHU-9D Utility,  
UK tariff 
Mean (SD), 
Median (IQR) 
CHU-9D Utility,  
Chinese tariff 
Mean (SD), 
Median (IQR) 
PedsQL  
total score 
Mean (SD), 
Median (IQR) 
CHU-9D Utility,  
UK tariff 
Mean (SD), 
Median (IQR) 
CHU-9D Utility,  
Chinese tariff 
Mean (SD), 
Median (IQR)  
PedsQL  
total score 
Weight status groups 
 
 
Underweight 
Healthy weight 
641 0.931 (0.072) 
0.951 (0.897-1.000) 
0.913 (0.099) 
0.938 (0.874-1.000) 
82.10 (11.74) 
83.69 (75.00-91.30) 
623 0.942 (0.065) 
0.963 (0.904-1.000) 
0.926 (0.091) 
0.955 (0.880-1.000) 
83.56 (10.54) 
84.78 (77.17-91.30) 
Overweight 
/Obese 
190 0.936 (0.072) 
0.963 (0.903-1.000) 
0.918 (0.096) 
0.943 (0.872-1.000) 
82.93 (11.68) 
85.86 (76.08-91.30) 
85 0.951 (0.051) 
0.963 (0.914-1.000) 
0.935 (0.072) 
0.955 (0.891-1.000) 
84.41 (10.58) 
86.95 (79.34-91.30) 
p-value** 
 
 0.29 0.41 0.28  0.45 0.79 0.38 
Weight status groups 
 Underweight 35 0.923 (0.070) 
0.929 (0.877-1.000) 
0.899 (0.096) 
0.922 (0.815-1.000) 
79.93 (14.55) 
83.69 (69.56-92.39) 
40 0.959 (0.060) 
0.989 (0.924-1.000) 
0.944 (0.084) 
0.998 (0.913-1.000) 
84.70 (8.97) 
86.95 (76.08-92.39) 
Healthy weight 606 0.932 (0.072) 
0.951 (0.900-1.000) 
0.914 (0.099) 
0.939 (0.876-1.000) 
82.23 (11.56) 
83.69 (75.00-91.30) 
583 0.940 (0.065) 
0.963 (0.902-1.000) 
0.925 (0.091) 
0.953 (0.875-1.000) 
83.48 (10.64) 
84.78 (77.17-91.30) 
Overweight 108 0.937 (0.069) 
0.963 (0.893-1.000) 
0.918 (0.094) 
0.953 (0.860-1.000) 
82.56 (12.26) 
85.86 (76.08-91.30) 
57 0.950 (0.052) 
0.963 (0.914-1.000) 
0.939 (0.065) 
0.955 (0.896-1.000) 
84.35 (10.38) 
85.86 (79.34-91.30) 
Obese 82 0.934 (0.077) 
0.951 (0.914-1.000) 
0.918 (0.100) 
0.943 (0.890-1.000) 
83.41 (10.92) 
86.41 (76.08-91.30) 
28 0.953 (0.051) 
0.963 (0.916-1.000) 
0.928 (0.086) 
0.940 (0.883-1.000) 
84.53 (11.15) 
87.77 (80.97-91.30) 
p-value** 
 
 0.27 0.29 0.22  0.84 0.58 0.57 
Mother’s university education 
 Yes 
 
508 0.931 (0.072) 
0.951 (0.901-1.000) 
0.914 (0.094) 
0.938 (0.876-1.000) 
81.95 (11.72) 
83.69 (75.00-91.30) 
455 0.942 (0.063) 
0.963 (0.907-1.000) 
0.926 (0.087) 
0.955 (0.878-1.000) 
83.28 (10.75) 
84.78 (77.17-91.30) 
No 
 
323 0.934 (0.072) 
0.963 (0.893-1.000) 
0.915 (0.104) 
0.943 (0.865-1.000) 
82.82 (11.73) 
85.86 (76.08-91.30) 
253 0.944 (0.064) 
0.965 (0.914-1.000) 
0.928 (0.092) 
0.956 (0.889-1.000) 
84.34 (10.14) 
85.86 (78.26-91.30) 
p-value* 
 
 0.25 0.43 0.21  0.66 0.70 0.20 
Father’s university education 
 Yes 
 
532 0.931 (0.072) 
0.951 (0.896-1.000) 
0.913 (0.095) 
0.938 (0.871-1.000) 
82.20 (11.45) 
83.69 (75.00-91.30) 
473 0.942 (0.063) 
0.963 (0.909-1.000) 
0.926 (0.086) 
0.953 (0.882-1.000) 
83.61 (10.56) 
84.78 (78.26-91.30) 
No 
 
299 0.935 (0.072) 
0.963 (0.902-1.000) 
0.915 (0.104) 
0.951 (0.875-1.000) 
82.46 (12.21) 
84.78 (76.08-91.30) 
235 0.945 (0.063) 
0.963 (0.908-1.000) 
0.927 (0.094) 
0.955 (0.881-1.000) 
83.68 (10.53) 
85.86 (76.08- 92.39) 
p-value* 
 
 0.15 0.29 0.44  0.54 0.82 0.94 
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6.3.3 Construct Validity 
Discriminant Validity 
As reported in section 6.3.2, HRQoL using both the CHU-9D and the PedsQL, was marginally 
higher in children from lower versus higher socio-economic background. 
The discriminant validity of the CHU-9D instrument was further explored. Table 6.7 shows that 
the mean (SD) utility values (using UK and Chinese tariffs) were significantly lower for 
children who had a PedsQL total score less than the median value, compared to those with 
scores greater than or equal to the median. 
 
Table 6.7 - CHU9D utility by PedsQL total score 
Group n Mean (SD) 
CHU-9D Utility,  
UK tariff 
Mean (SD) 
CHU-9D Utility,  
Chinese tariff 
PedsQL total score <median 793 0.909 (0.075) 
 
0.881 (0.106) 
 
PedsQL total score >=median 746 0.967 (0.043) 
 
0.961 (0.056) 
 
p-value  <0.001 <0.001 
 
Table 6.8 summarises the mean PedsQL total scores across the dimension levels of the CHU-
9D. The majority of children reported themselves in good health, with the largest proportion 
reporting themselves at the highest level for all dimensions of the CHU-9D. In general, the 
mean PedsQL total scores corresponded well, decreasing mostly linearly with increasing levels 
of severity on each dimension of the CHU-9D. This result was statistically significant (p-value 
= <0.001) for each of the dimensions. 
179 
 
Table 6.8 - Mean PedsQL total scores by each level of CHU9D dimension 
CHU-9D Dimensions Level n (%) Mean (SD) 
PedsQL  
total 
score 
p-value* 
Worried No 1375 (89.4) 83.93 (10.56) <0.001 
 A little bit 88 (5.8) 78.11 (12.01)  
 A bit 34 (2.2) 71.59 (12.61)  
 Quite 23 (1.4) 67.81 (13.93)  
 Very 19 (1.2) 70.65 (11.23)  
Sad No 1439 (93.5) 83.59 (10.74) <0.001 
 A little bit 55 (3.7) 76.17 (11.42)  
 A bit 22 (1.4) 69.81 (15.32)  
 Quite 7 (0.4) 79.65 (13.17)  
 Very 16 (1.0) 65.72 (13.98)  
Pain No 1353 (87.9) 83.91 (10.60) <0.001 
 A little bit 97 (6.4) 77.71 (12.16)  
 A bit 49 (3.2) 74.46 (11.25)  
 Quite 28 (1.8) 73.72 (14.71)  
 Very 12 (0.7) 70.10 (17.89)  
Tired No 1235 (80.3) 84.71 (10.25) <0.001 
 A little bit 171 (11.1) 78.01 (10.80)  
 A bit 69 (4.5) 74.85 (11.19)  
 Quite 31 (2.0) 70.53 (14.75)  
 Very 33 (2.1) 70.06 (13.80)  
Annoyed No 1400 (91.0) 83.84 (10.68) <0.001 
 A little bit 63 (4.1) 75.70 (11.02)  
 A bit 33 (2.1) 70.69 (11.97)  
 Quite 18 (1.2) 74.03 (13.66)  
 Very 25 (1.6) 72.30 (14.24)  
School work/Home work No problems 1213 (78.8) 84.72 (10.34) <0.001 
 A few problems 156 (10.1) 79.86 (10.15)  
 Some problems 129 (8.5) 74.23 (11.09)  
 Many problems 33 (2.1) 70.75 (14.53)  
 Can’t do 8 (0.5) 59.64 (12.10)  
Sleep No problems 1291 (83.9) 84.05 (10.71) <0.001 
 A few problems 145 (9.4) 78.83 (11.38)  
 Some problems 43 (2.8) 75.15 (11.03)  
 Many problems 21 (1.4) 74.94 (9.07)  
 Can’t do 39 (2.5) 73.49 (14.90)  
Daily routine No problems 1410 (91.6) 83.67 (10.78) <0.001 
 A few problems 100 (6.6) 76.55 (10.77)  
 Some problems 19 (1.2) 70.50 (16.21)  
 Many problems 9 (0.5) 62.92 (15.84)  
 Can’t do 1 (0.1) 81.52 (.)  
Ability to join in activities Any 906 (58.8) 85.37 (10.20) <0.001 
 Most 238 (15.4) 81.81 (11.81)  
 Some 186 (12.1) 78.35 (11.59)  
 A few 147 (9.5) 77.42 (11.56)  
 No 62 (4.2) 78.14 (10.21)  
*Non-parametric test for trend    
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Convergent Validity 
Figure 6.1 shows a scatter plot comparison of the relationship between the CHU-9D utility 
values (using UK tariff) and the PedsQL total scores. Some anomalies are apparent. For 
instance, one child reported a high CHU-9D utility score of 0.963, yet had a low PedsQL total 
score of 34.78. However, in general, there is a moderate association between the instruments 
with higher CHU-9D utility values corresponding with higher PedsQL total scores (the CHU-
9D utility values and PedsQL total scores converging towards the highest end of the scale).  
 
 
Figure 6.1 - Relationship between CHU9D utility scores, UK tariff, and PedsQL scores 
 
 
Figure 6.2 shows a scatter plot comparison of the relationship between the CHU-9D utility 
values (using Chinese tariff) and the PedsQL total scores. Figure 2 is similar to Figure 1 but 
some wider anomalies are apparent. For instance, one child reported a high CHU-9D utility 
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score of 0.996, yet had a low PedsQL total score of 34.78, and another child reported a low 
CHU-9D utility score of 0.535, yet had a high PedsQL total score of 82.60. However, in general, 
again there is a moderate association between the instruments with higher CHU-9D utility 
values corresponding with higher PedsQL total scores (the CHU-9D utility values and PedsQL 
total scores converging towards the highest end of the scale).  
 
 
Figure 6.2 - Relationship between CHU9D utility scores, Chinese tariff, and PedsQL 
scores 
 
 
Table 6.9 summarises the relationship between the distribution of CHU-9D utility scores and 
the PedsQL total scores in terms of Spearman’s correlation coefficients. Overall, the correlation 
between the CHU-9D utility values (using both UK and Chinese tariffs) and PedsQL total 
scores showed a statistically significant moderate positive correlation (Rs = 0.5221, p = <0.001) 
and (Rs = 0.5316, p = <0.001) respectively.   
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Table 6.9 - Correlation between CHU9D utility score and PedsQL total score 
CHU-9D utility score Correlation with PedsQL 
total score 
Spearman’s rho p-value 
 
Using UK tariff PedsQL total score 0.52 <0.001 
 
Using Chinese tariff PedsQL total score 0.53 <0.001 
 
*Both were significant at 0.01 level 
 
The content and coverage of the two instruments were further compared by examining the 
correlation between each of the CHU-9D dimensions and the theoretically similar PedsQL 
domain functioning scores (Table 6.10). 
Using conventional cut-off values for Spearman’s rho, each CHU-9D dimension was either 
weakly, or very weakly correlated with each of the predetermined PedsQL domain functioning 
scores (there was very weak evidence for convergent validity in relation to dimensions and 
domains: between pain and physical functioning, between sleep and physical functioning, 
between daily routine and physical functioning). Since the CHU-9D dimensions are labelled 
with 1 as highest level and 5 as lowest level, the signs on the coefficients were consistently 
negative. All correlations were significant at the 0.01 level. 
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Table 6.10 - Correlation between CHU9D dimensions and PedsQL domain scores 
CHU-9D dimension Correlation with PedsQL 
domain functioning score 
Spearman’s 
rho 
p-value* 
 
Worried Emotional functioning -0.24 <0.001 
 
Sad Emotional functioning -0.22 <0.001 
 
Pain Physical functioning -0.18 <0.001 
 
Tired Physical functioning -0.25 <0.001 
 
Annoyed Emotional functioning -0.22 <0.001 
 
School work/Home work School functioning -0.25 <0.001 
 
Sleep Physical functioning -0.14 <0.001 
 
Daily routine Physical functioning -0.18 <0.001 
 
Ability to join in activities Social functioning -0.21 <0.001 
 
*All were significant at 0.01 level 
 
The paired comparison of the CHU-9D utility scores, using UK and Chinese tariffs, is presented 
in Table 6.11. The difference between the means was found to be statistically significant (p < 
0.001). In addition, exactly the same proportion of the total sample reported themselves in full 
health (utility value = 1.0) for the CHU-9D using both UK and Chinese tariffs (32.1%, n = 494). 
The Spearman’s rho indicated a very strong level of agreement overall between the CHU-9D, 
using the UK and Chinese tariffs. 
 
Table 6.11 - Paired comparison of CHU9D utility scores using UK and Chinese tariff 
Mean (SD),  
Median (IQR) 
CHU-9D Utility,  
UK tariff 
Mean (SD), 
Median (IQR) 
CHU-9D Utility, 
Chinese tariff 
Difference 
between means 
Spearman’s Rank 
correlation 
coefficient Rs 
 
 
 
0.937 (0.068) 
0.963 (0.903-1.000)  
0.920 (0.094) 
0.943 (0.876-1.000) 
0.017* 0.95 
 
 *p-value < 0.001 
184 
 
6.4 Discussion 
Mapping algorithms provide an empirical tool for estimating CHU-9D index scores and for 
undertaking CUA within clinical studies that have only collected PedsQL data. They are valid 
for children aged 5 years or older (preferably up to a maximum of 13 years old) [289]. It has 
been shown that mapping algorithms also provide an empirical tool for estimating health 
utilities in childhood when EQ-5D data are not available [290]. These can be used to inform 
future economic evaluations of childhood interventions. They are likely to be robust for a 
population of children aged 11-15 years whose characteristics are comparable to the study by 
khan et al. 2014 [290]. However, the performance of these algorithms in younger children with 
different clinical characteristics remains to be evaluated and they are, therefore, not useful for 
the CHIRPY DRAGON study. Mapping is always regarded as a ‘second best option’ to 
empirically collecting the data and as the CHU-9D data was empirically collected within the 
CHIRPY DRAGON study, mapping was not applied. 
 
6.4.1 Statement of Principal Findings  
Aim (a) 
The findings suggest that HRQoL in this study population was marginally higher in children 
who were overweight/living with obesity compared to children in healthy weight, although 
these associations were not statistically significant. Girls reported significantly higher HRQoL, 
compared to boys, using both the CHU-9D and the PedsQL. 
When children were categorised by gender, there was no evidence of differentiating HRQoL, 
using either instrument. 
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Aim (b) 
Regarding the discriminant validity, it was found that the CHU-9D discriminated according to 
the median PedsQL total score. Furthermore, the mean PedsQL total scores decreased mostly 
linearly with increasing levels of severity on each dimension of the CHU-9D. However, 
contrary to studies conducted in Western countries, and although not statistically significant, it 
was found that HRQoL, using both the CHU-9D and the PedsQL, was higher in children whose 
parents had lower levels of education, compared to those whose parents were university 
educated.  
With respect to convergent validity, although there was a moderate significant positive 
correlation between CHU-9D utility values (using both UK and Chinese tariffs) and PedsQL 
total scores, the correlation between individual CHU-9D dimensions and the theoretically 
similar PedsQL domains were weak or very weak.  
 
6.4.2 Strengths and Limitations of this Study 
Strengths include the large sample size (1539 children), diverse population (selected to include 
a range of socio-economic backgrounds) and standardised data collection procedures as part of 
the randomised controlled trial. 
Furthermore, this study is one of the very few studies worldwide and the first study in China, 
which collected utility-based HRQoL information in children as young as 6 years. It used both 
UK and Chinese tariffs for calculating the utility scores and reports on the psychometric 
properties of the CHU-9D in direct comparison to the widely used PedsQL instrument.  
The study had some limitations to note however: in this chapter, the “underweight” and “healthy 
weight” children were pooled into one weight category as a very small number of children in 
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the sample (5%) were measured as “underweight”. Although some population studies have 
reported that the HRQoL of underweight children was generally no different from those with 
healthy weight [291], this could not be explored in this study as the underweight sample size 
was so small.  
Another concern about the findings of this study was that data analysis was limited to data 
collected as part of the trial. For example, discriminant validity of the CHU-9D could not be 
assessed compared to an obesity-specific quality of life measure. However, the PedsQL as a 
‘gold standard’ is a widely used HRQoL instrument validated for use with young children in 
diverse populations [189, 190]. 
 
6.4.3 Comparison with Other Studies 
Aim (a) 
There is no robust evidence on the direction of the relationship between weight status and 
utility-based HRQoL in this population. This is compounded by the challenging nature of 
measuring utility in a paediatric population more generally [292]. In four previous studies which 
have explored this relationship in children (three UK-based studies using the CHU-9D [42, 280, 
286] and one US-based study using the HUI instrument [188]), the opposite direction of effect 
was found (lower HRQoL in participants with overweight/obesity compared with their 
underweight/healthy weight counterparts). However, like this study, the results were not 
statistically significant (no evidence of a negative relationship between health utility and weight 
status in children aged 5-6 years [42], aged 6-7 years [286], aged 5-10 years [280] or in children 
and adolescents aged 5-18 years [188] was found). In contrast, however, the findings of one 
recent study from Australia using the CHU-9D in children aged 9-12 years [293] and one study 
from the UK using the EQ-5D-Y in children aged 11-15 years [294], found a significant 
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negative relationship between weight status and health utility. Among all these studies, a higher 
utility-based HRQoL in children who were overweight/obese compared to underweight/healthy 
weight was only found in this Chinese study. Therefore, despite these reports of a negative 
relationship between utility-based HRQoL and being overweight in children, the direction of 
the relationship is not robust, the evidence for understanding this relationship is inconsistent 
and is mixed in terms of whether this effect reaches statistical significance. 
The weak relationship between weight status and utility-based HRQoL may be attributed to the 
CHU-9D not being sensitive enough to detect a difference in very young children as it was 
originally developed for use with children aged 7–11 years [41]. Although the findings of a 
UK-based study suggested the instrument to be acceptable and feasible to administer for 
children aged 6–7 years [38], there are still concerns with regard to the instrument’s reliability 
in young children [38, 295]. A wide range of previous studies demonstrate that childhood 
obesity is associated with lower HRQoL when non-utility instruments are used [102, 294, 296-
299]. However, the findings are not consistent and, for example, in addition to this study, 
another study from China [127] and one from the UK [42] found no significant relationship 
between weight status and HRQoL measured using the PedsQL. Cultural differences may play 
a role. Most Chinese parents and, moreover, grandparents, aspire for children to be overweight, 
as this is taken to be a sign of health, growth and prosperity [82, 300]. Obesity trends follow a 
different pattern in China compared with high-income countries with the risk of obesity being 
greater in children from higher socio-economic backgrounds. The lack of association may also 
be related to the fact that co-morbidities attached to obesity do not substantially affect utility in 
this age group and, possibly, it is only once these children approach adolescence that the effects 
of obesity starts to impact negatively on utility-based HRQoL. 
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Within a UK-based study, the opposite direction of effect was found compared to this study 
regarding the relationship between utility-based HRQoL and gender, but there was no statistical 
difference between utility values and gender in children aged 5–6 years [42]. Within an 
Australian-based study, the same direction of effect was found compared to this study, but, 
again, there was no statistical difference between utility values and gender in children [41].  
 
Aim (b) 
Regarding the discriminant validity, two of the findings were in line with a previous study 
reported from a UK setting [42]. However, unlike studies from the West (a UK study using the 
CHU-9D and PedsQL in children aged 5-6 years, and an Australian study using the CHU-9D 
in children aged 11-17 years) [41, 42], there was no evidence of lower HRQoL in those from a 
lower socio-economic background - and the direction of effect suggested that any association 
was the reverse of that observed in other studies. A Chinese study setting reported a statistically 
significant trend for higher HRQoL scores (using PedsQL) in children with increased years of 
parental education [127].  
With respect to the convergent validity, the findings were similar to the previous study in the 
UK [42]. The weak, or very weak correlation between the individual dimensions of each 
instrument might be because these individual dimensions actually describe something that is 
quite specific and different while appearing quite similar.  
Sensitivity to change was not part of the psychometric analysis. As only the relationship 
between weight status and HRQoL, along with the construct validity of the CHU-9D, was 
checked, only baseline data was used. Every other study whose results were compared with 
these findings, also used baseline data. 
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6.4.4 Implications for Practice, Policy and Research 
Aim (a) 
The results of this chapter has methodological and policy implications in terms of how the cost-
effectiveness of childhood obesity interventions is measured in children aged 6-7 years. Obesity 
prevention and treatment interventions tend to target young populations, therefore information 
about how weight status is associated with HRQoL in utility terms in this age group is useful 
for the design of economic evaluations. Within health economic studies conducted globally, 
utility values are often used to derive QALYs to inform resource allocation decisions. To help 
inform the methods of economic evaluations alongside clinical trials of childhood obesity 
prevention and treatment interventions, future studies need to determine the relationship 
between weight status and utility-based HRQoL in different age groups, and across different 
country settings. In addition, it is recommended that future studies aiming to prevent obesity in 
young children (age 6-12) do not rely solely on utility-based HRQoL measures for economic 
evaluation, and capture clinical or wellbeing outcomes as well. This is because: CHU-9D might 
not be sensitive enough to detect a difference in very young children [41]. Also, there are still 
concerns with regard to the instrument’s reliability when used with young children [38, 295]. 
Furthermore, it remains unknown how the co-morbidities associated with obesity affect utility 
in this age group and, possibly, it is only once these children approach adolescence that the 
effects of obesity start to impact negatively on utility-based HRQoL. 
 
Aim (b) 
Overall, the findings provide support for the discriminant and convergent validity of the CHU-
9D when used as a utility score within a Chinese population aged 6-7 years. This is because the 
CHU-9D discriminated according to the PedsQL median score, and the mean PedsQL total 
190 
 
scores decreased linearly with increasing levels of severity on each dimension of the CHU-9D. 
However, there still remains uncertainty, as the CHU-9D dimensions were only weakly 
correlated with theoretically similar PedsQL dimensions. So we recommend future studies 
continue to test the validity of the CHU-9D in different age groups and country settings. 
 
6.5 Conclusion 
Aim (a) 
The results of this chapter suggest that HRQoL using both CHU-9D and PedsQL instruments 
is slightly higher among children who are overweight/obese compared to underweight/healthy 
weight. However, this difference is not statistically significant. Findings of sub-group analyses 
are consistent with the analysis on whole groups. Some studies from high-income countries 
suggest that overweight/obesity in children is negatively associated with utility-based HRQoL. 
However, the extent of the relationship, how it varies across age groups, and how this translates 
to utility-based HRQoL across different settings is as yet under researched.  
 
Aim (b) 
This chapter contributes utility data generated from a large Chinese sample of children. It 
reports on the psychometric properties of the CHU-9D instrument. The findings support the 
discriminant and convergent validity of the CHU-9D, as a measure of utility-based HRQoL for 
application in economic evaluation of prevention interventions within Chinese children aged 6-
7 years. 
In the following chapter, a discussion of the findings of the whole thesis is reported. This 
includes a summary of the findings, discussion on applied findings to inform policy 
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development, reflections on the methods used for conducting the economic evaluation, 
implications for policy making and recommendations for future research. 
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CHAPTER 7. DISCUSSION 
 
7.1 Introduction 
To address the evidence gap of what interventions to implement to prevent childhood obesity 
in China, and to address the methodological challenges of conducting economic evaluation 
within this setting, the CHIRPY DRAGON study was developed. 
The primary aim of this thesis was to contribute to the methodology of conducting economic 
evaluation in LMICs and to estimate the cost-effectiveness of a school- and family-based 
childhood obesity intervention in a Chinese setting. For this purpose, trial data was used and 
the economic evaluation methods were derived from a combination of published literature and 
guidelines for conducting economic evaluation. A comprehensive economic evaluation was 
conducted (from a public sector and societal perspective using both clinical and economic 
outcome measures). The economic evaluation results reflect the costs and benefits of preventing 
childhood obesity through schools in China. The methodological challenges of conducting an 
economic evaluation within a Chinese setting and including spillover effects were explored. 
The uncertainty surrounding the results was fully explored and reported to help inform policy 
recommendations and to plan future research.  
The motivations for undertaking the research in this thesis came from the increasing concerns 
regarding the high and fast growing prevalence of childhood obesity in China [12, 58]; and 
CDC recommendations, which called for research on the costs and benefits of strategies to 
prevent childhood obesity. 
As was shown in the systematic review presented in chapter four of this thesis, there are 
relatively few published economic evaluations of obesity prevention intervention studies (the 
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only study in China was not conducted from a societal perspective and only included clinical 
outcome measures). Furthermore, the systematic review findings showed that the majority of 
published economic evaluations are for interventions with an individual behaviour change 
component. The review found heterogeneity with respect to methods applied making a 
synthesis of findings challenging.  
Obesity is a particularly interesting condition to consider for two main reasons: first, the 
condition is chronic and some symptoms occur later in life; and second, the condition is known 
to greatly impact on both health and non-health aspects of individuals’ lives. With the condition 
of obesity, an assessment of QoL is one of the primary indicators of prevention success, so the 
secondary aim of this thesis was to consider the suitability of economic outcome measures for 
interventions targeting school-aged children in China. The extra-welfarist outcome measure, 
the QALY, is currently recommended by UK decision-makers such as NICE. This is why it 
was chosen as the main economic outcome measure in the trial. For the secondary aim, first, 
how weight status relates to HRQoL was explored; then the construct validity of the CHU-9D 
was assessed. For both of these aims, the baseline data from the CHIRPY DRAGON trial was 
used.  
This discussion starts by revisiting the aims of this thesis; and provides a summary of the key 
findings from the entire thesis perspective and discusses them within the context of the wider 
literature. This is followed by a discussion of the applied findings to inform policy development 
and reflections on the methods used for conducting the economic evaluation, highlighting the 
main strengths and limitations of the approach. The final sections discuss the implications for 
current policy making, and suggest future research recommendations. 
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7.2 Summary of the Findings 
This section reports the main findings and discusses them with regard to current available 
evidence. Both the systematic review and the CHIRPY DRAGON obesity prevention 
programme followed pre-specified, peer-reviewed protocols which were published in scientific 
journals [126, 210]. The findings were reported in accordance with PRISMA guidelines [209] 
for a systematic review, and CHEERs guidelines [48] for economic evaluation. Findings have 
been disseminated through two publications; two conference papers and two oral presentations 
at an international conference and four poster presentations including one pitch poster 
presentation at national conferences. 
The research has made several original and pertinent contributions to the literature on obesity 
research, both in terms of the methodological approach and also for the information made 
available to inform policy decision making with respect to childhood obesity prevention. These 
relate to the: 
 Undertaking of a rigorous systematic review of methods, study quality and results of 
trial-based and model-based economic evaluations for childhood and adolescent obesity 
interventions which found heterogeneity with respect to methods applied.  
 Describing the methodological challenges both of conducting this first economic 
evaluation of an obesity prevention intervention (CHIRPY DRAGON) in a Chinese 
setting and of including spillover costs/effects in the evaluation. The methodological 
challenges relate to methods for converting costs; sourcing unit costs; dealing with lack 
of an appropriate value set; dealing with clustering; managing lack of equivalent 
threshold values for outcome gains; and measuring household costs and outcome data. 
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 Undertaking an economic evaluation in a Chinese setting from both a public sector and 
societal perspective. 
 Exploring the suitability of economic outcome measures within a Chinese childhood 
population. 
 
Systematic Review 
A systematic review of methods, study quality and results of trial-based and model-based 
economic evaluations for childhood and adolescent obesity interventions was presented in 
chapter 4. The results showed that current economic evaluations are mainly set in developed 
countries and the majority focus on the prevention of obesity in children, compared to treatment. 
Moreover, the findings of this review showed that the majority of published economic 
evaluations are for interventions with an individual behaviour change component. The majority, 
particularly “behavioural and policy” preventive interventions, were cost-effective, even cost-
saving. However, this review found that relatively few policy interventions designed to prevent 
obesity have been rigorously evaluated from an economic perspective. The review found 
heterogeneity with respect to methods applied. So, to improve the evidence base further and to 
enhance comparability across interventions, a consistent and expanded form of economic 
evaluation which captures both health and non-health costs and consequences beyond health-
gain was recommended. The systematic review also raised concerns regarding the 
generalisability of results to other contexts as interventions targeted individual health 
behaviours which are highly dependent on cultural, infrastructural and other system-related 
aspects.  
In general, the systematic review results showed that the following main gaps exist in the 
current literature: 
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 Economic evaluations of obesity prevention intervention in developing countries. 
 Inclusion of societal costs and outcomes in economic evaluations that are relevant to 
family members of the children affected by obesity. 
 CUAs of trial-based studies comparing obesity prevention strategies, whose results can 
be used by decision makers and compared with other public health programmes.  
 
Economic Evaluation of CHIRPY DRAGON Programme 
As mentioned, some gaps were found in the findings of the systematic review presented in 
chapter 4. In order to fill these, an economic evaluation of the CHIRPY DRAGON programme 
was undertaken, which is presented in chapter 5. The aim was to explore the methodological 
challenges of conducting a comprehensive economic evaluation, including spillover effects, 
within a Chinese setting. This was achieved using the CHIRPY DRAGON trial as a case study. 
In total, 1641 children were recruited and randomized to 20 intervention (n= 832) and 20 control 
(n= 809) schools. The intervention consisted of four components targeting diet and physical 
activity behaviours of children and their families in primary schools in Guangzhou, China. The 
12-month programme, delivered by trained project staff known as CHIRPY DRAGON 
teachers, included (i) educational and skills-based workshops aimed at children aged 6-7 years 
and their parents or grandparents to promote physical activity and healthy eating; (ii) a school 
food improvement component involving school caterers; and physical activity initiatives (iii) 
within and (iv) outside school. Control schools continued with usual activities. 
The costs linked to the intervention were divided into three categories: development, 
implementation and delivery. Unit costs were identified from Chinese sources. GDP PPPs were 
used to convert Yuan into Pounds and Dollars. The clinical measure of effectiveness was BMI 
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z-score. The economic outcome measure was QALYs. Utility-data was collected using the 
CHU-9D for children and EQ-5D-3L for carers, applying the UK and the Chinese value set for 
both. The reasons for missing data differed for the resource use and outcome data. As the 
missing data was low, modified intention to treat approach was used. 
Since a time horizon of 1 year was used, costs and outcomes were not discounted, as 
recommended by NICE. For the public sector perspective, the cost-effectiveness was estimated 
based on cost per QALY and BMI z-score change. For this, the ICER was calculated based on 
the fully adjusted costs and effects. In the absence of an agreed Chinese threshold for the value 
of a QALY, decision uncertainty was assessed using established UK and US thresholds, and 
presented using CEAC. Three sensitivity analyses were undertaken to assess the robustness of 
the results to assumptions made in the analysis. For the societal perspective, children’s QALYs 
were adjusted for family spillover effects using a ‘multiplier’ approach, developed by Al Janabi 
et al (2016). The family costs were simply averaged for each child by assuming they had at 
least two family members attend the workshops. Then, the ICER was calculated. Four 
sensitivity analyses were undertaken. 
The economic evaluation from a public sector perspective showed that the CHIRPY DRAGON 
intervention had a relatively low cost and significant intervention benefits over the course of 12 
months, suggesting it was highly cost-effective. The intervention was cost-effective using the 
conventional decision making rules within a CEA and CUA. Broadening the evaluative space 
to include household costs and QALYs had the effect of increasing the ICER however the 
intervention remained cost-effective. The ICER did not change substantially in sensitivity 
analyses: a maximum of £16,709/$23,767 per QALY from a societal perspective when 
predictive mean matching multiple imputation was applied. 
198 
 
According to the systematic review reported in chapter 4 [47], with the exception of one study 
[249], all reported evaluations of school-based obesity interventions appear cost-effective using 
a ‘cost per weight-specific outcome’. However, without thresholds for obesity-related 
outcomes, it is difficult to judge value for money. The ICER for the CHIRPY DRAGON 
programme was lower than two previous trial-based intervention studies which used BMI z-
score as their measure of effectiveness: one Chinese study, targeting dietary habits and physical 
activity in children 6-13 years [17]; the other, an Australian study, targeting physical activity 
in adolescents 13-16 years [206]. However, a similar study in the UK, targeting dietary habits 
and physical activity in children 6-7 years, was not cost-effective using BMI z-score as the 
outcome measure. The UK study was cost-effective using QALY outcome (ICER: £26,815 per 
QALY gained from a public sector perspective), however there was a high level of uncertainty 
as demonstrated by the net-benefit equation and the corresponding CEAC [249]. 
 
Association between Weight and HRQoL; and Construct Validity of CHU-9D 
The aims of chapter 6 were (a) to examine how children’s weight status relates to their HRQoL 
and (b) to assess the construct validity of the CHU-9D instrument.  
The results suggested that HRQoL using both CHU-9D and PedsQL instruments was slightly 
higher among children who were overweight/obese compared to underweight/healthy weight. 
However, this difference was not statistically significant. The findings of the sub-group 
analyses were consistent with the analysis on whole groups. Some studies from high-income 
countries suggest that overweight/obesity in children is negatively associated with utility-based 
HRQoL. However, the extent of the relationship, how it varies across age groups and how this 
translates to utility-based HRQoL across different settings is as yet under researched. 
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Chapter 6 reported on the psychometric properties of the CHU-9D instrument and showed 
support for the discriminant and convergent validity of the CHU-9D, as a measure of utility-
based HRQoL for application in economic evaluation of prevention interventions within 
Chinese children aged 6-7 years. Regarding the discriminant validity, two of the findings were 
in line with a previous study reported from a UK setting [42]. However, unlike studies from the 
West [41, 42], there was no evidence of lower HRQoL in children from a lower socio-economic 
background – in fact the direction of effect was the reverse. This was in contrast to another 
Chinese study setting that reported a statistically significant trend for higher HRQoL scores 
(using PedsQL) in children with increased years of parental education [127].  
With respect to the convergent validity of the CHU-9D, the findings were similar to the previous 
study in the UK [42]. 
 
7.3 Applied Findings to Inform Policy Development 
The following section discusses the applied findings from the whole thesis to inform policy 
development. 
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The Novelty of CHIRPY DRAGON 
Today, childhood obesity prevention is well-established and a growing research field. In 2009, 
when the CHIRPY DRAGON intervention study began development, it was among one of the 
very few trials, with a rigorous and theoretically informed intervention development process 
[301], to evaluate the effectiveness and cost-effectiveness of an obesity prevention intervention 
programme in children as young as 6 years and their family members, outside of high income 
countries.  
CHIRPY DRAGON was a study promoting healthy eating and physical activity behaviour, 
closely embedded in a school setting with a cluster RCT design, feasible to implement in such 
a setting. There was adherence to international guidelines for trial design and implementation. 
The trial included a wide range of outcomes which were objectively assessed, where possible, 
and there were high follow up rates. In addition, a comprehensive process evaluation which 
demonstrated high fidelity and engagement was provided. Process evaluation helps to further 
identify facilitators or hindering factors on the pathway between intervention and effects [302]. 
 
CHIRPY DRAGON Effectiveness in Relation to other Studies 
Findings of this trial added to the current knowledge base in relation to the effectiveness of 
childhood obesity prevention interventions within a global context. International research 
(including the updated published Cochrane review which included trials, approximately 90% 
of which were conducted in high income countries) has shown that well-designed and well-
implemented school obesity prevention interventions were effective in the reduction of BMI in 
children [116, 117]. A systematic review of the effectiveness of preventive school-based obesity 
interventions in LMICs has demonstrated that interventions which focused on combining 
dietary and physical activity initiatives were effective in the reduction of BMI in children [124]. 
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A few Chinese studies have demonstrated that comprehensive school-based interventions, 
which combined diet and physical activity, were effective [15-17]. However, the findings from 
the CHIRPY DRAGON trial are at variance with recently completed, similar and well 
conducted trials in a UK context, one of which used similar development and evaluation 
methodology [118-120]. These UK trials found no evidence for the effectiveness of school 
based prevention interventions. This highlights the importance of taking into account country 
‘context’ in determining intervention effectiveness. 
 
Generalisability of the Findings  
The intervention would probably be generalisable to other urban areas of China given the 
centrally managed education system and similar cultures across the country, although some 
degree of local adaptions might be beneficial. However, the generalisability of the findings to 
rural and migrant children would be challenging. 
Given the differences in contextual factors (including differences in the stage of the childhood 
obesity epidemic, dissimilar national health care systems), cultural factors and intervention 
differences (e.g. target, components and how these were delivered), a translation of economic 
findings from China to another country seems challenging and of limited use. For example, 
there might be implications for how to replicate any specific components of the intervention in 
another context. The CHIRPY DRAGON intervention targeted individual health behaviours 
which are highly dependent on cultural, infrastructural and other system-related aspects. For 
example, there is a more hierarchical structure and respect for schools and teachers in China 
compared to high income countries. So the generalisability of the results to other contexts, 
particularly from China to developed country settings, could be questionable [247].  
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There have been rapid socioeconomic and nutritional transitions in many urban Chinese 
populations which have contributed to the rising prevalence of overweight and obesity among 
Chinese school-aged children over a short period of time. Although the prevalence of obesity 
in rural areas of China has also increased over the past decades, it is not as high as in urban 
areas and there are growing economic and health inequities between urban and rural residents 
[57]. The CHIRPY DRAGON population may not be entirely representative of the general 
Chinese population in terms of different factors such as socio-economic status.  
According to a recent qualitative study, lack of influence from grandparents; fewer 
opportunities for unhealthy snacking; and less pressure for academic attainment, which leads 
to more active play, were found as potential “protective” factors for obesity among migrant 
children [61]. However, lack of parental monitoring after school and unsafe neighbourhoods 
reduced physical activity in migrant communities. Two further barriers which restricted child 
physical activity in the migrant community were limited home space and cultural differences, 
which inhibited interactive play with local children [61]. Understanding the perceived 
contributors of obesity can provide valuable insights to plan or modify preventive interventions 
in different populations of China.  
 
Short Term versus Long Term Cost-Effectiveness Evidence 
This thesis undertook a trial-based economic evaluation which demonstrates short-term 
evidence and the analysis is constrained by the one year time horizon of the intervention. A 
longer time horizon is particularly relevant to the evaluation of obesity prevention interventions, 
where health benefits and cost savings may be visible into adulthood. Having a short time 
horizon can potentially underestimate differences between the intervention and control groups. 
Trial-based economic evaluations may give either an under- or overestimation and might 
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therefore be of limited use. Whilst the intervention appears to be cost-effective and able to 
obtain benefits for both clinical and economic outcomes in children for a relatively low cost, 
the sustainability of these behaviours remains unknown. 
However, this is one of the very few economic evaluations of obesity prevention studies 
worldwide and the first in China, which collected utility-based HRQoL information in children 
as young as 6 years and family members to calculate QALYs, and included societal costs. The 
intent was to open the debate for new ways of tackling the obesity issue in children.  
In the context of obesity, it seems important to model prevention over a long time horizon 
(preferably life time). This is because interventions to prevent obesity have a wider effect and 
impact on costs over time and the outcomes may only be realised long after the trial has finished. 
To capture the long term effects of an intervention, and to evaluate whether the effects and the 
cost-effectiveness are sustainable in the long term a model should be used. Model-based 
economic evaluation can capture the uncertainty linked to any assumptions made and could 
also improve the generalization of results obtained in one setting to other settings [174]. Model-
based health economic evaluations are today widely accepted as policy-making tools that can 
inform resource allocation decisions. However, there are some severe flaws with regard to 
current model-based economic evaluations in the field of childhood obesity. Firstly, the risk of 
obesity changes with individuals’ attitudes and lifestyles and the sustainability of these 
behaviours are unknown. Secondly, findings from modelling studies are only as good as the 
data input, and high-quality input data for the costs and effects in the field of childhood obesity 
prevention intervention are sparse. Thirdly, to be able to extrapolate the effects over a life-time 
horizon, data on benefit maintenance are needed from early childhood to adulthood.  
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In general, the limitations of models are that they are a simplification of reality. Therefore, 
when a model developer translates reality into a series of definitive pathways there will always 
be some loss of information. One of the biggest challenges with modelling complex 
interventions is finding the balance between incorporating all relevant interactions and 
pathways, without overcomplicating the model structure. According to Squires and Boyd 
(2019), there are five key challenges with regard to modelling public health interventions: (1) 
incorporating equity; (2) extrapolating multi-component intervention effectiveness beyond 
study data; (3) modelling behaviour of individuals; (4) capturing relevant complex relationships 
of a complex system; and (5) capturing relevant non-health costs and benefits and the 
relationship between human and social determinants [303]. However, there are two approaches 
which could help to address these issues: (1) adopting an iterative approach to the evaluation, 
using early-stage decision modelling, to guide primary data collection; (2) using a conceptual 
modelling framework to guide the model development process [303]. 
Modelling was not applied as it was beyond the scope of this thesis. 
 
7.4 Reflection on the Economic Evaluation Methods Taken  
Economic evaluation should be conducted with respect to guidelines on methodology. This 
following section summarises reflections on the methodological approaches taken within the 
thesis for conducting economic evaluation. 
 
Perspective 
Where possible, recent literature advocates for a societal approach [47], given the nature of 
obesity and the public health strategies used to prevent/treat it. One of the most important 
strengths of this thesis is that it has attempted a societal perspective.  
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By using a societal perspective, a number of methodological challenges were encountered. As 
household members’ resource use and outcome data are very rarely considered in economic 
evaluations, guidelines for including these data were limited. A further limitation was that the 
number of responses from household members was smaller than the number of children. 
Additionally, there was a lack of information on the salaries of parents/grandparents. Instead, 
the Chinese population average salary was assumed in order to estimate the value of lost time 
and therefore it is possible parental productivity losses might have been either under- or 
overestimated. Furthermore, the multiplier approach was not applied to the resource use data 
as it was not possible to link each component of the family-related costs to the respective child.  
The research in this thesis demonstrates the feasibility of collecting and including household 
members’ cost and outcome data in cost utility analysis. In this case the intervention did not 
impact significantly on household members’ health, but inclusion of household spillovers may 
make a difference in other contexts. 
 
Population 
Doing research in children has some extra challenges. One potential challenge relates to the 
way HRQoL information was collected from children. There may have been an influence on 
how children completed the questionnaire as items and possible responses within the CHU-9D 
and PedsQL were read to children, on a one-to-one basis, by the interviewers (research staff). 
This could have led to responder-bias [42]. Moreover, because of the lack of validated dietary 
assessment instruments for Chinese children, tools developed and validated for English children 
were adapted [304]. However, similar adapted tools to assess dietary behaviours of Chinese 
children were previously used in the same city [305]. 
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Measures of Effectiveness and Type of Economic Evaluation  
Economic evaluations of obesity prevention interventions should be conducted using both 
clinical (e.g. BMI z-score) and economic (QALYs) outcomes.  
Clinical outcomes are easier to measure, however harder to compare to other interventions 
across health and non-health settings. CEA is useful to compare interventions, which target the 
same health condition, and is particularly useful in a clinical setting. Although a CEA is an 
extra-welfarist evaluation, a major limitation of it for decision makers is its inability to directly 
compare cost-effectiveness of interventions across various areas of health conditions, or sectors 
of the economy, due to the disease-specific nature of the outcome measure used [46].  
The QALY measure is universal. Therefore, various programmes across different health 
conditions which are evaluated using QALYs can be compared. Although, the ‘reference case’ 
approach, applied to a traditional HTA, takes an extra-welfarist perspective using outcomes 
expressed in QALYs to maximise health subject to a budget constraint [30], this cost utility 
approach offers limited support for public health decision makers. This is partly for considering 
health as the only relevant outcome, and ignoring the production of wider benefits which are 
not captured in the QALY. Also, there might be a lack of sensitivity of utility-based HRQoL 
instruments to changes in overweight/obesity in younger children [42]. Although there is no 
gold standard for measuring utility-based HRQoL in primary school-aged children, previous 
research has shown the CHU-9D, a recently developed instrument, is the most appropriate 
choice [38]. As a utility-based instrument, it is preference-based. It is designed for application 
in cost-effectiveness analyses of prevention, treatment and service programmes targeted at 
young people where the QALY is the desired outcome measure [183]. 
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Researchers in the obesity field should not rely on a single measure and should use both clinical 
and economic measures in order to strengthen the evidence [47]. 
 
Resource Use and Costs 
Public health priorities vary from country to country, and also from region to region. Like many 
other countries, China suffers from a scarcity of public health resources and decision makers 
need to prioritise spending towards policies that offer the greatest value for money [23]. 
Prevalence of overweight and obesity is high therefore large amounts of resources need to be 
invested in treatment and prevention interventions. Given the scarce public resources, economic 
evaluations are needed to aid decision-makers in prioritising and determining how and where 
to get the best value for money. Economic evaluations are well-established and fairly 
straightforward for therapeutic interventions. However, for preventive public health 
interventions (e.g. obesity prevention) the use of economic evaluations is more complex, where 
the vast majority of costs and consequences fall in the future and outside the health care sector. 
To capture all possible costs and effects, data from various sources (e.g. clinical, 
epidemiological, and economic) are needed. The development of a toolbox including good-
practice guidelines for intervention developers and evaluators would be useful in order to 
collect relevant data alongside the trial. While benefits of interventions are often captured in a 
standardized way, resource use data is usually collected using non-standardised resource use 
questionnaires which are difficult to compare with each other because of the heterogeneity of 
cost categories.  
All methods for estimating costs should explicitly be documented and reported, like this study, 
to provide information that will inform future evaluations and policy making. In the CHIRPY 
DRAGON trial, the approach taken regarding the costing of the programme was thorough. The 
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costs linked to the intervention were divided into three categories: development, 
implementation and delivery. According to standard practice, the base case analysis assumed 
that the intervention was in a ‘running state’ and therefore only costs associated with the 
delivery of the intervention were included. All of the other costs (set-up and implementation) 
were, however, reported separately and implementation costs were fully explored within the 
sensitivity analysis. A single standardized form was used to record all working time spent by 
each CHIRPY DRAGON teacher on the various intervention activities including their 
administration time. It has been determined that obesity prevention interventions are more 
effective when delivered by dedicated staff rather than classroom teachers [281]. The staff 
employed to deliver the intervention in this trial were well accepted by schools and their costs 
were incorporated in the economic evaluation. All costs were converted into either UK pounds 
or US dollars using GDP PPPs. All unit costs were sourced relevant to a Chinese context. 
However, more data are needed regarding indirect costs that already occur in childhood (e.g. 
educational attainment) [26]. 
 
7.5 Implications for Policy Making 
The decision of what interventions to fund falls to the policy-maker. Evidence-based decision 
making has been advocated and evidence is available in terms of the implications of each choice 
in order to make the right decision. However, there is uncertainty regarding these decisions. 
Also, the choice requires value judgements, which may be weak or strong, depending on the 
available evidence. 
The literature suggests school-based interventions delivered in high income country settings are 
cost-effective [47]. The cost-effectiveness results reported in this thesis, using both QALYs and 
clinical outcome (BMI z-score) as a measure of effectiveness, showed that this intervention was 
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highly cost-effective in preventing obesity in China. Including societal costs and effects, using 
the decision-maker recommended EQ-5D-3L, increased the ICER, however the intervention 
remained cost-effective using established cost-effectiveness thresholds. Moreover, the 
sensitivity analyses presented in this thesis showed that the intervention was cost-effective.  
Such cost-effective results should prompt decision-makers in China to take action towards 
developing and implementing childhood obesity prevention interventions in schools. Important 
considerations should focus on what should be offered.  
The results of chapter 6 of this thesis have methodological and policy implications in terms of 
how the cost-effectiveness of childhood obesity interventions is measured in children aged 6-7 
years. Obesity prevention and treatment interventions tend to target young populations, 
therefore information about how weight status is associated with HRQoL in utility terms in this 
age group is useful for the design of economic evaluations. Within health economic studies 
conducted globally, utility values are often used to derive QALYs to inform resource allocation 
decisions. To help inform the methods of economic evaluations alongside clinical trials of 
childhood obesity prevention and treatment interventions, future studies need to determine the 
relationship between weight status and utility-based HRQoL in different age groups, and across 
different country settings. The findings of chapter 6 provides support for the discriminant and 
convergent validity of the CHU-9D within Chinese children aged 6-7 years.  
 
7.6 Future Research Recommendations 
The research developed within this thesis makes a valuable and novel contribution to the 
existing literature of obesity research. However, it also serves to outline the following 
recommendations for future research. 
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As has been highlighted in the literature, obesity can be prevented/treated through 
“behavioural”, “behavioural and environmental” and “behavioural and policy” interventions. 
Most countries have implemented “behavioural” interventions. However, “behavioural and 
policy” interventions are encouraged. 
The research in this thesis demonstrates the feasibility of collecting and including household 
members’ cost and outcome data in cost utility analysis in LMICs. However, as household 
members’ resource use and outcome data are very rarely considered in economic evaluations, 
guidelines for how to include these data are limited. For preventive public health interventions 
(e.g. obesity prevention) the use of a societal perspective in economic evaluations is more 
complex compared to health perspective, and the vast majority of consequences and therefore 
costs prevented fall in the future. To capture all possible societal costs and effects, data from 
various sources (e.g. clinical, epidemiological, and economic) are needed. The development of 
a toolbox including good-practice guidelines for intervention developers and evaluators would 
be useful in order to collect relevant data alongside trials. All methods for estimating societal 
costs should explicitly be documented and reported to provide information that will inform 
future evaluations and policy making. In the CHIRPY DRAGON trial, the approach taken 
regarding the costing of the programme was thorough. As economic evaluation is uncommon 
in LMICs and due to the lack of an equivalent threshold value for most of these settings, 
established threshold values for a QALY alongside GDP per capita threshold should be used to 
judge cost-effectiveness. 
Currently, there are no thresholds for obesity-related outcomes. This may be an area for future 
research. Also, a threshold value for how much decision makers are willing to pay for a unit 
gain in a QALY in a Chinese setting may be an area for future research. In addition, more effort 
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should be placed on the inclusion of QALY measures for children in trial-based evaluations 
worldwide and spill-over effects (e.g. towards siblings) need to be further investigated 
worldwide. Furthermore, more research is needed on the indirect (e.g. educational attainment) 
costs of obesity/overweight in childhood in China and worldwide. 
In general, the methodological challenges of conducting an economic evaluation of an obesity 
prevention intervention in LMICs (e.g. converting costs, sourcing unit costs, lack of an 
appropriate value set, dealing with clustering, lack of equivalent threshold value for a QALY) 
and including spillover costs/effects (e.g. measuring household costs and outcome data) need 
to be further investigated. 
Future research on obesity intervention could benefit from taking a CBA approach. Obesity is 
a complex issue that involves socio-demographic determinants such as age, ethnicity, 
geography, lifestyle and religious/cultural traditions. To consider broader outcomes going 
beyond health and to account for inequalities, efforts are being made to adapt methodologies 
within the health economics community [245]. Consideration of broader outcomes going 
beyond the health sector allows for inclusion of costs and effects from multiple sectors and is 
particularly relevant for obesity intervention. This is an emerging area of development within 
economic evaluation and efforts are being made to adapt methodologies to promote the use of 
CBA [245] and to account for non-health opportunity costs in CUA [28]. These approaches 
have been recommended by the UK Treasury guidance to evaluate (usually non-health) public 
sector projects [246]. 
Future economic evaluations of childhood obesity prevention interventions should adopt a 
longer time horizon, because health benefits and cost savings may manifest themselves even 
into adulthood. 
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Moreover, considering the previous point regarding extrapolating over the long term, it would 
be valuable to undertake a suitable model to make full use of all routinely collected data as well 
as data generated from experimental settings. 
The association between weight status and HRQoL in different age groups, and across different 
country settings needs to be further investigated. In addition, it is recommended that future 
studies aiming to prevent obesity in young children (age 6-12) do not rely solely on utility-
based HRQoL measures for economic evaluation, and capture clinical or wellbeing outcomes 
as well. Future studies also need to further test the validity of the CHU-9D or other similar 
utility-based paediatric instruments in different age groups and country settings using different 
tariff value sets.  
The CHIRPY DRAGON study used dedicated (rather than school) staff. This helped to 
maximise the consistency and quality of implementation as Chinese school teachers are often 
overloaded and, in this context, the extra workload would not be welcomed or sustainable. The 
results of the economic evaluation included staff training and employment costs and still 
showed evidence of cost effectiveness. The sensitivity analyses and other discussion points 
suggest the evidence of effectiveness and cost-effectiveness is likely to be generalizable to a 
wider set of school settings in China. These findings can help inform Chinese obesity policy 
and the education sector. However, in terms of understanding the impact of the intervention on 
multiple outcomes, a more disaggregated analysis (e.g. a CCA) alongside a CEA and CUA 
could have been undertaken. This would give a ‘list’ rather than offset against the costs. Thus 
decision makers would understand how the benefits are distributed across the different sectors 
(health and education) and this could then act as a tool to facilitate cross-sectoral decision 
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making. Using a CCA could also give decision makers confidence that the data are valid to use 
as the basis for resource allocation decisions. 
Multi-sectoral interventions which focus on the different root causes of obesity (e.g. 
neighbourhood influence) are necessary. These need a shift in responsibilities and a stronger 
political commitment in the fight against obesity. Although schools are an ideal setting to 
deliver population-based interventions, these types of interventions might not be sufficiently 
intense to impact the school, the family environment, and the weight status of children - as was 
experienced in a few recent studies from Europe (e.g. UK). Although the CHIRPY DRAGON 
prevention intervention was cost-effective, this could change as China becomes more 
developed and the obesity epidemic more established. Over time, school based interventions 
may no longer be sufficient, as is seen increasingly in higher income settings. Therefore, focus 
on more upstream determinants of obesity and using whole systems approaches to complex 
public health issues like obesity, as well as realistic reviews of the literature, may be a good 
way of conducting future research in China and worldwide. It needs to be acknowledged that 
complex public health research faces various challenges and therefore requires consideration of 
different research methods.  
 
7.7 Conclusion 
This thesis estimated the cost-effectiveness of the ‘CHIRPY DRAGON’ obesity prevention 
intervention in Chinese primary school-aged children from both a public sector and societal 
perspective, and raised relevant questions to be addressed in future research. The results of the 
economic evaluation from a public sector perspective showed that this intervention was highly 
cost-effective. Including societal costs and effects increased the ICER, however the intervention 
remained cost-effective using established cost-effectiveness thresholds.  
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HRQoL using both CHU-9D and PedsQL instruments was slightly higher among children who 
were overweight/obese compared to underweight/healthy weight which highlights the need for 
future research that takes account of cultural context. The findings of this thesis support the 
discriminant and convergent validity of the CHU-9D, as a measure of utility-based HRQoL for 
application in economic evaluation of prevention interventions within Chinese children aged 6-
7 years. However, future studies need to further test the validity of the CHU-9D in different age 
groups and country settings using different tariff value sets. 
The research has made several original and pertinent contributions to the literature on obesity 
research, both in terms of the methodological approach and also for the information made 
available to inform policy makers. Given that the obesity crisis persists, new approaches may 
be needed, and further research required to prevent obesity in children.  
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APPENDICES 
 
APPENDIX 1. Systematic Review of Economic Evaluations: Search Strategy, 
Drummond Checklist, Data Extraction, and Quality Assessment of Studies 
 
Appendix 1.1 - Search Strategy 
 
MEDLINE (Ovid) 
1. exp Obesity/ 
2. Obese.mp. 
3. exp Overweight/ 
4. (BMI or body mass index).af. 
5. Weight gain/ 
6. (Overweight or over weight or obesity or adipose).af. 
7. exp Child/ 
8. exp Infant/ 
9. (Child* or adolescen* or infant*).af. 
10. Schoolchild*.mp. 
11. exp Adolescent/ 
12. (Boys or girls or youth or youths).af. 
13. (Teenage* or young person).af. 
14. (Nutrition adj2 intervent*).af. 
15. (Obesity adj2 prevent* or treat*).af. 
16. Counsel?ing.mp. 
216 
 
17. exp support groups/ 
18. exp Health Behaviour.mp. 
19. exp Life Style/  
20. exp Delivery of Health Care/ 
21. exp Social Support/ 
22. exp Family Practice/  
23. exp Parent-Child Relations/ 
24. Food Habits .mp. 
25. exp Diet therapy/ 
26. exp Food Preferences/  
27. exp Exercise therapy/ 
28. Physical activit*.mp. 
29. Economic Evaluat*.mp. 
30. Cost*.ti. 
31. Cost?Benefit*.mp. 
32. Cost?Utilit*.mp.  
33. Cost?Effective*.mp. 
34. exp "costs and cost analysis"/ 
35. 1 or 2 or 3 or 4 or 5 or 6 
36. 7 or 8 or 9 or 10 or 11 or 12 or 13 
37. 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28   
38. 29 or 30 or 31 or 32 or 33 or 34 
39. 35 and 36 and 37 and 38 
40. Limit 39 to (yr=”2001-Current”)  
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EMBASE (Ovid) 
1. exp Obesity/ 
2. Obese.mp. 
3. exp Overweight/ 
4. (BMI or body mass index).af. 
5. Weight gain/ 
6. (Overweight or over weight or obesity or adipose).af. 
7. exp Child/ 
8. exp Infant/ 
9. (Child* or adolescen* or infant*).af. 
10. Schoolchild*.mp. 
11. exp Adolescent/ 
12. (Boys or girls or youth or youths).af. 
13. (Teenage* or young person).af. 
14. (Nutrition adj2 intervent*).af. 
15. (Obesity adj2 prevent* or treat*).af. 
16. Counsel?ing.mp. 
17. exp support groups/ 
18. exp Health Behaviour.mp. 
19. exp Life Style/  
20. exp Delivery of Health Care/ 
21. exp Social Support/ 
22. exp Family Practice/  
23. exp Parent-Child Relations/ 
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24. Food Habits .mp. 
25. exp Diet therapy/ 
26. exp Food Preferences/  
27. exp Exercise therapy/ 
28. Physical activit*.mp. 
29. Economic Evaluat*.mp. 
30. Cost*.ti. 
31. Cost?Benefit*.mp. 
32. Cost?Utilit*.mp.  
33. Cost?Effective*.mp. 
34. exp "costs and cost analysis"/ 
35. 1 or 2 or 3 or 4 or 5 or 6 
36.7 or 8 or 9 or 10 or 11 or 12 or 13 
37. 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28   
38. 29 or 30 or 31 or 32 or 33 or 34 
39. 35 and 36 and 37 and 38 
40. Limit 39 to (yr=”2001-Current”) 
 
PsycINFO 
1. exp Obesity/ 
2. Obese.mp. 
3. exp Overweight/ 
4. (BMI or body mass index).af. 
5. Weight gain/ 
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6. (Overweight or over weight or obesity or adipose).af. 
7. exp Child/ 
8. exp Infant/ 
9. (Child* or adolescen* or infant*).af. 
10. Schoolchild*.mp. 
11. exp Adolescent/ 
12. (Boys or girls or youth or youths).af. 
13. (Teenage* or young person).af. 
14. (Nutrition adj2 intervent*).af. 
15. (Obesity adj2 prevent* or treat*).af. 
16. Counsel?ing.mp. 
17. exp support groups/ 
18. exp Health Behaviour.mp. 
19. exp Life Style/  
20. exp Delivery of Health Care/ 
21. exp Social Support/ 
22. exp Family Practice/  
23. exp Parent-Child Relations/ 
24. Food Habits .mp. 
25. exp Diet therapy/ 
26. exp Food Preferences/  
27. exp Exercise therapy/ 
28. Physical activit*.mp. 
29. Economic Evaluat*.mp. 
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30. Cost*.ti. 
31. Cost?Benefit*.mp. 
32. Cost?Utilit*.mp.  
33. Cost?Effective*.mp. 
34. exp "costs and cost analysis"/ 
35. 1 or 2 or 3 or 4 or 5 or 6 
36. 7 or 8 or 9 or 10 or 11 or 12 or 13 
37. 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28   
38. 29 or 30 or 31 or 32 or 33 or 34 
39. 35 and 36 and 37 and 38 
40. Limit 39 to (yr=”2001-Current”) 
 
Web of Science 
1. TS= (Obesity OR obese OR overweight) 
2. TS= (Child OR infant OR schoolchild* OR adolescent) 
3. TS= (Interven* OR prevent* OR therapeutics OR counseling OR “primary health care” 
OR “preventive health services” OR “health behaviour” OR “life style” OR “health 
knowledge, practice, attitudes” OR “delivery of health care” OR “social support” OR 
“family practice” OR “parent-child relations” OR “food habits” OR “food preferences” 
OR exercise OR sports) 
4. TS= (“Economic evaluat*” OR costs* OR “cost?benefit*” OR “cost?utilit*” OR 
“cost?effective*”) 
5. #1 AND #2 AND #3 AND #4 Timespan 2001-2017 
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CINAHL Plus 
S1. (MH “Obesity+”) 
S2. “obese” 
S3. “overweight” 
S4. (MH "Child+")  
S5. (MH "Infant+")  
S6. "schoolchild*"  
S7. "adolescent" 
S8. "Interven*" 
S9. "prevent*" 
S10. (MH "Therapeutics+")  
S11. "counseling"  
S12. (MH "Primary Health Care")  
S13. "preventive health services"  
S14. (MH "Health Behavior")  
S15. (MH "Life Style+") 
S16. "health knowledge, practice, attitudes"  
S17. "delivery of health care" 
S18. "social support"  
S19. (MH "Family Practice") 
S20. (MH "Parent-Child Relations")  
S21. (MH "Food Habits") 
S22. (MH "Food Preferences")  
S23. (MH "Exercise+")  
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S24. (MH "Sports+")   
S25. "Economic evaluat*"  
S26. "costs*" 
S27. "cost?benefit*" 
S28. “cost?utilit*” 
S29. “cost?effective*” 
S30. S1 OR S2 OR S3 
S31. S4 OR S5 OR S6 OR S7 
S32. S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 
OR S19 OR S20 OR S21 OR S22 OR S23 OR S24  
S33. S25 OR S26 OR S27 OR S28 OR S29 
S34. S30 AND S31 AND S32 AND S33 
S35. Limit S34 to Publication Year: 2001-2017 
 
EconLit 
S1. (MH “Obesity+”) 
S2. “obese” 
S3. “overweight” 
S4.  (MH "Child+")  
S5. (MH "Infant+")  
S6. "schoolchild*"  
S7. "adolescent" 
S8. "Interven*" 
S9. "prevent*" 
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S10. (MH "Therapeutics+")  
S11. "counseling"  
S12. (MH "Primary Health Care")  
S13.  "preventive health services"  
S14. (MH "Health Behavior")  
S15. (MH "Life Style+") 
S16. "health knowledge, practice, attitudes"  
S17. "delivery of health care" 
S18. "social support"  
S19. (MH "Family Practice") 
S20. (MH "Parent-Child Relations")  
S21. (MH "Food Habits") 
S22. (MH "Food Preferences")  
S23. (MH "Exercise+")  
S24. (MH "Sports+")   
S25. "Economic evaluat*"  
S26.  "costs*" 
S27. "cost?benefit*" 
S28.  “cost?utilit*” 
S29. “cost?effective*” 
S30. S1 OR S2 OR S3 
S31. S4 OR S5 OR S6 OR S7 
S32. S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 
OR S19 OR S20 OR S21 OR S22 OR S23 OR S24  
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S33. S25 OR S26 OR S27 OR S28 OR S29 
S34. S30 AND S31 AND S32 AND S33 
S35.  Limit S34 to Publication Year: 2001-2017 
 
CRD (DARE, NHS EED, HTA) 
1. MeSH DESCRIPTOR Obesity EXPLODE ALL TREES 
2. (Obese) OR (Overweight): any field 
3. MeSH DESCRIPTOR Child EXPLODE ALL TREES 
4. MeSH DESCRIPTOR Infant EXPLODE ALL TREES 
5. (Schoolchild*): any field 
6. MeSH DESCRIPTOR Adolescent EXPLODE ALL TREES 
7. (Interven*) OR (prevent*): any field 
8. MeSH DESCRIPTOR Therapeutics EXPLODE ALL TREES 
9. MeSH DESCRIPTOR Counseling EXPLODE ALL TREES 
10. MeSH DESCRIPTOR Primary Health Care EXPLODE ALL TREES 
11. MeSH DESCRIPTOR Preventive Health Services EXPLODE ALL TREES      
12. MeSH DESCRIPTOR Health Behavior EXPLODE ALL TREES 
13. MeSH DESCRIPTOR Life Style EXPLODE ALL TREES 
14. (Health knowledge, practice, attitudes): any field 
15. MeSH DESCRIPTOR Delivery of Health Care EXPLODE ALL TREES 
16. MeSH DESCRIPTOR Social Support EXPLODE ALL TREES 
17. MeSH DESCRIPTOR Family Practice EXPLODE ALL TREES 
18. MeSH DESCRIPTOR Parent-Child Relations EXPLODE ALL TREES 
19. (Food Habits): any field 
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20. MeSH DESCRIPTOR Food Preferences EXPLODE ALL TREES 
21. MeSH DESCRIPTOR Exercise EXPLODE ALL TREES 
22. MeSH DESCRIPTOR Sports EXPLODE ALL TREES 
23. MeSH DESCRIPTOR Costs and Cost Analysis EXPLODE ALL TREES 
24. MeSH DESCRIPTOR Economics EXPLODE ALL TREES 
25. (Cost) OR (Economic): any field 
26. (#1 or #2) and (#3 or #4 or #5 or #6) and (#7 or #8 or #9 or #10 or #11 or #12 or #13 or 
#14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22) and (#23 or #24 or #25) 
From 2001-2017 
 
CENTRAL and CDSR 
1. "MeSH descriptor: [Obesity] explode all trees 
2. Obese or overweight: ti, ab.kw (Word variations have been searched) 
3. "MeSH descriptor: [Child] explode all trees 
4. "MeSH descriptor: [Infant] explode all trees 
5. Schoolchild*: ti, ab.kw (Word variations have been searched) 
6. "MeSH descriptor: [Adolescent] explode all trees 
7. Interven* or prevent*: ti, ab.kw (Word variations have been searched) 
8. "MeSH descriptor: [Therapeutics] explode all trees 
9. "MeSH descriptor: [Counseling] explode all trees 
10. "MeSH descriptor: [Primary Health Care] explode all trees 
11. "MeSH descriptor: [Preventive Health Services] explode all trees 
12. "MeSH descriptor: [Health Behavior] explode all trees 
13. "MeSH descriptor: [Life Style] explode all trees 
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14. Health knowledge, practice, attitudes: ti, ab.kw (Word variations have been searched) 
15. "MeSH descriptor: [Delivery of Health Care] explode all trees 
16. "MeSH descriptor: [Social Support] explode all trees 
17. "MeSH descriptor: [Family Practice] explode all trees 
18. "MeSH descriptor: [Parent-Child Relations] explode all trees 
19. "MeSH descriptor: [Food Habits] explode all trees 
20. "MeSH descriptor: [Food Preferences] explode all trees 
21. "MeSH descriptor: [Exercise] explode all trees 
22. "MeSH descriptor: [Sports] explode all trees 
23. "MeSH descriptor: [Costs and Cost Analysis] explode all trees 
24. "MeSH descriptor: [Economics] explode all trees 
25. Cost or economic: ti, ab.kw (Word variations have been searched) 
26. (#1 or #2) and (#3 or #4 or #5 or #6) and (#7 or #8 or #9 or #10 or #11 or #12 or #13 or 
#14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22) and (#23 or #24 or #25) 
From 2001-2017, in other reviews or economic evaluations 
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Appendix 1.2 - Drummond Checklist for Critically Appraising Relevant Studies 
Drummond checklist for assessing primary economic evaluations 
 
 
    
Study design 
1 The research question is stated     
2 The economic importance of the research question is stated     
3 The viewpoint (s) of the analysis are clearly stated and justified     
4 The rationale for choosing alternative programmes or interventions compared is stated     
5 The alternatives being compared are clearly described     
6 The form of economic evaluation used is stated     
7 The choice of form of economic evaluation is justified in relation to the questions addressed     
Data collection 
8 The source (s) of effectiveness estimates used are stated     
9 Details of the design and results of effectiveness study are given (if based on a single study)     
10 Details of the methods of synthesis or meta-analysis of estimates are given (if based on a synthesis of a number of effectiveness 
studies) 
    
11 The primary outcome measure (s) for the economic evaluation are clearly stated     
12 Methods to value benefits are stated     
13 Details of the subjects from whom valuations were obtained were given     
14 Productivity changes (if included) are reported separately     
15 The relevance of productivity changes to the study question is discussed     
16 Quantities of resource use are reported separately from their unit costs     
17 Methods for the estimation of quantities and unit costs are described     
18 Currency and price data are recorded     
19 Details of currency of price adjustments for inflation or currency conversion are given     
20 Details of any model used are given     
21 The choice of model used and the key parameters on which it is based are justified     
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Analysis and interpretation of results 
22 Time horizon of costs and benefits is stated     
23 The discount rate (s) is stated     
24 The choice of discount rate (s) is justified     
25 An explanation is given if costs and benefits are not discounted     
26 Details of statistical tests and confidence intervals are given for stochastic data     
27 The approach to sensitivity analysis is given     
28 The choice of variables for sensitivity analysis is justified     
29 The ranges over which the variables are varied are justified     
30 Relevant alternatives are compared     
31 Incremental analysis is reported     
32 Major outcomes are presented in a disaggregated as well as aggregated form     
33 The answer to the study question is given     
34 Conclusions follow from the data reported     
35 Conclusions are accompanied by the appropriate caveats     
 
Notes: Y= Yes; N=No; NC= Not clear; N.A. = Not applicable 
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Appendix 1.3 (i) - 1.3 (iv) - Data Extraction (Details about Study Context) 
Appendix 1.3 (i) - Details about study context (trial-based prevention studies) (alphabetically sorted) 
Authors Year Country Study 
design 
Setting Target  
population/ 
age group 
N 
(analytical 
sample) 
Parents/ 
guardians 
included 
Intervention 
overview 
/target 
Intervention 
aim 
/mode of 
delivery 
Comparator 
Hayes  
et al. [229] 
 
2014 Australia RCT 
 
Home Up to age 2 
years,  
boys/girls 
from a 
mixed-weight 
group 
324  
parents 
with infants 
Yes: 
Not for 
indirect and 
direct non-
medical 
costs 
8 one-to-one 
consultations 
with education 
and advice on 
feeding, 
nutrition and 
physical activity 
Prevention 
/nurse 
Usual care, 
plus  
home safety 
information 
sent  
by mail 
Kesztyus  
et al. [235] 
 
2011 Germany RCT 
 
School 7-8 years, 
boys/girls 
from a 
mixed-weight 
group 
945 
children 
Yes: 
parents 
involved 
but not 
costed 
28 units, health 
education, 
physical activity 
breaks 
Prevention 
/teacher 
Usual care 
Krauth  
et al. [236] 
 
2013 Germany Cohort 
 
School 6-10 years, 
boys/girls 
from a 
mixed- 
weight group 
660 
children 
Yes  
 
3 additional 
lessons per 
week regarding 
physical activity 
Prevention 
/teacher 
Usual care 
Martinez  
et al. [237] 
 
2011 Spain RCT 
 
School  
 
9-10 years, 
boys/girls 
from a 
mixed-weight 
group 
1,409 
children 
Yes: 
parents 
involved 
but not 
costed 
3 sessions, 
school-based 
physical activity 
program 
Prevention 
/teacher 
Usual care 
McAuley  
et al. [227] 
 
2010 New  
Zealand 
RCT 
 
School-
community 
5–12 years, 
boys/girls 
from a 
mixed-weight 
group 
279 
children 
Yes: 
parents 
involved 
but not 
costed 
A pilot program 
for nutrition and 
physical activity 
 
Prevention 
/activity 
coordinator 
Usual care 
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Appendix 1.3 (i) - Details about study context (trial-based prevention studies) (alphabetically sorted) continued 
Authors Year Country Study 
design 
Setting Target  
population/ 
age group 
N 
(analytical 
sample) 
Parents/ 
guardians 
included 
Intervention 
overview 
/target 
Intervention 
aim 
/mode of 
delivery 
Comparator 
Meng  
et al. [17] 
2013 China RCT 
 
School 6-13 years, 
boys/girls 
from a mixed-
weight group 
 
8, 301 
children 
Yes: 
parents 
involved 
but not 
costed 
6 times, 
nutrition 
education for 
children, parents 
and teachers, 
physical activity 
intervention and 
comprehensive 
intervention. 
Prevention 
/teacher 
Usual care 
Peterson  
et al. [228] 
2008 USA Cross-
sectional 
 
State 
 
12–18 years, 
boys/girls 
from a mixed-
weight group 
 
3,782  
adolescents 
No Th  g t up and 
do something 
media campaign 
(Television 
and/or 
billboards) for 
physical activity 
Prevention 
(policy) 
/media 
Usual care 
Sutherland  
et al. [206] 
2016 Australia RCT 
 
School-
community 
13-16 years, 
boys/girls 
from a mixed-
weight group  
1,150 
adolescents 
Yes: 
Not for 
indirect 
and direct 
non-
medical 
costs 
 
Seven physical 
activity 
promotion 
strategies and 
six additional 
strategies 
Prevention 
/trained 
teacher 
Usual care 
 
 
 
 
Wang  
et al. [115] 
2008 USA RCT 
 
School  
(after  
hours) 
6-10 years, 
boys/girls 
from a mixed-
weight group 
 
182 
children 
Yes After school 
environment 
program: 
physical 
activity, healthy 
snacks 
Prevention 
/coordinator 
Usual care 
 
 
 
Notes: RCT = randomised controlled trial 
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Appendix 1.3 (ii) - Details about study context (trial-based treatment studies) (alphabetically sorted) 
Authors Year Country Study 
design 
Setting Target  
population/ 
age group 
N 
(analytical 
sample) 
Parents/ 
guardians 
included 
Intervention 
overview 
/target 
Intervention 
aim 
/mode of 
delivery 
Comparator 
Epstein  
et al. [230] 
2014 USA RCT 
 
Primary 
care 
8-12 years, 
boys/girls 
with obesity/ 
overweight 
50  
children  
with 
parents 
Yes Family-based 
behavioural 
treatment, 
15 sessions (12 
weekly, 2 
biweekly and 1 
monthly): diet, 
physical activity 
and behaviour 
change for both 
treatment groups 
Treatment 
/staff 
Separate 
group 
treatment 
(parent and 
child)  
Goldfield  
et al. [231] 
2001 Canada RCT 
 
Primary 
care 
8-12 years,  
boys/girls 
with obesity 
 
24 
children  
with 
parents 
Yes: 
Not for 
indirect and 
direct non-
medical 
costs 
Group 
treatment, 
13 sessions 
(8 weekly, 4 bi-
weekly, and 1 
monthly): diet, 
physical activity 
and behaviour 
change for both 
treatment groups 
Treatment 
/counselling 
degree 
Mixed 
family-based 
behavioural 
treatment 
Hollinghurst 
et al. [232] 
2013 UK RCT 
 
Primary  
care/ 
home/ 
hospital 
5-16 years 
and  
9-17 years, 
boys/girls 
with obesity 
 
 
143 
children 
and 
adolescents 
 
 
Yes: 
Parents 
involved 
but not 
costed 
Every 3 months, 
nurse-led, input 
from dietitian 
and exercise 
specialist and an 
intensive 
intervention  
Mandometer 
Treatment 
/doctor, 
nurse,  
exercise 
specialist, 
dietitian 
Hospital, 
Consultant-
led care with 
discretionary 
input from 
dietitian and 
exercise 
specialist 
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Appendix 1.3 (ii) - Details about study context (trial-based treatment studies) (alphabetically sorted) continued 
Authors Year Country Study 
design 
Setting Target  
population/ 
age group 
N 
(analytical 
sample) 
Parents/ 
guardians 
included 
Intervention 
overview 
/target 
Intervention 
aim 
/mode of 
delivery 
Comparator 
Janicke 
et al. [233] 
2009 USA RCT 
 
Community 8-14 years, 
boys/girls 
with obesity/ 
overweight 
76  
children 
Yes: 
Not for 
indirect and 
direct non-
medical 
costs 
Parent only 
behavioural 
intervention,  
group sessions: 
weekly: 8, bi-
weekly: 4/ 
diet and 
physical activity 
for both 
treatment groups 
Treatment 
/post-
doctoral  
psychologist 
and graduate 
students in 
clinical 
psychology 
Family-based 
behavioural 
intervention, 
 
Kalavainen 
et al. [238] 
2009 Finland RCT 
 
Primary 
care 
7–9 years, 
boys/girls 
with obesity 
70  
children 
with  
parents 
Yes: 
Not for 
indirect and 
direct non-
medical 
costs 
Routine 
counselling 
treatment, 
2 appointments 
for children: diet 
 
Treatment 
/nurses, 
nutritionists 
Group 
treatment, 
15 separate 
sessions for 
parents and 
children: diet 
Robertson  
et al. [205] 
2017 UK RCT 
 
 
NHS 
primary 
care 
6-11 years, 
boys/girls 
with obesity/ 
overweight 
128 
children 
with 
137 
parents/ 
carers 
Yes 1 per week, 
parenting skills, 
social and 
emotional 
development/ 
physical activity 
and diet  
Treatment 
/intervention 
team 
Usual care 
Wake 
et al. [234] 
2008 Australia RCT 
 
Primary 
care 
5–9 years, 
boys/girls 
with obesity/ 
overweight 
163 
children 
with 
parents 
Yes Training of GP  
(3 times 2.5 h), 
4 consultations 
over a 12-week 
period/physical 
activity, diet 
Treatment 
/GP 
Usual care 
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Appendix 1.3 (iii) - Details about study context (model-based prevention studies) (alphabetically sorted) 
Authors Year Country Study 
design 
Setting Target  
population/ 
age group 
N 
(analytical 
sample) 
Parents/ 
guardians 
included 
Intervention 
overview 
/target 
Intervention 
aim 
/mode of 
delivery 
Comparator 
Barrett 
et al. [211] 
2015 USA Cohort 
 
State's 
school 
6–11 years, 
boys/girls 
from a mixed-
weight group 
 
 
17.6 
million 
children 
No Active physical 
education policy 
(Active PE) 
Prevention 
(policy) 
/teachers 
Usual care 
Brown 
et al. [212] 
2007 USA Cohort 
 
School 8-11 years, 
Boys/girls 
from a mixed-
weight group 
 
423 
children 
No Physical 
education, 
school food 
service 
modification, 
family- and 
home-based 
program 
Prevention 
/teacher, 
trainer 
Usual care 
Carter 
et al. [196] 
2009 Australia RCT 
 
School 7–11 years, 
boys/girls 
from a mixed-
weight group 
 
595, 000  
children 
over 5 
years 
(119,000 
each year) 
Yes: 
Parents 
involved 
but not 
costed 
Education 
programme to 
reduce sugar 
sweetened drink 
consumption 
Prevention 
/trained 
project staff 
Usual care 
Carter 
et al. [196] 
2009 Australia Cohort 
 
School 6 years, 
boys/girls 
from a mixed-
weight group 
 
114, 630 
children 
Yes:  
Parents 
involved 
but not 
costed 
Education to 
improve 
nutrition and 
physical 
activity, with an 
active physical 
education  
Prevention 
/teacher 
Usual care 
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Appendix 1.3 (iii) - Details about study context (model-based prevention studies) (alphabetically sorted) continued 
Authors Year Country Study 
design 
Setting Target  
population/ 
age group 
N 
(analytical 
sample) 
Parents/ 
guardians 
included 
Intervention 
overview 
/target 
Intervention 
aim 
/mode of 
delivery 
Comparator 
Carter 
et al. [196] 
2009 Australia RCT 
 
School 8–10 years, 
boys/girls 
from a mixed-
weight group 
 
268, 600 
children 
Yes:  
parents 
involved 
but not 
costed 
Education 
programme to 
reduce 
television 
viewing of 
snacks 
Prevention 
/teacher 
Usual care 
Carter 
et al. [196] 
2009 Australia Cohort 
 
School 6 years, 
boys/girls 
from a mixed-
weight group 
 
114, 630 
children 
Yes:  
parents 
involved 
but not 
costed 
Education to 
improve 
nutrition and 
physical 
activity, 
without an 
active physical 
education  
Prevention 
/teacher 
Usual care 
Graziose 
et al. [207] 
2016 USA RCT 
 
School 10-11 years, 
boys/girls 
from a mixed-
weight group 
 
769 
children 
No 24 lessons, 
obesity 
prevention 
nutrition 
education  
Prevention 
/trained 
teacher 
Usual care 
Long 
et al. [213] 
2015 USA Cohort 
 
State 2-19 years, 
boys/girls 
from a mixed-
weight group 
 
74  
million 
children 
No Sugar-
sweetened 
beverage 
excise tax/diet 
Prevention 
(policy) 
/government, 
industry 
Usual care 
Magnus 
et al. [214] 
2009 Australia RCT 
 
State 5-14 years, 
boys/girls 
from a mixed-
weight group 
 
2.4  
million 
children 
Yes: 
parents 
involved 
but not 
costed 
Removing TV 
advertising of 
energy-dense 
nutrition-poor 
(EDNP) food 
and beverages 
 
Prevention 
(policy) 
/media 
Usual care 
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Appendix 1.3 (iii) - Details about study context (model-based prevention studies) (alphabetically sorted) continued 
Authors Year Country Study 
design 
Setting Target  
population/ 
age group 
N 
(analytical 
sample) 
Parents/ 
guardians 
included 
Intervention 
overview 
/target 
Intervention 
aim 
/mode of 
delivery 
Comparator 
Moodie 
et al. [215] 
 
2009 Australia Cohort 
 
School-
community 
 
 
5-7 years, 
boys/girls 
from a 
mixed-weight  
7, 840 
children 
Yes Walking school 
bus program, 
encouraging 
physical activity 
Prevention 
/volunteer 
conductors 
Usual care 
Moodie 
et al. [216] 
 
2010 Australia Cohort 
 
School 
(after 
hours)  
5-11 years, 
boys/girls 
from a 
mixed-weight  
99, 000 
children 
Yes Active after-
school 
communities, 
physical activity  
Prevention 
/organizations 
Usual care 
Moodie 
et al. [217] 
2011 Australia Cohort 
 
School-
community 
10–11 years, 
boys/girls 
from a 
mixed-weight  
267, 700 
children 
Yes: 
parents 
involved 
but not 
costed 
Travel smart 
school, 
promotion of 
physical activity 
Prevention 
/teachers 
Usual care 
Moodie 
et al. [218] 
2013 Australia Quasi-
experime 
ntal, 
 
School-
community 
4-12 years, 
boys/girls 
from a 
mixed-weight  
2, 184 
children 
Yes The be active 
eat well 
program, 
diet and 
physical activity 
Prevention 
/community 
service 
Usual care 
Pringle 
et al. [219] 
2010 UK _ 
 
Community 10-17 years, 
boys/girls 
from a 
mixed-weight  
343 
children 
and  
adolescents 
Yes: 
Not for 
indirect and 
direct non-
medical 
costs 
Free swimming 
activities, 
campaigns, 
exercise classes, 
motivational 
interviews 
Prevention 
/trainer 
Other 
interventions 
Rush 
et al. [220] 
2014 New 
Zealand 
RCT 
 
School 6-8 years  
and  
9-11 years,  
boys/girls 
from a 
mixed-weight  
2, 474 
younger 
and 
2, 330 older 
children 
Yes: 
parents 
involved 
but not 
costed 
Project 
Energize: 
Multicomponent 
physical activity 
and nutrition 
Prevention 
/organizations 
Usual care 
236 
 
Appendix 1.3 (iii) - Details about study context (model-based prevention studies) (alphabetically sorted) continued 
Authors Year Country Study 
design 
Setting Target  
population/ 
age group 
N 
(analytical 
sample) 
Parents/ 
guardians 
included 
Intervention 
overview 
/target 
Intervention 
aim 
/mode of 
delivery 
Comparator  
Sonneville 
et al. [221] 
2015 USA Cohort 
 
State 2-19 years, 
boys/girls 
from a 
mixed-
weight group 
 
74 million 
Children 
and 
adolescents 
 
No Elimination of the 
tax subsidy of TV 
advertising costs 
for nutritionally  
poor foods and 
beverages 
advertised 
Prevention 
(policy) 
/industry 
Usual care  
Wang 
et al. [222] 
2003 USA RCT 
 
School 10-14 years, 
girls from a 
mixed-
weight group 
 
620 
children 
No Lessons, sport 
materials, wellness,  
teacher training, 
targeting diet and 
physical activity, 
reduction of TV 
viewing time 
Prevention/te
acher, 
trainer 
Usual care  
Wang 
et al. [223] 
2011 USA RCT 
 
School 10-14 years, 
girls from a 
mixed-
weight group 
 
480 
children 
No Lessons, sport 
materials, wellness,  
teacher training, 
targeting diet and 
physical activity 
Prevention/te
acher, trainer 
Usual care  
Wright 
et al. [224] 
 
2015 USA Cohort 
 
State 2.5-5 years, 
boys/girls 
from a 
mixed-
weight group 
 
3.7  
million 
children 
 
No Early care and 
education policy 
change, physical 
activity, diet and 
reduction of TV 
viewing time 
Prevention 
(policy) 
/Child care 
trainers 
Usual care  
Notes: RCT = randomised controlled trial 
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Appendix 1.3 (iv) - Details about study context (model-based treatment studies) (alphabetically sorted) 
Authors Year Country Study 
design 
Setting Target  
population/ 
age group 
N 
(analytical 
sample) 
Parents/ 
guardians 
included 
Intervention 
overview 
/target 
Intervention 
aim 
/mode of 
delivery 
Comparator 
Carter  
et al. [196] 
2009 Australia Cohort 
 
School 7–10 years, 
boys/girls  
with obesity/ 
overweight 
17, 000  
children 
over 4 
years, 
(4 200 
each year) 
Yes: 
Parents 
involved 
but not 
costed 
Multifaceted 
targeted 
programme, 
diet and 
physical activity 
Treatment/ 
teacher 
 Usual care 
Carter  
et al. [196] 
2009 Australia RCT 
 
Primary  
Care 
10–11 years, 
boys/girls  
with obesity 
5, 800 
children 
Yes: 
Parents 
involved 
but not 
costed 
Primary care-
based program, 
children with 
obesity and their 
parents, 
diet 
Treatment/ 
GPs, 
paediatricians, 
psychologists, 
dietitians 
  Usual care 
Hollingworth 
et al. [225] 
2012 UK RCT 
 
Hospital-
community 
4-5 years  
and  
10-11 years, 
boys/girls  
with obesity/ 
overweight 
9, 956 
younger 
and 
9, 698 
older  
children 
Yes: 
Parents 
involved 
but not 
costed 
Interventions 
aimed  
at modifying 
behaviour, diet 
and/or physical 
activity 
Treatment/GP, 
paediatricians, 
nurse,  
exercise 
specialist, 
dietitian 
Usual care or 
minimal 
intervention 
Moodie 
et al. [226] 
2008 Australia RCT 
 
Primary  
Care 
5–9 years, 
boys/girls  
with obesity/ 
overweight 
9, 685 
children 
Yes Training of GP  
(3 times 2.5 h), 
4 consultations 
over a 12-week 
period/physical 
activity, diet 
Treatment/GP  Usual care 
Notes: GP = general practitioner; RCT = randomised controlled trial 
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Appendix 1.4 (i) - 1.4 (iv) - Data Extraction (Detailed Account of the Economic Evaluation Methods A) 
Appendix 1.4 (i) - Detailed account of the economic evaluation methods A (trial-based prevention studies) (alphabetically sorted) 
Authors 
and  
year 
Measures of 
effectiveness/ 
study type 
Type of 
modelling 
approach 
Study 
perspective 
Duration of 
intervention/ 
follow-up 
Time 
horizon 
Price 
year 
Currency 
unit 
Discount  
rate 
Hayes  
et al. 2014 
[229] 
Reduction in BMI (z-score),  
unit BMI avoided/CEA 
N.A. Health care 
funder 
2 years/ 2 years after  
randomisation 
2 years 2012 AU$ Costs: 5% 
Effects: 5% 
Kesztyus  
et al. 2011 
[235] 
Reduction in BMI, 
cm WC and unit WHtR 
prevented/CEA 
N.A. Societal 1 year/ 1 year after 
randomisation 
1 year 2008 € N.A. 
Krauth  
et al. 2013 
[236] 
Reduction in BMI,  
(increase in physical activity: 
the measure was not specified)/CCA 
N.A. Societal 4 years/ 4, 5 and 6 
years after intervention 
6 years No 
price 
year 
€ Not stated 
Martinez  
et al. 2011 
[237] 
Percent point decrease in triceps  
skinfold thickness and body fat/CEA 
N.A. Societal and 
institutional 
8 months/ 8 months 
after randomisation 
8 
months 
2005 € N.A. 
McAuley  
et al. 2010 
[227] 
Reduction in BMI (z-score),   
cm WC prevented,   
weight gain prevented, HRQoL/CEA  
N.A. Societal 2 years/ 2 and 4 years 
after intervention 
4 years 2006 NZ$ Costs at 5% 
Effects: Not 
reported 
Meng  
et al. 2013 
[17] 
Reduction in BMI, BMI (z-score), 
overweight and obesity case 
avoided/CEA 
N.A. Social 1 year/ 1 year after 
randomisation 
1 year 2010 RMB/ 
US$ 
N.A. 
Peterson  
et al. 2008 
[228] 
(Increase in physical activity: 
the measure was not specified)/CEA 
N.A. Not specified Not reported Not 
reported 
No 
price 
year 
US$ N.A. 
Sutherland  
et al. 2016 
[206] 
MVPA (min/day) gained,   
BMI unit avoided and  
reduction in BMI (z-score)/CEA 
N.A. Societal 2 years/ 1 year (mid-
intervention), 
2 years after  
2 years 2014 AU$ Not stated 
Wang  
et al. 2008 
[115] 
Reduction in body fat/CEA N.A. Societal 1 year/ 1 year after 
randomisation 
1 year 2003 US$ N.A. 
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Appendix 1.4 (ii) - Detailed account of the economic evaluation methods A (trial-based treatment studies) (alphabetically sorted) 
Authors 
and  
year 
Measures of 
effectiveness/ 
study type 
Type of 
modelling 
approach 
Study 
perspective 
Duration of 
intervention/ 
follow-up 
Time 
horizon 
Price 
year 
Currency 
unit 
Discount 
rate 
Epstein  
et al. 2014 
[230] 
BMI change and  
weight for children and 
parents/CEA 
N.A. Societal  
(payer plus 
participant 
costs) 
1 year/ 1 year after 
randomisation 
1 year No 
price 
year 
US$ N.A. 
Goldfield  
et al. 2001 
[231] 
Reduction in BMI (z-score) and 
percentage overweight/CEA 
N.A. Not specified 6 months/ 6 and 12 
months after 
randomisation 
1 year No 
price 
year 
$ N.A. 
Hollinghurst 
et al. 2013 
[232] 
Reduction in BMI sd/CEA 
 
N.A. Healthcare 1 year/ 1 year after 
randomisation 
1 year No 
price 
year 
£ N.A. 
Janicke 
et al. 2009 
[233] 
Reduction in BMI/CEA N.A. Not specified 4 months/ 4 and 10 
months after 
randomisation 
10 
months 
No 
price 
year 
US$ N.A. 
Kalavainen 
et al. 2009 
[238] 
Reduction in weight  
for height and BMI/CEA 
N.A. Service 
provider 
(healthcare) 
6 months/ 6 and 12 
months after 
randomisation 
1 year 2004 € N.A. 
Robertson  
et al. 2017 
[205] 
Reduction in waist z-score,  
body fat, WC, MVPA (min/day) 
gained,  
change in BMI (z-score) and  
QALYs gained/CEA, CUA 
N.A. NHS and 
PSS 
(healthcare) 
3 months/ 3 and 12 
months after 
randomisation 
1 year 2013, 
2014 
£ N.A. 
Wake 
et al. 2008 
[234] 
Reduction in BMI, 
parent-reported physical activity 
and dietary habits/CCA 
N.A. Societal 9 months/ 
9 and 15 months 
after randomisation 
15 
months 
2003 AU$ Not stated 
Notes: BMI = body mass index; CCA = cost-consequence analysis; CEA = Cost-effectiveness analysis; CUA = cost-utility analysis; 
QALYs = quality-adjusted life years; MVPA = moderate-to-vigorous physical activity; NHS = National Health Service; PSS = personal 
social services; WC = waist circumference; N.A. = not applicable 
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Appendix 1.4 (iii) -Detailed account of the economic evaluation methods A (model-based prevention studies) (alphabetically sorted) 
Authors 
and  
year 
Measures of 
effectiveness/ 
study type 
Type of 
modelling 
approach 
Study 
perspective 
Duration of 
intervention/ 
follow-up 
Time 
horizon 
Price 
year 
Currency 
unit 
Discount 
rate 
Barrett 
et al. 2015 
[211] 
Reduction in BMI and  
obesity-related healthcare  
expenditure, increase in minutes of 
MVPA and MET-hours/CEA 
Markov  
model 
Societal 2 years/ 
2 years 
 
10 years 2014 US$ Costs: 3% 
Effects: 3% 
Brown 
et al. 2007 
[212] 
Cases of adult overweight 
prevented,  
QALYs saved/CUA 
Decision 
tree 
Societal 3 years/ 
 
 
25 years 
From age 
40 to 64 
2004 US$ Costs: 3% 
Effects: 3% 
Carter 
et al. 2009 
(4 the same) 
[196] 
BMI unit saved, DALYs 
saved/CUA 
Markov 
model 
Societal  
 
1  year/ Lifetime 2001 AU$ Costs: 3% 
Effects: 3% 
Graziose 
et al. 2016 
[207] 
Reduction in adult obesity, 
QALYs saved/CUA 
Decision  
tree 
Societal 1 year/ Lifetime 2012 US$ Costs: 3% 
Effects: 3% 
Long 
et al. 2015 
[213] 
Changes in BMI,  
reductions in disease burden and  
healthcare expenditures,  
DALYs averted and QALYs 
gained/CEA, CUA 
Markov  
model 
Societal 2 years/ 
2 years 
10 years 2014 US$ Costs: 3% 
Effects: 3% 
Magnus 
et al. 2009 
[214] 
BMI unit saved, DALYs 
saved/CEA, CUA 
Markov 
model 
Societal  
 
1 year/ Lifetime 2001 AU$ Costs: 3% 
Effects: 3% 
Moodie 
et al. 2009 
[215] 
BMI unit saved, DALYs saved,  
increase in physical activity (MET) 
and energy expenditure/CEA, CUA 
Markov 
model 
Societal 1 year/ Lifetime 2001 AU$ Costs: 3% 
Effects: 3% 
Moodie 
et al. 2010 
[216] 
BMI unit saved,  
DALYs saved,  
increase in physical activity (MET) 
and energy expenditure/CEA, CUA 
Markov  
model 
Societal 1 year/ Lifetime 2001 AU$ Costs: 3% 
Effects: 3% 
241 
 
Appendix 1.4 (iii) - Detailed account of the economic evaluation methods A (model-based prevention studies) (alphabetically 
sorted) continued 
Authors 
and  
year 
Measures of 
effectiveness/ 
study type 
Type of 
modelling 
approach 
Study 
perspective 
Duration of 
intervention/ 
follow-up 
Time 
horizon 
Price 
year 
Currency 
unit 
Discount 
rate 
Moodie 
et al. 2011 
[217] 
BMI unit saved, DALYs saved,  
increase in physical activity (MET) 
and energy expenditure/CEA, CUA 
Markov 
model 
Societal 1 year/ Lifetime 2001 AU$ Costs: 3% 
Effects: 3% 
Moodie 
et al. 2013 
[218] 
Reduction in BMI,  
DALYs saved/CEA, CUA 
Markov 
model 
Societal 3 years/  Lifetime 2006 AU$ Costs: 3% 
Effects: 3% 
Pringle 
et al. 2010 
[219] 
Change in MPA,  
QALYs saved/CEA, CUA 
Decision tree Not specified Not reported Not 
reported 
2003 £ N.A. 
Rush 
et al. 2014 
[220] 
Reduction in BMI,  
QALYs saved, 
increased life expectancy/CUA 
Markov 
model 
Health treatment 
payer 
(Health care) 
2 years/ 
5 years 
Lifetime 2011 NZ$ Costs: 3.5% 
Effects: 3.5% 
Sonneville 
et al. 2015 
[221] 
Reduction in BMI,  
reductions in disease burden, 
healthcare expenditures and  
QALYs gained/CEA, CUA 
Markov  
model 
Societal 2 years/ 
2 years 
10 years 2014 US$ Costs: 3% 
Effects: 3% 
Wang 
et al. 2003 
[222] 
Cases of adult overweight  
prevented,  
QALYs saved/CUA 
Decision 
tree 
Societal 2 years/ 25 years 
From age 
40 to 65 
1996 US$ Costs: 3% 
Effects: 3% 
Wang 
et al. 2011 
[223] 
DWCB avoided,  
QALYs saved/CUA 
Decision 
tree 
Societal 2 years/ 10 years 2010 US$ Costs: 3% 
Effects: 3% 
Wright 
et al. 2015 
[224] 
Unit BMI avoided,  
reduction in obesity-related  
healthcare expenditure/CEA 
Markov  
model 
Societal 2 years/ 
2 years 
10 years 2014 US$ Costs: 3% 
Effects: 3% 
Notes: BMI = body mass index; CEA = Cost-effectiveness analysis; DALYs = disability-adjusted life years; DWCB = disordered weight 
control behaviours; QALYs = quality-adjusted life years; MVPA = moderate-to-vigorous physical activity; MPA = moderate physical 
activity; N.A. = not applicable 
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Appendix 1.4 (iv) - Detailed account of the economic evaluation methods A (model-based treatment studies) (alphabetically sorted) 
Authors 
and  
year 
Measures of 
effectiveness/ 
study type 
Type of 
modelling 
approach 
Study  
perspective 
Duration of 
intervention/ 
follow-up 
Time 
horizon 
Price 
year 
Currency 
unit 
Discount 
rate 
Carter 
et al. 2009 
(2 the same) 
[196] 
BMI unit saved,  
DALYs saved/CUA 
Markov 
model 
Societal 1 year/ Lifetime 2001 AU$ Costs: 3% 
Effects: 3% 
Hollingworth 
et al. 2012 
[225] 
Reduction in BMI sd,  
life year gained/CEA 
Markov 
model 
NHS 
(healthcare) 
1 year/ Lifetime 2009 £ Costs: 3% 
Effects: 3% 
Moodie 
et al. 2008 
[226] 
BMI unit saved,  
DALYs saved/CEA, CUA 
Markov 
model 
Societal 1 year/ Lifetime 2001 AU$ Costs: 3% 
Effects: 3% 
Notes: BMI = body mass index; CEA = Cost-effectiveness analysis; CUA = cost-utility analysis; DALYs = disability-adjusted life years; 
NHS = National Health Service; NHF = National Health Forum 
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Appendix 1.5 (i) - 1.5 (iv) - Data Extraction (Detailed Account of the Economic Evaluation Methods B) 
Appendix 1.5 (i) - Detailed account of the economic evaluation methods B (trial-based prevention studies) (alphabetically sorted) 
Authors 
and  
year 
Methods for estimating/collecting  
resource use  
Cost categories Largest cost 
drivers 
Excluded costs Average  
costs per 
participant 
Funding  
source 
Hayes  
et al. 2014 
[229] 
Local health district records, 
patient-level data linkage 
Programme delivery, 
direct medical 
Hospitalisation 
and doctor visits 
Research and 
development, birth, 
evaluation or 
administration of the 
clinical trial 
AU$ 1, 309 Academic 
Kesztyus  
et al. 2011 
[235] 
Official statistics of the state of 
Bavaria 
Programme delivery 
 
Scientific 
coordinator 
Development, 
scientific evaluation, 
classroom time 
€ 24.09 Academic 
Krauth  
et al. 2013 
[236] 
Questionnaire, school admin Programme delivery, 
indirect 
Training Not stated € 619 Academic 
Martinez  
et al. 2011 
[237] 
Not stated Programme delivery,  
labour 
Personnel 
(coordinator) 
Parents’ care costs € 269.83 Academic 
McAuley  
et al. 2010 
[227] 
Not stated Programme delivery coordinator Research and 
development, 
planning phase, 
time costs of the 
children and their 
parents 
NZ$ 1, 281 Academic 
Meng  
et al. 2013 
[17] 
Not stated Programme delivery, 
labour, money, 
evaluation 
 
Materials Not stated Combined: 
RMB 182.4 
(US$ 26.8), 
nutrition: RMB 
52.8 (US$ 7.8), 
PA: RMB  
52.3 (US$ 7.7) 
Academic 
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Appendix 1.5 (i) - Detailed account of the economic evaluation methods B (trial-based prevention studies) (alphabetically sorted) 
continued 
Authors 
and  
year 
Methods for estimating/collecting  
resource use  
Cost categories Largest cost 
drivers 
Excluded costs Average  
costs per 
participant 
Funding  
source 
Peterson  
et al. 2008 
[228] 
Not stated Development,  
media production 
and placement 
Not stated Not stated Per person to 
become more 
active:  
Individual sections: 
US$ 5.11- 153.19  
Whole: 
US$ 8.87 
Not stated 
Sutherland  
et al. 2016 
[206] 
 
Using market rates, Australian 
Bureau of Statistics, Industrial 
Relations Commission of 
NSW/project records 
Programme delivery 
 
Consultant Research and 
development, 
potential effects on 
healthcare costs 
AU$ 394 Academic 
Wang  
et al. 2008 
[115] 
Not stated Programme delivery, 
usual after-school 
care costs without 
intervention, 
indirect 
Personnel Not stated US$ 956 Academic 
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Appendix 1.5 (ii) - Detailed account of the economic evaluation methods B (trial-based treatment studies) (alphabetically sorted) 
Authors 
and  
year 
Methods for estimating/collecting  
resource use  
Cost categories Largest cost 
drivers 
Excluded costs Average  
costs per 
participant 
Funding  
source 
Epstein  
et al. 2014 
[230] 
Tracking and recording by staff 
members, Google maps 
calculations 
Programme delivery,  
direct medical, 
direct non-medical, 
indirect 
 
Treatment time Recruitment  Cost per family: 
FBT: US$ 1, 448, 
PC-1: US$ 2, 260, 
PC-2: US$ 2, 124  
Academic 
Goldfield  
et al. 2001 
[231] 
 
Not stated  Programme delivery, 
direct medical 
Salary Reduced cost of 
medical care, 
purchasing new 
clothes, time costs 
for being physically 
active 
Cost per family: 
group treatment: 
US$ 491 
Mixed treatment: 
US$ 1, 390 
Academic 
Hollinghurst 
et al. 2013 
[232] 
Patient-level data linkage Programme delivery, 
direct medical 
Mandometer 
device 
Development of the  
Mandometer and 
staff training 
Mandometer 
group: £ 1, 749 
(SD £ 243),  
primary care 
group: £ 301 
(SD £76),  
hospital groups:  
£ 263 (SD £ 88) 
and 
£ 209 (SD £ 81) 
Academic 
Janicke 
et al. 2009 
[233] 
Not stated Programme delivery, 
direct medical 
 
Group leaders Research 
(assessment, 
recruitment),  
participants (travel, 
purchasing healthier  
foods) 
Family-based 
group:  
US$ 872, 
Parent-only:  
US$ 521 
Academic 
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Appendix 1.5 (ii) - Detailed account of the economic evaluation methods B (trial-based treatment studies) (alphabetically sorted) 
continued 
Authors 
and  
year 
Methods for estimating/collecting  
resource use  
Cost categories Largest cost 
drivers 
Excluded costs Average  
costs per 
participant 
Funding  
source 
Kalavainen 
et al. 2009 
[238] 
Not stated Programme delivery, 
labour, 
direct medical 
Labour Research component, 
participating families 
Cost per family: 
group treatment:  
€ 327, 
routine 
counselling: 
€ 61 
Academic 
Robertson  
et al. 2017 
[205] 
 
Questionnaire and secondary  
national tariff sets 
Programme delivery, 
direct medical, 
indirect 
 
 
Hospital visits, 
salary (GP) 
Not stated £ 998 Academic 
Wake 
et al. 2008 
[234] 
3 main sources: the Live, Eat and 
Play (LEAP) team records, practice 
audit, and 
parent written questionnaires at 9 
months 
Programme delivery,  
direct medical, 
direct non-medical, 
indirect 
 
 
Practice Set-up, research and 
development, 
training  
 
AU$ 705 Academic 
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Appendix 1.5 (iii) - Detailed account of the economic evaluation methods B (model-based prevention studies) (alphabetically sorted) 
Authors 
and  
year 
Methods for estimating/collecting  
resource use  
Cost categories Largest cost  
drivers 
Excluded costs Average  
costs per 
participant 
Funding  
source 
Barrett 
et al. 2015 
[211] 
Beta, normal or uniform distribution 
form, different databases (school 
administrators, interventions, survey)  
Programme delivery,  
avoided direct medical 
Sets (nationally) of 
active PE 
curricula and 
equipment 
Start-up US$ 4.03 Academic 
Brown 
et al. 2007 
[212] 
 
Not stated 
 
Programme delivery,  
avoided direct 
medical, 
avoided indirect 
(productivity loss) 
Promotional Not stated US$ 104 Academic 
Carter 
et al. 2009 
[196] 
Not stated Programme delivery 
 
Not stated Set-up  AU$ 28 Academic 
Carter 
et al. 2009 
[196] 
Not stated Programme delivery 
 
Not stated 
 
 
Set-up, 
Teacher classroom 
time 
AU$ 473 Academic 
Carter 
et al. 2009 
[196] 
Not stated Programme delivery Not stated Set-up, 
Teacher classroom 
time 
AU$ 103 Academic 
Carter 
et al. 2009 
[196] 
Not stated Programme delivery Not stated  Set-up, 
Teacher classroom 
time 
AU$ 211 Academic 
Graziose 
et al. 2016 
[207] 
New York City Department of 
Education (NYCDOE) and  
author estimate 
Programme delivery, 
future obesity-related 
medical, 
avoided direct medical 
Teacher preparation 
time 
Development and 
evaluation 
US$ 111 Academic 
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Appendix 1.5 (iii) - Detailed account of the economic evaluation methods B (model-based prevention studies) (alphabetically sorted) 
continued 
Authors 
and  
year 
Methods for estimating/collecting  
resource use  
Cost categories Largest cost  
drivers 
Excluded costs Average  
costs per 
participant 
Funding  
source 
Long 
et al. 2015 
[213] 
Beta, normal or uniform distribution 
form, different databases 
(interventions, revenue department, 
bureau of labour statistics 2013) 
Programme delivery, 
labour, 
avoided direct medical 
Industry auditor salary Not stated US$ 0.68 Academic 
Magnus 
et al. 2009 
[214] 
Not stated 
 
Programme delivery, 
other sectors 
 
Government regulators Set-up AU$ 0.54 Academic 
Moodie 
et al. 2009 
[215] 
Middle of Australian public service 
Level 6, Australian bureau of 
statistics and Victorian department of 
education and training 
Programme delivery, 
direct non-medical, 
indirect, other sectors, 
 
Education e.g.  
programme 
coordinator 
Set-up, research and 
development 
implementation 
AU$ 2, 908 Academic 
Moodie 
et al. 2010 
[216] 
Middle of Australian public service 
level 6 and Victorian department of 
education and training 
Programme delivery, 
indirect, other sectors 
Sport and recreation Set-up, research and 
development, 
implementation, 
external evaluation 
and maintenance 
AU$ 488.5 Academic 
Moodie 
et al. 2011 
[217] 
Middle of Australian public service 
level 6, Victorian department of 
education and training 
Programme delivery, 
other sectors 
Education e.g. 
Central coordinator 
Set-up, research and 
development 
AU$ 49.68 Academic 
Moodie 
et al. 2013 
[218] 
Australian bureau of statistics,  
Victorian department of education 
and training, etc. 
Programme delivery, 
direct non-medical, 
indirect, other sectors 
Personnel time Student time, spin-off 
activities, changes in 
the physical activity 
and eating patterns of 
participating families 
AU$ 344 Academic 
Pringle 
et al. 2010 
[219] 
Not stated  Programme delivery, 
 
Primary care referral Not stated 
 
 
_ Academic 
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Appendix 1.5 (iii) - Detailed account of the economic evaluation methods B (model-based prevention studies) (alphabetically sorted) 
continued 
Authors 
and  
year 
Methods for estimating/collecting  
resource use  
Cost categories Largest cost  
drivers 
Excluded costs Average  
costs per 
participant 
Funding  
source 
Rush 
et al. 2014 
[220] 
 
Not stated Programme delivery, 
avoided direct medical 
 
Not stated Set-up and 
development, 
indirect,  
out-of-pocket,  
 
NZ$ 44.96 Academic 
Sonneville 
et al. 2015 
[221] 
Normal or beta distribution form, 
different databases (bureau of 
labour statistics 2013, etc) 
 
Programme delivery, 
labour, 
avoided direct medical 
Industry auditor salary Not stated US$ 0.015 Academic 
Wang 
et al. 2003 
[222] 
Not stated 
 
 
Programme delivery,  
avoided direct medical, 
avoided indirect 
(productivity loss) 
Subject teachers Classroom time US$ 28 Academic 
Wang 
et al. 2011 
[223] 
Not stated Programme delivery, 
avoided direct medical 
 
Subject teachers Not stated US$ 184.27 Academic 
Wright 
et al. 2015 
[224] 
Different databases (bureau  
of labour statistics 2013, etc) 
Programme delivery,  
avoided direct medical 
Supervising and training Not stated US$ 1.29 Academic 
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Appendix 1.5 (iv) - Detailed account of the economic evaluation methods B (model-based treatment studies) (alphabetically sorted) 
Authors 
and  
year 
Methods for estimating/collecting  
resource use 
Cost categories Largest cost  
drivers 
Excluded costs Average 
costs per 
participant 
Funding  
source 
Carter 
et al. 2009 
[196] 
Not stated Programme delivery Not stated Set-up 
 
AU$ 129 Academic 
Carter 
et al. 2009 
[196] 
Not stated Programme delivery Not stated Set-up, 
 
AU$ 1,896 Academic 
Hollingworth 
et al. 2012 
[225] 
Not stated Programme delivery, 
lifetime treatment, 
obesity-related diseases 
Salary (GP) Not stated  £108 - 662 Academic 
Moodie 
et al. 2008 
[226] 
Middle of Australian public service 
Level 6, LEAP trial, etc. 
Programme delivery, 
direct medical, 
direct non-medical, 
indirect 
 
Project coordinator 
 
 
Set-up, research and 
development, 
resultant changes in 
patient behaviour 
AU$ 650.5 Academic 
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Appendix 1.6 (i) - 1.6 (iv) - Data Extraction (Detailed Account of the Economic Evaluation Methods C) 
Appendix 1.6 (i) - Detailed account of the economic evaluation methods C (trial-based prevention studies) (alphabetically sorted) 
Authors 
and  
year 
ICER/average cost per benefit Uncertainty 
analysis 
Sensitivity  
analysis type 
Sensitivity analysis 
 
Cost-effective 
Hayes  
et al. 2014 
[229] 
AU$ 4, 230 per unit BMI avoided, 
AU$ 631 per 0.1 reduction in BMI (z-score) 
_ DSA Adjustments in nurse travel time Likely to be 
Kesztyus  
et al. 2011 
[235] 
€ 11.11 per WC cm prevented 
€ 18.55 per WHtR unit prevented 
_ DSA Teachers individual working 
time to prepare the lessons, 
difference in effects tested at a 
10, 20 and 30% lower value 
Likely to be 
Krauth  
et al. 2013 
[236] 
N.A. _ DSA 
 
_ N.A. 
Martinez  
et al. 2011 
[237] 
ICER: No 
€ 500 per 1% decrease  
in triceps skinfold thickness 
_ DSA Differences in costs 
(modification of the venue cost) 
Likely to be 
McAuley  
et al. 2010 
[227] 
ICER: No 
NZ$ 664–1708 per kg of weight gain 
prevented (depending on age), 
_ DSA Differences in weight z-score 
(ranged from 0.5 to 1.0 in the 
youngest children and 1.4 to 2.4 
in the oldest children) 
Likely to be 
Meng  
et al. 2013 
[17] 
Combined intervention: 
US$ 120.3 per 1 kg/m2 BMI reduction,        
US$ 249.3 per BMI z-score change (BAZ),  
US$ 1308.9 per one overweight and obesity 
case avoided  
_ Not stated N.A. Likely to be 
Peterson  
et al. 2008 
[228] 
ICER: No 
Entire campaign: 
US$ 4.01: to see the ad, 
US$ 7.35:  to consider being more active, 
US$ 8.87:  actually become more active, 
with bill-boards the most cost-effectiveness 
_ Not stated N.A. Likely to be 
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Appendix 1.6 (i) - Detailed account of the economic evaluation methods C (trial-based prevention studies) (alphabetically sorted) 
continued 
Authors 
and  
year 
ICER/average cost per benefit Uncertainty 
analysis 
Sensitivity 
analysis type 
Sensitivity analysis 
 
Cost-effective 
Sutherland  
et al. 2016 
[206] 
AU$ 56 per additional minute of MVPA,  
AU$ 1 per MET hour gained per person per 
day,  
AU$ 1, 408 per BMI unit avoided,  
AU$ 563 per 10 % reduction in BMI z-score 
_ DSA 
 
Higher and lower estimate of the 
assumed opportunity cost, varying 
the magnitude of the effect size, 
extending the benefit of physical 
activity recess and lunchtime 
activities to students beyond the 
target year, extending the benefit 
of multiple strategies to all 
students 
Scenario: State wide rollout 
(current model), state wide roll 
out – Alternative (real world) 
model 
Likely to be 
Wang  
et al. 2008 
[115] 
US$ 317 per 0.76% body fat reduction _ DSA Changing the per capita usual 
after-school care costs (ranging 
from US$ 5.00 to US$ 10.00) 
Likely to be 
Notes: BAZ = BMI (z-score); BMI = body mass index; DSA = deterministic sensitivity analysis; MVPA = moderate-to-vigorous physical activity; WC 
= waist circumference; WHtR = waist-to-height ratio; N.A. = not applicabl 
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Appendix 1.6 (ii) - Detailed account of the economic evaluation methods C (trial-based treatment studies) (alphabetically sorted) 
Authors 
and  
year 
ICER/average cost per benefit Uncertainty 
analysis 
Sensitivity  
analysis type 
Sensitivity analysis Cost-effective 
Epstein  
et al. 2014 
[230] 
ICER: No 
Children: 
FBT US$ 209.17 per % over BMI,  
PC1 US$ 1, 036.50 per % over BMI,  
PC2 US$ 973.98 per % over BMI,  
Parents:  
FBT US$ 132.97 per pound (lb), 
PC1 US$ 373.53 per pound (lb), 
PC2 US$ 351.00 per pound (lb) 
_ Not stated N.A. Likely to be 
Goldfield  
et al. 2001 
[231] 
ICER: No 
US$ 1, 000 per 10%  overweight reduction 
US$ 1, 000 per 0.6 decrease in BMI z-score 
_ Not stated N.A. Likely to be 
Hollinghurst 
et al. 2013 
[232] 
£ 432 per 0.1 reduction in BMI sd _ Not stated N.A. Likely to be 
Janicke 
et al. 2009 
[233] 
ICER: No 
Family-based group: 
US$ 758 per 0.10 decrease in BMI z-score, 
Parent-only: 
US$ 579 per 0.10 decrease in BMI z-score 
_ Not stated N.A. Likely to be 
Kalavainen 
et al. 2009 
[238] 
€ 53 per 1% decrease in weight for height 
€ 266 per 0.1 decrease in BMI   
_ DSA Group treatment costs:  
salaries of two group 
leaders included in costs 
Likely to be 
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Appendix 1.6 (ii) - Detailed account of the economic evaluation methods C (trial-based treatment studies) (alphabetically sorted) 
continued 
Authors 
and  
year 
ICER/average cost per benefit Uncertainty 
analysis 
Sensitivity  
analysis type 
Sensitivity analysis 
 
Cost-effective 
Robertson  
et al. 2017 
[205] 
£ 552, 175 per QALY saved, 
£ - 3, 935 per unit change in BMI (z-score) 
_ DSA ‘programme completers’: 
families that participated in 5 
or more sessions, multiple 
imputation of all missing cost 
and outcomes data, alternative 
sources and inputs for EQ-5D 
utility values 
Unlikely to be 
Wake 
et al. 2008 
[234] 
N.A. _ DSA Baseline: Value of parents’ 
time, equal parent's time, unit 
cost of GP visit, economies of 
scale 
Combinations: 
N.A. 
Notes: BMI = body mass index; DSA = deterministic sensitivity analysis; FBT = family-based behavioural treatment; QALYs = quality-
adjusted life years; PC = parent and child; N.A. = not applicabl 
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Appendix 1.6 (iii) - Detailed account of the economic evaluation methods C (model-based prevention studies) (alphabetically 
sorted) 
Authors 
and  
year 
ICER/average cost per benefit Uncertainty 
analysis 
Sensitivity 
analysis type 
Sensitivity analysis Cost-effective 
Barrett 
et al. 2015 
[211] 
US$ 401 per unit BMI avoided: 2 years 
US$ 1, 720 per BMI unit reduced: 10 years 
Reduction of healthcare costs by $ 60.5 
million: 10 years 
PSA DSA, PSA Physical activity and BMI 
changes, more PE time, cost of 
intervention 
Likely to be 
Brown 
et al. 2007 
[212] 
US$ 900 per QALY saved _ PSA Both overall and Hispanics 
(Cases of adult overweight 
prevented, QALYs saved, 
medical costs averted, costs of 
lost labour productivity averted 
Likely to be 
Carter 
et al. 2009 
[196] 
AU$ 5, 000 per DALY saved PSA DSA, PSA _ 
 
 
Dominant 
 
 
Carter 
et al. 2009 
[196] 
AU$ 1, 800 per DALY saved PSA DSA, PSA _ Dominant 
 
 
 
Carter 
et al. 2009 
[196] 
AU$ 5, 100 per DALY saved PSA DSA, PSA _ Dominant 
 
 
Carter 
et al. 2009 
[196] 
AU$ 5, 600 per DALY saved PSA DSA, PSA _ Likely to be 
 
 
Graziose 
et al. 2016 
[207] 
US$ 275 per QALY saved PSA DSA, PSA  
 
Relapse into adulthood, 
intervention is effective only for 
Hispanic and black students, 
intervention is effective only for 
male students 
Likely to be 
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Appendix 1.6 (iii) - Detailed account of the economic evaluation methods C (model-based prevention studies) (alphabetically 
sorted) continued 
Authors 
and  
year 
ICER/average cost per benefit Uncertainty 
analysis 
Sensitivity 
analysis type 
Sensitivity analysis 
 
Cost-effective 
Long 
et al. 2015 
[213] 
US$ 8.54 per unit BMI avoided: 2 years, 
 
PSA DSA, PSA Change in SSB consumption 
and BMI, cost of implementing 
SSB excise tax 
Dominant 
Magnus 
et al. 2009 
[214] 
AU$ 5.00 per BMI unit saved, 
AU$ 3.70 per DALY saved 
PSA DSA, PSA 
 
BMI and cost changes Dominant 
Moodie 
et al. 2009 
[215] 
AU$ 87, 000 per BMI unit saved,  
AU$ 760, 000 per DALY saved 
 
PSA DSA, PSA 
 
Reduce costs, improve capacity 
utilisation and recruitment, 
increase participants receiving 
benefit, combine scenarios 
Unlikely to be 
Moodie 
et al. 2010 
[216] 
AU$ 8, 200 per BMI unit saved, 
AU$ 82, 000 per DALY saved 
 
PSA DSA, PSA Reduction in the number of sites 
and co-ordinators, application of 
the same wage rate to all site co-
ordinators (school, OSHC), 
combination scenarios, all 
participants receive full 
intervention benefit 
Unlikely to be 
Moodie 
et al. 2011 
[217] 
AU$ 13, 000 per BMI unit saved, 
AU$ 117, 000 per DALY saved 
PSA DSA, PSA joint cost attribution across 
multiple objectives,  
broadening of the benefit to 
include other children in the 
school 
Unlikely to be 
Moodie 
et al. 2013 
[218] 
AU$ 576 per BMI unit saved, 
AU$ 29, 798 per DALY saved 
 
PSA DSA, PSA Alternative decay of effect, if 
only 50% of children received 
the benefit 
Likely to be 
Pringle 
et al. 2010 
[219] 
ICER: No 
£ 47 - 509 per QALY gained, 
£ 260 -  2, 786  per completer improving at 
least one MPA  
_ Not stated N.A. Dominant 
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Appendix 1.6 (iii) - Detailed account of the economic evaluation methods C (model-based prevention studies) (alphabetically 
sorted) continued 
Authors 
and  
year 
ICER/average cost per benefit Uncertainty 
analysis 
Sensitivity 
analysis type 
Sensitivity analysis 
 
Cost-effective 
Rush 
et al. 2014 
[220] 
NZ$ 24, 690 per QALY saved: older 
children NZ$ 30, 438 per QALY saved: 
younger children 
_ DSA, PSA Varied conditions for younger and 
older children (varying of the cost 
of intervention, BMI, the annual 
discount rate and the horizon of 
the model) 
Likely to be 
Sonneville 
et al. 2015 
[221] 
US$ 1.16 per unit BMI avoided: 2 years, 
 
PSA DSA, PSA Differences in BMI associated 
with the number of fast 
food advertising messages seen, 
cost of intervention 
Dominant 
Wang 
et al. 2003 
[222] 
US$ 4, 035 per QALY saved _ DSA, PSA Cases of adult overweight 
prevented, years of healthy life, 
annual discount rate, medical care 
costs averted, annual workdays 
lost averted 
Dominant 
Wang 
et al. 2011 
[223] 
 
US$ 2, 966 per QALY saved PSA DSA, PSA Percentage of girls with DWCB 
who had SED, progression 
probability, long-term medical 
costs per BN patients, 
HRQoL of BN patients, time to 
recovery 
Dominant 
Wright 
et al. 2015 
[224] 
US$ 57.80 per BMI unit avoided: 2 years 
Net healthcare cost savings of $ 51.6 
million:  
10 years 
 
PSA DSA, PSA Time spent in care, alternative 
policy adherence estimates and 
outcomes 
Dominant 
Notes: BMI = body mass index; BN = Bulimia Nervosa; DALYs = disability-adjusted life years; DSA = deterministic sensitivity analysis; 
DWCB = disordered weight control behaviours; HRQoL = health-related quality of life; QALYs = quality-adjusted life years; MPA = 
moderate physical activity; PE = physical education; PSA = probabilistic sensitivity analysis; SED = sub-diagnostic eating disorders; SSB 
= sugar sweetened beverage; N.A. = not applicable   
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Appendix 1.6 (iv) - Detailed account of the economic evaluation methods C (model-based treatment studies) (alphabetically sorted) 
Authors 
and  
year 
ICER/average cost per benefit Uncertainty 
analysis 
Sensitivity  
analysis type 
Sensitivity analysis Cost-effective 
Carter 
et al. 2009 
[196] 
AU$ 3, 300 per DALY saved PSA  DSA, PSA      _   Dominant 
Carter 
et al. 2009 
[196] 
AU$ 1, 500 per DALY saved PSA DSA, PSA _   Dominant 
Hollingworth 
et al. 2012 
[225] 
£ 400 per 0.13 reduction in BMI sd, 
£ 13, 589 per life year gained  
_ DSA BMI sd (minimal, median, or 
maximal effect size) and 
intervention cost (low, moderate 
and high) 
Dominant 
Moodie 
et al. 2008 
[226] 
 
 
 
AU$ 4, 670 per DALY saved PSA DSA, PSA Full maintenance of the BMI 
benefit into adulthood/vs. half 
maintenance, outlier removal, 
delivery of intervention, (family 
attendance, etc), recruitment 
rates 
Likely to be 
Notes: BMI = body mass index; DALYs = disability-adjusted life years; DSA = deterministic sensitivity analysis; PSA = probabilistic 
sensitivity analysis 
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Appendix 1.7 (i) - Critically appraising trial-based prevention studies (alphabetically sorted)  
Hayes et al.  
2014 [229] 
Kesztyus et al. 
2011 [235] 
Krauth et al. 
2013 [236] 
Martinez et al. 
2011 [237] 
McAuley et al. 
2010 [227] 
Meng et al. 
2013 [17] 
Peterson et al. 
2008 [228] 
Sutherland et al. 
2016 [206] 
Wang et al. 
2008 [115] 
1 
2 
3 
4 
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Y 
Y 
Y 
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Y 
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NC 
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Y 
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N.A. 
N.A. 
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N 
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Y 
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Y 
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N 
N 
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NC 
Y 
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22 
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24 
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Y 
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N.A. 
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Y 
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Y 
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Y 
NC 
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N 
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N.A. 
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27 
28 
29 
30 
31 
32 
33 
34 
35 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
N 
N 
Y 
Y 
Y 
Y 
Y 
Y 
N 
Y 
N 
N 
N 
N.A. 
N.A. 
Y 
Y 
Y 
NC 
Y 
N 
N 
Y 
N 
N 
Y 
Y 
Y 
Y 
Y 
NC 
NC 
Y 
N 
N 
Y 
Y 
Y 
Y 
N 
N.A. 
N.A. 
N.A. 
Y 
Y 
Y 
Y 
Y 
N 
N 
N.A. 
N.A. 
N.A. 
N 
N 
Y 
Y 
NC 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
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Y 
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Y 
Notes: Y= Yes; N=No; NC= Not clear; N.A. = Not applicable 
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Appendix 1.7 (ii) - Critically appraising trial-based treatment studies (alphabetically sorted)  
Epstein et al.  
2014 [230] 
Goldfield et al.  
2001 [231] 
Hollinghurst et al.  
2013 [232] 
Janicke et al.  
2009 [233] 
Kalavainen et al.  
2009 [238] 
Robertson et al. 
2017 [205] 
Wake et al. 
2008 [234] 
1 
2 
3 
4 
5 
Y 
Y 
Y 
Y 
Y 
Y 
NC 
Y 
N 
Y 
Y 
Y 
Y 
N 
Y 
Y 
Y 
Y 
N 
Y 
Y 
Y 
Y 
N 
Y 
Y 
Y 
Y 
NC 
Y 
Y 
Y 
Y 
N 
NC 
6 Y Y Y Y Y Y Y 
7 NC N NC N Y NC Y 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
Y 
Y 
N.A. 
Y 
Y 
Y 
NC 
N 
N 
N 
NC 
N 
N.A. 
N.A. 
Y 
Y 
N.A. 
Y 
N.A. 
N.A. 
N.A. 
N.A. 
NC 
N 
NC 
N 
N.A. 
N.A. 
Y 
Y 
N.A. 
Y 
N.A. 
N.A. 
N.A. 
N.A. 
Y 
Y 
NC 
N 
N.A. 
N.A. 
Y 
Y 
N.A. 
Y 
N.A. 
N.A. 
N.A. 
N.A. 
Y 
N 
NC 
N 
N.A. 
N.A. 
Y 
Y 
N.A. 
Y 
N.A. 
N.A. 
N.A. 
N.A. 
Y 
N 
Y 
N 
N.A. 
N.A. 
Y 
Y 
N.A. 
Y 
N.A. 
N.A. 
N.A. 
N.A. 
NC 
Y 
Y 
Y 
N.A. 
N.A. 
Y 
Y 
N.A. 
Y 
Y 
NC 
NC 
N 
NC 
NC 
Y 
N.A. 
N.A. 
N.A. 
22 
23 
24 
25 
Y 
N.A. 
N.A. 
N.A. 
Y 
N.A. 
N.A. 
N.A. 
Y 
N.A. 
N.A. 
N.A. 
Y 
N.A. 
N.A. 
N.A. 
Y 
N.A. 
N.A. 
N.A. 
Y 
N.A. 
N.A. 
N.A. 
Y 
N.A. 
N.A. 
N.A. 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
Y 
N 
N.A. 
N.A. 
N.A. 
N 
N 
Y 
Y 
Y 
Y 
N 
N.A. 
N.A. 
N.A. 
N 
N 
Y 
Y 
Y 
NC 
N 
N.A. 
N.A. 
N.A. 
Y 
Y 
Y 
Y 
Y 
NC 
N 
N.A. 
N.A. 
N.A. 
N 
N 
Y 
Y 
Y 
Y 
Y 
NC 
NC 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
NC 
Y 
Y 
Y 
Y 
N.A. 
N.A. 
Y 
Y 
Y 
Notes: Y= Yes; N=No; NC= Not clear; N.A. = Not applicable 
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Appendix 1.7 (iii) - Critically appraising model-based prevention studies (alphabetically sorted)  
Barrett et al. 
2015 [211] 
Brown et al. 
2007 [212] 
Carter et al. 
2009 [196] 
Graziose et al. 
2016 [207] 
Long et al. 
2015 [213] 
Magnus et al. 
2009 [214] 
Moodie et al. 
2009 [215] 
Moodie et al. 
2010 [216] 
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Notes: Y= Yes; N=No; NC= Not clear; N.A. = Not applicable 
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Appendix 1.7 (iii) - Critically appraising model-based prevention studies (alphabetically sorted) continued    
Moodie et al. 
2011 [217] 
Moodie et al. 
2013 [218] 
Pringle et al. 
2010 [219] 
Rush et al. 
2014 [220] 
Sonneville et al. 
2015 [221] 
Wang et al. 
2003 [222] 
Wang et al. 
2011 [223] 
Wright et al. 
2015 [224] 
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Notes: Y= Yes; N=No; NC= Not clear; N.A. = Not applicable 
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Appendix 1.7 (iv) - Critically appraising model-based treatment studies (alphabetically sorted) 
 
Notes: Y= Yes; N=No; NC= Not clear; N.A. = Not applicable 
 
Carter et al. 
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APPENDIX 2. Economic Evaluation alongside CHIRPY DRAGON Trial: CHEERS 
Guidelines, Methods and Results Tables 
 
Appendix 2.1  - CHEERS Guidelines for Reporting Economic Evaluations 
Section/item 
Item  
No Recommendation 
Title and abstract   
Title 1 Identify the study as an economic evaluation, or use more specific 
terms such as “cost-effectiveness analysis” and describe the 
interventions compared. 
Abstract 2 Provide a structured summary of objectives, perspective, setting, 
methods (including study design and inputs), results (including 
base-case and uncertainty analyses), and conclusions. 
Introduction   
Background and 
objectives 
3 Provide an explicit statement of the broader context for the study. 
  
Present the study question and its relevance for health policy or 
practice decisions. 
Methods   
Target population 
and subgroups 
4 Describe characteristics of the base-case population and subgroups 
analysed including why they were chosen. 
Setting and 
location 
5 State relevant aspects of the system(s) in which the decision(s) 
need(s) to be made. 
Study perspective 6 Describe the perspective of the study and relate this to the costs 
being evaluated. 
Comparators 7 Describe the interventions or strategies being compared and state 
why they were chosen. 
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Section/item 
Item  
No Recommendation 
Time horizon 8 State the time horizon(s) over which costs and consequences are 
being evaluated and say why appropriate. 
Discount rate 9 Report the choice of discount rate(s) used for costs and outcomes 
and say why appropriate. 
Choice of health 
outcomes 
 10 Describe what outcomes were used as the measure(s) of benefit in the 
evaluation and their relevance for the type of analysis performed. 
Measurement of 
effectiveness 
11a Single study–based estimates: Describe fully the design features of 
the single effectiveness study and why the single study was a 
sufficient source of clinical effectiveness data. 
 11b Synthesis-based estimates: Describe fully the methods used for the 
identification of included studies and synthesis of clinical 
effectiveness data. 
Measurement and 
valuation of 
preference-based 
outcomes 
 12 If applicable, describe the population and methods used to elicit 
preferences for outcomes. 
Estimating 
resources and costs 
13a Single study–based economic evaluation: Describe approaches used 
to estimate resource use associated with the alternative 
interventions. Describe primary or secondary research methods for 
valuing each resource item in terms of its unit cost. Describe any 
adjustments made to approximate to opportunity costs. 
 13b Model-based economic evaluation: Describe approaches and data 
sources used to estimate resource use associated with model health 
states. Describe primary or secondary research methods for valuing 
each resource item in terms of its unit cost. Describe any 
adjustments made to approximate to opportunity costs. 
Currency, price 
date, and 
conversion 
14 Report the dates of the estimated resource quantities and unit costs. 
Describe methods for adjusting estimated unit costs to the year of 
reported costs if necessary. Describe methods for converting costs 
into a common currency base and the exchange rate. 
Choice of model 15 Describe and give reasons for the specific type of decision-analytic 
model used. Providing a figure to show model structure is strongly 
recommended. 
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Section/item 
Item  
No Recommendation 
Assumptions 16 Describe all structural or other assumptions underpinning the 
decision-analytic model. 
Analytic methods  17 Describe all analytic methods supporting the evaluation. This could 
include methods for dealing with skewed, missing, or censored data; 
extrapolation methods; methods for pooling data; approaches to 
validate or make adjustments (e.g., half-cycle corrections) to a model; 
and methods for handling population heterogeneity and uncertainty. 
Results   
Study parameters 18 Report the values, ranges, references, and if used, probability 
distributions for all parameters. Report reasons or sources for 
distributions used to represent uncertainty where appropriate. 
Providing a table to show the input values is strongly 
recommended. 
Incremental costs 
and outcomes 
 19 For each intervention, report mean values for the main categories of 
estimated costs and outcomes of interest, as well as mean differences 
between the comparator groups. If applicable, report incremental cost-
effectiveness ratios. 
Characterizing 
uncertainty 
20a Single study–based economic evaluation: Describe the effects of 
sampling uncertainty for estimated incremental cost, incremental 
effectiveness, and incremental cost-effectiveness, together with the 
impact of methodological assumptions (such as discount rate, study 
perspective). 
 20b Model-based economic evaluation: Describe the effects on the 
results of uncertainty for all input parameters, and uncertainty 
related to the structure of the model and assumptions. 
Characterizing 
heterogeneity 
21 If applicable, report differences in costs, outcomes, or cost-
effectiveness that can be explained by variations between subgroups 
of patients with different baseline characteristics or other observed 
variability in effects that are not reducible by more information. 
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Section/item 
Item  
No Recommendation 
Discussion   
Study findings, 
limitations, 
generalizability, 
and current 
knowledge 
 22 Summarize key study findings and describe how they support the 
conclusions reached. Discuss limitations and the generalizability of 
the findings and how the findings fit with current knowledge. 
Other   
Source of funding 23 Describe how the study was funded and the role of the funder in the 
identification, design, conduct, and reporting of the analysis. 
Describe other nonmonetary sources of support. 
Conflicts of 
interest 
 24 Describe any potential for conflict of interest among study 
contributors in accordance with journal policy. In the absence of a 
journal policy, we recommend authors comply with International 
Committee of Medical Journal Editors’ recommendations. 
   
 
Note. For consistency, the CHEERS statement checklist format is based on the format of the CONSORT 
statement checklist. 
  
268 
 
Appendix 2.2  - Details for the Use of GDP PPPs 
 
 
Exchange rates are an unsatisfactory means of converting between currencies because they 
can vary considerably within a short timeframe. Instead, PPPs were used to convert the 
costs of goods and services priced in different currencies to UK costs [253]. PPPs are rates 
of currency conversion that equalise the purchasing power of different currencies by 
eliminating the differences in price levels between countries. In their simplest form, PPPs 
show the ratio of prices, in national currencies, of the same good or service in different 
countries and can eliminate some of the drawbacks of using exchange rates [254]. 
However, there is uncertainty as to which type of PPP, health service specific or related 
to GDP, is the more appropriate conversion method. Health PPPs are calculated using only 
the prices of a basket of health related goods and services whereas GDP PPPs are based 
on the prices of a basket of all goods in the economy. Previous attempts to establish the 
stability of either health PPP or GDP PPP conversion factors have come to differing 
conclusions. The Department of Health register of cost effectiveness studies recommends 
the use of GDP PPPs, though others argue that the choice makes no difference [253].  
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Appendix 2.3 - An Explanation of What the Expected Time Requirements were for Each Intervention Activity  
Activity 
identification 
letter 
Intervention activity 
Standard duration, in 
minutes, of the activity 
(according to protocol) 
Notes 
E 
Children workshops 
(Component 1) 
 
40 
If it takes more than 45 
minutes or less than 35 
minutes, please record the 
actual time spent 
One child workshop =  
E1 = 40 minutes 
 
J 
Main carers workshops 
(Component 1) 
 
60 
If it takes more than 65 
minutes or less than 55 
minutes, please record the 
actual time spent 
One childcare workshop = 
J1 = 60 minutes 
Q 
Physically active family friendly 
games learnt and practiced at 
school 
(Component 3) 
30 
If it takes more than 35 
minutes or less than 25 
minutes, please record the 
actual time spent 
One event of Q =  
Q1 = 30 minutes 
K 
Cross-generation family quiz 
(Component 1) 
60 
If it takes more than 65 
minutes or less than 55 
minutes, please record the 
actual time spent 
One event of K =  
K1 = 60 minutes 
S 
Reviewing (and/or giving 
feedback on) the performance of 
family healthy behavioural 
challenges 
(Component 1 and 3) 
Record the actual time 
spent 
  
Z 
Monthly meeting with relevant 
school staff and student 
representatives 
(Component 4) 
Record the actual time 
spent 
  
X 
Supportive regular evaluations 
and feedbacks to the catering 
teams 
(Component 2) 
Record the actual time 
spent 
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Appendix 2.4 i - CHIRPY DRAGON Teachers’ Record of Minutes Worked per Week 
 Time  
 
Minutes worked per week for delivering the intervention 
2016 (28/03-01/04) 
 
 Z:47 Z:25 Z:22 Z:25 
2016 (04/04-08/04) E:40, J:120 Q1:115, 
Z:35, X:15 
E:120, J:180, Q:90, 
Z:60 
E:80, J1:92, Q1:55, 
Z:55, S:20   
E:80, J:120, Q:120, 
Z:40, S:10   
E:120, J1:171, Q1:105, 
Z:55      
2016 (11/04-15/04) E:80, J:300, Q1:165 
S:20   
E:160, J:180, Q1:85 
S:70 
E:80, J:120, Q1:53 
S:20 
E:120, J1:151, Q:120 
S:10   
E1:211, J1:289, Q:210 
S:25       
2016 (18/04-22/04) E:160, Q1:75, S:20    
X:20 
E:200, J:180, Q:90 
S:153 
E:160, J:120, Q1:85 
S:20 
E:200, J1:69, Q1:100 
S:10  
E1:82, J1:110, Q1:80, 
S:10, X:30 
2016 (25/04-29/04) J:120, E:160, Q1:95, 
S:50 
E:240, J:120, Q:60 
S:146 
E:240, J1:45, Q1:40 
S:20, Z:80 
E:80, S:10    E:240, S:275 
 
2016 (02/05-06/05) E:120, J:60, Q1:40 
K:60, Z:25, S:50 
E:120, J:120, Q:60, 
Z:100, S:60 
k:60, S:40   E:40, J1:41, Q:30, 
Z:70 S:10 
E:120, J1:150, Q1:126 
S:45, Z:40 
2016 (09/05-13/05) E:160, J1:105, Q1:130 
S:20 
E:160, J:180, Q1:80 
S:160 
E:280, J:120, Q1:80 
S:90  
E:120, J:60, Q:60 
Z:30, S:10 
E:120, J1:215, Q1:126 
Z:90 
2016 (16/05-20/05) E1:282, J:120, Q1:100 
Z:20, S:60 
E:80, S:225 E:40, J1:45, Q1:40 
S:50   
E:80, J:60, Q:60 
S:10 
E1:271, J:120, Q1:84 
S:155 
2016 (23/05-27/05) 
 
E:280, Q:60, S:55 
 
E:80, S:250 E:240, J1:125, Q1:40 
S:30 
E:240, J1:100, Q:60 
S:10 
E:120, J1:50, Q1:42 
S:45 
2016 (30/05-03/06) 
 
Z:20, S:65  Z:25, S:87 E:80, J1:45, Q1:40 
S:30 
E:240, S:10 E:160, S:20 
2016 (06/06-10/06) 
 
S:70 Z:60, S:205 S:20  S:360 
2016 (13/06-17/06) 
 
S:30 S:85 E:80, S:10   S:20 
2016 (20/06-24/06)  
 
S:60   S:145 
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Appendix 2.4 ii - CHIRPY DRAGON Teachers’ Record of Minutes Worked per Week (Continued) 
Time 
 
Minutes worked per week for delivering the intervention 
2016 (19/09-23/09) 
 
E:240 E:320 E:320 E:320 E:320 
2016 (26/09-30/09) 
 
E:280  E:200, S:182 E:200, S:480 E:160, S:120 E:240, S:120     
2016 (10/10-14/10) 
 
E:200, J1:170, S:120 
Q1:195 
E:360, J1:195, 
Q1:130 
S:106 
E:200, J1:50, S: 340 E:40, S:750 E:240, J:240, Q1:160 
S:240 
2016 (17/10-21/10) E:240, J1:100, S:50 
Q1:130 
E:80, J1:115, Q1:125 
S:30 
E1:135, J1: 145, 
Q1:50 
S:40 
E:160, S:430 E:120, J:120, Q1:80 
S:70 
2016 (24/10-28/10) 
 
E:120, J1:105, S:55 
Q1:152 
E1:251, J:60, Q:150 
S:95 
E:40, J1:195, Q:120 
S:230 
E:80, J:120, S:830 E:160, J:60, S:230 
2016 (31/10-04/11) K:150, S:165 K:130, S:212 S:100 
 
K:60, S:480  
2016 (07/11-11/11) K:150, S:95 K:120, S:118 K:110, S:120 
 
K:120, S:540 S:160 
2016 (14/11-18/11) K:50 K:50, S:51 
 
K:50, S:100 S:420 S:40 
2016 (21/11-25/11) K:60, S:50 
    
S:30 S:110 S:270, K:60  
 
2016 (28/11-02/12)   
 
 S:160  
2016 (05/12-09/12)  
 
  S:100 S:60 
2016 (12/12-16/12) S:75   S:300 S:170 
 
2016 (19/12-23/12) S:130 S:148 
 
S:150 S:320 S:340 
2016 (26/12-30/12) S:140 S:130 S:160 S:320 S:430 
 
2017 (03/01-06/01)  
 
  S:50 S:110 
2017 (09/01-13/01)  
 
  S:30 K:50 
2017 (27/02-03/03)  S:20 S:120  S:80 
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Appendix 2.4 iii - CHIRPY DRAGON Teachers’ Record of Minutes Worked per Week (Continued) 
Time 
 
Minutes worked per week for delivering the intervention 
2017 (06/03-
10/03) 
 
S:40 
 
S:130 S:87 
 
S:60 S:60  
2017 (13/03-
17/03) 
 
S:170 S:68 
 
S:120 S:140 S:70  
2017 (20/03-
24/03) 
S:140 S:190 S:70 S:180 S:80 S:25 
 
2017 (27/03-
31/03) 
S:140 S:170 S:65 S:110 S:90 S:20 
 
2017 (04/04-
07/04) 
S:140 
 
 S:135 S:110 S:80 S:95 
 
2017 (10/04-
14/04) 
S:100  S:50 S:100 S:100 S:30 
 
2017 (17/04-
21/04) 
S:100   S:80 S:80 S:25 
 
2017 (24/04-
28/04) 
  S:60    
 
 
Notes: Working hours for delivering the intervention: 42,510 minutes (708.5 hours), Working cost: 708.5*50 = 35,425 Yuan 
E: 11,830 m (197 h) *50 = 9,850 C; J: 5,835 m (97 h) *50 = 4,850 C; Q: 5,432 m (90.5 h) *50 = 4,525 C; K: 1,095 m (18 h) *50 = 900 C;  
S: 17,482 m (291 h) *50 = 14,550 C; Z: 805 m (14 h) *50 = 700 C; X: 65 m (1 h) * 50 = 50 C 
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Appendix 2.5 - CHU9D Utility Scores at Each Time Point (Chinese Tariff) 
 CHU-9D utility scores 
 All participants Control group Intervention group 
Time Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) 
Baseline 
(N= 1605) 
0.920 
(.094) 
0.916 0.925 0.919 
(.094) 
0.913 0.926 0.921 
(.094) 
0.914 0.927 
12 months 
follow up  
(N= 1587) 
0.919 
(.085) 
0.915 0.923 0.913 
(.089) 
0.906 0.919 0.925 
(.082) 
 
0.919 0.931 
 
 
Appendix 2.6 - Unadjusted QALYs Accrued (CHU9D, Chinese Tariff) 
 Unadjusted QALYs accrued 
 All participants Control group Intervention group 
Time Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) 
12 months 
follow up  
(N= 1554) 
0.919 
(.071) 
0.916 0.923 0.916 
(.072) 
0.911 0.921 0.923 
(.069) 
0.918 0.928 
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Appendix 2.7 - Incremental Difference in QALYs (CHU9D, Chinese Tariff) 
 No adjustment Adjusted for clustering and baseline 
utility a 
Adjusted for clustering, baseline utility,  
co-variates b 
Measur
ement 
time 
Mean 
difference 
(95% CI) P-value Mean 
difference 
(95% CI) P-value Mean 
difference 
(95% CI) P-value 
12 
months 
follow 
up  
0.007 
 
-0.005 
 
0.019 
 
0.296 
 
0.006 0.000 0.011 0.044 0.006 0.000 0.012 0.046 
 
a: Adjusted for baseline outcome. b: Adjusted for baseline outcome, pre-specified school- (i.e. whether the school provides mid-morning 
snack, whether the school has an indoor activity room) and child-level covariates (sex, mother education level, daily average servings of fruit 
and vegetables, weekly servings of unhealthy snacks and sugar added drink, objectively measured time in MVPA (minutes/24 hours) and 
objectively measured sedentary time (minutes/24 hours).  
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Appendix 2.8 - EQ-5D-3L Utility Scores at Each Time Point (Chinese Tariff) 
 EQ-5D-3L utility scores (parents/grandparents) 
 All participants Control group Intervention group 
Time Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) 
Baseline 
(N= 1235) 
0.969 
 
(.066) 
0.965 0.973 0.969 
 
(.065) 
0.964 0.974 0.970 
(.067) 
0.964 0.974 
12 months 
follow up 
 
(N = 1226) 
 
0.975 
 
(.059) 
0.972 0.978 0.974 
 
(.057) 
0.969 0.978 0.977 
 
(.060) 
0.972 0.981 
 
 
Appendix 2.9 - Unadjusted QALYs Accrued (EQ-5D-3L, Chinese Tariff) 
 Unadjusted QALYs accrued 
 All participants Control group Intervention group 
Time Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) Mean 
(SD) 
(95% CI) 
12 months 
follow up  
(N= 1224) 
0.973 
(.050) 
 
0.969 0.975 0.972 
(.047) 
0.968 0.976 0.973 
(.052) 
0.968 0.977 
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Appendix 2.10 - Incremental Difference in QALYs (EQ-5D-3L, Chinese Tariff) 
 No adjustment  Adjusted for clustering and baseline 
utility 
Adjusted for clustering, baseline utility,  
co-variates 
Time Mean 
difference 
(95% CI) 
 
P-value Mean 
difference 
(95% CI) P-value Mean 
difference 
(95% CI) P-value 
12 
months 
follow up 
 
 
0.001 -0.005 0.006 0.907 0.002 -0.002 0.005 0.363 0.001 -0.001 0.004 0.450 
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Appendix 2.11 - Outcomes at Baseline and 12 months (Post-Imputation) 
 
SD, Standard Deviation; CI, Confidence Interval; QALYs, Quality-Adjusted Life Years;  
a = adjusted for clustering and baseline utility; b = adjusted for clustering, baseline utility and co-variates 
  
 Raw Mean (SD) Adjusted Mean (95% CI) 
Outcomes Control  
group 
Intervention  
group 
Difference a 
(Intervention vs control) 
P-value Difference b 
(Intervention vs control) 
P-value 
Baseline 
CHU-9D utility 
 
0.935 (0.066) 0.940 (0.069)  
EQ-5D-3L utility 
 
0.962 (0.087) 0.964 (0.082) 
At the end of the trial 
CHU-9D QALYs 
 
0.933 (0.052) 0.938 (0.046) 0.004 
(0.000 to 0.006) 
0.041 0.003 
(0.000, 0.007) 
0.059 
EQ-5D-3L QALYs  0.966 (0.063) 0.968 (0.066) 0.001 
(-0.002 to 0.004) 
0.337 0.002 
(-0.002, 0.008) 
0.442 
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Appendix 2.12 i - Number (%) of Completed Monthly Household Expenditure for Consented Families  
Categories of family expenditure Baseline 12 months follow up 
All  
participants 
 
Control 
group 
 
Intervention 
group 
 
All  
participants 
 
Control 
group 
 
Intervention 
group 
 
Electricity/gas 1470 (89.5%) 700 (86.5%) 770 (92.5%) 1492 (90.9%) 729 (90.1%) 763 (91.7%) 
Transport 1504 (91.7%) 722 (89.3%) 782 (94%) 1516 (92.4%) 736 (90.9%) 780 (93.8%) 
Recreation 1426 (86.9%) 686 (84.8%) 740 (88.9%) 1482 (90.3%) 715 (88.4%) 767 (92.2%) 
Food/non-alcoholic drinks 1479 (90.1%) 713 (88.1%) 766 (92.1%) 1495 (91.1%) 724 (89.5%) 771 (92.7%) 
Alcoholic drinks, tobacco/narcotics 1392 (84.8%) 675 (83.4%) 717 (86.2%) 1415 (86.2%) 684 (84.5%) 731 (87.9%) 
Eating out 1474 (89.8%) 712 (88%) 762 (91.6%) 1505 (91.7%) 733 (90.6%) 772 (92.8%) 
Clothing 1421 (86.6%) 676 (83.6%) 745 (89.6%) 1462 (89.1%) 711 (87.9%) 751 (90.3%) 
Communications 1446 (88.1%) 698 (86.3%) 748 (89.9%) 1481 (90.2%) 721 (89.1%) 760 (91.3%) 
Household goods/services 1381 (84.1%) 666 (82.3%) 715 (85.9%) 1399 (85.3%) 687 (84.9%) 712 (85.6%) 
Other goods/services 1396 (85.1%) 678 (83.8%) 718 (86.3%) 1441 (87.8%) 700 (86.5%) 741 (89.1%) 
Education  1423 (86.7%) 687 (84.9%) 736 (88.5%) 1478 (90.1%) 720 (90%) 758 (91.2%) 
Healthcare 1372 (83.6%) 663 (82%) 709 (85.2%) 1420 (86.5%) 689 (85.2%) 731 (87.9%) 
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Appendix 2.12 ii - Number (%) of Completed Weekly Household Expenditure for 
Consented Families  
Categories 
of family 
expenditure 
Baseline 12 months follow up 
All 
participants 
 
Control 
group 
 
Intervention 
group 
All 
participants 
 
Control 
group 
Intervention 
group 
Total food 
expenditure 
 
 
1543 
(94%) 
746 
(92.2%) 
797 
(95.8%) 
1543 
(94%) 
751 
(92.8%) 
792 
(95.2%) 
Fruit and 
vegetables 
 
 
1556 
(94.8%) 
752 
(93%) 
804 
(96.6%) 
1535 
(93.5%) 
750 
(92.7%) 
785 
(94.3%) 
Ready 
meals, fast 
food and 
takeaways 
1551 
(94.5%) 
751 
(92.8%) 
800 
(96.2%) 
1531 
(93.3%) 
748 
(92.5%) 
783 
(94.1%) 
 
 
Appendix 2.12 iii - Number (%) of Completed Monthly Income for Consented Families  
Time Point All participants 
 
Control  
group 
Intervention 
Group 
 
Baseline 1507 (91.8%) 
 
727 (89.9%) 780 (93.8%) 
12 months follow up 1431 (87.2%) 
 
696 (86%) 735 (88.4%) 
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Appendix 2.13 i - Monthly mean (SD) of expense in Yuan on different households 
Categories of 
family 
expenditure 
Baseline 12 months follow up 
All  Control 
group 
Intervention 
group 
All  Control 
group 
Intervention 
group 
Electricity/gas 530.44 
(550.62) 
543.23 
(584.39) 
518.82 
(518.14) 
539.02 
(679.09) 
534.78 
(672.83) 
543.07 
(685.44) 
Transport 1078.12 
(1033.84) 
1109.69 
(1056.65) 
1048.97 
(1012.12) 
1055.73 
(1004.72) 
1053.36 
(1020.68) 
1057.97 
(990.08) 
Recreation 418.92 
(416.18) 
429.12 
(422.95) 
409.46 
(409.85) 
423.39 
(418.68) 
416.64 
(411.64) 
429.67 
(425.32) 
Food/non-
alcoholic drinks 
1862.57 
(1089.82) 
1770.70 
(1074.59) 
1948.09 
(1097.61) 
1903.05 
(1172.43) 
1878.38 
(1167.80) 
1926.23 
(1177.04) 
Alcoholic drinks, 
tobacco/narcotics 
243.57 
(377.67) 
234.98 
(357.72) 
251.41 
(395.1) 
240.19 
(384.14) 
240.72 
(399.01) 
239.67 
(369.22) 
Eating out 812.35 
(640.03) 
805.5 
(644.79) 
818.74 
(635.91) 
836.19 
(663.63) 
825.92 
(656.98) 
845.94 
(670.16) 
Clothing 844.47 
(683.05) 
832.43 
(689.2) 
855.4 
(677.7) 
890.14 
(750.94) 
883.53 
(756.17) 
896.39 
(746.39) 
Communications 389.53 
(259.2) 
387.18 
(268.52) 
 
391.72 
(250.36) 
393.61 
(279.66) 
393.02 
(294.11) 
394.17 
(265.42) 
Household 
goods/services 
679.99 
(1042.46) 
646.14 
(984.02) 
711.43 
(1093.74) 
810.38 
(1257.83) 
827.95 
(1264.99) 
793.43 
(1251.54) 
Other 
goods/services 
327.31 
(367.45) 
315.43 
(346.79) 
338.53 
(385.84) 
358.98 
(409.23) 
367.62 
(430.26) 
350.83 
(388.43) 
Education 1122.07 
(990.59) 
1167.5 
(1035.66) 
1079.66 
(945.33) 
1514.7 
(1252.79) 
1541.66 
(1284.73) 
1489.1 
(1231.78) 
Healthcare 380.43 
(428.85) 
383.18 
(429.83) 
377.86 
(428.22) 
410.58 
(448.09) 
426.68 
(457.86) 
395.4 
(438.46) 
 
 
Appendix 2.13 ii - Weekly mean (SD) of expense in Yuan on different households 
Categories 
of family 
expenditure 
Baseline 
 
12 months follow up 
All 
Participants 
Control 
group 
Intervention 
group 
All 
participants 
Control 
group 
Intervention 
group 
Total food 
expenditure 
 
1064.67 
(603.19) 
1066.08  
(604.07) 
1063.36 
(602.74) 
1086.77 
(595.86) 
1079.66 
(608.69) 
1093.52 
(583.73) 
Fruit and 
vegetables 
 
223.92 
(118.96) 
226.23 
(117.09) 
221.76 
(120.71) 
232.19 
(118.72) 
232.2 
(119.25) 
232.29 
(118.29) 
Ready 
meals, fast 
food and 
takeaways 
88.16 
(96.47) 
87.05 
(97.06) 
89.21 
(95.97) 
98.72 
(103.1) 
98.02 
(102.59) 
99.39 
(103.64) 
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APPENDIX 3. Assessment of Construct Validity of CHU9D: Results Tables 
 
Appendix 3.1 - Characteristics of the Study Population 
Characteristics 
Measures of socio-economic status  
Maternal work: n (%)  
Yes 
No 
1190 (77.3) 
349 (22.7) 
Maternal employment status: n (%)  
5 Working full-time 
4 Working part time 
3 Unemployed or looking for work 
2 Looking after the family/house 
1 Other 
1043 (67.8) 
147 (9.5) 
15 (1.0) 
280 (18.2) 
54 (3.5) 
Paternal work: n (%) 
Yes 
No 
1421 (92.3) 
118 (7.7) 
Paternal employment status: n (%)  
5 Working full-time 
4 Working part time 
3 Unemployed or looking for work 
2 Looking after the family/house 
1 Other 
1378 (89.5) 
43 (2.8) 
10 (0.7) 
17 (1.1) 
91 (5.9) 
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Appendix 3.2 - Mean (SD), median (IQR) for CHU9D, PedsQL scores based on characteristics 
 Number 
(%) 
CHU-9D Utility, UK tariff 
 
Mean (SD), Median (IQR) 
CHU-9D Utility, Chinese tariff 
 
Mean (SD), Median (IQR) 
 
PedsQL total score 
 
Mean (SD), Median (IQR)  
 
Mother’s employment 
Yes 
No 
1190 (77.3) 
349 (22.7) 
0.936 (0.069), 0.963 (0.900-1.000) 
0.940 (0.065), 0.965 (0.909-1.000) 
0.919 (0.095), 0.943 (0.876-1.000) 
0.923 (0.091), 0.946 (0.878-1.000) 
82.51 (11.49), 84.09 (75.00-91.30) 
83.04 (11.13), 84.78 (76.08-91.30) 
p-value*  0.60 0.73 0.50 
Mother employment status 
5 Working full-time 
4 Working part time 
3 Unemployed or looking for work 
2 Looking after the family/house 
1 Other 
1043 (67.8) 
147 (9.5) 
15 (1.0) 
280 (18.2) 
54 (3.5) 
0.936 (0.069), 0.962 (0.900-1.000) 
0.936 (0.073), 0.963 (0.893-1.000) 
0.892 (0.104), 0.915 (0.812-0.963) 
0.942 (0.063), 0.963 (0.914-1.000) 
0.940 (0.058), 0.952 (0.904-1.000) 
0.919 (0.094), 0.943 (0.875-1.000) 
0.919 (0.107), 0.953 (0.881-1.000) 
0.872 (0.122), 0.892 (0.760-0.996) 
0.925 (0.090), 0.949 (0.881-1.000) 
0.925 (0.083), 0.939 (0.880-1.000) 
82.99 (10.94), 84.78 (76.08-91.30) 
81.74 (11.93), 82.60 (75.00-91.30) 
81.15 (12.16), 84.78 (71.73-89.13) 
82.73 (11.40), 84.78 (76.08-91.30) 
83.46 (12.43), 86.95 (76.08-92.39) 
p-value**  0.57 0.65 0.60 
Father’s employment 
Yes 
No 
1421 (92.3) 
118 (7.7) 
0.937 (0.068), 0.963 (0.899-1.000) 
0.938 (0.065), 0.964 (0.903-1.000) 
0.920 (0.094), 0.943 (0.876-1.000) 
0.922 (0.095), 0.950 (0.880-1.000) 
82.79 (11.23), 84.78 (76.08- 91.30) 
84.48 (10.92), 86.95 (76.08-92.39) 
p-value*  0.93 0.91 0.07 
Father employment status 
5 Working full-time 
4 Working part time 
3 Unemployed or looking for work 
2 Looking after the family/house 
1 Other 
1378 (89.5) 
43 (2.8) 
10 (0.7) 
17 (1.1) 
91 (5.9) 
0.937 (0.068), 0.963 (0.903-1.000) 
0.923 (0.087), 0.952 (0.893-0.978) 
0.948 (0.040), 0.957 (0.928-0.963) 
0.931 (0.063), 0.940 (0.897-0.978) 
0.937 (0.068), 0 .963 (0.897-1.000) 
0.921 (0.093), 0.943 (0.876-1.000) 
0.895 (0.119), 0.937 (0.848-0.958) 
0.936 (0.054), 0.946 (0.896-0.996) 
0.898 (0.112), 0.916 (0.851-0.996) 
0.924 (0.095), 0.955 (0.880-1.000) 
82.81 (11.25), 84.78 (76.08-91.30) 
82.30 (10.65), 82.60 (76.08-91.30) 
87.06 (8.20), 90.21 (83.69-91.30) 
85.80 (10.91), 90.21 (75.00-94.56) 
83.95 (11.21), 85.86 (77.17-92.39) 
p-value**  0.97 0.84 0.17 
*Kruskal-Wallis test; **non-parametric test for trend 
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